ID	Gene Name	Species	BBID	BIOCARTA	GOTERM_BP_FAT	GOTERM_CC_FAT	GOTERM_MF_FAT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_SEQ_FEATURE
37166_at	3-hydroxyanthranilate 3,4-dioxygenase(HAAO)	Homo sapiens			GO:1901606~alpha-amino acid catabolic process,GO:1901605~alpha-amino acid metabolic process,GO:1901566~organonitrogen compound biosynthetic process,GO:1901565~organonitrogen compound catabolic process,GO:1901361~organic cyclic compound catabolic process,GO:1901293~nucleoside phosphate biosynthetic process,GO:0090407~organophosphate biosynthetic process,GO:0072525~pyridine-containing compound biosynthetic process,GO:0072524~pyridine-containing compound metabolic process,GO:0070050~neuron cellular homeostasis,GO:0060249~anatomical structure homeostasis,GO:0055114~oxidation-reduction process,GO:0055086~nucleobase-containing small molecule metabolic process,GO:0051188~cofactor biosynthetic process,GO:0051186~cofactor metabolic process,GO:0046874~quinolinate metabolic process,GO:0046700~heterocycle catabolic process,GO:0046686~response to cadmium ion,GO:0046496~nicotinamide nucleotide metabolic process,GO:0046395~carboxylic acid catabolic process,GO:0046394~carboxylic acid biosynthetic process,GO:0046218~indolalkylamine catabolic process,GO:0044712~single-organism catabolic process,GO:0044283~small molecule biosynthetic process,GO:0044282~small molecule catabolic process,GO:0044270~cellular nitrogen compound catabolic process,GO:0044106~cellular amine metabolic process,GO:0043650~dicarboxylic acid biosynthetic process,GO:0043648~dicarboxylic acid metabolic process,GO:0043436~oxoacid metabolic process,GO:0043420~anthranilate metabolic process,GO:0042592~homeostatic process,GO:0042537~benzene-containing compound metabolic process,GO:0042436~indole-containing compound catabolic process,GO:0042430~indole-containing compound metabolic process,GO:0042402~cellular biogenic amine catabolic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034627~'de novo' NAD biosynthetic process,GO:0034354~'de novo' NAD biosynthetic process from tryptophan,GO:0032787~monocarboxylic acid metabolic process,GO:0022900~electron transport chain,GO:0019805~quinolinate biosynthetic process,GO:0019752~carboxylic acid metabolic process,GO:0019725~cellular homeostasis,GO:0019674~NAD metabolic process,GO:0019637~organophosphate metabolic process,GO:0019439~aromatic compound catabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0019363~pyridine nucleotide biosynthetic process,GO:0019362~pyridine nucleotide metabolic process,GO:0019359~nicotinamide nucleotide biosynthetic process,GO:0018130~heterocycle biosynthetic process,GO:0016054~organic acid catabolic process,GO:0016053~organic acid biosynthetic process,GO:0010043~response to zinc ion,GO:0010038~response to metal ion,GO:0010035~response to inorganic substance,GO:0009435~NAD biosynthetic process,GO:0009310~amine catabolic process,GO:0009308~amine metabolic process,GO:0009165~nucleotide biosynthetic process,GO:0009117~nucleotide metabolic process,GO:0009108~coenzyme biosynthetic process,GO:0009074~aromatic amino acid family catabolic process,GO:0009072~aromatic amino acid family metabolic process,GO:0009063~cellular amino acid catabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006753~nucleoside phosphate metabolic process,GO:0006733~oxidoreduction coenzyme metabolic process,GO:0006732~coenzyme metabolic process,GO:0006586~indolalkylamine metabolic process,GO:0006576~cellular biogenic amine metabolic process,GO:0006569~tryptophan catabolic process,GO:0006568~tryptophan metabolic process,GO:0006520~cellular amino acid metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006082~organic acid metabolic process,												GO:0005829~cytosol,												GO:0051213~dioxygenase activity,GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0016701~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,GO:0009055~electron carrier activity,GO:0008198~ferrous iron binding,GO:0005506~iron ion binding,GO:0000334~3-hydroxyanthranilate 3,4-dioxygenase activity,												IPR016700:3hydroanth_dOase_met,IPR014710:RmlC-like_jellyroll,IPR011051:RmlC_Cupin_sf,IPR010329:3hydroanth_dOase,												hsa01240:Biosynthesis of cofactors,hsa01100:Metabolic pathways,hsa00380:Tryptophan metabolism,												617660~Vertebral, cardiac, renal, and limb defects syndrome 1,												PIRSF017681:3hydroanth_dOase_animal,													REGION:Linker,REGION:Domain B,REGION:Domain A (catalytic),
34467_g_at	5-hydroxytryptamine receptor 4(HTR4)	Homo sapiens			GO:0099537~trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0098916~anterograde trans-synaptic signaling,GO:0098664~G-protein coupled serotonin receptor signaling pathway,GO:0070254~mucus secretion,GO:0060249~anatomical structure homeostasis,GO:0050878~regulation of body fluid levels,GO:0048871~multicellular organismal homeostasis,GO:0046903~secretion,GO:0042592~homeostatic process,GO:0032941~secretion by tissue,GO:0032098~regulation of appetite,GO:0031667~response to nutrient levels,GO:0030277~maintenance of gastrointestinal epithelium,GO:0022600~digestive system process,GO:0010669~epithelial structure maintenance,GO:0009991~response to extracellular stimulus,GO:0009605~response to external stimulus,GO:0007589~body fluid secretion,GO:0007586~digestion,GO:0007268~chemical synaptic transmission,GO:0007267~cell-cell signaling,GO:0007210~serotonin receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007186~G-protein coupled receptor signaling pathway,GO:0003008~system process,GO:0001894~tissue homeostasis,												GO:0097458~neuron part,GO:0045202~synapse,GO:0043005~neuron projection,GO:0036477~somatodendritic compartment,GO:0030425~dendrite,GO:0005768~endosome,												GO:0099600~transmembrane receptor activity,GO:0099589~serotonin receptor activity,GO:0060089~molecular transducer activity,GO:0038023~signaling receptor activity,GO:0030594~neurotransmitter receptor activity,GO:0008227~G-protein coupled amine receptor activity,GO:0004993~G-protein coupled serotonin receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0004872~receptor activity,GO:0004871~signal transducer activity,												IPR017452:GPCR_Rhodpsn_7TM,IPR001520:5HT4_rcpt,IPR000276:GPCR_Rhodpsn,												hsa04726:Serotonergic synapse,hsa04080:Neuroactive ligand-receptor interaction,hsa04024:cAMP signaling pathway,hsa04020:Calcium signaling pathway,														SM01381:7TM_GPCR_Srsx,												TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=1,TRANSMEM:Helical,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,LIPID:S-palmitoyl cysteine,DOMAIN:G-protein coupled receptors family 1 profile,CARBOHYD:N-linked (GlcNAc...) asparagine,
41703_r_at	A-kinase anchoring protein 7(AKAP7)	Homo sapiens			GO:2001259~positive regulation of cation channel activity,GO:2001257~regulation of cation channel activity,GO:1904064~positive regulation of cation transmembrane transport,GO:1904062~regulation of cation transmembrane transport,GO:1903818~positive regulation of voltage-gated potassium channel activity,GO:1902531~regulation of intracellular signal transduction,GO:1902261~positive regulation of delayed rectifier potassium channel activity,GO:1902259~regulation of delayed rectifier potassium channel activity,GO:1901701~cellular response to oxygen-containing compound,GO:1901700~response to oxygen-containing compound,GO:1901699~cellular response to nitrogen compound,GO:1901698~response to nitrogen compound,GO:1901381~positive regulation of potassium ion transmembrane transport,GO:1901379~regulation of potassium ion transmembrane transport,GO:1901018~positive regulation of potassium ion transmembrane transporter activity,GO:1901016~regulation of potassium ion transmembrane transporter activity,GO:0098662~inorganic cation transmembrane transport,GO:0098660~inorganic ion transmembrane transport,GO:0098655~cation transmembrane transport,GO:0071805~potassium ion transmembrane transport,GO:0071804~cellular potassium ion transport,GO:0071495~cellular response to endogenous stimulus,GO:0071417~cellular response to organonitrogen compound,GO:0071407~cellular response to organic cyclic compound,GO:0071320~cellular response to cAMP,GO:0071310~cellular response to organic substance,GO:0070887~cellular response to chemical stimulus,GO:0065009~regulation of molecular function,GO:0060306~regulation of membrane repolarization,GO:0055085~transmembrane transport,GO:0051591~response to cAMP,GO:0051050~positive regulation of transport,GO:0051049~regulation of transport,GO:0050804~modulation of synaptic transmission,GO:0046683~response to organophosphorus,GO:0044093~positive regulation of molecular function,GO:0043270~positive regulation of ion transport,GO:0043269~regulation of ion transport,GO:0043268~positive regulation of potassium ion transport,GO:0043266~regulation of potassium ion transport,GO:0042391~regulation of membrane potential,GO:0035556~intracellular signal transduction,GO:0034767~positive regulation of ion transmembrane transport,GO:0034765~regulation of ion transmembrane transport,GO:0034764~positive regulation of transmembrane transport,GO:0034762~regulation of transmembrane transport,GO:0034220~ion transmembrane transport,GO:0033036~macromolecule localization,GO:0032414~positive regulation of ion transmembrane transporter activity,GO:0032412~regulation of ion transmembrane transporter activity,GO:0032411~positive regulation of transporter activity,GO:0032409~regulation of transporter activity,GO:0030001~metal ion transport,GO:0023051~regulation of signaling,GO:0022898~regulation of transmembrane transporter activity,GO:0016310~phosphorylation,GO:0015672~monovalent inorganic cation transport,GO:0014074~response to purine-containing compound,GO:0014070~response to organic cyclic compound,GO:0010959~regulation of metal ion transport,GO:0010738~regulation of protein kinase A signaling,GO:0010646~regulation of cell communication,GO:0010243~response to organonitrogen compound,GO:0010033~response to organic substance,GO:0009966~regulation of signal transduction,GO:0009719~response to endogenous stimulus,GO:0008104~protein localization,GO:0006813~potassium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0001508~action potential,												GO:0098686~hippocampal mossy fiber to CA3 synapse,GO:0098590~plasma membrane region,GO:0045202~synapse,GO:0045177~apical part of cell,GO:0016328~lateral plasma membrane,GO:0016324~apical plasma membrane,GO:0005829~cytosol,												GO:1901363~heterocyclic compound binding,GO:1901265~nucleoside phosphate binding,GO:0097159~organic cyclic compound binding,GO:0051018~protein kinase A binding,GO:0036094~small molecule binding,GO:0034237~protein kinase A regulatory subunit binding,GO:0019901~protein kinase binding,GO:0019900~kinase binding,GO:0019899~enzyme binding,GO:0016301~kinase activity,GO:0000166~nucleotide binding,												IPR019511:AKAP7_RI-RII-bd_dom,IPR019510:AKAP7-like_phosphoesterase,IPR009097:Cyclic_Pdiesterase,																REGION:Required for membrane localization,REGION:Required for apical membrane localization,REGION:RII-binding,REGION:RI-alpha-binding,REGION:PKA-RII-alpha subunit binding domain,REGION:Disordered,MUTAGEN:GQLCC->AQLAA: Abolishes membrane localization and affects its ability to inhibit ENaC activity in a sodium-dependent manner.,LIPID:S-palmitoyl cysteine,LIPID:N-myristoyl glycine,DOMAIN:A-kinase anchor protein 7-like phosphoesterase,DOMAIN:A-kinase anchor protein 7 RI-RII subunit-binding,COMPBIAS:Polar residues,
40350_at	ADAM metallopeptidase domain 23(ADAM23)	Homo sapiens			GO:1990830~cellular response to leukemia inhibitory factor,GO:1990823~response to leukemia inhibitory factor,GO:0071345~cellular response to cytokine stimulus,GO:0071310~cellular response to organic substance,GO:0070887~cellular response to chemical stimulus,GO:0034097~response to cytokine,GO:0022610~biological adhesion,GO:0010033~response to organic substance,GO:0007417~central nervous system development,GO:0007399~nervous system development,GO:0007229~integrin-mediated signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0007155~cell adhesion,GO:0006508~proteolysis,												GO:0098978~glutamatergic synapse,GO:0098793~presynapse,GO:0098590~plasma membrane region,GO:0097458~neuron part,GO:0097060~synaptic membrane,GO:0045202~synapse,GO:0044456~synapse part,GO:0042734~presynaptic membrane,GO:0005576~extracellular region,												GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0050839~cell adhesion molecule binding,GO:0044877~macromolecular complex binding,GO:0032403~protein complex binding,GO:0008237~metallopeptidase activity,GO:0008233~peptidase activity,GO:0005178~integrin binding,GO:0005102~receptor binding,GO:0004222~metalloendopeptidase activity,GO:0004175~endopeptidase activity,												IPR036436:Disintegrin_dom_sf,IPR034027:Reprolysin_adamalysin,IPR024079:MetalloPept_cat_dom_sf,IPR013111:EGF_extracell,IPR006586:ADAM_Cys-rich,IPR002870:Peptidase_M12B_N,IPR001762:Disintegrin_dom,IPR001590:Peptidase_M12B,IPR000742:EGF-like_dom,															SM00608:ACR,SM00050:DISIN,												TRANSMEM:Helical,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,REGION:May bind the integrin receptor,REGION:Disordered,MUTAGEN:E->A: Significantly lower of adhesion-promoting activity.,DOMAIN:Peptidase M12B,DOMAIN:EGF-like,DOMAIN:Disintegrin,DOMAIN:ADAM cysteine-rich,CARBOHYD:N-linked (GlcNAc...) asparagine,
1575_at	ATP binding cassette subfamily B member 1(ABCB1)	Homo sapiens		h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,h_mrpPathway:Multi-Drug Resistance Factors,												GO:2001225~regulation of chloride transport,GO:1990962~drug transport across blood-brain barrier,GO:1990961~drug transmembrane export,GO:1905039~carboxylic acid transmembrane transport,GO:1903961~positive regulation of anion transmembrane transport,GO:1903959~regulation of anion transmembrane transport,GO:1903825~organic acid transmembrane transport,GO:1903793~positive regulation of anion transport,GO:1903047~mitotic cell cycle process,GO:1901529~positive regulation of anion channel activity,GO:0099040~ceramide translocation,GO:0099039~sphingolipid translocation,GO:0098656~anion transmembrane transport,GO:0097035~regulation of membrane lipid distribution,GO:0080134~regulation of response to stress,GO:0072089~stem cell proliferation,GO:0071705~nitrogen compound transport,GO:0071466~cellular response to xenobiotic stimulus,GO:0070887~cellular response to chemical stimulus,GO:0070633~transepithelial transport,GO:0065009~regulation of molecular function,GO:0061024~membrane organization,GO:0055085~transmembrane transport,GO:0051050~positive regulation of transport,GO:0051049~regulation of transport,GO:0047484~regulation of response to osmotic stress,GO:0046942~carboxylic acid transport,GO:0046865~terpenoid transport,GO:0046864~isoprenoid transport,GO:0046618~drug export,GO:0045332~phospholipid translocation,GO:0044839~cell cycle G2/M phase transition,GO:0044802~single-organism membrane organization,GO:0044772~mitotic cell cycle phase transition,GO:0044770~cell cycle phase transition,GO:0044093~positive regulation of molecular function,GO:0044070~regulation of anion transport,GO:0043270~positive regulation of ion transport,GO:0043269~regulation of ion transport,GO:0042886~amide transport,GO:0042493~response to drug,GO:0035627~ceramide transport,GO:0034767~positive regulation of ion transmembrane transport,GO:0034765~regulation of ion transmembrane transport,GO:0034764~positive regulation of transmembrane transport,GO:0034762~regulation of transmembrane transport,GO:0034220~ion transmembrane transport,GO:0034204~lipid translocation,GO:0033036~macromolecule localization,GO:0032414~positive regulation of ion transmembrane transporter activity,GO:0032412~regulation of ion transmembrane transporter activity,GO:0032411~positive regulation of transporter activity,GO:0032409~regulation of transporter activity,GO:0022898~regulation of transmembrane transporter activity,GO:0022402~cell cycle process,GO:0015914~phospholipid transport,GO:0015893~drug transport,GO:0015849~organic acid transport,GO:0015748~organophosphate ester transport,GO:0015711~organic anion transport,GO:0010876~lipid localization,GO:0010359~regulation of anion channel activity,GO:0009410~response to xenobiotic stimulus,GO:0008283~cell proliferation,GO:0007049~cell cycle,GO:0006869~lipid transport,GO:0006855~drug transmembrane transport,GO:0006820~anion transport,GO:0006811~ion transport,GO:0006805~xenobiotic metabolic process,GO:0000278~mitotic cell cycle,GO:0000086~G2/M transition of mitotic cell cycle,												GO:1903561~extracellular vesicle,GO:0098591~external side of apical plasma membrane,GO:0098590~plasma membrane region,GO:0098552~side of membrane,GO:0070062~extracellular exosome,GO:0045177~apical part of cell,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0016324~apical plasma membrane,GO:0009986~cell surface,GO:0009897~external side of plasma membrane,GO:0005576~extracellular region,												GO:1904121~phosphatidylethanolamine transporter activity,GO:1901363~heterocyclic compound binding,GO:1901265~nucleoside phosphate binding,GO:0099038~ceramide-translocating ATPase activity,GO:0097367~carbohydrate derivative binding,GO:0097159~organic cyclic compound binding,GO:0090555~phosphatidylethanolamine-translocating ATPase activity,GO:0090554~phosphatidylcholine-translocating ATPase activity,GO:0090484~drug transporter activity,GO:0046943~carboxylic acid transmembrane transporter activity,GO:0046624~sphingolipid transporter activity,GO:0046623~sphingolipid-translocating ATPase activity,GO:0044389~ubiquitin-like protein ligase binding,GO:0043492~ATPase activity, coupled to movement of substances,GO:0043168~anion binding,GO:0043167~ion binding,GO:0042910~xenobiotic transporter activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0042623~ATPase activity, coupled,GO:0036094~small molecule binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0035620~ceramide transporter activity,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0031625~ubiquitin protein ligase binding,GO:0030554~adenyl nucleotide binding,GO:0022804~active transmembrane transporter activity,GO:0019899~enzyme binding,GO:0017111~nucleoside-triphosphatase activity,GO:0017076~purine nucleotide binding,GO:0016887~ATPase activity,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016462~pyrophosphatase activity,GO:0015562~efflux transmembrane transporter activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015238~drug transmembrane transporter activity,GO:0008559~xenobiotic-transporting ATPase activity,GO:0008525~phosphatidylcholine transporter activity,GO:0008514~organic anion transmembrane transporter activity,GO:0008509~anion transmembrane transporter activity,GO:0005548~phospholipid transporter activity,GO:0005524~ATP binding,GO:0005342~organic acid transmembrane transporter activity,GO:0005319~lipid transporter activity,GO:0004012~phospholipid-translocating ATPase activity,GO:0000166~nucleotide binding,												IPR039421:Type_1_exporter,IPR036640:ABC1_TM_sf,IPR027417:P-loop_NTPase,IPR017871:ABC_transporter-like_CS,IPR011527:ABC1_TM_dom,IPR003593:AAA+_ATPase,IPR003439:ABC_transporter-like_ATP-bd,												hsa05226:Gastric cancer,hsa05206:MicroRNAs in cancer,hsa04976:Bile secretion,hsa02010:ABC transporters,												612244~Inflammatory bowel disease 13,120080~Colchicine resistance,													SM00382:AAA,												TRANSMEM:Helical,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,REGION:Disordered,DOMAIN:ABC transporter 2,DOMAIN:ABC transporter 1,DOMAIN:ABC transporter,DOMAIN:ABC transmembrane type-1 2,DOMAIN:ABC transmembrane type-1 1,DOMAIN:ABC transmembrane type-1,CARBOHYD:N-linked (GlcNAc...) asparagine,
40294_at	ATP binding cassette subfamily B member 9(ABCB9)	Homo sapiens			GO:0071705~nitrogen compound transport,GO:0055085~transmembrane transport,GO:0045184~establishment of protein localization,GO:0043603~cellular amide metabolic process,GO:0042886~amide transport,GO:0035672~oligopeptide transmembrane transport,GO:0033036~macromolecule localization,GO:0015833~peptide transport,GO:0015031~protein transport,GO:0008104~protein localization,GO:0006857~oligopeptide transport,GO:0006518~peptide metabolic process,												GO:0098852~lytic vacuole membrane,GO:0044437~vacuolar part,GO:0044432~endoplasmic reticulum part,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0005789~endoplasmic reticulum membrane,GO:0005783~endoplasmic reticulum,GO:0005774~vacuolar membrane,GO:0005773~vacuole,GO:0005765~lysosomal membrane,GO:0005764~lysosome,GO:0000323~lytic vacuole,												GO:1904680~peptide transmembrane transporter activity,GO:1901363~heterocyclic compound binding,GO:1901265~nucleoside phosphate binding,GO:0097367~carbohydrate derivative binding,GO:0097159~organic cyclic compound binding,GO:0046983~protein dimerization activity,GO:0043492~ATPase activity, coupled to movement of substances,GO:0043168~anion binding,GO:0043167~ion binding,GO:0042887~amide transmembrane transporter activity,GO:0042803~protein homodimerization activity,GO:0042802~identical protein binding,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0042623~ATPase activity, coupled,GO:0036094~small molecule binding,GO:0035673~oligopeptide transmembrane transporter activity,GO:0035639~purine ribonucleoside triphosphate binding,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0022804~active transmembrane transporter activity,GO:0017111~nucleoside-triphosphatase activity,GO:0017076~purine nucleotide binding,GO:0016887~ATPase activity,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016462~pyrophosphatase activity,GO:0015440~peptide-transporting ATPase activity,GO:0015421~oligopeptide-transporting ATPase activity,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015198~oligopeptide transporter activity,GO:0015197~peptide transporter activity,GO:0005524~ATP binding,GO:0000166~nucleotide binding,												IPR039421:Type_1_exporter,IPR036640:ABC1_TM_sf,IPR030254:ABCB9_6-TMD,IPR027417:P-loop_NTPase,IPR017871:ABC_transporter-like_CS,IPR011527:ABC1_TM_dom,IPR003593:AAA+_ATPase,IPR003439:ABC_transporter-like_ATP-bd,												hsa04142:Lysosome,hsa02010:ABC transporters,													PIRSF002773:ABC_prm/ATPase_B,												SM00382:AAA,												TRANSMEM:Helical,SITE:Intramolecular salt bridge with Asp-17. Essential for the release from the ER,SITE:Intramolecular salt bridge with Arg-57. Essential for the release from the ER,SITE:Important for the second trafficking step from the Golgi to the endosomal and lysosomal compartments,REGION:Disordered,MUTAGEN:R->D: Loss of lysosomal localization. Does not affect lysosomal localization; when associated with R-17. Does not affect interaction between coreABCB9 and TMD0 domains. Does not affect interaction between coreABCB9 and TMD0 domains; when associated with R-17.,MUTAGEN:R->A: Decreases lysosomal localization. Loss of lysosomal localization; when associated with A-100.,MUTAGEN:LL->AA: No effect on lysosomal localization.,MUTAGEN:K->D: Decreases lysosomal localization. Loss of lysosomal localization; when assosiated with R-17. Loss of lysosomal localization; when assosiated with K-45 and K-49. Does not affect peptide transport activity; when assosiated with K-45 and K-49. Does not affect interaction between coreABCB9 and TMD0 domains. Does not affect interaction between coreABCB9 and TMD0 domains; when associated with R-17.,MUTAGEN:K->A: Loss of peptide transport activity; whena ssociated with A-699.,MUTAGEN:K->A: Decreases lysosomal localization. Loss of lysosomal localization; when associated with A-57.,MUTAGEN:H->A: Loss of peptide transport activity; whena ssociated with A-545.,MUTAGEN:D->R: Loss of lysosomal localization. Does not affect lysosomal localization; when associated with D-57. Does not affect interaction between coreABCB9 and TMD0 domains. Does not affect interaction between coreABCB9 and TMD0 domains; when associated with D-57. Does not affect interaction between coreABCB9 and TMD0 domains; when associated with D-100.,MUTAGEN:D->N: Loss of lysosomal localization. Does not affect interaction between coreABCB9 and TMD0 domains. Does not affect dimerization. Does not affect peptide transport activity. Decreases interaction with YIF1B.,MUTAGEN:D->N: Decreases lysosomal localization; when associated with N-49.,MUTAGEN:D->N: Decreases lysosomal localization; when associated with N-45.,MUTAGEN:D->K: Loss of lysosomal localization; when assosiated with K-49. Loss of lysosomal localization; when assosiated with K-49 and D-100. Does not affect peptide transport activity; when assosiated with K-49 and D-100.,MUTAGEN:D->K: Loss of lysosomal localization; when assosiated with K-45. Loss of lysosomal localization; when assosiated with K-45 and D-100. Does not affect peptide transport activity; when assosiated with K-45 and D-100.,DOMAIN:ABC transporter,DOMAIN:ABC transmembrane type-1,
32439_at	ATPase H+/K+ transporting subunit beta(ATP4B)	Homo sapiens			GO:1990573~potassium ion import across plasma membrane,GO:1902600~hydrogen ion transmembrane transport,GO:1901700~response to oxygen-containing compound,GO:1901698~response to nitrogen compound,GO:0098771~inorganic ion homeostasis,GO:0098739~import across plasma membrane,GO:0098662~inorganic cation transmembrane transport,GO:0098660~inorganic ion transmembrane transport,GO:0098657~import into cell,GO:0098655~cation transmembrane transport,GO:0071805~potassium ion transmembrane transport,GO:0071804~cellular potassium ion transport,GO:0071436~sodium ion export,GO:0055085~transmembrane transport,GO:0055082~cellular chemical homeostasis,GO:0055080~cation homeostasis,GO:0055078~sodium ion homeostasis,GO:0055075~potassium ion homeostasis,GO:0055067~monovalent inorganic cation homeostasis,GO:0055065~metal ion homeostasis,GO:0051707~response to other organism,GO:0050801~ion homeostasis,GO:0048878~chemical homeostasis,GO:0045851~pH reduction,GO:0043207~response to external biotic stimulus,GO:0042592~homeostatic process,GO:0036376~sodium ion export from cell,GO:0035725~sodium ion transmembrane transport,GO:0034220~ion transmembrane transport,GO:0033993~response to lipid,GO:0032496~response to lipopolysaccharide,GO:0030007~cellular potassium ion homeostasis,GO:0030004~cellular monovalent inorganic cation homeostasis,GO:0030003~cellular cation homeostasis,GO:0030001~metal ion transport,GO:0022610~biological adhesion,GO:0019725~cellular homeostasis,GO:0015992~proton transport,GO:0015672~monovalent inorganic cation transport,GO:0010243~response to organonitrogen compound,GO:0010107~potassium ion import,GO:0010033~response to organic substance,GO:0009719~response to endogenous stimulus,GO:0009617~response to bacterium,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0007155~cell adhesion,GO:0006885~regulation of pH,GO:0006883~cellular sodium ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006873~cellular ion homeostasis,GO:0006818~hydrogen transport,GO:0006814~sodium ion transport,GO:0006813~potassium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,GO:0002237~response to molecule of bacterial origin,												GO:1990351~transporter complex,GO:1904949~ATPase complex,GO:1902495~transmembrane transporter complex,GO:0098590~plasma membrane region,GO:0098533~ATPase dependent transmembrane transport complex,GO:0090533~cation-transporting ATPase complex,GO:0045177~apical part of cell,GO:0031226~intrinsic component of plasma membrane,GO:0016324~apical plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,GO:0005889~hydrogen:potassium-exchanging ATPase complex,GO:0005887~integral component of plasma membrane,												GO:1901363~heterocyclic compound binding,GO:0098772~molecular function regulator,GO:0060590~ATPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,GO:0046873~metal ion transmembrane transporter activity,GO:0043492~ATPase activity, coupled to movement of substances,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0042625~ATPase coupled ion transmembrane transporter activity,GO:0042623~ATPase activity, coupled,GO:0030234~enzyme regulator activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0022853~active ion transmembrane transporter activity,GO:0022804~active transmembrane transporter activity,GO:0019829~cation-transporting ATPase activity,GO:0017111~nucleoside-triphosphatase activity,GO:0016887~ATPase activity,GO:0016820~hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016462~pyrophosphatase activity,GO:0015662~ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,GO:0015405~P-P-bond-hydrolysis-driven transmembrane transporter activity,GO:0015399~primary active transmembrane transporter activity,GO:0015079~potassium ion transmembrane transporter activity,GO:0015078~hydrogen ion transmembrane transporter activity,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0008900~hydrogen:potassium-exchanging ATPase activity,GO:0008556~potassium-transporting ATPase activity,GO:0008324~cation transmembrane transporter activity,GO:0008047~enzyme activator activity,GO:0001671~ATPase activator activity,												IPR038702:Na/K_ATPase_sub_beta_sf,IPR000402:Na/K_ATPase_sub_beta,												hsa04971:Gastric acid secretion,hsa04966:Collecting duct acid secretion,hsa01100:Metabolic pathways,hsa00190:Oxidative phosphorylation,															TRANSMEM:Helical; Signal-anchor for type II membrane protein,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,REGION:immunoglobulin-like,CARBOHYD:N-linked (GlcNAc...) asparagine,
39469_s_at	ATPase phospholipid transporting 8A2(ATP8A2)	Homo sapiens			GO:2001140~positive regulation of phospholipid transport,GO:2001138~regulation of phospholipid transport,GO:1905954~positive regulation of lipid localization,GO:1905952~regulation of lipid localization,GO:1903793~positive regulation of anion transport,GO:1902589~single-organism organelle organization,GO:0097035~regulation of membrane lipid distribution,GO:0090596~sensory organ morphogenesis,GO:0061564~axon development,GO:0061092~positive regulation of phospholipid translocation,GO:0061091~regulation of phospholipid translocation,GO:0061024~membrane organization,GO:0060284~regulation of cell development,GO:0060052~neurofilament cytoskeleton organization,GO:0060042~retina morphogenesis in camera-type eye,GO:0060041~retina development in camera-type eye,GO:0051962~positive regulation of nervous system development,GO:0051960~regulation of nervous system development,GO:0051606~detection of stimulus,GO:0051240~positive regulation of multicellular organismal process,GO:0051130~positive regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051094~positive regulation of developmental process,GO:0051050~positive regulation of transport,GO:0051049~regulation of transport,GO:0050962~detection of light stimulus involved in sensory perception,GO:0050953~sensory perception of light stimulus,GO:0050908~detection of light stimulus involved in visual perception,GO:0050906~detection of stimulus involved in sensory perception,GO:0050905~neuromuscular process,GO:0050884~neuromuscular process controlling posture,GO:0050881~musculoskeletal movement,GO:0050879~multicellular organismal movement,GO:0050877~neurological system process,GO:0050769~positive regulation of neurogenesis,GO:0050767~regulation of neurogenesis,GO:0048858~cell projection morphogenesis,GO:0048839~inner ear development,GO:0048812~neuron projection morphogenesis,GO:0048699~generation of neurons,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048666~neuron development,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048639~positive regulation of developmental growth,GO:0048638~regulation of developmental growth,GO:0048598~embryonic morphogenesis,GO:0048593~camera-type eye morphogenesis,GO:0048592~eye morphogenesis,GO:0048589~developmental growth,GO:0048568~embryonic organ development,GO:0048562~embryonic organ morphogenesis,GO:0048468~cell development,GO:0045927~positive regulation of growth,GO:0045666~positive regulation of neuron differentiation,GO:0045664~regulation of neuron differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0045332~phospholipid translocation,GO:0045104~intermediate filament cytoskeleton organization,GO:0045103~intermediate filament-based process,GO:0044802~single-organism membrane organization,GO:0044070~regulation of anion transport,GO:0043588~skin development,GO:0043583~ear development,GO:0043270~positive regulation of ion transport,GO:0043269~regulation of ion transport,GO:0043010~camera-type eye development,GO:0042755~eating behavior,GO:0042472~inner ear morphogenesis,GO:0042471~ear morphogenesis,GO:0042127~regulation of cell proliferation,GO:0040018~positive regulation of multicellular organism growth,GO:0040014~regulation of multicellular organism growth,GO:0040008~regulation of growth,GO:0040007~growth,GO:0035264~multicellular organism growth,GO:0034204~lipid translocation,GO:0033036~macromolecule localization,GO:0032990~cell part morphogenesis,GO:0032989~cellular component morphogenesis,GO:0032370~positive regulation of lipid transport,GO:0032368~regulation of lipid transport,GO:0031346~positive regulation of cell projection organization,GO:0031344~regulation of cell projection organization,GO:0031175~neuron projection development,GO:0030182~neuron differentiation,GO:0030030~cell projection organization,GO:0022008~neurogenesis,GO:0015914~phospholipid transport,GO:0015748~organophosphate ester transport,GO:0015711~organic anion transport,GO:0010996~response to auditory stimulus,GO:0010976~positive regulation of neuron projection development,GO:0010975~regulation of neuron projection development,GO:0010876~lipid localization,GO:0010842~retina layer formation,GO:0010720~positive regulation of cell development,GO:0010259~multicellular organism aging,GO:0009887~animal organ morphogenesis,GO:0009790~embryo development,GO:0009628~response to abiotic stimulus,GO:0009612~response to mechanical stimulus,GO:0009605~response to external stimulus,GO:0009584~detection of visible light,GO:0009583~detection of light stimulus,GO:0009582~detection of abiotic stimulus,GO:0009581~detection of external stimulus,GO:0009416~response to light stimulus,GO:0009314~response to radiation,GO:0008340~determination of adult lifespan,GO:0008285~negative regulation of cell proliferation,GO:0008283~cell proliferation,GO:0007631~feeding behavior,GO:0007610~behavior,GO:0007601~visual perception,GO:0007600~sensory perception,GO:0007568~aging,GO:0007423~sensory organ development,GO:0007409~axonogenesis,GO:0007399~nervous system development,GO:0007010~cytoskeleton organization,GO:0006941~striated muscle contraction,GO:0006936~muscle contraction,GO:0006869~lipid transport,GO:0006820~anion transport,GO:0006811~ion transport,GO:0003407~neural retina development,GO:0003012~muscle system process,GO:0003011~involuntary skeletal muscle contraction,GO:0003009~skeletal muscle contraction,GO:0003008~system process,GO:0001654~eye development,GO:0000904~cell morphogenesis involved in differentiation,GO:0000902~cell morphogenesis,												GO:1990531~Lem3p-Dnf1p complex,GO:1990351~transporter complex,GO:1904949~ATPase complex,GO:0044440~endosomal part,GO:0044433~cytoplasmic vesicle part,GO:0044431~Golgi apparatus part,GO:0010008~endosome membrane,GO:0005794~Golgi apparatus,GO:0005768~endosome,GO:0005654~nucleoplasm,GO:0000139~Golgi membrane,												GO:1904121~phosphatidylethanolamine transporter activity,GO:1901363~heterocyclic compound binding,GO:1901265~nucleoside phosphate binding,GO:0097367~carbohydrate derivative binding,GO:0097159~organic cyclic compound binding,GO:0090556~phosphatidylserine-translocating ATPase activity,GO:0090555~phosphatidylethanolamine-translocating ATPase activity,GO:0046872~metal ion binding,GO:0043492~ATPase activity, coupled to movement of substances,GO:0043169~cation binding,GO:0043168~anion binding,GO:0043167~ion binding,GO:0042623~ATPase activity, coupled,GO:0036094~small molecule binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0017111~nucleoside-triphosphatase activity,GO:0017076~purine nucleotide binding,GO:0016887~ATPase activity,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016462~pyrophosphatase activity,GO:0015247~aminophospholipid transporter activity,GO:0005548~phospholipid transporter activity,GO:0005524~ATP binding,GO:0005319~lipid transporter activity,GO:0004012~phospholipid-translocating ATPase activity,GO:0000287~magnesium ion binding,GO:0000166~nucleotide binding,												IPR044492:P_typ_ATPase_HD_dom,IPR036412:HAD-like_sf,IPR032631:P-type_ATPase_N,IPR032630:P_typ_ATPase_c,IPR023299:ATPase_P-typ_cyto_dom_N,IPR023298:ATPase_P-typ_TM_dom_sf,IPR023214:HAD_sf,IPR018303:ATPase_P-typ_P_site,IPR008250:ATPase_P-typ_transduc_dom_A_sf,IPR006539:P-type_ATPase_IV,IPR001757:P_typ_ATPase,												hsa04148:Efferocytosis,												615268~Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 4,														TRANSMEM:Helical,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,SITE:Involved in the release of the transported lipid into the cytosolic leaflet,SITE:Involved in the recognition of the lipid substrate on the exoplasmic side,REGION:Disordered,MUTAGEN:Q->E: Reduced flippase activity toward phosphatidylserine. Like the wild type, it is unable to translocate phosphatidylcholine.,MUTAGEN:Q->A: No effect on flippase activity toward phosphatidylserine. Like the wild type, it is unable to translocate phosphatidylcholine.,MUTAGEN:K->R: Abolishes ATPase activity.,MUTAGEN:K->L: Abolishes ATPase activity.,MUTAGEN:K->A: Abolishes ATPase activity.,DOMAIN:P-type ATPase N-terminal,DOMAIN:P-type ATPase C-terminal,ACT_SITE:4-aspartylphosphate intermediate,
33685_at	ATPase phospholipid transporting 8B3(ATP8B3)	Homo sapiens			GO:0097035~regulation of membrane lipid distribution,GO:0061024~membrane organization,GO:0051649~establishment of localization in cell,GO:0051641~cellular localization,GO:0045332~phospholipid translocation,GO:0044802~single-organism membrane organization,GO:0044703~multi-organism reproductive process,GO:0044702~single organism reproductive process,GO:0035036~sperm-egg recognition,GO:0034204~lipid translocation,GO:0033036~macromolecule localization,GO:0022414~reproductive process,GO:0019953~sexual reproduction,GO:0015914~phospholipid transport,GO:0015748~organophosphate ester transport,GO:0015711~organic anion transport,GO:0010876~lipid localization,GO:0010256~endomembrane system organization,GO:0009988~cell-cell recognition,GO:0009566~fertilization,GO:0008037~cell recognition,GO:0007339~binding of sperm to zona pellucida,GO:0007338~single fertilization,GO:0007030~Golgi organization,GO:0006869~lipid transport,GO:0006820~anion transport,GO:0006811~ion transport,GO:0000003~reproduction,												GO:1990531~Lem3p-Dnf1p complex,GO:1990351~transporter complex,GO:1904949~ATPase complex,GO:0099503~secretory vesicle,GO:0098791~Golgi subcompartment,GO:0097223~sperm part,GO:0044433~cytoplasmic vesicle part,GO:0044432~endoplasmic reticulum part,GO:0044431~Golgi apparatus part,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0031984~organelle subcompartment,GO:0030667~secretory granule membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0030141~secretory granule,GO:0012506~vesicle membrane,GO:0005802~trans-Golgi network,GO:0005794~Golgi apparatus,GO:0005789~endoplasmic reticulum membrane,GO:0005783~endoplasmic reticulum,GO:0002080~acrosomal membrane,GO:0001669~acrosomal vesicle,												GO:1901363~heterocyclic compound binding,GO:1901265~nucleoside phosphate binding,GO:0097367~carbohydrate derivative binding,GO:0097159~organic cyclic compound binding,GO:0090556~phosphatidylserine-translocating ATPase activity,GO:0046872~metal ion binding,GO:0043492~ATPase activity, coupled to movement of substances,GO:0043169~cation binding,GO:0043168~anion binding,GO:0043167~ion binding,GO:0042623~ATPase activity, coupled,GO:0036094~small molecule binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0017111~nucleoside-triphosphatase activity,GO:0017076~purine nucleotide binding,GO:0016887~ATPase activity,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016462~pyrophosphatase activity,GO:0015247~aminophospholipid transporter activity,GO:0005548~phospholipid transporter activity,GO:0005524~ATP binding,GO:0005319~lipid transporter activity,GO:0004012~phospholipid-translocating ATPase activity,GO:0000287~magnesium ion binding,GO:0000166~nucleotide binding,												IPR044492:P_typ_ATPase_HD_dom,IPR036412:HAD-like_sf,IPR032631:P-type_ATPase_N,IPR032630:P_typ_ATPase_c,IPR023299:ATPase_P-typ_cyto_dom_N,IPR023298:ATPase_P-typ_TM_dom_sf,IPR023214:HAD_sf,IPR018303:ATPase_P-typ_P_site,IPR008250:ATPase_P-typ_transduc_dom_A_sf,IPR006539:P-type_ATPase_IV,IPR001757:P_typ_ATPase,																TRANSMEM:Helical,TOPO_DOM:Exoplasmic loop,TOPO_DOM:Cytoplasmic,REGION:Disordered,DOMAIN:P-type ATPase N-terminal,COMPBIAS:Polar residues,COMPBIAS:Basic and acidic residues,ACT_SITE:4-aspartylphosphate intermediate,
33027_at	ArfGAP with GTPase domain, ankyrin repeat and PH domain 4(AGAP4)	Homo sapiens			GO:0090630~activation of GTPase activity,GO:0065009~regulation of molecular function,GO:0051345~positive regulation of hydrolase activity,GO:0051336~regulation of hydrolase activity,GO:0050790~regulation of catalytic activity,GO:0044093~positive regulation of molecular function,GO:0043547~positive regulation of GTPase activity,GO:0043087~regulation of GTPase activity,GO:0043085~positive regulation of catalytic activity,													GO:0098772~molecular function regulator,GO:0060589~nucleoside-triphosphatase regulator activity,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0030695~GTPase regulator activity,GO:0030234~enzyme regulator activity,GO:0017111~nucleoside-triphosphatase activity,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016462~pyrophosphatase activity,GO:0008047~enzyme activator activity,GO:0005096~GTPase activator activity,GO:0003924~GTPase activity,												IPR038508:ArfGAP_dom_sf,IPR037278:ARFGAP/RecO,IPR036770:Ankyrin_rpt-contain_sf,IPR011993:PH-like_dom_sf,IPR002110:Ankyrin_rpt,IPR001849:PH_domain,IPR001164:ArfGAP_dom,												hsa04144:Endocytosis,														SM00248:ANK,SM00233:PH,SM00105:ArfGap,												ZN_FING:C4-type,REPEAT:ANK 2,REPEAT:ANK 1,REPEAT:ANK,REGION:Disordered,DOMAIN:PH,DOMAIN:Arf-GAP,COMPBIAS:Basic and acidic residues,
1910_s_at	BCL2 apoptosis regulator(BCL2)	Homo sapiens	99.NF-kB_activation,86.Apoptosis_Nematode&_Vert,83.Growth_factors_Survival_factors_Mitogens,46.P13K_PTEN,38.Cell_cycle_arrest_and_apoptosis_ceramide,152.altered_synaptic_signalling-neurodegenerative_disorders,127.Mito-stress,												h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,h_prionPathway:Prion Pathway,h_p53Pathway:p53 Signaling Pathway,h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,h_melanocytePathway:Melanocyte Development and Pigmentation Pathway,h_keratinocytePathway:Keratinocyte Differentiation,h_il7Pathway:IL-7 Signal Transduction,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_hsp27Pathway:Stress Induction of HSP Regulation,h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_ceramidePathway:Ceramide Signaling Pathway,h_badPathway:Regulation of BAD phosphorylation,												GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,GO:2001242~regulation of intrinsic apoptotic signaling pathway,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,GO:2001239~regulation of extrinsic apoptotic signaling pathway in absence of ligand,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,GO:2001236~regulation of extrinsic apoptotic signaling pathway,GO:2001234~negative regulation of apoptotic signaling pathway,GO:2001233~regulation of apoptotic signaling pathway,GO:2001021~negative regulation of response to DNA damage stimulus,GO:2001020~regulation of response to DNA damage stimulus,GO:2000811~negative regulation of anoikis,GO:2000672~negative regulation of motor neuron apoptotic process,GO:2000671~regulation of motor neuron apoptotic process,GO:2000669~negative regulation of dendritic cell apoptotic process,GO:2000668~regulation of dendritic cell apoptotic process,GO:2000378~negative regulation of reactive oxygen species metabolic process,GO:2000377~regulation of reactive oxygen species metabolic process,GO:2000209~regulation of anoikis,GO:2000147~positive regulation of cell motility,GO:2000146~negative regulation of cell motility,GO:2000145~regulation of cell motility,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000107~negative regulation of leukocyte apoptotic process,GO:2000106~regulation of leukocyte apoptotic process,GO:2000045~regulation of G1/S transition of mitotic cell cycle,GO:2000027~regulation of organ morphogenesis,GO:2000021~regulation of ion homeostasis,GO:1904180~negative regulation of membrane depolarization,GO:1904036~negative regulation of epithelial cell apoptotic process,GO:1904035~regulation of epithelial cell apoptotic process,GO:1904019~epithelial cell apoptotic process,GO:1903900~regulation of viral life cycle,GO:1903431~positive regulation of cell maturation,GO:1903429~regulation of cell maturation,GO:1903047~mitotic cell cycle process,GO:1903018~regulation of glycoprotein metabolic process,GO:1902807~negative regulation of cell cycle G1/S phase transition,GO:1902806~regulation of cell cycle G1/S phase transition,GO:1902589~single-organism organelle organization,GO:1902532~negative regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:1902254~negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,GO:1902253~regulation of intrinsic apoptotic signaling pathway by p53 class mediator,GO:1902230~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,GO:1902229~regulation of intrinsic apoptotic signaling pathway in response to DNA damage,GO:1902166~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:1902165~regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:1901991~negative regulation of mitotic cell cycle phase transition,GO:1901990~regulation of mitotic cell cycle phase transition,GO:1901988~negative regulation of cell cycle phase transition,GO:1901987~regulation of cell cycle phase transition,GO:1901863~positive regulation of muscle tissue development,GO:1901861~regulation of muscle tissue development,GO:1901797~negative regulation of signal transduction by p53 class mediator,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1901700~response to oxygen-containing compound,GO:1901698~response to nitrogen compound,GO:1901615~organic hydroxy compound metabolic process,GO:1901215~negative regulation of neuron death,GO:1901214~regulation of neuron death,GO:1901135~carbohydrate derivative metabolic process,GO:1901099~negative regulation of signal transduction in absence of ligand,GO:0098773~skin epidermis development,GO:0098771~inorganic ion homeostasis,GO:0098609~cell-cell adhesion,GO:0098542~defense response to other organism,GO:0097435~supramolecular fiber organization,GO:0097193~intrinsic apoptotic signaling pathway,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097190~apoptotic signaling pathway,GO:0097049~motor neuron apoptotic process,GO:0097048~dendritic cell apoptotic process,GO:0090596~sensory organ morphogenesis,GO:0090559~regulation of membrane permeability,GO:0080135~regulation of cellular response to stress,GO:0080134~regulation of response to stress,GO:0072593~reactive oxygen species metabolic process,GO:0072511~divalent inorganic cation transport,GO:0072507~divalent inorganic cation homeostasis,GO:0072503~cellular divalent inorganic cation homeostasis,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:0072331~signal transduction by p53 class mediator,GO:0072171~mesonephric tubule morphogenesis,GO:0072164~mesonephric tubule development,GO:0072163~mesonephric epithelium development,GO:0072088~nephron epithelium morphogenesis,GO:0072080~nephron tubule development,GO:0072078~nephron tubule morphogenesis,GO:0072073~kidney epithelium development,GO:0072028~nephron morphogenesis,GO:0072009~nephron epithelium development,GO:0072006~nephron development,GO:0072001~renal system development,GO:0071887~leukocyte apoptotic process,GO:0071496~cellular response to external stimulus,GO:0071456~cellular response to hypoxia,GO:0071453~cellular response to oxygen levels,GO:0071310~cellular response to organic substance,GO:0070997~neuron death,GO:0070887~cellular response to chemical stimulus,GO:0070838~divalent metal ion transport,GO:0070665~positive regulation of leukocyte proliferation,GO:0070663~regulation of leukocyte proliferation,GO:0070661~leukocyte proliferation,GO:0070647~protein modification by small protein conjugation or removal,GO:0070482~response to oxygen levels,GO:0070233~negative regulation of T cell apoptotic process,GO:0070232~regulation of T cell apoptotic process,GO:0070231~T cell apoptotic process,GO:0070229~negative regulation of lymphocyte apoptotic process,GO:0070228~regulation of lymphocyte apoptotic process,GO:0070227~lymphocyte apoptotic process,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0065009~regulation of molecular function,GO:0061564~axon development,GO:0061458~reproductive system development,GO:0061333~renal tubule morphogenesis,GO:0061326~renal tubule development,GO:0061138~morphogenesis of a branching epithelium,GO:0061061~muscle structure development,GO:0061024~membrane organization,GO:0060993~kidney morphogenesis,GO:0060675~ureteric bud morphogenesis,GO:0060562~epithelial tube morphogenesis,GO:0060548~negative regulation of cell death,GO:0060538~skeletal muscle organ development,GO:0060537~muscle tissue development,GO:0060485~mesenchyme development,GO:0060429~epithelium development,GO:0060402~calcium ion transport into cytosol,GO:0060401~cytosolic calcium ion transport,GO:0060341~regulation of cellular localization,GO:0060322~head development,GO:0060284~regulation of cell development,GO:0060249~anatomical structure homeostasis,GO:0060218~hematopoietic stem cell differentiation,GO:0055123~digestive system development,GO:0055085~transmembrane transport,GO:0055082~cellular chemical homeostasis,GO:0055080~cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055067~monovalent inorganic cation homeostasis,GO:0055065~metal ion homeostasis,GO:0055002~striated muscle cell development,GO:0055001~muscle cell development,GO:0051962~positive regulation of nervous system development,GO:0051960~regulation of nervous system development,GO:0051926~negative regulation of calcium ion transport,GO:0051924~regulation of calcium ion transport,GO:0051902~negative regulation of mitochondrial depolarization,GO:0051900~regulation of mitochondrial depolarization,GO:0051899~membrane depolarization,GO:0051882~mitochondrial depolarization,GO:0051881~regulation of mitochondrial membrane potential,GO:0051726~regulation of cell cycle,GO:0051707~response to other organism,GO:0051674~localization of cell,GO:0051649~establishment of localization in cell,GO:0051641~cellular localization,GO:0051607~defense response to virus,GO:0051480~regulation of cytosolic calcium ion concentration,GO:0051454~intracellular pH elevation,GO:0051453~regulation of intracellular pH,GO:0051452~intracellular pH reduction,GO:0051402~neuron apoptotic process,GO:0051384~response to glucocorticoid,GO:0051272~positive regulation of cellular component movement,GO:0051271~negative regulation of cellular component movement,GO:0051270~regulation of cellular component movement,GO:0051251~positive regulation of lymphocyte activation,GO:0051249~regulation of lymphocyte activation,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051241~negative regulation of multicellular organismal process,GO:0051240~positive regulation of multicellular organismal process,GO:0051174~regulation of phosphorus metabolic process,GO:0051155~positive regulation of striated muscle cell differentiation,GO:0051153~regulation of striated muscle cell differentiation,GO:0051149~positive regulation of muscle cell differentiation,GO:0051147~regulation of muscle cell differentiation,GO:0051146~striated muscle cell differentiation,GO:0051128~regulation of cellular component organization,GO:0051094~positive regulation of developmental process,GO:0051093~negative regulation of developmental process,GO:0051051~negative regulation of transport,GO:0051049~regulation of transport,GO:0050942~positive regulation of pigment cell differentiation,GO:0050932~regulation of pigment cell differentiation,GO:0050931~pigment cell differentiation,GO:0050871~positive regulation of B cell activation,GO:0050867~positive regulation of cell activation,GO:0050865~regulation of cell activation,GO:0050864~regulation of B cell activation,GO:0050853~B cell receptor signaling pathway,GO:0050851~antigen receptor-mediated signaling pathway,GO:0050801~ion homeostasis,GO:0050792~regulation of viral process,GO:0050778~positive regulation of immune response,GO:0050776~regulation of immune response,GO:0050769~positive regulation of neurogenesis,GO:0050767~regulation of neurogenesis,GO:0050671~positive regulation of lymphocyte proliferation,GO:0050670~regulation of lymphocyte proliferation,GO:0048878~chemical homeostasis,GO:0048873~homeostasis of number of cells within a tissue,GO:0048872~homeostasis of number of cells,GO:0048871~multicellular organismal homeostasis,GO:0048870~cell motility,GO:0048864~stem cell development,GO:0048863~stem cell differentiation,GO:0048858~cell projection morphogenesis,GO:0048857~neural nucleus development,GO:0048812~neuron projection morphogenesis,GO:0048762~mesenchymal cell differentiation,GO:0048754~branching morphogenesis of an epithelial tube,GO:0048753~pigment granule organization,GO:0048747~muscle fiber development,GO:0048743~positive regulation of skeletal muscle fiber development,GO:0048742~regulation of skeletal muscle fiber development,GO:0048741~skeletal muscle fiber development,GO:0048732~gland development,GO:0048730~epidermis morphogenesis,GO:0048729~tissue morphogenesis,GO:0048699~generation of neurons,GO:0048678~response to axon injury,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048666~neuron development,GO:0048643~positive regulation of skeletal muscle tissue development,GO:0048641~regulation of skeletal muscle tissue development,GO:0048639~positive regulation of developmental growth,GO:0048638~regulation of developmental growth,GO:0048636~positive regulation of muscle organ development,GO:0048634~regulation of muscle organ development,GO:0048609~multicellular organismal reproductive process,GO:0048608~reproductive structure development,GO:0048599~oocyte development,GO:0048592~eye morphogenesis,GO:0048589~developmental growth,GO:0048585~negative regulation of response to stimulus,GO:0048584~positive regulation of response to stimulus,GO:0048565~digestive tract development,GO:0048546~digestive tract morphogenesis,GO:0048545~response to steroid hormone,GO:0048538~thymus development,GO:0048536~spleen development,GO:0048534~hematopoietic or lymphoid organ development,GO:0048511~rhythmic process,GO:0048477~oogenesis,GO:0048469~cell maturation,GO:0048468~cell development,GO:0048087~positive regulation of developmental pigmentation,GO:0048070~regulation of developmental pigmentation,GO:0048066~developmental pigmentation,GO:0048041~focal adhesion assembly,GO:0046902~regulation of mitochondrial membrane permeability,GO:0046671~negative regulation of retinal cell programmed cell death,GO:0046668~regulation of retinal cell programmed cell death,GO:0046666~retinal cell programmed cell death,GO:0046661~male sex differentiation,GO:0046660~female sex differentiation,GO:0046651~lymphocyte proliferation,GO:0046649~lymphocyte activation,GO:0046632~alpha-beta T cell differentiation,GO:0046631~alpha-beta T cell activation,GO:0046546~development of primary male sexual characteristics,GO:0046545~development of primary female sexual characteristics,GO:0045937~positive regulation of phosphate metabolic process,GO:0045930~negative regulation of mitotic cell cycle,GO:0045927~positive regulation of growth,GO:0045926~negative regulation of growth,GO:0045852~pH elevation,GO:0045851~pH reduction,GO:0045844~positive regulation of striated muscle tissue development,GO:0045786~negative regulation of cell cycle,GO:0045666~positive regulation of neuron differentiation,GO:0045664~regulation of neuron differentiation,GO:0045636~positive regulation of melanocyte differentiation,GO:0045634~regulation of melanocyte differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0045321~leukocyte activation,GO:0045216~cell-cell junction organization,GO:0045165~cell fate commitment,GO:0045137~development of primary sexual characteristics,GO:0045069~regulation of viral genome replication,GO:0045058~T cell selection,GO:0044843~cell cycle G1/S phase transition,GO:0044802~single-organism membrane organization,GO:0044772~mitotic cell cycle phase transition,GO:0044770~cell cycle phase transition,GO:0044764~multi-organism cellular process,GO:0044708~single-organism behavior,GO:0044706~multi-multicellular organism process,GO:0044703~multi-organism reproductive process,GO:0044702~single organism reproductive process,GO:0044419~interspecies interaction between organisms,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044085~cellular component biogenesis,GO:0043903~regulation of symbiosis, encompassing mutualism through parasitism,GO:0043900~regulation of multi-organism process,GO:0043588~skin development,GO:0043583~ear development,GO:0043524~negative regulation of neuron apoptotic process,GO:0043523~regulation of neuron apoptotic process,GO:0043473~pigmentation,GO:0043375~CD8-positive, alpha-beta T cell lineage commitment,GO:0043374~CD8-positive, alpha-beta T cell differentiation,GO:0043369~CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,GO:0043368~positive T cell selection,GO:0043279~response to alkaloid,GO:0043276~anoikis,GO:0043271~negative regulation of ion transport,GO:0043269~regulation of ion transport,GO:0043207~response to external biotic stimulus,GO:0043200~response to amino acid,GO:0043069~negative regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043029~T cell homeostasis,GO:0042981~regulation of apoptotic process,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0042698~ovulation cycle,GO:0042692~muscle cell differentiation,GO:0042633~hair cycle,GO:0042596~fear response,GO:0042594~response to starvation,GO:0042592~homeostatic process,GO:0042551~neuron maturation,GO:0042542~response to hydrogen peroxide,GO:0042440~pigment metabolic process,GO:0042391~regulation of membrane potential,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0042303~molting cycle,GO:0042149~cellular response to glucose starvation,GO:0042127~regulation of cell proliferation,GO:0042113~B cell activation,GO:0042110~T cell activation,GO:0042100~B cell proliferation,GO:0040018~positive regulation of multicellular organism growth,GO:0040017~positive regulation of locomotion,GO:0040014~regulation of multicellular organism growth,GO:0040013~negative regulation of locomotion,GO:0040012~regulation of locomotion,GO:0040011~locomotion,GO:0040008~regulation of growth,GO:0040007~growth,GO:0038034~signal transduction in absence of ligand,GO:0036473~cell death in response to oxidative stress,GO:0036294~cellular response to decreased oxygen levels,GO:0036293~response to decreased oxygen levels,GO:0036211~protein modification process,GO:0036037~CD8-positive, alpha-beta T cell activation,GO:0035556~intracellular signal transduction,GO:0035295~tube development,GO:0035265~organ growth,GO:0035264~multicellular organism growth,GO:0035239~tube morphogenesis,GO:0035094~response to nicotine,GO:0034976~response to endoplasmic reticulum stress,GO:0034762~regulation of transmembrane transport,GO:0034645~cellular macromolecule biosynthetic process,GO:0034599~cellular response to oxidative stress,GO:0034333~adherens junction assembly,GO:0034332~adherens junction organization,GO:0034330~cell junction organization,GO:0034329~cell junction assembly,GO:0034097~response to cytokine,GO:0033993~response to lipid,GO:0033689~negative regulation of osteoblast proliferation,GO:0033688~regulation of osteoblast proliferation,GO:0033687~osteoblast proliferation,GO:0033555~multicellular organismal response to stress,GO:0033554~cellular response to stress,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0033135~regulation of peptidyl-serine phosphorylation,GO:0033077~T cell differentiation in thymus,GO:0033059~cellular pigmentation,GO:0033033~negative regulation of myeloid cell apoptotic process,GO:0033032~regulation of myeloid cell apoptotic process,GO:0033028~myeloid cell apoptotic process,GO:0032990~cell part morphogenesis,GO:0032989~cellular component morphogenesis,GO:0032946~positive regulation of mononuclear cell proliferation,GO:0032944~regulation of mononuclear cell proliferation,GO:0032943~mononuclear cell proliferation,GO:0032880~regulation of protein localization,GO:0032848~negative regulation of cellular pH reduction,GO:0032847~regulation of cellular pH reduction,GO:0032845~negative regulation of homeostatic process,GO:0032844~regulation of homeostatic process,GO:0032835~glomerulus development,GO:0032504~multicellular organism reproduction,GO:0032469~endoplasmic reticulum calcium ion homeostasis,GO:0032446~protein modification by small protein conjugation,GO:0032409~regulation of transporter activity,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0031960~response to corticosteroid,GO:0031669~cellular response to nutrient levels,GO:0031668~cellular response to extracellular stimulus,GO:0031667~response to nutrient levels,GO:0031647~regulation of protein stability,GO:0031589~cell-substrate adhesion,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031330~negative regulation of cellular catabolic process,GO:0031329~regulation of cellular catabolic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031324~negative regulation of cellular metabolic process,GO:0031175~neuron projection development,GO:0031103~axon regeneration,GO:0031102~neuron projection regeneration,GO:0031099~regeneration,GO:0031069~hair follicle morphogenesis,GO:0030902~hindbrain development,GO:0030890~positive regulation of B cell proliferation,GO:0030888~regulation of B cell proliferation,GO:0030641~regulation of cellular pH,GO:0030336~negative regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0030334~regulation of cell migration,GO:0030318~melanocyte differentiation,GO:0030308~negative regulation of cell growth,GO:0030307~positive regulation of cell growth,GO:0030279~negative regulation of ossification,GO:0030278~regulation of ossification,GO:0030217~T cell differentiation,GO:0030183~B cell differentiation,GO:0030182~neuron differentiation,GO:0030155~regulation of cell adhesion,GO:0030098~lymphocyte differentiation,GO:0030097~hemopoiesis,GO:0030036~actin cytoskeleton organization,GO:0030030~cell projection organization,GO:0030029~actin filament-based process,GO:0030004~cellular monovalent inorganic cation homeostasis,GO:0030003~cellular cation homeostasis,GO:0030001~metal ion transport,GO:0023057~negative regulation of signaling,GO:0023051~regulation of signaling,GO:0022898~regulation of transmembrane transporter activity,GO:0022612~gland morphogenesis,GO:0022610~biological adhesion,GO:0022607~cellular component assembly,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022602~ovulation cycle process,GO:0022414~reproductive process,GO:0022412~cellular process involved in reproduction in multicellular organism,GO:0022405~hair cycle process,GO:0022404~molting cycle process,GO:0022402~cell cycle process,GO:0022037~metencephalon development,GO:0022008~neurogenesis,GO:0021747~cochlear nucleus development,GO:0021700~developmental maturation,GO:0021548~pons development,GO:0019953~sexual reproduction,GO:0019748~secondary metabolic process,GO:0019725~cellular homeostasis,GO:0019220~regulation of phosphate metabolic process,GO:0019058~viral life cycle,GO:0018958~phenol-containing compound metabolic process,GO:0018209~peptidyl-serine modification,GO:0018193~peptidyl-amino acid modification,GO:0018105~peptidyl-serine phosphorylation,GO:0016567~protein ubiquitination,GO:0016477~cell migration,GO:0016310~phosphorylation,GO:0016202~regulation of striated muscle tissue development,GO:0016050~vesicle organization,GO:0016049~cell growth,GO:0016032~viral process,GO:0014911~positive regulation of smooth muscle cell migration,GO:0014910~regulation of smooth muscle cell migration,GO:0014909~smooth muscle cell migration,GO:0014904~myotube cell development,GO:0014902~myotube differentiation,GO:0014812~muscle cell migration,GO:0014706~striated muscle tissue development,GO:0014070~response to organic cyclic compound,GO:0014042~positive regulation of neuron maturation,GO:0014041~regulation of neuron maturation,GO:0014031~mesenchymal cell development,GO:0012501~programmed cell death,GO:0010959~regulation of metal ion transport,GO:0010948~negative regulation of cell cycle process,GO:0010942~positive regulation of cell death,GO:0010941~regulation of cell death,GO:0010831~positive regulation of myotube differentiation,GO:0010830~regulation of myotube differentiation,GO:0010810~regulation of cell-substrate adhesion,GO:0010721~negative regulation of cell development,GO:0010720~positive regulation of cell development,GO:0010648~negative regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010623~programmed cell death involved in cell development,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010564~regulation of cell cycle process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010559~regulation of glycoprotein biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010523~negative regulation of calcium ion transport into cytosol,GO:0010522~regulation of calcium ion transport into cytosol,GO:0010507~negative regulation of autophagy,GO:0010506~regulation of autophagy,GO:0010468~regulation of gene expression,GO:0010332~response to gamma radiation,GO:0010243~response to organonitrogen compound,GO:0010224~response to UV-B,GO:0010212~response to ionizing radiation,GO:0010039~response to iron ion,GO:0010038~response to metal ion,GO:0010035~response to inorganic substance,GO:0010033~response to organic substance,GO:0009994~oocyte differentiation,GO:0009991~response to extracellular stimulus,GO:0009968~negative regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009895~negative regulation of catabolic process,GO:0009894~regulation of catabolic process,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0009887~animal organ morphogenesis,GO:0009791~post-embryonic development,GO:0009725~response to hormone,GO:0009719~response to endogenous stimulus,GO:0009636~response to toxic substance,GO:0009628~response to abiotic stimulus,GO:0009615~response to virus,GO:0009611~response to wounding,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0009416~response to light stimulus,GO:0009411~response to UV,GO:0009410~response to xenobiotic stimulus,GO:0009314~response to radiation,GO:0009267~cellular response to starvation,GO:0009100~glycoprotein metabolic process,GO:0008637~apoptotic mitochondrial changes,GO:0008631~intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0008585~female gonad development,GO:0008584~male gonad development,GO:0008544~epidermis development,GO:0008406~gonad development,GO:0008285~negative regulation of cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008283~cell proliferation,GO:0008219~cell death,GO:0007610~behavior,GO:0007565~female pregnancy,GO:0007548~sex differentiation,GO:0007519~skeletal muscle tissue development,GO:0007517~muscle organ development,GO:0007423~sensory organ development,GO:0007420~brain development,GO:0007417~central nervous system development,GO:0007409~axonogenesis,GO:0007399~nervous system development,GO:0007346~regulation of mitotic cell cycle,GO:0007292~female gamete generation,GO:0007281~germ cell development,GO:0007276~gamete generation,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007166~cell surface receptor signaling pathway,GO:0007160~cell-matrix adhesion,GO:0007155~cell adhesion,GO:0007049~cell cycle,GO:0007045~cell-substrate adherens junction assembly,GO:0007044~cell-substrate junction assembly,GO:0007015~actin filament organization,GO:0007010~cytoskeleton organization,GO:0007006~mitochondrial membrane organization,GO:0007005~mitochondrion organization,GO:0006979~response to oxidative stress,GO:0006974~cellular response to DNA damage stimulus,GO:0006959~humoral immune response,GO:0006955~immune response,GO:0006952~defense response,GO:0006928~movement of cell or subcellular component,GO:0006915~apoptotic process,GO:0006914~autophagy,GO:0006885~regulation of pH,GO:0006875~cellular metal ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006873~cellular ion homeostasis,GO:0006839~mitochondrial transport,GO:0006816~calcium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,GO:0006808~regulation of nitrogen utilization,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006582~melanin metabolic process,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0003254~regulation of membrane depolarization,GO:0003014~renal system process,GO:0003008~system process,GO:0003006~developmental process involved in reproduction,GO:0002931~response to ischemia,GO:0002903~negative regulation of B cell apoptotic process,GO:0002902~regulation of B cell apoptotic process,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0002764~immune response-regulating signaling pathway,GO:0002757~immune response-activating signal transduction,GO:0002696~positive regulation of leukocyte activation,GO:0002694~regulation of leukocyte activation,GO:0002684~positive regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002521~leukocyte differentiation,GO:0002520~immune system development,GO:0002429~immune response-activating cell surface receptor signaling pathway,GO:0002363~alpha-beta T cell lineage commitment,GO:0002360~T cell lineage commitment,GO:0002326~B cell lineage commitment,GO:0002320~lymphoid progenitor cell differentiation,GO:0002260~lymphocyte homeostasis,GO:0002253~activation of immune response,GO:0002252~immune effector process,GO:0002244~hematopoietic progenitor cell differentiation,GO:0002209~behavioral defense response,GO:0002009~morphogenesis of an epithelium,GO:0001952~regulation of cell-matrix adhesion,GO:0001942~hair follicle development,GO:0001934~positive regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,GO:0001894~tissue homeostasis,GO:0001836~release of cytochrome c from mitochondria,GO:0001823~mesonephros development,GO:0001822~kidney development,GO:0001783~B cell apoptotic process,GO:0001782~B cell homeostasis,GO:0001776~leukocyte homeostasis,GO:0001775~cell activation,GO:0001763~morphogenesis of a branching structure,GO:0001666~response to hypoxia,GO:0001662~behavioral fear response,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001657~ureteric bud development,GO:0001656~metanephros development,GO:0001655~urogenital system development,GO:0001654~eye development,GO:0001558~regulation of cell growth,GO:0001541~ovarian follicle development,GO:0001503~ossification,GO:0001101~response to acid chemical,GO:0000904~cell morphogenesis involved in differentiation,GO:0000902~cell morphogenesis,GO:0000302~response to reactive oxygen species,GO:0000278~mitotic cell cycle,GO:0000209~protein polyubiquitination,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000003~reproduction,												GO:0097138~BAD-BCL-2 complex,GO:0097136~Bcl-2 family protein complex,GO:0046930~pore complex,GO:0044432~endoplasmic reticulum part,GO:0044429~mitochondrial part,GO:0043209~myelin sheath,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0031975~envelope,GO:0031968~organelle outer membrane,GO:0031967~organelle envelope,GO:0031966~mitochondrial membrane,GO:0031965~nuclear membrane,GO:0019867~outer membrane,GO:0005829~cytosol,GO:0005789~endoplasmic reticulum membrane,GO:0005783~endoplasmic reticulum,GO:0005741~mitochondrial outer membrane,GO:0005740~mitochondrial envelope,GO:0005739~mitochondrion,GO:0005635~nuclear envelope,												GO:1901363~heterocyclic compound binding,GO:0098772~molecular function regulator,GO:0097159~organic cyclic compound binding,GO:0070513~death domain binding,GO:0060090~binding, bridging,GO:0051721~protein phosphatase 2A binding,GO:0051434~BH3 domain binding,GO:0051400~BH domain binding,GO:0046983~protein dimerization activity,GO:0046982~protein heterodimerization activity,GO:0044389~ubiquitin-like protein ligase binding,GO:0043565~sequence-specific DNA binding,GO:0042803~protein homodimerization activity,GO:0042802~identical protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0022803~passive transmembrane transporter activity,GO:0019904~protein domain specific binding,GO:0019903~protein phosphatase binding,GO:0019902~phosphatase binding,GO:0019899~enzyme binding,GO:0016248~channel inhibitor activity,GO:0016247~channel regulator activity,GO:0015267~channel activity,GO:0003677~DNA binding,GO:0003676~nucleic acid binding,GO:0002020~protease binding,												IPR046371:Bcl-2_BH1-3,IPR036834:Bcl-2-like_sf,IPR026298:Bcl-2_fam,IPR020731:Bcl2_BH4_motif_CS,IPR020728:Bcl2_BH3_motif_CS,IPR020726:Bcl2_BH2_motif_CS,IPR020717:Bcl2_BH1_motif_CS,IPR013278:Apop_reg_Bcl2,IPR004725:Bcl2/BclX,IPR003093:Bcl2_BH4,IPR002475:Bcl2-like,												hsa05418:Fluid shear stress and atherosclerosis,hsa05417:Lipid and atherosclerosis,hsa05226:Gastric cancer,hsa05222:Small cell lung cancer,hsa05215:Prostate cancer,hsa05210:Colorectal cancer,hsa05207:Chemical carcinogenesis - receptor activation,hsa05206:MicroRNAs in cancer,hsa05200:Pathways in cancer,hsa05170:Human immunodeficiency virus 1 infection,hsa05169:Epstein-Barr virus infection,hsa05168:Herpes simplex virus 1 infection,hsa05162:Measles,hsa05161:Hepatitis B,hsa05152:Tuberculosis,hsa05145:Toxoplasmosis,hsa05132:Salmonella infection,hsa05131:Shigellosis,hsa05022:Pathways of neurodegeneration - multiple diseases,hsa05014:Amyotrophic lateral sclerosis,hsa04933:AGE-RAGE signaling pathway in diabetic complications,hsa04928:Parathyroid hormone synthesis, secretion and action,hsa04915:Estrogen signaling pathway,hsa04725:Cholinergic synapse,hsa04722:Neurotrophin signaling pathway,hsa04630:JAK-STAT signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04510:Focal adhesion,hsa04340:Hedgehog signaling pathway,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04217:Necroptosis,hsa04215:Apoptosis - multiple species,hsa04210:Apoptosis,hsa04151:PI3K-Akt signaling pathway,hsa04141:Protein processing in endoplasmic reticulum,hsa04140:Autophagy - animal,hsa04115:p53 signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04064:NF-kappa B signaling pathway,hsa01524:Platinum drug resistance,hsa01522:Endocrine resistance,hsa01521:EGFR tyrosine kinase inhibitor resistance,												Leukemia/lymphoma, B-cell, 2~Leukemia/lymphoma, B-cell, 2,													SM00337:BCL,SM00265:BH4,												TRANSMEM:Helical,SITE:Cleavage; by caspase-3,REGION:Required for interaction with SEPTIN4 isoform ARTS. Required XIAP-mediated ubiquitination and apoptosis,REGION:Disordered,MUTAGEN:W->A: Loss of BAX-binding and of anti-apoptotic activity; when associated with A-145 and A146.,MUTAGEN:W->A: Loss of BAX-binding and of anti-apoptotic activity. No effect on homodimerization.,MUTAGEN:R->A: Loss of BAX-binding and of anti-apoptotic activity; when associated with A-144 and A145.,MUTAGEN:Q->L: Partial loss of BAX-binding and 50% decrease in anti-apoptotic activity; when associated with A-191 and A-192. No effect on homodimerization; when associated with L-190 and A-191.,MUTAGEN:N->A: Partial loss of BAX-binding and 50% decrease in anti-apoptotic activity; when associated with L-190 and A-191. No effect on homodimerization; when associated with L-190 and A-191.,MUTAGEN:Missing: Loss of BAX-binding and of anti-apoptotic activity. May also affect protein stability.,MUTAGEN:G->E: Loss of BAX-binding and of anti-apoptotic activity. No effect on homodimerization.,MUTAGEN:G->A: Loss of BAX-binding and of anti-apoptotic activity. No effect on NLRP1-induced IL1B release, nor on homodimerization. Loss of BAX-binding and of anti-apoptotic activity; when associated with A-145 and A146.,MUTAGEN:FRDG->AAAA: Loss of BAX-binding and of anti-apoptotic activity.,MUTAGEN:E->A: Partial loss of BAX-binding and 50% decrease in anti-apoptotic activity.,MUTAGEN:D->A: No effect on cleavage by caspase-3.,MUTAGEN:D->A: No effect on BAX-binding, nor on anti-apoptotic activity. Partial loss of BAX-binding and 50% decrease in anti-apoptotic activity; when associated with L-190 and A-192. No effect on homodimerization; when associated with L-190 and A-191.,MUTAGEN:D->A: Abolishes cleavage by caspase-3.,MOTIF:BH4,MOTIF:BH3,MOTIF:BH2,MOTIF:BH1,DOMAIN:Apoptosis regulator Bcl-2 family BH4,
40089_at	BUD23 rRNA methyltransferase and ribosome maturation factor(BUD23)	Homo sapiens			GO:2000234~positive regulation of rRNA processing,GO:2000232~regulation of rRNA processing,GO:0090070~positive regulation of ribosome biogenesis,GO:0090069~regulation of ribosome biogenesis,GO:0070476~rRNA (guanine-N7)-methylation,GO:0070475~rRNA base methylation,GO:0051276~chromosome organization,GO:0051254~positive regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0044089~positive regulation of cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044085~cellular component biogenesis,GO:0043414~macromolecule methylation,GO:0042254~ribosome biogenesis,GO:0036265~RNA (guanine-N7)-methylation,GO:0036260~RNA capping,GO:0034660~ncRNA metabolic process,GO:0034470~ncRNA processing,GO:0032259~methylation,GO:0031325~positive regulation of cellular metabolic process,GO:0031167~rRNA methylation,GO:0022613~ribonucleoprotein complex biogenesis,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0016072~rRNA metabolic process,GO:0016070~RNA metabolic process,GO:0010628~positive regulation of gene expression,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0009893~positive regulation of metabolic process,GO:0009452~7-methylguanosine RNA capping,GO:0009451~RNA modification,GO:0006396~RNA processing,GO:0006364~rRNA processing,GO:0006325~chromatin organization,GO:0001510~RNA methylation,GO:0000154~rRNA modification,												GO:0048471~perinuclear region of cytoplasm,GO:0005730~nucleolus,GO:0005654~nucleoplasm,												GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0046983~protein dimerization activity,GO:0046982~protein heterodimerization activity,GO:0016741~transferase activity, transferring one-carbon groups,GO:0016435~rRNA (guanine) methyltransferase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0008649~rRNA methyltransferase activity,GO:0008173~RNA methyltransferase activity,GO:0008168~methyltransferase activity,GO:0003723~RNA binding,GO:0003676~nucleic acid binding,												IPR039769:Bud23-like,IPR029063:SAM-dependent_MTases_sf,IPR022238:Bud23_C,IPR013216:Methyltransf_11,																REGION:Disordered,MUTAGEN:K->R: Resistant to down-regulation in response to TNF and IFNG combined treatment and effective coactivator for NR3C1, even in the presence of TNF and IFNG; when associated R-196.,MUTAGEN:K->R: Resistant to down-regulation in response to TNF and IFNG combined treatment and effective coactivator for NR3C1, even in the presence of TNF and IFNG; when associated R-180.,DOMAIN:Methyltransferase type 11,DOMAIN:18S rRNA (guanine(1575)-N(7))-methyltransferase Bud23 C-terminal,
37454_at	C-C motif chemokine ligand 13(CCL13)	Homo sapiens	109.Chemokine_families,													GO:1990266~neutrophil migration,GO:1902533~positive regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:0098771~inorganic ion homeostasis,GO:0097530~granulocyte migration,GO:0097529~myeloid leukocyte migration,GO:0072677~eosinophil migration,GO:0072676~lymphocyte migration,GO:0072507~divalent inorganic cation homeostasis,GO:0072503~cellular divalent inorganic cation homeostasis,GO:0071674~mononuclear cell migration,GO:0071621~granulocyte chemotaxis,GO:0071356~cellular response to tumor necrosis factor,GO:0071347~cellular response to interleukin-1,GO:0071346~cellular response to interferon-gamma,GO:0071345~cellular response to cytokine stimulus,GO:0071310~cellular response to organic substance,GO:0070887~cellular response to chemical stimulus,GO:0070555~response to interleukin-1,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0070371~ERK1 and ERK2 cascade,GO:0070098~chemokine-mediated signaling pathway,GO:0065009~regulation of molecular function,GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide,GO:0060326~cell chemotaxis,GO:0055082~cellular chemical homeostasis,GO:0055080~cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055065~metal ion homeostasis,GO:0051707~response to other organism,GO:0051674~localization of cell,GO:0051345~positive regulation of hydrolase activity,GO:0051336~regulation of hydrolase activity,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051128~regulation of cellular component organization,GO:0050900~leukocyte migration,GO:0050801~ion homeostasis,GO:0050790~regulation of catalytic activity,GO:0048878~chemical homeostasis,GO:0048870~cell motility,GO:0048584~positive regulation of response to stimulus,GO:0048247~lymphocyte chemotaxis,GO:0048245~eosinophil chemotaxis,GO:0045937~positive regulation of phosphate metabolic process,GO:0045087~innate immune response,GO:0044364~disruption of cells of other organism,GO:0044093~positive regulation of molecular function,GO:0043547~positive regulation of GTPase activity,GO:0043410~positive regulation of MAPK cascade,GO:0043408~regulation of MAPK cascade,GO:0043207~response to external biotic stimulus,GO:0043087~regulation of GTPase activity,GO:0043085~positive regulation of catalytic activity,GO:0042592~homeostatic process,GO:0042330~taxis,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0040011~locomotion,GO:0036211~protein modification process,GO:0035821~modification of morphology or physiology of other organism,GO:0035556~intracellular signal transduction,GO:0034612~response to tumor necrosis factor,GO:0034341~response to interferon-gamma,GO:0034097~response to cytokine,GO:0032989~cellular component morphogenesis,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0031640~killing of cells of other organism,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031325~positive regulation of cellular metabolic process,GO:0030595~leukocyte chemotaxis,GO:0030593~neutrophil chemotaxis,GO:0030003~cellular cation homeostasis,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0023014~signal transduction by protein phosphorylation,GO:0022604~regulation of cell morphogenesis,GO:0022603~regulation of anatomical structure morphogenesis,GO:0019730~antimicrobial humoral response,GO:0019725~cellular homeostasis,GO:0019221~cytokine-mediated signaling pathway,GO:0019220~regulation of phosphate metabolic process,GO:0016477~cell migration,GO:0016310~phosphorylation,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010033~response to organic substance,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009893~positive regulation of metabolic process,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0008360~regulation of cell shape,GO:0007267~cell-cell signaling,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0007010~cytoskeleton organization,GO:0006959~humoral immune response,GO:0006955~immune response,GO:0006954~inflammatory response,GO:0006952~defense response,GO:0006935~chemotaxis,GO:0006928~movement of cell or subcellular component,GO:0006875~cellular metal ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006873~cellular ion homeostasis,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0002548~monocyte chemotaxis,GO:0001934~positive regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,GO:0001906~cell killing,GO:0000902~cell morphogenesis,GO:0000165~MAPK cascade,												GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:0048020~CCR chemokine receptor binding,GO:0042379~chemokine receptor binding,GO:0008009~chemokine activity,GO:0005126~cytokine receptor binding,GO:0005125~cytokine activity,GO:0005102~receptor binding,GO:0001664~G-protein coupled receptor binding,												IPR039809:Chemokine_b/g/d,IPR036048:Interleukin_8-like_sf,IPR001811:Chemokine_IL8-like_dom,IPR000827:Chemokine_CC_CS,												hsa04064:NF-kappa B signaling pathway,hsa04062:Chemokine signaling pathway,hsa04061:Viral protein interaction with cytokine and cytokine receptor,hsa04060:Cytokine-cytokine receptor interaction,														SM00199:SCY,												DOMAIN:Chemokine interleukin-8-like,
36703_at	C-C motif chemokine ligand 25(CCL25)	Homo sapiens			GO:2000146~negative regulation of cell motility,GO:2000145~regulation of cell motility,GO:1990266~neutrophil migration,GO:1904995~negative regulation of leukocyte adhesion to vascular endothelial cell,GO:1904994~regulation of leukocyte adhesion to vascular endothelial cell,GO:1903237~negative regulation of leukocyte tethering or rolling,GO:1903236~regulation of leukocyte tethering or rolling,GO:1903038~negative regulation of leukocyte cell-cell adhesion,GO:1903037~regulation of leukocyte cell-cell adhesion,GO:1902533~positive regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:0098609~cell-cell adhesion,GO:0098602~single organism cell adhesion,GO:0097530~granulocyte migration,GO:0097529~myeloid leukocyte migration,GO:0072677~eosinophil migration,GO:0072676~lymphocyte migration,GO:0071674~mononuclear cell migration,GO:0071621~granulocyte chemotaxis,GO:0071356~cellular response to tumor necrosis factor,GO:0071347~cellular response to interleukin-1,GO:0071346~cellular response to interferon-gamma,GO:0071345~cellular response to cytokine stimulus,GO:0071310~cellular response to organic substance,GO:0070887~cellular response to chemical stimulus,GO:0070555~response to interleukin-1,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0070371~ERK1 and ERK2 cascade,GO:0070098~chemokine-mediated signaling pathway,GO:0065009~regulation of molecular function,GO:0061756~leukocyte adhesion to vascular endothelial cell,GO:0060326~cell chemotaxis,GO:0051674~localization of cell,GO:0051345~positive regulation of hydrolase activity,GO:0051336~regulation of hydrolase activity,GO:0051271~negative regulation of cellular component movement,GO:0051270~regulation of cellular component movement,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0050901~leukocyte tethering or rolling,GO:0050900~leukocyte migration,GO:0050790~regulation of catalytic activity,GO:0048870~cell motility,GO:0048584~positive regulation of response to stimulus,GO:0048247~lymphocyte chemotaxis,GO:0048245~eosinophil chemotaxis,GO:0045937~positive regulation of phosphate metabolic process,GO:0045785~positive regulation of cell adhesion,GO:0045123~cellular extravasation,GO:0045087~innate immune response,GO:0044093~positive regulation of molecular function,GO:0043547~positive regulation of GTPase activity,GO:0043410~positive regulation of MAPK cascade,GO:0043408~regulation of MAPK cascade,GO:0043087~regulation of GTPase activity,GO:0043085~positive regulation of catalytic activity,GO:0042330~taxis,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0040013~negative regulation of locomotion,GO:0040012~regulation of locomotion,GO:0040011~locomotion,GO:0036211~protein modification process,GO:0035556~intracellular signal transduction,GO:0034612~response to tumor necrosis factor,GO:0034341~response to interferon-gamma,GO:0034097~response to cytokine,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0031589~cell-substrate adhesion,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031325~positive regulation of cellular metabolic process,GO:0030595~leukocyte chemotaxis,GO:0030593~neutrophil chemotaxis,GO:0030336~negative regulation of cell migration,GO:0030334~regulation of cell migration,GO:0030155~regulation of cell adhesion,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0023014~signal transduction by protein phosphorylation,GO:0022610~biological adhesion,GO:0022408~negative regulation of cell-cell adhesion,GO:0022407~regulation of cell-cell adhesion,GO:0019221~cytokine-mediated signaling pathway,GO:0019220~regulation of phosphate metabolic process,GO:0016477~cell migration,GO:0016337~single organismal cell-cell adhesion,GO:0016310~phosphorylation,GO:0010811~positive regulation of cell-substrate adhesion,GO:0010810~regulation of cell-substrate adhesion,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010033~response to organic substance,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009893~positive regulation of metabolic process,GO:0009605~response to external stimulus,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0007162~negative regulation of cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007159~leukocyte cell-cell adhesion,GO:0007155~cell adhesion,GO:0006955~immune response,GO:0006954~inflammatory response,GO:0006952~defense response,GO:0006935~chemotaxis,GO:0006928~movement of cell or subcellular component,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0002692~negative regulation of cellular extravasation,GO:0002691~regulation of cellular extravasation,GO:0002686~negative regulation of leukocyte migration,GO:0002685~regulation of leukocyte migration,GO:0002683~negative regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002548~monocyte chemotaxis,GO:0001954~positive regulation of cell-matrix adhesion,GO:0001952~regulation of cell-matrix adhesion,GO:0001934~positive regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,GO:0000165~MAPK cascade,												GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:0048020~CCR chemokine receptor binding,GO:0042379~chemokine receptor binding,GO:0031735~CCR10 chemokine receptor binding,GO:0008009~chemokine activity,GO:0005179~hormone activity,GO:0005126~cytokine receptor binding,GO:0005125~cytokine activity,GO:0005102~receptor binding,GO:0001664~G-protein coupled receptor binding,												IPR036048:Interleukin_8-like_sf,IPR034133:Chemokine_CC_DCCL,IPR001811:Chemokine_IL8-like_dom,												hsa04672:Intestinal immune network for IgA production,hsa04062:Chemokine signaling pathway,hsa04061:Viral protein interaction with cytokine and cytokine receptor,hsa04060:Cytokine-cytokine receptor interaction,														SM00199:SCY,												DOMAIN:Chemokine interleukin-8-like,
1403_s_at	C-C motif chemokine ligand 5(CCL5)	Homo sapiens	34.Chemokines_in_EAE,33.GProt-coupled_Rec_T_Cell_med_Inflamm,22.Cytokine-chemokine_CNS,18.Cytokine_astocytes,109.Chemokine_families,												h_eosinophilsPathway:The Role of Eosinophils in the Chemokine Network of Allergy,												GO:2001141~regulation of RNA biosynthetic process,GO:2000503~positive regulation of natural killer cell chemotaxis,GO:2000501~regulation of natural killer cell chemotaxis,GO:2000406~positive regulation of T cell migration,GO:2000404~regulation of T cell migration,GO:2000403~positive regulation of lymphocyte migration,GO:2000401~regulation of lymphocyte migration,GO:2000147~positive regulation of cell motility,GO:2000145~regulation of cell motility,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000110~negative regulation of macrophage apoptotic process,GO:2000109~regulation of macrophage apoptotic process,GO:2000108~positive regulation of leukocyte apoptotic process,GO:2000107~negative regulation of leukocyte apoptotic process,GO:2000106~regulation of leukocyte apoptotic process,GO:1990266~neutrophil migration,GO:1905523~positive regulation of macrophage migration,GO:1905521~regulation of macrophage migration,GO:1905517~macrophage migration,GO:1904894~positive regulation of STAT cascade,GO:1904892~regulation of STAT cascade,GO:1903902~positive regulation of viral life cycle,GO:1903901~negative regulation of viral life cycle,GO:1903900~regulation of viral life cycle,GO:1903530~regulation of secretion by cell,GO:1903039~positive regulation of leukocyte cell-cell adhesion,GO:1903037~regulation of leukocyte cell-cell adhesion,GO:1902679~negative regulation of RNA biosynthetic process,GO:1902533~positive regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:1901623~regulation of lymphocyte chemotaxis,GO:1901566~organonitrogen compound biosynthetic process,GO:0098771~inorganic ion homeostasis,GO:0098609~cell-cell adhesion,GO:0098602~single organism cell adhesion,GO:0098586~cellular response to virus,GO:0097696~STAT cascade,GO:0097530~granulocyte migration,GO:0097529~myeloid leukocyte migration,GO:0090276~regulation of peptide hormone secretion,GO:0090087~regulation of peptide transport,GO:0090026~positive regulation of monocyte chemotaxis,GO:0090025~regulation of monocyte chemotaxis,GO:0080134~regulation of response to stress,GO:0072678~T cell migration,GO:0072677~eosinophil migration,GO:0072676~lymphocyte migration,GO:0072511~divalent inorganic cation transport,GO:0072507~divalent inorganic cation homeostasis,GO:0072503~cellular divalent inorganic cation homeostasis,GO:0071888~macrophage apoptotic process,GO:0071887~leukocyte apoptotic process,GO:0071774~response to fibroblast growth factor,GO:0071705~nitrogen compound transport,GO:0071677~positive regulation of mononuclear cell migration,GO:0071675~regulation of mononuclear cell migration,GO:0071674~mononuclear cell migration,GO:0071622~regulation of granulocyte chemotaxis,GO:0071621~granulocyte chemotaxis,GO:0071495~cellular response to endogenous stimulus,GO:0071363~cellular response to growth factor stimulus,GO:0071356~cellular response to tumor necrosis factor,GO:0071347~cellular response to interleukin-1,GO:0071346~cellular response to interferon-gamma,GO:0071345~cellular response to cytokine stimulus,GO:0071310~cellular response to organic substance,GO:0070887~cellular response to chemical stimulus,GO:0070848~response to growth factor,GO:0070838~divalent metal ion transport,GO:0070665~positive regulation of leukocyte proliferation,GO:0070663~regulation of leukocyte proliferation,GO:0070661~leukocyte proliferation,GO:0070555~response to interleukin-1,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0070371~ERK1 and ERK2 cascade,GO:0070234~positive regulation of T cell apoptotic process,GO:0070233~negative regulation of T cell apoptotic process,GO:0070232~regulation of T cell apoptotic process,GO:0070231~T cell apoptotic process,GO:0070230~positive regulation of lymphocyte apoptotic process,GO:0070229~negative regulation of lymphocyte apoptotic process,GO:0070228~regulation of lymphocyte apoptotic process,GO:0070227~lymphocyte apoptotic process,GO:0070201~regulation of establishment of protein localization,GO:0070100~negative regulation of chemokine-mediated signaling pathway,GO:0070099~regulation of chemokine-mediated signaling pathway,GO:0070098~chemokine-mediated signaling pathway,GO:0065009~regulation of molecular function,GO:0060761~negative regulation of response to cytokine stimulus,GO:0060759~regulation of response to cytokine stimulus,GO:0060548~negative regulation of cell death,GO:0060326~cell chemotaxis,GO:0060193~positive regulation of lipase activity,GO:0060191~regulation of lipase activity,GO:0055082~cellular chemical homeostasis,GO:0055080~cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055065~metal ion homeostasis,GO:0052472~modulation by host of symbiont transcription,GO:0052312~modulation of transcription in other organism involved in symbiotic interaction,GO:0051928~positive regulation of calcium ion transport,GO:0051924~regulation of calcium ion transport,GO:0051897~positive regulation of protein kinase B signaling,GO:0051896~regulation of protein kinase B signaling,GO:0051851~modification by host of symbiont morphology or physiology,GO:0051817~modification of morphology or physiology of other organism involved in symbiotic interaction,GO:0051707~response to other organism,GO:0051702~interaction with symbiont,GO:0051674~localization of cell,GO:0051347~positive regulation of transferase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051338~regulation of transferase activity,GO:0051336~regulation of hydrolase activity,GO:0051272~positive regulation of cellular component movement,GO:0051270~regulation of cellular component movement,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051251~positive regulation of lymphocyte activation,GO:0051249~regulation of lymphocyte activation,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051223~regulation of protein transport,GO:0051174~regulation of phosphorus metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051050~positive regulation of transport,GO:0051049~regulation of transport,GO:0051046~regulation of secretion,GO:0050921~positive regulation of chemotaxis,GO:0050920~regulation of chemotaxis,GO:0050918~positive chemotaxis,GO:0050900~leukocyte migration,GO:0050870~positive regulation of T cell activation,GO:0050867~positive regulation of cell activation,GO:0050865~regulation of cell activation,GO:0050863~regulation of T cell activation,GO:0050801~ion homeostasis,GO:0050796~regulation of insulin secretion,GO:0050792~regulation of viral process,GO:0050790~regulation of catalytic activity,GO:0050778~positive regulation of immune response,GO:0050776~regulation of immune response,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:0050727~regulation of inflammatory response,GO:0050708~regulation of protein secretion,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0050673~epithelial cell proliferation,GO:0050671~positive regulation of lymphocyte proliferation,GO:0050670~regulation of lymphocyte proliferation,GO:0048878~chemical homeostasis,GO:0048870~cell motility,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048659~smooth muscle cell proliferation,GO:0048585~negative regulation of response to stimulus,GO:0048584~positive regulation of response to stimulus,GO:0048525~negative regulation of viral process,GO:0048524~positive regulation of viral process,GO:0048247~lymphocyte chemotaxis,GO:0048246~macrophage chemotaxis,GO:0048245~eosinophil chemotaxis,GO:0046903~secretion,GO:0046883~regulation of hormone secretion,GO:0046879~hormone secretion,GO:0046782~regulation of viral transcription,GO:0046651~lymphocyte proliferation,GO:0046649~lymphocyte activation,GO:0046427~positive regulation of JAK-STAT cascade,GO:0046425~regulation of JAK-STAT cascade,GO:0045948~positive regulation of translational initiation,GO:0045937~positive regulation of phosphate metabolic process,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045860~positive regulation of protein kinase activity,GO:0045859~regulation of protein kinase activity,GO:0045785~positive regulation of cell adhesion,GO:0045744~negative regulation of G-protein coupled receptor protein signaling pathway,GO:0045727~positive regulation of translation,GO:0045321~leukocyte activation,GO:0045184~establishment of protein localization,GO:0045089~positive regulation of innate immune response,GO:0045088~regulation of innate immune response,GO:0045087~innate immune response,GO:0045071~negative regulation of viral genome replication,GO:0045070~positive regulation of viral genome replication,GO:0045069~regulation of viral genome replication,GO:0044764~multi-organism cellular process,GO:0044419~interspecies interaction between organisms,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0044093~positive regulation of molecular function,GO:0044033~multi-organism metabolic process,GO:0043922~negative regulation by host of viral transcription,GO:0043921~modulation by host of viral transcription,GO:0043903~regulation of symbiosis, encompassing mutualism through parasitism,GO:0043902~positive regulation of multi-organism process,GO:0043901~negative regulation of multi-organism process,GO:0043900~regulation of multi-organism process,GO:0043604~amide biosynthetic process,GO:0043603~cellular amide metabolic process,GO:0043549~regulation of kinase activity,GO:0043547~positive regulation of GTPase activity,GO:0043491~protein kinase B signaling,GO:0043410~positive regulation of MAPK cascade,GO:0043408~regulation of MAPK cascade,GO:0043270~positive regulation of ion transport,GO:0043269~regulation of ion transport,GO:0043207~response to external biotic stimulus,GO:0043087~regulation of GTPase activity,GO:0043085~positive regulation of catalytic activity,GO:0043069~negative regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043043~peptide biosynthetic process,GO:0042981~regulation of apoptotic process,GO:0042976~activation of Janus kinase activity,GO:0042886~amide transport,GO:0042592~homeostatic process,GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein,GO:0042509~regulation of tyrosine phosphorylation of STAT protein,GO:0042330~taxis,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0042129~regulation of T cell proliferation,GO:0042127~regulation of cell proliferation,GO:0042119~neutrophil activation,GO:0042110~T cell activation,GO:0042102~positive regulation of T cell proliferation,GO:0042098~T cell proliferation,GO:0040017~positive regulation of locomotion,GO:0040012~regulation of locomotion,GO:0040011~locomotion,GO:0036336~dendritic cell migration,GO:0036230~granulocyte activation,GO:0036211~protein modification process,GO:0035821~modification of morphology or physiology of other organism,GO:0035747~natural killer cell chemotaxis,GO:0035556~intracellular signal transduction,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034612~response to tumor necrosis factor,GO:0034341~response to interferon-gamma,GO:0034250~positive regulation of cellular amide metabolic process,GO:0034248~regulation of cellular amide metabolic process,GO:0034112~positive regulation of homotypic cell-cell adhesion,GO:0034110~regulation of homotypic cell-cell adhesion,GO:0034109~homotypic cell-cell adhesion,GO:0034097~response to cytokine,GO:0033674~positive regulation of kinase activity,GO:0033634~positive regulation of cell-cell adhesion mediated by integrin,GO:0033632~regulation of cell-cell adhesion mediated by integrin,GO:0033631~cell-cell adhesion mediated by integrin,GO:0033630~positive regulation of cell adhesion mediated by integrin,GO:0033628~regulation of cell adhesion mediated by integrin,GO:0033627~cell adhesion mediated by integrin,GO:0033036~macromolecule localization,GO:0033033~negative regulation of myeloid cell apoptotic process,GO:0033032~regulation of myeloid cell apoptotic process,GO:0033028~myeloid cell apoptotic process,GO:0033002~muscle cell proliferation,GO:0032946~positive regulation of mononuclear cell proliferation,GO:0032944~regulation of mononuclear cell proliferation,GO:0032943~mononuclear cell proliferation,GO:0032940~secretion by cell,GO:0032897~negative regulation of viral transcription,GO:0032880~regulation of protein localization,GO:0032774~RNA biosynthetic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032147~activation of protein kinase activity,GO:0032103~positive regulation of response to external stimulus,GO:0032101~regulation of response to external stimulus,GO:0031584~activation of phospholipase D activity,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031349~positive regulation of defense response,GO:0031347~regulation of defense response,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031324~negative regulation of cellular metabolic process,GO:0030595~leukocyte chemotaxis,GO:0030593~neutrophil chemotaxis,GO:0030335~positive regulation of cell migration,GO:0030334~regulation of cell migration,GO:0030155~regulation of cell adhesion,GO:0030072~peptide hormone secretion,GO:0030003~cellular cation homeostasis,GO:0030001~metal ion transport,GO:0023061~signal release,GO:0023057~negative regulation of signaling,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0023014~signal transduction by protein phosphorylation,GO:0022610~biological adhesion,GO:0022409~positive regulation of cell-cell adhesion,GO:0022407~regulation of cell-cell adhesion,GO:0019725~cellular homeostasis,GO:0019438~aromatic compound biosynthetic process,GO:0019221~cytokine-mediated signaling pathway,GO:0019220~regulation of phosphate metabolic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019083~viral transcription,GO:0019080~viral gene expression,GO:0019079~viral genome replication,GO:0019058~viral life cycle,GO:0018212~peptidyl-tyrosine modification,GO:0018193~peptidyl-amino acid modification,GO:0018130~heterocycle biosynthetic process,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0016477~cell migration,GO:0016337~single organismal cell-cell adhesion,GO:0016310~phosphorylation,GO:0016192~vesicle-mediated transport,GO:0016070~RNA metabolic process,GO:0016032~viral process,GO:0015833~peptide transport,GO:0015031~protein transport,GO:0014911~positive regulation of smooth muscle cell migration,GO:0014910~regulation of smooth muscle cell migration,GO:0014909~smooth muscle cell migration,GO:0014812~muscle cell migration,GO:0012501~programmed cell death,GO:0010959~regulation of metal ion transport,GO:0010942~positive regulation of cell death,GO:0010941~regulation of cell death,GO:0010820~positive regulation of T cell chemotaxis,GO:0010819~regulation of T cell chemotaxis,GO:0010818~T cell chemotaxis,GO:0010817~regulation of hormone levels,GO:0010759~positive regulation of macrophage chemotaxis,GO:0010758~regulation of macrophage chemotaxis,GO:0010648~negative regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010629~negative regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010608~posttranscriptional regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010536~positive regulation of activation of Janus kinase activity,GO:0010533~regulation of activation of Janus kinase activity,GO:0010518~positive regulation of phospholipase activity,GO:0010517~regulation of phospholipase activity,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010033~response to organic substance,GO:0009968~negative regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009914~hormone transport,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0009891~positive regulation of biosynthetic process,GO:0009890~negative regulation of biosynthetic process,GO:0009719~response to endogenous stimulus,GO:0009636~response to toxic substance,GO:0009615~response to virus,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0009306~protein secretion,GO:0008284~positive regulation of cell proliferation,GO:0008283~cell proliferation,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0008219~cell death,GO:0008104~protein localization,GO:0007267~cell-cell signaling,GO:0007260~tyrosine phosphorylation of STAT protein,GO:0007259~JAK-STAT cascade,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0007159~leukocyte cell-cell adhesion,GO:0007155~cell adhesion,GO:0006955~immune response,GO:0006954~inflammatory response,GO:0006952~defense response,GO:0006935~chemotaxis,GO:0006928~movement of cell or subcellular component,GO:0006925~inflammatory cell apoptotic process,GO:0006915~apoptotic process,GO:0006887~exocytosis,GO:0006875~cellular metal ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006873~cellular ion homeostasis,GO:0006816~calcium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006518~peptide metabolic process,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0006446~regulation of translational initiation,GO:0006417~regulation of translation,GO:0006413~translational initiation,GO:0006412~translation,GO:0002791~regulation of peptide secretion,GO:0002790~peptide secretion,GO:0002696~positive regulation of leukocyte activation,GO:0002694~regulation of leukocyte activation,GO:0002690~positive regulation of leukocyte chemotaxis,GO:0002688~regulation of leukocyte chemotaxis,GO:0002687~positive regulation of leukocyte migration,GO:0002685~regulation of leukocyte migration,GO:0002684~positive regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002676~regulation of chronic inflammatory response,GO:0002548~monocyte chemotaxis,GO:0002407~dendritic cell chemotaxis,GO:0002274~myeloid leukocyte activation,GO:0001960~negative regulation of cytokine-mediated signaling pathway,GO:0001959~regulation of cytokine-mediated signaling pathway,GO:0001934~positive regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,GO:0001775~cell activation,GO:0000165~MAPK cascade,												GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:0098772~molecular function regulator,GO:0060229~lipase activator activity,GO:0048020~CCR chemokine receptor binding,GO:0048019~receptor antagonist activity,GO:0046983~protein dimerization activity,GO:0046817~chemokine receptor antagonist activity,GO:0043621~protein self-association,GO:0042803~protein homodimerization activity,GO:0042802~identical protein binding,GO:0042578~phosphoric ester hydrolase activity,GO:0042379~chemokine receptor binding,GO:0042056~chemoattractant activity,GO:0031730~CCR5 chemokine receptor binding,GO:0031729~CCR4 chemokine receptor binding,GO:0031726~CCR1 chemokine receptor binding,GO:0030547~receptor inhibitor activity,GO:0030545~receptor regulator activity,GO:0030298~receptor signaling protein tyrosine kinase activator activity,GO:0030296~protein tyrosine kinase activator activity,GO:0030295~protein kinase activator activity,GO:0030234~enzyme regulator activity,GO:0019887~protein kinase regulator activity,GO:0019209~kinase activator activity,GO:0019207~kinase regulator activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0016301~kinase activity,GO:0016298~lipase activity,GO:0016004~phospholipase activator activity,GO:0008081~phosphoric diester hydrolase activity,GO:0008047~enzyme activator activity,GO:0008009~chemokine activity,GO:0005126~cytokine receptor binding,GO:0005125~cytokine activity,GO:0005102~receptor binding,GO:0004672~protein kinase activity,GO:0004629~phospholipase C activity,GO:0004620~phospholipase activity,GO:0004435~phosphatidylinositol phospholipase C activity,GO:0001664~G-protein coupled receptor binding,												IPR039809:Chemokine_b/g/d,IPR036048:Interleukin_8-like_sf,IPR001811:Chemokine_IL8-like_dom,IPR000827:Chemokine_CC_CS,												hsa05417:Lipid and atherosclerosis,hsa05323:Rheumatoid arthritis,hsa05168:Herpes simplex virus 1 infection,hsa05164:Influenza A,hsa05163:Human cytomegalovirus infection,hsa05142:Chagas disease,hsa05131:Shigellosis,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05020:Prion disease,hsa04668:TNF signaling pathway,hsa04623:Cytosolic DNA-sensing pathway,hsa04621:NOD-like receptor signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04062:Chemokine signaling pathway,hsa04061:Viral protein interaction with cytokine and cytokine receptor,hsa04060:Cytokine-cytokine receptor interaction,												609423~HIV-1 disease, rapid progression of,609423~HIV-1 disease, delayed progression of,													SM00199:SCY,												SITE:Cleavage; by DPP4,MUTAGEN:T->A: Reduced inhibition of activity by tick evasin-4.,MUTAGEN:T->A: No effect on inhibition of activity by tick evasin-4.,MUTAGEN:RKNR->AANA: No effect on inhibition of activity by tick evasin-4.,MUTAGEN:KKWVR->AAWVA: No effect on inhibition of activity by tick evasin-4.,MUTAGEN:H->A: No effect on inhibition of activity by tick evasin-4.,MUTAGEN:G->A,K: No effect on inhibition of activity by tick evasin-4.,MUTAGEN:E->A: No effect on inhibition of activity by tick evasin-4.,DOMAIN:Chemokine interleukin-8-like,CARBOHYD:O-linked (GalNAc...) serine; partial,
822_s_at	CASP2 and RIPK1 domain containing adaptor with death domain(CRADD)	Homo sapiens		h_tnfr1Pathway:TNFR1 Signaling Pathway,h_stressPathway:TNF/Stress Related Signaling,h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,												GO:2001235~positive regulation of apoptotic signaling pathway,GO:2001233~regulation of apoptotic signaling pathway,GO:2001056~positive regulation of cysteine-type endopeptidase activity,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,GO:2000116~regulation of cysteine-type endopeptidase activity,GO:2000045~regulation of G1/S transition of mitotic cell cycle,GO:1903047~mitotic cell cycle process,GO:1902807~negative regulation of cell cycle G1/S phase transition,GO:1902806~regulation of cell cycle G1/S phase transition,GO:1902403~signal transduction involved in mitotic DNA integrity checkpoint,GO:1902402~signal transduction involved in mitotic DNA damage checkpoint,GO:1902400~intracellular signal transduction involved in G1 DNA damage checkpoint,GO:1901991~negative regulation of mitotic cell cycle phase transition,GO:1901990~regulation of mitotic cell cycle phase transition,GO:1901988~negative regulation of cell cycle phase transition,GO:1901987~regulation of cell cycle phase transition,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097190~apoptotic signaling pathway,GO:0090068~positive regulation of cell cycle process,GO:0072431~signal transduction involved in mitotic G1 DNA damage checkpoint,GO:0072422~signal transduction involved in DNA damage checkpoint,GO:0072413~signal transduction involved in mitotic cell cycle checkpoint,GO:0072401~signal transduction involved in DNA integrity checkpoint,GO:0072395~signal transduction involved in cell cycle checkpoint,GO:0072331~signal transduction by p53 class mediator,GO:0071496~cellular response to external stimulus,GO:0071260~cellular response to mechanical stimulus,GO:0071214~cellular response to abiotic stimulus,GO:0071158~positive regulation of cell cycle arrest,GO:0071156~regulation of cell cycle arrest,GO:0065009~regulation of molecular function,GO:0052548~regulation of endopeptidase activity,GO:0052547~regulation of peptidase activity,GO:0051726~regulation of cell cycle,GO:0051345~positive regulation of hydrolase activity,GO:0051336~regulation of hydrolase activity,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0050790~regulation of catalytic activity,GO:0048584~positive regulation of response to stimulus,GO:0045930~negative regulation of mitotic cell cycle,GO:0045862~positive regulation of proteolysis,GO:0045787~positive regulation of cell cycle,GO:0045786~negative regulation of cell cycle,GO:0044843~cell cycle G1/S phase transition,GO:0044819~mitotic G1/S transition checkpoint,GO:0044783~G1 DNA damage checkpoint,GO:0044774~mitotic DNA integrity checkpoint,GO:0044773~mitotic DNA damage checkpoint,GO:0044772~mitotic cell cycle phase transition,GO:0044770~cell cycle phase transition,GO:0044093~positive regulation of molecular function,GO:0043281~regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043085~positive regulation of catalytic activity,GO:0043068~positive regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043065~positive regulation of apoptotic process,GO:0042981~regulation of apoptotic process,GO:0042770~signal transduction in response to DNA damage,GO:0035556~intracellular signal transduction,GO:0033554~cellular response to stress,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0031571~mitotic G1 DNA damage checkpoint,GO:0031570~DNA integrity checkpoint,GO:0031325~positive regulation of cellular metabolic process,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0030162~regulation of proteolysis,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0022402~cell cycle process,GO:0012501~programmed cell death,GO:0010952~positive regulation of peptidase activity,GO:0010950~positive regulation of endopeptidase activity,GO:0010948~negative regulation of cell cycle process,GO:0010942~positive regulation of cell death,GO:0010941~regulation of cell death,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010564~regulation of cell cycle process,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009893~positive regulation of metabolic process,GO:0009628~response to abiotic stimulus,GO:0009612~response to mechanical stimulus,GO:0009605~response to external stimulus,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0008219~cell death,GO:0007346~regulation of mitotic cell cycle,GO:0007166~cell surface receptor signaling pathway,GO:0007093~mitotic cell cycle checkpoint,GO:0007050~cell cycle arrest,GO:0007049~cell cycle,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0006974~cellular response to DNA damage stimulus,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006915~apoptotic process,GO:0006508~proteolysis,GO:0000278~mitotic cell cycle,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000077~DNA damage checkpoint,GO:0000075~cell cycle checkpoint,												GO:1905369~endopeptidase complex,GO:1905368~peptidase complex,GO:0005829~cytosol,GO:0005730~nucleolus,												GO:0070513~death domain binding,GO:0060090~binding, bridging,GO:0030674~protein binding, bridging,GO:0019904~protein domain specific binding,GO:0019899~enzyme binding,GO:0002020~protease binding,												IPR042148:CARD_RAIDD,IPR037939:CRADD,IPR037926:CRADD_Death,IPR011029:DEATH-like_dom_sf,IPR001315:CARD,IPR000488:Death_domain,													614499~Intellectual developmental disorder, autosomal recessive 34, with variant lissencephaly,													SM00114:CARD,SM00005:DEATH,												REGION:Disordered,MUTAGEN:Y->A: Loss of interaction with PIDD1. Decreased PIDDosome assembly. Decreased CASP2 activation.,MUTAGEN:V->W,D: No effect on interaction with PIDD1.,MUTAGEN:V->D: Loss of interaction with PIDD1. Loss of PIDDosome assembly. Loss of CASP2 activation.,MUTAGEN:R->E: Loss of interaction with PIDD1. Loss of PIDDosome assembly. Loss of CASP2 activation.,MUTAGEN:R->A: Partial loss of interaction with PIDD1.,MUTAGEN:R->A: Loss of interaction with PIDD1. Decreased PIDDosome assembly. Decreased CASP2 activation.,MUTAGEN:Q->E: Partial loss of interaction with PIDD1.,MUTAGEN:Q->E: Loss of interaction with PIDD1.,MUTAGEN:Q->A: Partial loss of interaction with PIDD1. Decreased PIDDosome assembly. Decreased CASP2 activation.,MUTAGEN:Q->A: Loss of interaction with PIDD1.,MUTAGEN:N->D: Loss of interaction with PIDD1.,MUTAGEN:L->F: Loss of interaction with CASP2.,MUTAGEN:L->E: Partial loss of interaction with PIDD1.,MUTAGEN:K->E: Loss of interaction with PIDD1.,MUTAGEN:H->A: Partial loss of interaction with PIDD1.,MUTAGEN:G->A: Loss of interaction with CASP2.,MUTAGEN:E->K: No effect on interaction with PIDD1.,DOMAIN:Death,DOMAIN:CARD,COMPBIAS:Basic and acidic residues,
32469_at	CEA cell adhesion molecule 3(CEACAM3)	Homo sapiens			GO:0002682~regulation of immune system process,												GO:0099503~secretory vesicle,GO:0044433~cytoplasmic vesicle part,GO:0042581~specific granule,GO:0035579~specific granule membrane,GO:0030667~secretory granule membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0030141~secretory granule,GO:0012506~vesicle membrane,GO:0009986~cell surface,												GO:1990782~protein tyrosine kinase binding,GO:0019901~protein kinase binding,GO:0019900~kinase binding,GO:0019899~enzyme binding,												IPR036179:Ig-like_dom_sf,IPR013783:Ig-like_fold,IPR013106:Ig_V-set,																TRANSMEM:Helical,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,REGION:Disordered,MUTAGEN:Y->F: Loss of phosphorylation and 30% reduction in bacterial uptake. More than 60% reduction in bacterial uptake and loss of RAC1 stimulation; when associated with F-241.,MUTAGEN:Y->F: Loss of phosphorylation and 30% reduction in bacterial uptake. More than 60% reduction in bacterial uptake and loss of RAC1 stimulation; when associated with F-230.,DOMAIN:Immunoglobulin V-set,DOMAIN:Ig-like V-type,COMPBIAS:Polar residues,CARBOHYD:N-linked (GlcNAc...) asparagine,
33530_at	CEA cell adhesion molecule 8(CEACAM8)	Homo sapiens			GO:0098742~cell-cell adhesion via plasma-membrane adhesion molecules,GO:0098609~cell-cell adhesion,GO:0022610~biological adhesion,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007155~cell adhesion,GO:0006955~immune response,												GO:1903561~extracellular vesicle,GO:0099503~secretory vesicle,GO:0098852~lytic vacuole membrane,GO:0098552~side of membrane,GO:0070821~tertiary granule membrane,GO:0070820~tertiary granule,GO:0070062~extracellular exosome,GO:0044437~vacuolar part,GO:0044433~cytoplasmic vesicle part,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0042582~azurophil granule,GO:0042581~specific granule,GO:0035579~specific granule membrane,GO:0035577~azurophil granule membrane,GO:0030667~secretory granule membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0030141~secretory granule,GO:0012506~vesicle membrane,GO:0009986~cell surface,GO:0005774~vacuolar membrane,GO:0005773~vacuole,GO:0005766~primary lysosome,GO:0005765~lysosomal membrane,GO:0005764~lysosome,GO:0005615~extracellular space,GO:0005576~extracellular region,GO:0000323~lytic vacuole,												GO:0046983~protein dimerization activity,GO:0046982~protein heterodimerization activity,												IPR036179:Ig-like_dom_sf,IPR013783:Ig-like_fold,IPR013106:Ig_V-set,IPR007110:Ig-like_dom,IPR003599:Ig_sub,IPR003598:Ig_sub2,															SM00409:IG,SM00408:IGc2,												PROPEP:Removed in mature form,MUTAGEN:TVDA->RVDG: No effect on heterophilic cell adhesion.,MUTAGEN:SNQQI->GTQQA: No effect on heterophilic cell adhesion.,MUTAGEN:R->Q: Inhibits heterophilic cell adhesion.,MUTAGEN:R->A: Does not affect the monomeric structure. Loss of heterodimerization with CEACAM6.,MUTAGEN:Q->A: Does not affect the monomeric structure. Decreases heterodimerization with CEACAM6.,MUTAGEN:N->S: Inhibits heterophilic cell adhesion.,MUTAGEN:N->G: No effect on heterophilic cell adhesion.,MUTAGEN:L->A: Does not affect the monomeric structure. Loss of heterodimerization with CEACAM6.,MUTAGEN:DPR->NRI: No effect on heterophilic cell adhesion.,MUTAGEN:AVPSNA->STPFNV: No effect on heterophilic cell adhesion.,LIPID:GPI-anchor amidated aspartate,DOMAIN:Ig-like V-type,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like,CARBOHYD:N-linked (GlcNAc...) asparagine,
35595_at	CGRP receptor component(CRCP)	Homo sapiens			GO:0098542~defense response to other organism,GO:0097659~nucleic acid-templated transcription,GO:0051707~response to other organism,GO:0051607~defense response to virus,GO:0045087~innate immune response,GO:0044764~multi-organism cellular process,GO:0044419~interspecies interaction between organisms,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0043207~response to external biotic stimulus,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0019438~aromatic compound biosynthetic process,GO:0018130~heterocycle biosynthetic process,GO:0016070~RNA metabolic process,GO:0016032~viral process,GO:0010467~gene expression,GO:0009615~response to virus,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0007218~neuropeptide signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0006955~immune response,GO:0006952~defense response,GO:0006384~transcription initiation from RNA polymerase III promoter,GO:0006383~transcription from RNA polymerase III promoter,GO:0006352~DNA-templated transcription, initiation,GO:0006351~transcription, DNA-templated,GO:0002252~immune effector process,												GO:0099503~secretory vesicle,GO:0097223~sperm part,GO:0061695~transferase complex, transferring phosphorus-containing groups,GO:0055029~nuclear DNA-directed RNA polymerase complex,GO:0044451~nucleoplasm part,GO:0042575~DNA polymerase complex,GO:0030880~RNA polymerase complex,GO:0030141~secretory granule,GO:0009360~DNA polymerase III complex,GO:0005829~cytosol,GO:0005666~DNA-directed RNA polymerase III complex,GO:0005654~nucleoplasm,GO:0001669~acrosomal vesicle,GO:0000428~DNA-directed RNA polymerase complex,												GO:1901363~heterocyclic compound binding,GO:1901265~nucleoside phosphate binding,GO:0099600~transmembrane receptor activity,GO:0097747~RNA polymerase activity,GO:0097642~calcitonin family receptor activity,GO:0097159~organic cyclic compound binding,GO:0060089~molecular transducer activity,GO:0038023~signaling receptor activity,GO:0036094~small molecule binding,GO:0034062~5'-3' RNA polymerase activity,GO:0016779~nucleotidyltransferase activity,GO:0008528~G-protein coupled peptide receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0004872~receptor activity,GO:0004871~signal transducer activity,GO:0003899~DNA-directed 5'-3' RNA polymerase activity,GO:0001653~peptide receptor activity,GO:0001635~calcitonin gene-related peptide receptor activity,GO:0000166~nucleotide binding,												IPR038846:RPC9,IPR038324:Rpb4/RPC9_sf,IPR010997:HRDC-like_sf,IPR006590:RNA_pol_Rpb4/RPC9_core,IPR005574:Rpb4/RPC9,												hsa03020:RNA polymerase,														SM00657:RPOL4c,												REGION:Disordered,
37814_g_at	DEAD-box helicase 51(DDX51)	Homo sapiens			GO:0044085~cellular component biogenesis,GO:0042254~ribosome biogenesis,GO:0034660~ncRNA metabolic process,GO:0034470~ncRNA processing,GO:0022613~ribonucleoprotein complex biogenesis,GO:0016072~rRNA metabolic process,GO:0016070~RNA metabolic process,GO:0010467~gene expression,GO:0006396~RNA processing,GO:0006364~rRNA processing,												GO:0005730~nucleolus,												GO:1901363~heterocyclic compound binding,GO:1901265~nucleoside phosphate binding,GO:0097367~carbohydrate derivative binding,GO:0097159~organic cyclic compound binding,GO:0043168~anion binding,GO:0043167~ion binding,GO:0036094~small molecule binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0017111~nucleoside-triphosphatase activity,GO:0017076~purine nucleotide binding,GO:0016887~ATPase activity,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016462~pyrophosphatase activity,GO:0005524~ATP binding,GO:0004386~helicase activity,GO:0003724~RNA helicase activity,GO:0003723~RNA binding,GO:0003676~nucleic acid binding,GO:0000166~nucleotide binding,												IPR027417:P-loop_NTPase,IPR014001:Helicase_ATP-bd,IPR011545:DEAD/DEAH_box_helicase_dom,IPR001650:Helicase_C,IPR000629:RNA-helicase_DEAD-box_CS,															SM00490:HELICc,SM00487:DEXDc,												REGION:Disordered,MOTIF:Q motif,MOTIF:DEAD box,DOMAIN:Helicase C-terminal,DOMAIN:Helicase ATP-binding,COMPBIAS:Basic and acidic residues,
34249_at	EPM2A glucan phosphatase, laforin(EPM2A)	Homo sapiens			GO:1990778~protein localization to cell periphery,GO:1905475~regulation of protein localization to membrane,GO:1905114~cell surface receptor signaling pathway involved in cell-cell signaling,GO:1905037~autophagosome organization,GO:1904589~regulation of protein import,GO:1904375~regulation of protein localization to cell periphery,GO:1903827~regulation of cellular protein localization,GO:1903729~regulation of plasma membrane organization,GO:1903533~regulation of protein targeting,GO:1903362~regulation of cellular protein catabolic process,GO:1903320~regulation of protein modification by small protein conjugation or removal,GO:1903076~regulation of protein localization to plasma membrane,GO:1903050~regulation of proteolysis involved in cellular protein catabolic process,GO:1902532~negative regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:1900180~regulation of protein localization to nucleus,GO:0198738~cell-cell signaling by wnt,GO:0090087~regulation of peptide transport,GO:0072657~protein localization to membrane,GO:0072511~divalent inorganic cation transport,GO:0071705~nitrogen compound transport,GO:0070925~organelle assembly,GO:0070838~divalent metal ion transport,GO:0070727~cellular macromolecule localization,GO:0070647~protein modification by small protein conjugation or removal,GO:0070201~regulation of establishment of protein localization,GO:0065009~regulation of molecular function,GO:0061136~regulation of proteasomal protein catabolic process,GO:0061024~membrane organization,GO:0060341~regulation of cellular localization,GO:0055114~oxidation-reduction process,GO:0051726~regulation of cell cycle,GO:0051649~establishment of localization in cell,GO:0051641~cellular localization,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0051346~negative regulation of hydrolase activity,GO:0051336~regulation of hydrolase activity,GO:0051248~negative regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051223~regulation of protein transport,GO:0051174~regulation of phosphorus metabolic process,GO:0051169~nuclear transport,GO:0051128~regulation of cellular component organization,GO:0051049~regulation of transport,GO:0050890~cognition,GO:0050877~neurological system process,GO:0050790~regulation of catalytic activity,GO:0048585~negative regulation of response to stimulus,GO:0046959~habituation,GO:0046958~nonassociative learning,GO:0046942~carboxylic acid transport,GO:0046907~intracellular transport,GO:0046835~carbohydrate phosphorylation,GO:0046822~regulation of nucleocytoplasmic transport,GO:0045936~negative regulation of phosphate metabolic process,GO:0045786~negative regulation of cell cycle,GO:0045184~establishment of protein localization,GO:0044802~single-organism membrane organization,GO:0044723~single-organism carbohydrate metabolic process,GO:0044708~single-organism behavior,GO:0044265~cellular macromolecule catabolic process,GO:0044264~cellular polysaccharide metabolic process,GO:0044262~cellular carbohydrate metabolic process,GO:0044257~cellular protein catabolic process,GO:0044092~negative regulation of molecular function,GO:0044085~cellular component biogenesis,GO:0044042~glucan metabolic process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043086~negative regulation of catalytic activity,GO:0042886~amide transport,GO:0042326~negative regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0042306~regulation of protein import into nucleus,GO:0042176~regulation of protein catabolic process,GO:0042063~gliogenesis,GO:0040008~regulation of growth,GO:0040007~growth,GO:0036211~protein modification process,GO:0035556~intracellular signal transduction,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0035305~negative regulation of dephosphorylation,GO:0035303~regulation of dephosphorylation,GO:0034645~cellular macromolecule biosynthetic process,GO:0034637~cellular carbohydrate biosynthetic process,GO:0034613~cellular protein localization,GO:0034504~protein localization to nucleus,GO:0033692~cellular polysaccharide biosynthetic process,GO:0033365~protein localization to organelle,GO:0033157~regulation of intracellular protein transport,GO:0033137~negative regulation of peptidyl-serine phosphorylation,GO:0033135~regulation of peptidyl-serine phosphorylation,GO:0033036~macromolecule localization,GO:0032880~regulation of protein localization,GO:0032386~regulation of intracellular transport,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032007~negative regulation of TOR signaling,GO:0032006~regulation of TOR signaling,GO:0031929~TOR signaling,GO:0031400~negative regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031396~regulation of protein ubiquitination,GO:0031331~positive regulation of cellular catabolic process,GO:0031329~regulation of cellular catabolic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031324~negative regulation of cellular metabolic process,GO:0030163~protein catabolic process,GO:0030162~regulation of proteolysis,GO:0030001~metal ion transport,GO:0023057~negative regulation of signaling,GO:0023051~regulation of signaling,GO:0022607~cellular component assembly,GO:0022008~neurogenesis,GO:0019941~modification-dependent protein catabolic process,GO:0019220~regulation of phosphate metabolic process,GO:0018209~peptidyl-serine modification,GO:0018193~peptidyl-amino acid modification,GO:0018105~peptidyl-serine phosphorylation,GO:0017038~protein import,GO:0016311~dephosphorylation,GO:0016310~phosphorylation,GO:0016241~regulation of macroautophagy,GO:0016239~positive regulation of macroautophagy,GO:0016236~macroautophagy,GO:0016055~Wnt signaling pathway,GO:0016051~carbohydrate biosynthetic process,GO:0015980~energy derivation by oxidation of organic compounds,GO:0015849~organic acid transport,GO:0015833~peptide transport,GO:0015813~L-glutamate transport,GO:0015807~L-amino acid transport,GO:0015800~acidic amino acid transport,GO:0015711~organic anion transport,GO:0015031~protein transport,GO:0014009~glial cell proliferation,GO:0010923~negative regulation of phosphatase activity,GO:0010921~regulation of phosphatase activity,GO:0010648~negative regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010629~negative regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010563~negative regulation of phosphorus metabolic process,GO:0010508~positive regulation of autophagy,GO:0010506~regulation of autophagy,GO:0010498~proteasomal protein catabolic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010256~endomembrane system organization,GO:0009968~negative regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009896~positive regulation of catabolic process,GO:0009894~regulation of catabolic process,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0009250~glucan biosynthetic process,GO:0009057~macromolecule catabolic process,GO:0008283~cell proliferation,GO:0008104~protein localization,GO:0007612~learning,GO:0007611~learning or memory,GO:0007610~behavior,GO:0007399~nervous system development,GO:0007267~cell-cell signaling,GO:0007166~cell surface receptor signaling pathway,GO:0007049~cell cycle,GO:0007033~vacuole organization,GO:0007009~plasma membrane organization,GO:0007005~mitochondrion organization,GO:0006914~autophagy,GO:0006913~nucleocytoplasmic transport,GO:0006886~intracellular protein transport,GO:0006865~amino acid transport,GO:0006835~dicarboxylic acid transport,GO:0006820~anion transport,GO:0006816~calcium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006605~protein targeting,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006508~proteolysis,GO:0006470~protein dephosphorylation,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0006112~energy reserve metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006073~cellular glucan metabolic process,GO:0005978~glycogen biosynthetic process,GO:0005977~glycogen metabolic process,GO:0005976~polysaccharide metabolic process,GO:0005975~carbohydrate metabolic process,GO:0003008~system process,GO:0001933~negative regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,GO:0001558~regulation of cell growth,GO:0000271~polysaccharide biosynthetic process,GO:0000045~autophagosome assembly,												GO:0098562~cytoplasmic side of membrane,GO:0098556~cytoplasmic side of rough endoplasmic reticulum membrane,GO:0098554~cytoplasmic side of endoplasmic reticulum membrane,GO:0098552~side of membrane,GO:0097458~neuron part,GO:0044432~endoplasmic reticulum part,GO:0044297~cell body,GO:0043204~perikaryon,GO:0043025~neuronal cell body,GO:0043005~neuron projection,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0036477~somatodendritic compartment,GO:0030867~rough endoplasmic reticulum membrane,GO:0030425~dendrite,GO:0005829~cytosol,GO:0005791~rough endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005783~endoplasmic reticulum,GO:0005654~nucleoplasm,												GO:2001070~starch binding,GO:2001069~glycogen binding,GO:0046983~protein dimerization activity,GO:0046527~glucosyltransferase activity,GO:0042803~protein homodimerization activity,GO:0042802~identical protein binding,GO:0042578~phosphoric ester hydrolase activity,GO:0035251~UDP-glucosyltransferase activity,GO:0030247~polysaccharide binding,GO:0030246~carbohydrate binding,GO:0019203~carbohydrate phosphatase activity,GO:0017018~myosin phosphatase activity,GO:0016791~phosphatase activity,GO:0016758~transferase activity, transferring hexosyl groups,GO:0016757~transferase activity, transferring glycosyl groups,GO:0008194~UDP-glycosyltransferase activity,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0004721~phosphoprotein phosphatase activity,GO:0004373~glycogen (starch) synthase activity,GO:0001871~pattern binding,												IPR045204:DSP_laforin-like,IPR042942:Laforin,IPR034831:CBM20_laforin,IPR029021:Prot-tyrosine_phosphatase-like,IPR020422:TYR_PHOSPHATASE_DUAL_dom,IPR016130:Tyr_Pase_AS,IPR013784:Carb-bd-like_fold,IPR013783:Ig-like_fold,IPR002044:CBM_fam20,IPR000387:Tyr_Pase_dom,IPR000340:Dual-sp_phosphatase_cat-dom,													254780~Myoclonic epilepsy of Lafora 1,													SM01065:CBM_2,SM00195:DSPc,												SITE:Required for homodimerization,REGION:Disordered,MUTAGEN:W->A: Strongly reduces phosphatase activity. Strongly reduces glycogen binding.,MUTAGEN:V->A: Loss of phosphatase activity. No effect on glycogen binding.,MUTAGEN:T->D: Does not affect interaction with NHLRC1, PPP1R3C or PRKAA2.,MUTAGEN:T->D: Abolishes interaction with NHLRC1.,MUTAGEN:T->A: Strongly decreased phosphatase activity. No effect on glycogen binding.,MUTAGEN:S->D: Partial loss of phosphatase activity. Increases interaction with NHLRC1. Does not affect interaction with NHLRC1, PPP1R3C or PRKAA2. Does not affect binding to carbohydrate. Does not affect homodimerization.,MUTAGEN:S->A: Partial loss of phosphatase activity. Abolishes homodimerization. Abolishes interaction with NHLRC1, PPP1R3C and PRKAA2. Does not affect glycogen binding. Reduces stability of the protein.,MUTAGEN:S->A,D: Abolishes interaction with NHLRC1.,MUTAGEN:R->A: No effect on phosphatase activity.,MUTAGEN:R->A: Complete loss of phosphatase activity.,MUTAGEN:Missing: Fails to homodimerize. Does not affect carbohydrate binding or phosphatase activity.,MUTAGEN:M->A: Complete loss of phosphatase activity. No effect on glycogen binding.,MUTAGEN:L->A: Impairs protein stability. Strongly reduces phosphatase activity. No effect on glycogen binding.,MUTAGEN:K->A: Loss of phosphatase activity. Abolishes glycogen binding.,MUTAGEN:I->T: Strongly decreased phosphatase activity. No effect on glycogen binding.,MUTAGEN:F->S: Impairs protein stability. Strongly reduces phosphatase activity. No effect on glycogen binding.,MUTAGEN:D->A: Strongly decreased phosphatase activity. No effect on glycogen binding.,MUTAGEN:D->A: Complete loss of phosphatase activity. Does not affect glycogen binding.,MUTAGEN:CC->SS: No effect on homodimerization or carbohydrate binding. Decreased phosphatase activity.,MUTAGEN:C->S: No effect on phosphatase activity.,MUTAGEN:C->S: No effect on homodimerization.,MUTAGEN:C->S: No effect on homodimerization or carbohydrate binding. Decreased phosphatase activity.,MUTAGEN:C->S: Fails to homodimerize. Does not affect carbohydrate binding, interaction with NHLRC1, phosphatase activity, or ubiquitination by NHLRC1.,MUTAGEN:C->S: Complete loss of phosphatase activity. Does not affect glycogen binding. Does not affect self-interaction. Increases the interaction with PPP1R3C.,MOTIF:Glucan phosphatase signature motif CXAGXGR,DOMAIN:Tyrosine-protein phosphatase,DOMAIN:CBM20,ACT_SITE:Phosphocysteine intermediate,
32148_at	FERM, ARH/RhoGEF and pleckstrin domain protein 1(FARP1)	Homo sapiens			GO:1905606~regulation of presynapse assembly,GO:1905477~positive regulation of protein localization to membrane,GO:1905475~regulation of protein localization to membrane,GO:1904398~positive regulation of neuromuscular junction development,GO:1904396~regulation of neuromuscular junction development,GO:1904395~positive regulation of skeletal muscle acetylcholine-gated channel clustering,GO:1904393~regulation of skeletal muscle acetylcholine-gated channel clustering,GO:1903911~positive regulation of receptor clustering,GO:1903909~regulation of receptor clustering,GO:1903829~positive regulation of cellular protein localization,GO:1903827~regulation of cellular protein localization,GO:1902589~single-organism organelle organization,GO:1901628~positive regulation of postsynaptic membrane organization,GO:1901626~regulation of postsynaptic membrane organization,GO:0099545~trans-synaptic signaling by trans-synaptic complex,GO:0099537~trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0098974~postsynaptic actin cytoskeleton organization,GO:0098942~retrograde trans-synaptic signaling by trans-synaptic protein complex,GO:0098917~retrograde trans-synaptic signaling,GO:0072657~protein localization to membrane,GO:0071340~skeletal muscle acetylcholine-gated channel clustering,GO:0070727~cellular macromolecule localization,GO:0061024~membrane organization,GO:0060341~regulation of cellular localization,GO:0051963~regulation of synapse assembly,GO:0051960~regulation of nervous system development,GO:0051668~localization within membrane,GO:0051641~cellular localization,GO:0051130~positive regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0050808~synapse organization,GO:0050807~regulation of synapse organization,GO:0050803~regulation of synapse structure or activity,GO:0048858~cell projection morphogenesis,GO:0048813~dendrite morphogenesis,GO:0048812~neuron projection morphogenesis,GO:0048699~generation of neurons,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048666~neuron development,GO:0048468~cell development,GO:0044802~single-organism membrane organization,GO:0044087~regulation of cellular component biogenesis,GO:0044085~cellular component biogenesis,GO:0043113~receptor clustering,GO:0035556~intracellular signal transduction,GO:0034613~cellular protein localization,GO:0033036~macromolecule localization,GO:0032990~cell part morphogenesis,GO:0032989~cellular component morphogenesis,GO:0032880~regulation of protein localization,GO:0031175~neuron projection development,GO:0030182~neuron differentiation,GO:0030036~actin cytoskeleton organization,GO:0030030~cell projection organization,GO:0030029~actin filament-based process,GO:0022607~cellular component assembly,GO:0022008~neurogenesis,GO:0016601~Rac protein signal transduction,GO:0016358~dendrite development,GO:0008104~protein localization,GO:0007528~neuromuscular junction development,GO:0007416~synapse assembly,GO:0007399~nervous system development,GO:0007267~cell-cell signaling,GO:0007265~Ras protein signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0007010~cytoskeleton organization,GO:0001941~postsynaptic membrane organization,GO:0000904~cell morphogenesis involved in differentiation,GO:0000902~cell morphogenesis,												GO:0098978~glutamatergic synapse,GO:0098890~extrinsic component of postsynaptic membrane,GO:0098858~actin-based cell projection,GO:0098794~postsynapse,GO:0098590~plasma membrane region,GO:0098562~cytoplasmic side of membrane,GO:0098552~side of membrane,GO:0097458~neuron part,GO:0097060~synaptic membrane,GO:0045211~postsynaptic membrane,GO:0045202~synapse,GO:0044456~synapse part,GO:0044309~neuron spine,GO:0043197~dendritic spine,GO:0043005~neuron projection,GO:0036477~somatodendritic compartment,GO:0030425~dendrite,GO:0030175~filopodium,GO:0019898~extrinsic component of membrane,GO:0019897~extrinsic component of plasma membrane,GO:0009898~cytoplasmic side of plasma membrane,GO:0005829~cytosol,												GO:0098772~molecular function regulator,GO:0051020~GTPase binding,GO:0031267~small GTPase binding,GO:0019899~enzyme binding,GO:0008092~cytoskeletal protein binding,GO:0005085~guanyl-nucleotide exchange factor activity,												IPR041788:FARP1/FARP2/FRMD7_FERM_C,IPR035963:FERM_2,IPR035899:DBL_dom_sf,IPR029071:Ubiquitin-like_domsf,IPR019749:Band_41_domain,IPR019748:FERM_central,IPR019747:FERM_CS,IPR018980:FERM_PH-like_C,IPR018979:FERM_N,IPR014847:FA,IPR014352:FERM/acyl-CoA-bd_prot_sf,IPR011993:PH-like_dom_sf,IPR001849:PH_domain,IPR000798:Ez/rad/moesin-like,IPR000299:FERM_domain,IPR000219:DH-domain,															SM01196:FERM_C,SM01195:FA,SM00325:RhoGEF,SM00295:B41,SM00233:PH,												REGION:Disordered,DOMAIN:PH 2,DOMAIN:PH 1,DOMAIN:PH,DOMAIN:FERM,DOMAIN:DH,COMPBIAS:Polar residues,COMPBIAS:Basic and acidic residues,
33293_at	Fas apoptotic inhibitory molecule 2(FAIM2)	Homo sapiens			GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,GO:2001236~regulation of extrinsic apoptotic signaling pathway,GO:2001234~negative regulation of apoptotic signaling pathway,GO:2001233~regulation of apoptotic signaling pathway,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1901215~negative regulation of neuron death,GO:1901214~regulation of neuron death,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097190~apoptotic signaling pathway,GO:0070997~neuron death,GO:0060548~negative regulation of cell death,GO:0060322~head development,GO:0051402~neuron apoptotic process,GO:0048699~generation of neurons,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048585~negative regulation of response to stimulus,GO:0043524~negative regulation of neuron apoptotic process,GO:0043523~regulation of neuron apoptotic process,GO:0043069~negative regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptotic process,GO:0042981~regulation of apoptotic process,GO:0030902~hindbrain development,GO:0030182~neuron differentiation,GO:0023057~negative regulation of signaling,GO:0023051~regulation of signaling,GO:0022037~metencephalon development,GO:0022008~neurogenesis,GO:0021953~central nervous system neuron differentiation,GO:0021702~cerebellar Purkinje cell differentiation,GO:0021697~cerebellar cortex formation,GO:0021696~cerebellar cortex morphogenesis,GO:0021695~cerebellar cortex development,GO:0021694~cerebellar Purkinje cell layer formation,GO:0021692~cerebellar Purkinje cell layer morphogenesis,GO:0021681~cerebellar granular layer development,GO:0021680~cerebellar Purkinje cell layer development,GO:0021587~cerebellum morphogenesis,GO:0021575~hindbrain morphogenesis,GO:0021549~cerebellum development,GO:0021533~cell differentiation in hindbrain,GO:0012501~programmed cell death,GO:0010941~regulation of cell death,GO:0010648~negative regulation of cell communication,GO:0010646~regulation of cell communication,GO:0009968~negative regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0008219~cell death,GO:0007420~brain development,GO:0007417~central nervous system development,GO:0007399~nervous system development,GO:0007166~cell surface receptor signaling pathway,GO:0006915~apoptotic process,GO:0002931~response to ischemia,												GO:0098857~membrane microdomain,GO:0098794~postsynapse,GO:0098590~plasma membrane region,GO:0098589~membrane region,GO:0097060~synaptic membrane,GO:0045211~postsynaptic membrane,GO:0045202~synapse,GO:0045121~membrane raft,GO:0044456~synapse part,GO:0005794~Golgi apparatus,GO:0005783~endoplasmic reticulum,													IPR006214:Bax_inhibitor_1-related,																TRANSMEM:Helical,REGION:Disordered,COMPBIAS:Polar residues,CARBOHYD:N-linked (GlcNAc...) asparagine,
37905_r_at	G protein nucleolar 1 (putative)(GNL1)	Homo sapiens			GO:0033554~cellular response to stress,GO:0006974~cellular response to DNA damage stimulus,GO:0006955~immune response,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002456~T cell mediated immunity,GO:0002449~lymphocyte mediated immunity,GO:0002443~leukocyte mediated immunity,GO:0002252~immune effector process,GO:0002250~adaptive immune response,												GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:1901363~heterocyclic compound binding,GO:1901265~nucleoside phosphate binding,GO:0097367~carbohydrate derivative binding,GO:0097159~organic cyclic compound binding,GO:0043168~anion binding,GO:0043167~ion binding,GO:0036094~small molecule binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0032561~guanyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0032550~purine ribonucleoside binding,GO:0032549~ribonucleoside binding,GO:0019001~guanyl nucleotide binding,GO:0017111~nucleoside-triphosphatase activity,GO:0017076~purine nucleotide binding,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016462~pyrophosphatase activity,GO:0005525~GTP binding,GO:0005198~structural molecule activity,GO:0003924~GTPase activity,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000166~nucleotide binding,												IPR043358:GNL1-like,IPR030378:G_CP_dom,IPR027417:P-loop_NTPase,IPR006073:GTP-bd,																REGION:Disordered,DOMAIN:G,DOMAIN:CP-type G,COMPBIAS:Basic and acidic residues,COMPBIAS:Acidic residues,
919_at	G protein subunit alpha 12(GNA12)	Homo sapiens		h_par1pathway:Thrombin signaling and protease-activated receptors,h_myosinPathway:PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase,h_akap13Pathway:Rho-Selective Guanine Exchange Factor AKAP13 Mediates Stress Fiber Formation,												GO:2000146~negative regulation of cell motility,GO:2000145~regulation of cell motility,GO:1990874~vascular smooth muscle cell proliferation,GO:1904753~negative regulation of vascular associated smooth muscle cell migration,GO:1904752~regulation of vascular associated smooth muscle cell migration,GO:1904738~vascular associated smooth muscle cell migration,GO:1904706~negative regulation of vascular smooth muscle cell proliferation,GO:1904705~regulation of vascular smooth muscle cell proliferation,GO:1903362~regulation of cellular protein catabolic process,GO:1903050~regulation of proteolysis involved in cellular protein catabolic process,GO:1902531~regulation of intracellular signal transduction,GO:0065009~regulation of molecular function,GO:0061136~regulation of proteasomal protein catabolic process,GO:0060173~limb development,GO:0051674~localization of cell,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0051345~positive regulation of hydrolase activity,GO:0051336~regulation of hydrolase activity,GO:0051271~negative regulation of cellular component movement,GO:0051270~regulation of cellular component movement,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051128~regulation of cellular component organization,GO:0050878~regulation of body fluid levels,GO:0050817~coagulation,GO:0050790~regulation of catalytic activity,GO:0048870~cell motility,GO:0048736~appendage development,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048659~smooth muscle cell proliferation,GO:0048598~embryonic morphogenesis,GO:0045937~positive regulation of phosphate metabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044093~positive regulation of molecular function,GO:0043666~regulation of phosphoprotein phosphatase activity,GO:0043085~positive regulation of catalytic activity,GO:0043009~chordate embryonic development,GO:0042733~embryonic digit morphogenesis,GO:0042176~regulation of protein catabolic process,GO:0042127~regulation of cell proliferation,GO:0042060~wound healing,GO:0040013~negative regulation of locomotion,GO:0040012~regulation of locomotion,GO:0040011~locomotion,GO:0036211~protein modification process,GO:0035556~intracellular signal transduction,GO:0035307~positive regulation of protein dephosphorylation,GO:0035306~positive regulation of dephosphorylation,GO:0035304~regulation of protein dephosphorylation,GO:0035303~regulation of dephosphorylation,GO:0035113~embryonic appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035107~appendage morphogenesis,GO:0033002~muscle cell proliferation,GO:0032989~cellular component morphogenesis,GO:0032516~positive regulation of phosphoprotein phosphatase activity,GO:0032434~regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032006~regulation of TOR signaling,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031329~regulation of cellular catabolic process,GO:0031325~positive regulation of cellular metabolic process,GO:0030336~negative regulation of cell migration,GO:0030334~regulation of cell migration,GO:0030326~embryonic limb morphogenesis,GO:0030163~protein catabolic process,GO:0030162~regulation of proteolysis,GO:0023051~regulation of signaling,GO:0022604~regulation of cell morphogenesis,GO:0022603~regulation of anatomical structure morphogenesis,GO:0019220~regulation of phosphate metabolic process,GO:0016477~cell migration,GO:0016311~dephosphorylation,GO:0014912~negative regulation of smooth muscle cell migration,GO:0014910~regulation of smooth muscle cell migration,GO:0014909~smooth muscle cell migration,GO:0014812~muscle cell migration,GO:0010922~positive regulation of phosphatase activity,GO:0010921~regulation of phosphatase activity,GO:0010762~regulation of fibroblast migration,GO:0010646~regulation of cell communication,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010498~proteasomal protein catabolic process,GO:0009966~regulation of signal transduction,GO:0009894~regulation of catabolic process,GO:0009893~positive regulation of metabolic process,GO:0009792~embryo development ending in birth or egg hatching,GO:0009790~embryo development,GO:0009611~response to wounding,GO:0009410~response to xenobiotic stimulus,GO:0009057~macromolecule catabolic process,GO:0008360~regulation of cell shape,GO:0008285~negative regulation of cell proliferation,GO:0008283~cell proliferation,GO:0008217~regulation of blood pressure,GO:0008015~blood circulation,GO:0007599~hemostasis,GO:0007596~blood coagulation,GO:0007266~Rho protein signal transduction,GO:0007265~Ras protein signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007186~G-protein coupled receptor signaling pathway,GO:0006928~movement of cell or subcellular component,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006508~proteolysis,GO:0006470~protein dephosphorylation,GO:0006464~cellular protein modification process,GO:0003013~circulatory system process,GO:0003008~system process,GO:0001701~in utero embryonic development,GO:0000902~cell morphogenesis,												GO:1905360~GTPase complex,GO:0098862~cluster of actin-based cell projections,GO:0098590~plasma membrane region,GO:0098562~cytoplasmic side of membrane,GO:0098552~side of membrane,GO:0097458~neuron part,GO:0070161~anchoring junction,GO:0044297~cell body,GO:0043025~neuronal cell body,GO:0043005~neuron projection,GO:0036477~somatodendritic compartment,GO:0031526~brush border membrane,GO:0031253~cell projection membrane,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0030055~cell-substrate junction,GO:0030054~cell junction,GO:0019898~extrinsic component of membrane,GO:0019897~extrinsic component of plasma membrane,GO:0016328~lateral plasma membrane,GO:0009898~cytoplasmic side of plasma membrane,GO:0005925~focal adhesion,GO:0005924~cell-substrate adherens junction,GO:0005912~adherens junction,GO:0005903~brush border,GO:0005834~heterotrimeric G-protein complex,												GO:1901363~heterocyclic compound binding,GO:1901265~nucleoside phosphate binding,GO:0098772~molecular function regulator,GO:0097367~carbohydrate derivative binding,GO:0097159~organic cyclic compound binding,GO:0051721~protein phosphatase 2A binding,GO:0050780~dopamine receptor binding,GO:0046872~metal ion binding,GO:0044877~macromolecular complex binding,GO:0043169~cation binding,GO:0043168~anion binding,GO:0043167~ion binding,GO:0036094~small molecule binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0032561~guanyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0032550~purine ribonucleoside binding,GO:0032549~ribonucleoside binding,GO:0032403~protein complex binding,GO:0031752~D5 dopamine receptor binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0030234~enzyme regulator activity,GO:0019903~protein phosphatase binding,GO:0019902~phosphatase binding,GO:0019899~enzyme binding,GO:0019888~protein phosphatase regulator activity,GO:0019208~phosphatase regulator activity,GO:0019001~guanyl nucleotide binding,GO:0017111~nucleoside-triphosphatase activity,GO:0017076~purine nucleotide binding,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016462~pyrophosphatase activity,GO:0005525~GTP binding,GO:0005102~receptor binding,GO:0003924~GTPase activity,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0001664~G-protein coupled receptor binding,GO:0000166~nucleotide binding,												IPR027417:P-loop_NTPase,IPR011025:GproteinA_insert,IPR001019:Gprotein_alpha_su,IPR000469:Gprotein_alpha_12/13,												hsa05200:Pathways in cancer,hsa05163:Human cytomegalovirus infection,hsa05130:Pathogenic Escherichia coli infection,hsa04928:Parathyroid hormone synthesis, secretion and action,hsa04810:Regulation of actin cytoskeleton,hsa04730:Long-term depression,hsa04270:Vascular smooth muscle contraction,hsa04072:Phospholipase D signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04010:MAPK signaling pathway,														SM00275:G_alpha,												REGION:G5 motif,REGION:G4 motif,REGION:G3 motif,REGION:G2 motif,REGION:G1 motif,LIPID:S-palmitoyl cysteine,DOMAIN:G-alpha,
38103_at	GRB10 interacting GYF protein 2(GIGYF2)	Homo sapiens			GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000045~regulation of G1/S transition of mitotic cell cycle,GO:1903047~mitotic cell cycle process,GO:1902807~negative regulation of cell cycle G1/S phase transition,GO:1902806~regulation of cell cycle G1/S phase transition,GO:1901991~negative regulation of mitotic cell cycle phase transition,GO:1901990~regulation of mitotic cell cycle phase transition,GO:1901988~negative regulation of cell cycle phase transition,GO:1901987~regulation of cell cycle phase transition,GO:1901566~organonitrogen compound biosynthetic process,GO:0080134~regulation of response to stress,GO:0072344~rescue of stalled ribosome,GO:0071357~cellular response to type I interferon,GO:0071345~cellular response to cytokine stimulus,GO:0071310~cellular response to organic substance,GO:0070887~cellular response to chemical stimulus,GO:0061157~mRNA destabilization,GO:0060761~negative regulation of response to cytokine stimulus,GO:0060759~regulation of response to cytokine stimulus,GO:0060339~negative regulation of type I interferon-mediated signaling pathway,GO:0060338~regulation of type I interferon-mediated signaling pathway,GO:0060337~type I interferon signaling pathway,GO:0060249~anatomical structure homeostasis,GO:0051726~regulation of cell cycle,GO:0051248~negative regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0050905~neuromuscular process,GO:0050885~neuromuscular process controlling balance,GO:0050881~musculoskeletal movement,GO:0050879~multicellular organismal movement,GO:0050877~neurological system process,GO:0050779~RNA destabilization,GO:0050777~negative regulation of immune response,GO:0050776~regulation of immune response,GO:0048873~homeostasis of number of cells within a tissue,GO:0048872~homeostasis of number of cells,GO:0048871~multicellular organismal homeostasis,GO:0048699~generation of neurons,GO:0048589~developmental growth,GO:0048585~negative regulation of response to stimulus,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0045947~negative regulation of translational initiation,GO:0045930~negative regulation of mitotic cell cycle,GO:0045824~negative regulation of innate immune response,GO:0045786~negative regulation of cell cycle,GO:0045088~regulation of innate immune response,GO:0045087~innate immune response,GO:0044843~cell cycle G1/S phase transition,GO:0044819~mitotic G1/S transition checkpoint,GO:0044783~G1 DNA damage checkpoint,GO:0044774~mitotic DNA integrity checkpoint,GO:0044773~mitotic DNA damage checkpoint,GO:0044772~mitotic cell cycle phase transition,GO:0044770~cell cycle phase transition,GO:0044708~single-organism behavior,GO:0043604~amide biosynthetic process,GO:0043603~cellular amide metabolic process,GO:0043488~regulation of mRNA stability,GO:0043487~regulation of RNA stability,GO:0043043~peptide biosynthetic process,GO:0042592~homeostatic process,GO:0040029~regulation of gene expression, epigenetic,GO:0040007~growth,GO:0035264~multicellular organism growth,GO:0034645~cellular macromolecule biosynthetic process,GO:0034340~response to type I interferon,GO:0034249~negative regulation of cellular amide metabolic process,GO:0034248~regulation of cellular amide metabolic process,GO:0034097~response to cytokine,GO:0033554~cellular response to stress,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0031571~mitotic G1 DNA damage checkpoint,GO:0031570~DNA integrity checkpoint,GO:0031348~negative regulation of defense response,GO:0031347~regulation of defense response,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031324~negative regulation of cellular metabolic process,GO:0030534~adult behavior,GO:0030182~neuron differentiation,GO:0023057~negative regulation of signaling,GO:0023051~regulation of signaling,GO:0022402~cell cycle process,GO:0022008~neurogenesis,GO:0021953~central nervous system neuron differentiation,GO:0021522~spinal cord motor neuron differentiation,GO:0021517~ventral spinal cord development,GO:0021515~cell differentiation in spinal cord,GO:0021510~spinal cord development,GO:0019221~cytokine-mediated signaling pathway,GO:0017148~negative regulation of translation,GO:0016458~gene silencing,GO:0016441~posttranscriptional gene silencing,GO:0010948~negative regulation of cell cycle process,GO:0010648~negative regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010629~negative regulation of gene expression,GO:0010608~posttranscriptional regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010564~regulation of cell cycle process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010033~response to organic substance,GO:0009968~negative regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009892~negative regulation of metabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0009791~post-embryonic development,GO:0008344~adult locomotory behavior,GO:0007631~feeding behavior,GO:0007626~locomotory behavior,GO:0007610~behavior,GO:0007417~central nervous system development,GO:0007399~nervous system development,GO:0007346~regulation of mitotic cell cycle,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0007093~mitotic cell cycle checkpoint,GO:0007049~cell cycle,GO:0006974~cellular response to DNA damage stimulus,GO:0006955~immune response,GO:0006952~defense response,GO:0006518~peptide metabolic process,GO:0006446~regulation of translational initiation,GO:0006417~regulation of translation,GO:0006414~translational elongation,GO:0006413~translational initiation,GO:0006412~translation,GO:0003008~system process,GO:0002683~negative regulation of immune system process,GO:0002682~regulation of immune system process,GO:0001960~negative regulation of cytokine-mediated signaling pathway,GO:0001959~regulation of cytokine-mediated signaling pathway,GO:0001894~tissue homeostasis,GO:0000278~mitotic cell cycle,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000077~DNA damage checkpoint,GO:0000075~cell cycle checkpoint,												GO:1990904~ribonucleoprotein complex,GO:1990635~proximal dendrite,GO:0097458~neuron part,GO:0044297~cell body,GO:0043204~perikaryon,GO:0043025~neuronal cell body,GO:0043005~neuron projection,GO:0036477~somatodendritic compartment,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0035770~ribonucleoprotein granule,GO:0030529~intracellular ribonucleoprotein complex,GO:0030425~dendrite,GO:0010494~cytoplasmic stress granule,GO:0005829~cytosol,GO:0005794~Golgi apparatus,GO:0005783~endoplasmic reticulum,GO:0005768~endosome,												GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0070064~proline-rich region binding,GO:0060090~binding, bridging,GO:0050839~cell adhesion molecule binding,GO:0045296~cadherin binding,GO:0003723~RNA binding,GO:0003676~nucleic acid binding,												IPR035445:GYF-like_dom_sf,IPR003169:GYF,													607688~Parkinson disease 11,													SM00444:GYF,												REGION:Required for interaction with SARS-CoV-2 non-structural protein 2 (nsp2),REGION:Required for GRB10-binding,REGION:Disordered,MUTAGEN:YRYGREEML->ARAGREEAA: Abolishes interaction with EIF4E2.,MUTAGEN:W->A: Abolishes interaction with DDX6.,MUTAGEN:F->A: Abolishes interaction with DDX6; when associated with A-306.,MUTAGEN:F->A: Abolishes interaction with DDX6; when associated with A-300.,MOTIF:DDX6 binding motif,MOTIF:4EHP-binding motif,DOMAIN:GYF,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),COMPBIAS:Polar residues,COMPBIAS:Basic and acidic residues,
34703_f_at	HHLA1 neighbor of OC90(HHLA1)	Homo sapiens				GO:0005576~extracellular region,													IPR037643:HHLA1,																REGION:Disordered,COMPBIAS:Polar residues,CARBOHYD:N-linked (GlcNAc...) asparagine,
39698_at	HOP homeobox(HOPX)	Homo sapiens		h_hopPathway:Hop Pathway in Cardiac Development,												GO:2001141~regulation of RNA biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1903598~positive regulation of gap junction assembly,GO:1903596~regulation of gap junction assembly,GO:1903522~regulation of blood circulation,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903036~positive regulation of response to wounding,GO:1903034~regulation of response to wounding,GO:1902679~negative regulation of RNA biosynthetic process,GO:1901890~positive regulation of cell junction assembly,GO:1901888~regulation of cell junction assembly,GO:0097659~nucleic acid-templated transcription,GO:0090303~positive regulation of wound healing,GO:0080134~regulation of response to stress,GO:0072359~circulatory system development,GO:0071822~protein complex subunit organization,GO:0070271~protein complex biogenesis,GO:0065003~macromolecular complex assembly,GO:0061061~muscle structure development,GO:0061041~regulation of wound healing,GO:0060541~respiratory system development,GO:0060537~muscle tissue development,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051155~positive regulation of striated muscle cell differentiation,GO:0051153~regulation of striated muscle cell differentiation,GO:0051149~positive regulation of muscle cell differentiation,GO:0051147~regulation of muscle cell differentiation,GO:0051146~striated muscle cell differentiation,GO:0051131~chaperone-mediated protein complex assembly,GO:0051130~positive regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051094~positive regulation of developmental process,GO:0051093~negative regulation of developmental process,GO:0048738~cardiac muscle tissue development,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048639~positive regulation of developmental growth,GO:0048638~regulation of developmental growth,GO:0048589~developmental growth,GO:0048584~positive regulation of response to stimulus,GO:0048286~lung alveolus development,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045927~positive regulation of growth,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045597~positive regulation of cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0045216~cell-cell junction organization,GO:0044089~positive regulation of cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044085~cellular component biogenesis,GO:0044057~regulation of system process,GO:0043933~macromolecular complex subunit organization,GO:0043623~cellular protein complex assembly,GO:0043416~regulation of skeletal muscle tissue regeneration,GO:0043415~positive regulation of skeletal muscle tissue regeneration,GO:0043403~skeletal muscle tissue regeneration,GO:0043009~chordate embryonic development,GO:0042692~muscle cell differentiation,GO:0042246~tissue regeneration,GO:0042060~wound healing,GO:0040008~regulation of growth,GO:0040007~growth,GO:0035295~tube development,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034622~cellular macromolecular complex assembly,GO:0034330~cell junction organization,GO:0034329~cell junction assembly,GO:0032774~RNA biosynthetic process,GO:0032101~regulation of response to external stimulus,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031324~negative regulation of cellular metabolic process,GO:0031099~regeneration,GO:0030324~lung development,GO:0030323~respiratory tube development,GO:0022607~cellular component assembly,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016264~gap junction assembly,GO:0016070~RNA metabolic process,GO:0014706~striated muscle tissue development,GO:0010629~negative regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0009892~negative regulation of metabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0009792~embryo development ending in birth or egg hatching,GO:0009790~embryo development,GO:0009611~response to wounding,GO:0009605~response to external stimulus,GO:0008016~regulation of heart contraction,GO:0008015~blood circulation,GO:0007507~heart development,GO:0007043~cell-cell junction assembly,GO:0006461~protein complex assembly,GO:0006366~transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0003229~ventricular cardiac muscle tissue development,GO:0003166~bundle of His development,GO:0003164~His-Purkinje system development,GO:0003161~cardiac conduction system development,GO:0003013~circulatory system process,GO:0003008~system process,GO:0001829~trophectodermal cell differentiation,GO:0001825~blastocyst formation,GO:0001824~blastocyst development,GO:0001701~in utero embryonic development,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,												GO:0044427~chromosomal part,GO:0005694~chromosome,GO:0000785~chromatin,												GO:1901363~heterocyclic compound binding,GO:0098772~molecular function regulator,GO:0097159~organic cyclic compound binding,GO:0035033~histone deacetylase regulator activity,GO:0030234~enzyme regulator activity,GO:0003677~DNA binding,GO:0003676~nucleic acid binding,												IPR039162:HOPX,IPR009057:Homeobox-like_sf,IPR001356:Homeobox_dom,															SM00389:HOX,												DNA_BIND:Homeobox; degenerate,
34618_at	Indian hedgehog signaling molecule(IHH)	Homo sapiens			GO:2001141~regulation of RNA biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1903708~positive regulation of hemopoiesis,GO:1903707~negative regulation of hemopoiesis,GO:1903706~regulation of hemopoiesis,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903039~positive regulation of leukocyte cell-cell adhesion,GO:1903038~negative regulation of leukocyte cell-cell adhesion,GO:1903037~regulation of leukocyte cell-cell adhesion,GO:1902680~positive regulation of RNA biosynthetic process,GO:1902107~positive regulation of leukocyte differentiation,GO:1902106~negative regulation of leukocyte differentiation,GO:1902105~regulation of leukocyte differentiation,GO:1901700~response to oxygen-containing compound,GO:1901135~carbohydrate derivative metabolic process,GO:0098609~cell-cell adhesion,GO:0098602~single organism cell adhesion,GO:0097659~nucleic acid-templated transcription,GO:0097421~liver regeneration,GO:0097264~self proteolysis,GO:0090596~sensory organ morphogenesis,GO:0090136~epithelial cell-cell adhesion,GO:0085029~extracellular matrix assembly,GO:0072498~embryonic skeletal joint development,GO:0072359~circulatory system development,GO:0072358~cardiovascular system development,GO:0070664~negative regulation of leukocyte proliferation,GO:0070663~regulation of leukocyte proliferation,GO:0070661~leukocyte proliferation,GO:0061448~connective tissue development,GO:0061371~determination of heart left/right asymmetry,GO:0061138~morphogenesis of a branching epithelium,GO:0061053~somite development,GO:0061037~negative regulation of cartilage development,GO:0061035~regulation of cartilage development,GO:0061008~hepaticobiliary system development,GO:0060562~epithelial tube morphogenesis,GO:0060548~negative regulation of cell death,GO:0060537~muscle tissue development,GO:0060429~epithelium development,GO:0060351~cartilage development involved in endochondral bone morphogenesis,GO:0060350~endochondral bone morphogenesis,GO:0060349~bone morphogenesis,GO:0060348~bone development,GO:0060323~head morphogenesis,GO:0060322~head development,GO:0060249~anatomical structure homeostasis,GO:0060220~camera-type eye photoreceptor cell fate commitment,GO:0060219~camera-type eye photoreceptor cell differentiation,GO:0060173~limb development,GO:0060135~maternal process involved in female pregnancy,GO:0060042~retina morphogenesis in camera-type eye,GO:0060041~retina development in camera-type eye,GO:0055123~digestive system development,GO:0051604~protein maturation,GO:0051254~positive regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051251~positive regulation of lymphocyte activation,GO:0051250~negative regulation of lymphocyte activation,GO:0051249~regulation of lymphocyte activation,GO:0051241~negative regulation of multicellular organismal process,GO:0051240~positive regulation of multicellular organismal process,GO:0051216~cartilage development,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051094~positive regulation of developmental process,GO:0051093~negative regulation of developmental process,GO:0050870~positive regulation of T cell activation,GO:0050868~negative regulation of T cell activation,GO:0050867~positive regulation of cell activation,GO:0050866~negative regulation of cell activation,GO:0050865~regulation of cell activation,GO:0050863~regulation of T cell activation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0050673~epithelial cell proliferation,GO:0050672~negative regulation of lymphocyte proliferation,GO:0050670~regulation of lymphocyte proliferation,GO:0048871~multicellular organismal homeostasis,GO:0048771~tissue remodeling,GO:0048754~branching morphogenesis of an epithelial tube,GO:0048745~smooth muscle tissue development,GO:0048736~appendage development,GO:0048732~gland development,GO:0048729~tissue morphogenesis,GO:0048706~embryonic skeletal system development,GO:0048705~skeletal system morphogenesis,GO:0048699~generation of neurons,GO:0048666~neuron development,GO:0048663~neuron fate commitment,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048609~multicellular organismal reproductive process,GO:0048598~embryonic morphogenesis,GO:0048596~embryonic camera-type eye morphogenesis,GO:0048593~camera-type eye morphogenesis,GO:0048592~eye morphogenesis,GO:0048589~developmental growth,GO:0048584~positive regulation of response to stimulus,GO:0048568~embryonic organ development,GO:0048566~embryonic digestive tract development,GO:0048565~digestive tract development,GO:0048562~embryonic organ morphogenesis,GO:0048557~embryonic digestive tract morphogenesis,GO:0048546~digestive tract morphogenesis,GO:0048534~hematopoietic or lymphoid organ development,GO:0048514~blood vessel morphogenesis,GO:0048477~oogenesis,GO:0048469~cell maturation,GO:0048468~cell development,GO:0048086~negative regulation of developmental pigmentation,GO:0048074~negative regulation of eye pigmentation,GO:0048073~regulation of eye pigmentation,GO:0048070~regulation of developmental pigmentation,GO:0048069~eye pigmentation,GO:0048066~developmental pigmentation,GO:0048048~embryonic eye morphogenesis,GO:0046849~bone remodeling,GO:0046651~lymphocyte proliferation,GO:0046649~lymphocyte activation,GO:0046639~negative regulation of alpha-beta T cell differentiation,GO:0046638~positive regulation of alpha-beta T cell differentiation,GO:0046637~regulation of alpha-beta T cell differentiation,GO:0046636~negative regulation of alpha-beta T cell activation,GO:0046635~positive regulation of alpha-beta T cell activation,GO:0046634~regulation of alpha-beta T cell activation,GO:0046632~alpha-beta T cell differentiation,GO:0046631~alpha-beta T cell activation,GO:0046552~photoreceptor cell fate commitment,GO:0046530~photoreceptor cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045880~positive regulation of smoothened signaling pathway,GO:0045785~positive regulation of cell adhesion,GO:0045621~positive regulation of lymphocyte differentiation,GO:0045620~negative regulation of lymphocyte differentiation,GO:0045619~regulation of lymphocyte differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0045582~positive regulation of T cell differentiation,GO:0045581~negative regulation of T cell differentiation,GO:0045580~regulation of T cell differentiation,GO:0045453~bone resorption,GO:0045321~leukocyte activation,GO:0045165~cell fate commitment,GO:0044706~multi-multicellular organism process,GO:0044703~multi-organism reproductive process,GO:0044702~single organism reproductive process,GO:0044259~multicellular organismal macromolecule metabolic process,GO:0044253~positive regulation of multicellular organismal metabolic process,GO:0044246~regulation of multicellular organismal metabolic process,GO:0044236~multicellular organism metabolic process,GO:0044085~cellular component biogenesis,GO:0043473~pigmentation,GO:0043069~negative regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptotic process,GO:0043062~extracellular structure organization,GO:0043010~camera-type eye development,GO:0043009~chordate embryonic development,GO:0042981~regulation of apoptotic process,GO:0042733~embryonic digit morphogenesis,GO:0042706~eye photoreceptor cell fate commitment,GO:0042592~homeostatic process,GO:0042130~negative regulation of T cell proliferation,GO:0042129~regulation of T cell proliferation,GO:0042127~regulation of cell proliferation,GO:0042110~T cell activation,GO:0042098~T cell proliferation,GO:0040008~regulation of growth,GO:0040007~growth,GO:0035988~chondrocyte proliferation,GO:0035803~egg coat formation,GO:0035295~tube development,GO:0035264~multicellular organism growth,GO:0035239~tube morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035107~appendage morphogenesis,GO:0035050~embryonic heart tube development,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0033993~response to lipid,GO:0033089~positive regulation of T cell differentiation in thymus,GO:0033088~negative regulation of immature T cell proliferation in thymus,GO:0033087~negative regulation of immature T cell proliferation,GO:0033085~negative regulation of T cell differentiation in thymus,GO:0033084~regulation of immature T cell proliferation in thymus,GO:0033083~regulation of immature T cell proliferation,GO:0033081~regulation of T cell differentiation in thymus,GO:0033080~immature T cell proliferation in thymus,GO:0033079~immature T cell proliferation,GO:0033077~T cell differentiation in thymus,GO:0032989~cellular component morphogenesis,GO:0032967~positive regulation of collagen biosynthetic process,GO:0032965~regulation of collagen biosynthetic process,GO:0032964~collagen biosynthetic process,GO:0032963~collagen metabolic process,GO:0032945~negative regulation of mononuclear cell proliferation,GO:0032944~regulation of mononuclear cell proliferation,GO:0032943~mononuclear cell proliferation,GO:0032774~RNA biosynthetic process,GO:0032504~multicellular organism reproduction,GO:0032355~response to estradiol,GO:0032331~negative regulation of chondrocyte differentiation,GO:0032330~regulation of chondrocyte differentiation,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031100~animal organ regeneration,GO:0031099~regeneration,GO:0031076~embryonic camera-type eye development,GO:0031016~pancreas development,GO:0030908~protein splicing,GO:0030855~epithelial cell differentiation,GO:0030704~vitelline membrane formation,GO:0030326~embryonic limb morphogenesis,GO:0030217~T cell differentiation,GO:0030198~extracellular matrix organization,GO:0030182~neuron differentiation,GO:0030155~regulation of cell adhesion,GO:0030098~lymphocyte differentiation,GO:0030097~hemopoiesis,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0022610~biological adhesion,GO:0022607~cellular component assembly,GO:0022414~reproductive process,GO:0022412~cellular process involved in reproduction in multicellular organism,GO:0022409~positive regulation of cell-cell adhesion,GO:0022408~negative regulation of cell-cell adhesion,GO:0022407~regulation of cell-cell adhesion,GO:0022008~neurogenesis,GO:0021700~developmental maturation,GO:0019953~sexual reproduction,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016540~protein autoprocessing,GO:0016539~intein-mediated protein splicing,GO:0016485~protein processing,GO:0016337~single organismal cell-cell adhesion,GO:0016070~RNA metabolic process,GO:0014070~response to organic cyclic compound,GO:0012501~programmed cell death,GO:0010941~regulation of cell death,GO:0010927~cellular component assembly involved in morphogenesis,GO:0010714~positive regulation of collagen metabolic process,GO:0010712~regulation of collagen metabolic process,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010628~positive regulation of gene expression,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010464~regulation of mesenchymal cell proliferation,GO:0010463~mesenchymal cell proliferation,GO:0010171~body morphogenesis,GO:0010033~response to organic substance,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009893~positive regulation of metabolic process,GO:0009891~positive regulation of biosynthetic process,GO:0009887~animal organ morphogenesis,GO:0009880~embryonic pattern specification,GO:0009855~determination of bilateral symmetry,GO:0009799~specification of symmetry,GO:0009792~embryo development ending in birth or egg hatching,GO:0009790~embryo development,GO:0009628~response to abiotic stimulus,GO:0009612~response to mechanical stimulus,GO:0009605~response to external stimulus,GO:0009100~glycoprotein metabolic process,GO:0008589~regulation of smoothened signaling pathway,GO:0008285~negative regulation of cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008283~cell proliferation,GO:0008219~cell death,GO:0007565~female pregnancy,GO:0007507~heart development,GO:0007423~sensory organ development,GO:0007399~nervous system development,GO:0007389~pattern specification process,GO:0007368~determination of left/right symmetry,GO:0007292~female gamete generation,GO:0007281~germ cell development,GO:0007276~gamete generation,GO:0007267~cell-cell signaling,GO:0007224~smoothened signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0007162~negative regulation of cell adhesion,GO:0007159~leukocyte cell-cell adhesion,GO:0007155~cell adhesion,GO:0006915~apoptotic process,GO:0006508~proteolysis,GO:0006366~transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0006029~proteoglycan metabolic process,GO:0003413~chondrocyte differentiation involved in endochondral bone morphogenesis,GO:0003407~neural retina development,GO:0003406~retinal pigment epithelium development,GO:0003382~epithelial cell morphogenesis,GO:0003143~embryonic heart tube morphogenesis,GO:0003007~heart morphogenesis,GO:0003006~developmental process involved in reproduction,GO:0002696~positive regulation of leukocyte activation,GO:0002695~negative regulation of leukocyte activation,GO:0002694~regulation of leukocyte activation,GO:0002684~positive regulation of immune system process,GO:0002683~negative regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002521~leukocyte differentiation,GO:0002520~immune system development,GO:0002064~epithelial cell development,GO:0002062~chondrocyte differentiation,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0002009~morphogenesis of an epithelium,GO:0001947~heart looping,GO:0001944~vasculature development,GO:0001894~tissue homeostasis,GO:0001889~liver development,GO:0001775~cell activation,GO:0001763~morphogenesis of a branching structure,GO:0001754~eye photoreceptor cell differentiation,GO:0001708~cell fate specification,GO:0001701~in utero embryonic development,GO:0001654~eye development,GO:0001649~osteoblast differentiation,GO:0001569~branching involved in blood vessel morphogenesis,GO:0001568~blood vessel development,GO:0001525~angiogenesis,GO:0001503~ossification,GO:0001501~skeletal system development,GO:0000904~cell morphogenesis involved in differentiation,GO:0000902~cell morphogenesis,GO:0000003~reproduction,												GO:0044432~endoplasmic reticulum part,GO:0044431~Golgi apparatus part,GO:0044421~extracellular region part,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0031012~extracellular matrix,GO:0005794~Golgi apparatus,GO:0005789~endoplasmic reticulum membrane,GO:0005783~endoplasmic reticulum,GO:0005615~extracellular space,GO:0005576~extracellular region,GO:0000139~Golgi membrane,												GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0008233~peptidase activity,GO:0005509~calcium ion binding,GO:0005113~patched binding,GO:0005102~receptor binding,												IPR036844:Hint_dom_sf,IPR009045:Hedgehog_sig/DD-Pept_Zn-bd_sf,IPR006141:Intein_N,IPR003587:Hint_dom_N,IPR003586:Hint_dom_C,IPR001767:Hedgehog_Hint,IPR001657:Hedgehog,IPR000320:Hedgehog_signalling_dom,												hsa05205:Proteoglycans in cancer,hsa04340:Hedgehog signaling pathway,												607778~Acrocapitofemoral dysplasia,112500~Brachydactyly, type A1,												PIRSF009400:Peptidase_C46,												SM00306:HintN,SM00305:HintC,												SITE:Involved in cholesterol transfer,SITE:Involved in auto-cleavage,SITE:Essential for auto-cleavage,SITE:Cleavage; by autolysis,MUTAGEN:E->G: Increases the lysosomal degradation of the indian hedgehog protein N-product.,LIPID:N-palmitoyl cysteine,LIPID:Cholesterol glycine ester,DOMAIN:Hint,CARBOHYD:N-linked (GlcNAc...) asparagine,
1645_at	KiSS-1 metastasis suppressor(KISS1)	Homo sapiens			GO:1903532~positive regulation of secretion by cell,GO:1903530~regulation of secretion by cell,GO:1902533~positive regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:0099537~trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0098916~anterograde trans-synaptic signaling,GO:0098771~inorganic ion homeostasis,GO:0090277~positive regulation of peptide hormone secretion,GO:0090276~regulation of peptide hormone secretion,GO:0090087~regulation of peptide transport,GO:0072507~divalent inorganic cation homeostasis,GO:0072503~cellular divalent inorganic cation homeostasis,GO:0071705~nitrogen compound transport,GO:0060986~endocrine hormone secretion,GO:0060124~positive regulation of growth hormone secretion,GO:0060123~regulation of growth hormone secretion,GO:0060112~generation of ovulation cycle rhythm,GO:0055082~cellular chemical homeostasis,GO:0055080~cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055065~metal ion homeostasis,GO:0051480~regulation of cytosolic calcium ion concentration,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051174~regulation of phosphorus metabolic process,GO:0051050~positive regulation of transport,GO:0051049~regulation of transport,GO:0051047~positive regulation of secretion,GO:0051046~regulation of secretion,GO:0050886~endocrine process,GO:0050806~positive regulation of synaptic transmission,GO:0050804~modulation of synaptic transmission,GO:0050801~ion homeostasis,GO:0048878~chemical homeostasis,GO:0048609~multicellular organismal reproductive process,GO:0048584~positive regulation of response to stimulus,GO:0048511~rhythmic process,GO:0046903~secretion,GO:0046887~positive regulation of hormone secretion,GO:0046883~regulation of hormone secretion,GO:0046879~hormone secretion,GO:0045937~positive regulation of phosphate metabolic process,GO:0044702~single organism reproductive process,GO:0044060~regulation of endocrine process,GO:0044057~regulation of system process,GO:0043410~positive regulation of MAPK cascade,GO:0043408~regulation of MAPK cascade,GO:0042886~amide transport,GO:0042698~ovulation cycle,GO:0042592~homeostatic process,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0042127~regulation of cell proliferation,GO:0036211~protein modification process,GO:0035556~intracellular signal transduction,GO:0033686~positive regulation of luteinizing hormone secretion,GO:0033684~regulation of luteinizing hormone secretion,GO:0032940~secretion by cell,GO:0032504~multicellular organism reproduction,GO:0032278~positive regulation of gonadotropin secretion,GO:0032276~regulation of gonadotropin secretion,GO:0032275~luteinizing hormone secretion,GO:0032274~gonadotropin secretion,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031325~positive regulation of cellular metabolic process,GO:0030252~growth hormone secretion,GO:0030072~peptide hormone secretion,GO:0030003~cellular cation homeostasis,GO:0023061~signal release,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0023014~signal transduction by protein phosphorylation,GO:0022602~ovulation cycle process,GO:0022414~reproductive process,GO:0019725~cellular homeostasis,GO:0019220~regulation of phosphate metabolic process,GO:0016310~phosphorylation,GO:0015833~peptide transport,GO:0010817~regulation of hormone levels,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009914~hormone transport,GO:0009893~positive regulation of metabolic process,GO:0008285~negative regulation of cell proliferation,GO:0008283~cell proliferation,GO:0007268~chemical synaptic transmission,GO:0007267~cell-cell signaling,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007010~cytoskeleton organization,GO:0006875~cellular metal ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006873~cellular ion homeostasis,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0003008~system process,GO:0002793~positive regulation of peptide secretion,GO:0002791~regulation of peptide secretion,GO:0002790~peptide secretion,GO:0001934~positive regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,GO:0000165~MAPK cascade,GO:0000003~reproduction,												GO:0098590~plasma membrane region,GO:0097458~neuron part,GO:0045177~apical part of cell,GO:0044421~extracellular region part,GO:0044297~cell body,GO:0043025~neuronal cell body,GO:0036477~somatodendritic compartment,GO:0016324~apical plasma membrane,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:0071855~neuropeptide receptor binding,GO:0031773~kisspeptin receptor binding,GO:0005102~receptor binding,GO:0001664~G-protein coupled receptor binding,												IPR020207:Metastasis-suppressor_KiSS-1,												hsa04929:GnRH secretion,hsa04080:Neuroactive ligand-receptor interaction,												614842~Hypogonadotropic hypogonadism 13 with or without anosmia,														SITE:Cleavage; by MMP2 and MMP9,REGION:Essential for receptor binding and receptor activation,REGION:Disordered,PEPTIDE:Metastin,PEPTIDE:Kisspeptin-14,PEPTIDE:Kisspeptin-13,PEPTIDE:Kisspeptin-10,COMPBIAS:Polar residues,
34577_at	MAGE family member A9(MAGEA9)	Homo sapiens			GO:2001141~regulation of RNA biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1902679~negative regulation of RNA biosynthetic process,GO:0097659~nucleic acid-templated transcription,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031324~negative regulation of cellular metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016070~RNA metabolic process,GO:0010629~negative regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0009892~negative regulation of metabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0006366~transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,													GO:0042826~histone deacetylase binding,GO:0019899~enzyme binding,												IPR041899:MAGE_WH2,IPR041898:MAGE_WH1,IPR037445:MAGE,IPR021072:MAGE_N,IPR002190:MHD_dom,															SM01392:MAGE_N,SM01373:MAGE,												REGION:Disordered,DOMAIN:MAGE,COMPBIAS:Polar residues,
1786_at	MER proto-oncogene, tyrosine kinase(MERTK)	Homo sapiens			GO:2000107~negative regulation of leukocyte apoptotic process,GO:2000106~regulation of leukocyte apoptotic process,GO:0098602~single organism cell adhesion,GO:0097350~neutrophil clearance,GO:0071887~leukocyte apoptotic process,GO:0065009~regulation of molecular function,GO:0061458~reproductive system development,GO:0060627~regulation of vesicle-mediated transport,GO:0060548~negative regulation of cell death,GO:0060068~vagina development,GO:0060041~retina development in camera-type eye,GO:0051674~localization of cell,GO:0051649~establishment of localization in cell,GO:0051641~cellular localization,GO:0051347~positive regulation of transferase activity,GO:0051338~regulation of transferase activity,GO:0051250~negative regulation of lymphocyte activation,GO:0051249~regulation of lymphocyte activation,GO:0051241~negative regulation of multicellular organismal process,GO:0051174~regulation of phosphorus metabolic process,GO:0051130~positive regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051050~positive regulation of transport,GO:0051049~regulation of transport,GO:0050878~regulation of body fluid levels,GO:0050866~negative regulation of cell activation,GO:0050865~regulation of cell activation,GO:0050817~coagulation,GO:0050790~regulation of catalytic activity,GO:0050766~positive regulation of phagocytosis,GO:0050764~regulation of phagocytosis,GO:0048872~homeostasis of number of cells,GO:0048870~cell motility,GO:0048806~genitalia development,GO:0048771~tissue remodeling,GO:0048609~multicellular organismal reproductive process,GO:0048608~reproductive structure development,GO:0048534~hematopoietic or lymphoid organ development,GO:0048468~cell development,GO:0048232~male gamete generation,GO:0046903~secretion,GO:0046660~female sex differentiation,GO:0046649~lymphocyte activation,GO:0045937~positive regulation of phosphate metabolic process,GO:0045807~positive regulation of endocytosis,GO:0045321~leukocyte activation,GO:0044703~multi-organism reproductive process,GO:0044702~single organism reproductive process,GO:0044093~positive regulation of molecular function,GO:0043549~regulation of kinase activity,GO:0043491~protein kinase B signaling,GO:0043085~positive regulation of catalytic activity,GO:0043069~negative regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptotic process,GO:0043010~camera-type eye development,GO:0042981~regulation of apoptotic process,GO:0042592~homeostatic process,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0042060~wound healing,GO:0040011~locomotion,GO:0036211~protein modification process,GO:0035556~intracellular signal transduction,GO:0034446~substrate adhesion-dependent cell spreading,GO:0033674~positive regulation of kinase activity,GO:0032989~cellular component morphogenesis,GO:0032940~secretion by cell,GO:0032504~multicellular organism reproduction,GO:0031589~cell-substrate adhesion,GO:0031325~positive regulation of cellular metabolic process,GO:0030540~female genitalia development,GO:0030168~platelet activation,GO:0030101~natural killer cell activation,GO:0030100~regulation of endocytosis,GO:0030098~lymphocyte differentiation,GO:0030097~hemopoiesis,GO:0022610~biological adhesion,GO:0022414~reproductive process,GO:0019953~sexual reproduction,GO:0019220~regulation of phosphate metabolic process,GO:0016477~cell migration,GO:0016310~phosphorylation,GO:0016192~vesicle-mediated transport,GO:0012501~programmed cell death,GO:0010941~regulation of cell death,GO:0010562~positive regulation of phosphorus metabolic process,GO:0009893~positive regulation of metabolic process,GO:0009611~response to wounding,GO:0008219~cell death,GO:0007599~hemostasis,GO:0007596~blood coagulation,GO:0007548~sex differentiation,GO:0007423~sensory organ development,GO:0007399~nervous system development,GO:0007283~spermatogenesis,GO:0007276~gamete generation,GO:0007267~cell-cell signaling,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0007155~cell adhesion,GO:0006928~movement of cell or subcellular component,GO:0006915~apoptotic process,GO:0006909~phagocytosis,GO:0006897~endocytosis,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0003006~developmental process involved in reproduction,GO:0002695~negative regulation of leukocyte activation,GO:0002694~regulation of leukocyte activation,GO:0002683~negative regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002521~leukocyte differentiation,GO:0002520~immune system development,GO:0002262~myeloid cell homeostasis,GO:0001818~negative regulation of cytokine production,GO:0001817~regulation of cytokine production,GO:0001816~cytokine production,GO:0001780~neutrophil homeostasis,GO:0001779~natural killer cell differentiation,GO:0001776~leukocyte homeostasis,GO:0001775~cell activation,GO:0001654~eye development,GO:0000904~cell morphogenesis involved in differentiation,GO:0000902~cell morphogenesis,GO:0000003~reproduction,												GO:0097733~photoreceptor cell cilium,GO:0097731~9+0 non-motile cilium,GO:0097730~non-motile cilium,GO:0097458~neuron part,GO:0044441~ciliary part,GO:0044421~extracellular region part,GO:0043235~receptor complex,GO:0005929~cilium,GO:0005615~extracellular space,GO:0005576~extracellular region,GO:0001750~photoreceptor outer segment,												GO:1901363~heterocyclic compound binding,GO:1901265~nucleoside phosphate binding,GO:0099600~transmembrane receptor activity,GO:0097367~carbohydrate derivative binding,GO:0097159~organic cyclic compound binding,GO:0060089~molecular transducer activity,GO:0043168~anion binding,GO:0043167~ion binding,GO:0038023~signaling receptor activity,GO:0036094~small molecule binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0019199~transmembrane receptor protein kinase activity,GO:0017076~purine nucleotide binding,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0016301~kinase activity,GO:0005524~ATP binding,GO:0004888~transmembrane signaling receptor activity,GO:0004872~receptor activity,GO:0004871~signal transducer activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004672~protein kinase activity,GO:0000166~nucleotide binding,												IPR036179:Ig-like_dom_sf,IPR036116:FN3_sf,IPR020635:Tyr_kinase_cat_dom,IPR017441:Protein_kinase_ATP_BS,IPR013783:Ig-like_fold,IPR013151:Immunoglobulin,IPR011009:Kinase-like_dom_sf,IPR008266:Tyr_kinase_AS,IPR007110:Ig-like_dom,IPR003961:FN3_dom,IPR003599:Ig_sub,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR000719:Prot_kinase_dom,												hsa04148:Efferocytosis,												613862~Retinitis pigmentosa 38,												PIRSF000615:TyrPK_CSF1-R,												SM00409:IG,SM00219:TyrKc,SM00060:FN3,												TRANSMEM:Helical,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,DOMAIN:Protein kinase,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III,CARBOHYD:N-linked (GlcNAc...) asparagine,ACT_SITE:Proton acceptor,
38128_at	N-acetyltransferase 8 (putative)(NAT8)	Homo sapiens			GO:1990000~amyloid fibril formation,GO:0097435~supramolecular fiber organization,GO:0043603~cellular amide metabolic process,GO:0043543~protein acylation,GO:0036211~protein modification process,GO:0018394~peptidyl-lysine acetylation,GO:0018393~internal peptidyl-lysine acetylation,GO:0018205~peptidyl-lysine modification,GO:0018193~peptidyl-amino acid modification,GO:0018003~peptidyl-lysine N6-acetylation,GO:0010628~positive regulation of gene expression,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0009893~positive regulation of metabolic process,GO:0006790~sulfur compound metabolic process,GO:0006749~glutathione metabolic process,GO:0006575~cellular modified amino acid metabolic process,GO:0006518~peptide metabolic process,GO:0006475~internal protein amino acid acetylation,GO:0006473~protein acetylation,GO:0006464~cellular protein modification process,												GO:0044432~endoplasmic reticulum part,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005789~endoplasmic reticulum membrane,GO:0005783~endoplasmic reticulum,												GO:0047198~cysteine-S-conjugate N-acetyltransferase activity,GO:0016747~transferase activity, transferring acyl groups other than amino-acyl groups,GO:0016746~transferase activity, transferring acyl groups,GO:0016410~N-acyltransferase activity,GO:0016407~acetyltransferase activity,GO:0008080~N-acetyltransferase activity,GO:0004468~lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,												IPR016181:Acyl_CoA_acyltransferase,IPR000182:GNAT_dom,												hsa01100:Metabolic pathways,hsa00480:Glutathione metabolism,															TRANSMEM:Helical; Signal-anchor for type II membrane protein,TOPO_DOM:Lumenal,TOPO_DOM:Cytoplasmic,MUTAGEN:R->K: Loss of the cysteine S-conjugate N-acetyltransferase activity. No effect on protein expression.,DOMAIN:N-acetyltransferase,
40058_s_at	PDZ and LIM domain 5(PDLIM5)	Homo sapiens			GO:1902589~single-organism organelle organization,GO:0098609~cell-cell adhesion,GO:0072359~circulatory system development,GO:0061061~muscle structure development,GO:0061049~cell growth involved in cardiac muscle cell development,GO:0061001~regulation of dendritic spine morphogenesis,GO:0060998~regulation of dendritic spine development,GO:0060996~dendritic spine development,GO:0060537~muscle tissue development,GO:0060419~heart growth,GO:0060284~regulation of cell development,GO:0055017~cardiac muscle tissue growth,GO:0055013~cardiac muscle cell development,GO:0055007~cardiac muscle cell differentiation,GO:0055006~cardiac cell development,GO:0055002~striated muscle cell development,GO:0055001~muscle cell development,GO:0051963~regulation of synapse assembly,GO:0051960~regulation of nervous system development,GO:0051146~striated muscle cell differentiation,GO:0051128~regulation of cellular component organization,GO:0050808~synapse organization,GO:0050807~regulation of synapse organization,GO:0050803~regulation of synapse structure or activity,GO:0050773~regulation of dendrite development,GO:0050767~regulation of neurogenesis,GO:0048858~cell projection morphogenesis,GO:0048814~regulation of dendrite morphogenesis,GO:0048813~dendrite morphogenesis,GO:0048812~neuron projection morphogenesis,GO:0048738~cardiac muscle tissue development,GO:0048699~generation of neurons,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048666~neuron development,GO:0048589~developmental growth,GO:0048588~developmental cell growth,GO:0048468~cell development,GO:0045664~regulation of neuron differentiation,GO:0045595~regulation of cell differentiation,GO:0044087~regulation of cellular component biogenesis,GO:0044085~cellular component biogenesis,GO:0042692~muscle cell differentiation,GO:0040007~growth,GO:0035265~organ growth,GO:0035051~cardiocyte differentiation,GO:0032990~cell part morphogenesis,GO:0032989~cellular component morphogenesis,GO:0031344~regulation of cell projection organization,GO:0031175~neuron projection development,GO:0030182~neuron differentiation,GO:0030036~actin cytoskeleton organization,GO:0030030~cell projection organization,GO:0030029~actin filament-based process,GO:0022610~biological adhesion,GO:0022604~regulation of cell morphogenesis,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022008~neurogenesis,GO:0016358~dendrite development,GO:0016049~cell growth,GO:0014897~striated muscle hypertrophy,GO:0014896~muscle hypertrophy,GO:0014706~striated muscle tissue development,GO:0010975~regulation of neuron projection development,GO:0010769~regulation of cell morphogenesis involved in differentiation,GO:0007507~heart development,GO:0007399~nervous system development,GO:0007155~cell adhesion,GO:0007010~cytoskeleton organization,GO:0003301~physiological cardiac muscle hypertrophy,GO:0003300~cardiac muscle hypertrophy,GO:0003298~physiological muscle hypertrophy,GO:0003012~muscle system process,GO:0003008~system process,GO:0000904~cell morphogenesis involved in differentiation,GO:0000902~cell morphogenesis,												GO:0099572~postsynaptic specialization,GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0099081~supramolecular polymer,GO:0099080~supramolecular complex,GO:0098984~neuron to neuron synapse,GO:0098794~postsynapse,GO:0098793~presynapse,GO:0097517~contractile actin filament bundle,GO:0097458~neuron part,GO:0070161~anchoring junction,GO:0045202~synapse,GO:0044456~synapse part,GO:0044449~contractile fiber part,GO:0043292~contractile fiber,GO:0042641~actomyosin,GO:0032432~actin filament bundle,GO:0032279~asymmetric synapse,GO:0031941~filamentous actin,GO:0031674~I band,GO:0030054~cell junction,GO:0030018~Z disc,GO:0030017~sarcomere,GO:0030016~myofibril,GO:0015629~actin cytoskeleton,GO:0014069~postsynaptic density,GO:0005912~adherens junction,GO:0005884~actin filament,GO:0005829~cytosol,GO:0001725~stress fiber,												GO:0098641~cadherin binding involved in cell-cell adhesion,GO:0098632~protein binding involved in cell-cell adhesion,GO:0098631~protein binding involved in cell adhesion,GO:0051393~alpha-actinin binding,GO:0051371~muscle alpha-actinin binding,GO:0050839~cell adhesion molecule binding,GO:0046872~metal ion binding,GO:0045296~cadherin binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0042805~actinin binding,GO:0019901~protein kinase binding,GO:0019900~kinase binding,GO:0019899~enzyme binding,GO:0008092~cytoskeletal protein binding,GO:0005080~protein kinase C binding,GO:0003779~actin binding,												IPR036034:PDZ_sf,IPR001781:Znf_LIM,IPR001478:PDZ,															SM00228:PDZ,SM00132:LIM,												REGION:Disordered,DOMAIN:PDZ,DOMAIN:LIM zinc-binding 3,DOMAIN:LIM zinc-binding 2,DOMAIN:LIM zinc-binding 1,DOMAIN:LIM zinc-binding,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,COMPBIAS:Polar residues,COMPBIAS:Basic and acidic residues,
33922_at	PR/SET domain 2(PRDM2)	Homo sapiens			GO:2001141~regulation of RNA biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1902680~positive regulation of RNA biosynthetic process,GO:1902679~negative regulation of RNA biosynthetic process,GO:0097659~nucleic acid-templated transcription,GO:0051276~chromosome organization,GO:0051254~positive regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0032259~methylation,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031324~negative regulation of cellular metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016070~RNA metabolic process,GO:0010629~negative regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010259~multicellular organism aging,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0009891~positive regulation of biosynthetic process,GO:0009890~negative regulation of biosynthetic process,GO:0008340~determination of adult lifespan,GO:0007568~aging,GO:0006366~transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0006338~chromatin remodeling,GO:0006325~chromatin organization,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,												GO:0005794~Golgi apparatus,GO:0005654~nucleoplasm,												GO:1990837~sequence-specific double-stranded DNA binding,GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0044212~transcription regulatory region DNA binding,GO:0043565~sequence-specific DNA binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0042054~histone methyltransferase activity,GO:0016741~transferase activity, transferring one-carbon groups,GO:0008276~protein methyltransferase activity,GO:0008270~zinc ion binding,GO:0008168~methyltransferase activity,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003690~double-stranded DNA binding,GO:0003677~DNA binding,GO:0003676~nucleic acid binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001071~nucleic acid binding transcription factor activity,GO:0001067~regulatory region nucleic acid binding,GO:0001012~RNA polymerase II regulatory region DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000975~regulatory region DNA binding,												IPR046341:SET_dom_sf,IPR044414:PRDM2_PR-SET,IPR036236:Znf_C2H2_sf,IPR013087:Znf_C2H2_type,IPR009170:PRDM2,IPR001214:SET_dom,												hsa01100:Metabolic pathways,hsa00310:Lysine degradation,													PIRSF002395:RIZ_SET,												SM00355:ZnF_C2H2,SM00317:SET,												ZN_FING:C2H2-type 8; atypical,ZN_FING:C2H2-type 7; atypical,ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 1,REGION:Retinoblastoma protein binding,REGION:Disordered,MUTAGEN:I->V: Loss of histone methyltransferase activity.,MUTAGEN:C->Y: Reduced histone methyltransferase activity.,MUTAGEN:A->V: Reduced histone methyltransferase activity.,MOTIF:SH3-binding,DOMAIN:SET,DOMAIN:C2H2-type,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),COMPBIAS:Pro residues,COMPBIAS:Polar residues,COMPBIAS:Basic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Acidic residues,
33371_s_at	RAB31, member RAS oncogene family(RAB31)	Homo sapiens			GO:1990778~protein localization to cell periphery,GO:1905155~positive regulation of membrane invagination,GO:1905153~regulation of membrane invagination,GO:1902580~single-organism cellular localization,GO:1901701~cellular response to oxygen-containing compound,GO:1901700~response to oxygen-containing compound,GO:1901699~cellular response to nitrogen compound,GO:1901698~response to nitrogen compound,GO:1901653~cellular response to peptide,GO:1901652~response to peptide,GO:0099024~plasma membrane invagination,GO:0098876~vesicle-mediated transport to the plasma membrane,GO:0090382~phagosome maturation,GO:0090150~establishment of protein localization to membrane,GO:0090002~establishment of protein localization to plasma membrane,GO:0072659~protein localization to plasma membrane,GO:0072657~protein localization to membrane,GO:0071705~nitrogen compound transport,GO:0071495~cellular response to endogenous stimulus,GO:0071417~cellular response to organonitrogen compound,GO:0071375~cellular response to peptide hormone stimulus,GO:0071310~cellular response to organic substance,GO:0070887~cellular response to chemical stimulus,GO:0070727~cellular macromolecule localization,GO:0061024~membrane organization,GO:0060627~regulation of vesicle-mediated transport,GO:0060100~positive regulation of phagocytosis, engulfment,GO:0060099~regulation of phagocytosis, engulfment,GO:0051649~establishment of localization in cell,GO:0051641~cellular localization,GO:0051130~positive regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051050~positive regulation of transport,GO:0051049~regulation of transport,GO:0050766~positive regulation of phagocytosis,GO:0050764~regulation of phagocytosis,GO:0048193~Golgi vesicle transport,GO:0046907~intracellular transport,GO:0046903~secretion,GO:0045807~positive regulation of endocytosis,GO:0045184~establishment of protein localization,GO:0045055~regulated exocytosis,GO:0044802~single-organism membrane organization,GO:0043434~response to peptide hormone,GO:0043112~receptor metabolic process,GO:0043001~Golgi to plasma membrane protein transport,GO:0042886~amide transport,GO:0034613~cellular protein localization,GO:0033036~macromolecule localization,GO:0032940~secretion by cell,GO:0032870~cellular response to hormone stimulus,GO:0032869~cellular response to insulin stimulus,GO:0032868~response to insulin,GO:0031623~receptor internalization,GO:0030100~regulation of endocytosis,GO:0016192~vesicle-mediated transport,GO:0015833~peptide transport,GO:0015031~protein transport,GO:0010324~membrane invagination,GO:0010256~endomembrane system organization,GO:0010243~response to organonitrogen compound,GO:0010033~response to organic substance,GO:0009725~response to hormone,GO:0009719~response to endogenous stimulus,GO:0008104~protein localization,GO:0007009~plasma membrane organization,GO:0006911~phagocytosis, engulfment,GO:0006909~phagocytosis,GO:0006898~receptor-mediated endocytosis,GO:0006897~endocytosis,GO:0006893~Golgi to plasma membrane transport,GO:0006892~post-Golgi vesicle-mediated transport,GO:0006887~exocytosis,GO:0006886~intracellular protein transport,												GO:0099503~secretory vesicle,GO:0098791~Golgi subcompartment,GO:0045335~phagocytic vesicle,GO:0044440~endosomal part,GO:0044433~cytoplasmic vesicle part,GO:0044431~Golgi apparatus part,GO:0036186~early phagosome membrane,GO:0032588~trans-Golgi network membrane,GO:0032009~early phagosome,GO:0031984~organelle subcompartment,GO:0031901~early endosome membrane,GO:0030670~phagocytic vesicle membrane,GO:0030667~secretory granule membrane,GO:0030666~endocytic vesicle membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0030141~secretory granule,GO:0030139~endocytic vesicle,GO:0012506~vesicle membrane,GO:0010008~endosome membrane,GO:0005829~cytosol,GO:0005802~trans-Golgi network,GO:0005794~Golgi apparatus,GO:0005769~early endosome,GO:0005768~endosome,GO:0001891~phagocytic cup,GO:0000139~Golgi membrane,												GO:1901363~heterocyclic compound binding,GO:1901265~nucleoside phosphate binding,GO:0097367~carbohydrate derivative binding,GO:0097159~organic cyclic compound binding,GO:0043168~anion binding,GO:0043167~ion binding,GO:0036094~small molecule binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0032561~guanyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0032550~purine ribonucleoside binding,GO:0032549~ribonucleoside binding,GO:0019003~GDP binding,GO:0019001~guanyl nucleotide binding,GO:0017111~nucleoside-triphosphatase activity,GO:0017076~purine nucleotide binding,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016462~pyrophosphatase activity,GO:0005525~GTP binding,GO:0003924~GTPase activity,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000166~nucleotide binding,												IPR027417:P-loop_NTPase,IPR005225:Small_GTP-bd_dom,IPR001806:Small_GTPase,												hsa04144:Endocytosis,														SM00176:RAN,SM00175:RAB,SM00174:RHO,SM00173:RAS,												REGION:Disordered,MUTAGEN:Q->L: No change in GTPase activity.,MOTIF:Effector region,LIPID:S-geranylgeranyl cysteine,
966_at	RAD54 like(RAD54L)	Homo sapiens			GO:1903046~meiotic cell cycle process,GO:0051321~meiotic cell cycle,GO:0051276~chromosome organization,GO:0048285~organelle fission,GO:0045003~double-strand break repair via synthesis-dependent strand annealing,GO:0044702~single organism reproductive process,GO:0035825~reciprocal DNA recombination,GO:0033554~cellular response to stress,GO:0022414~reproductive process,GO:0022402~cell cycle process,GO:0010259~multicellular organism aging,GO:0010212~response to ionizing radiation,GO:0009628~response to abiotic stimulus,GO:0009410~response to xenobiotic stimulus,GO:0009314~response to radiation,GO:0008340~determination of adult lifespan,GO:0007568~aging,GO:0007131~reciprocal meiotic recombination,GO:0007127~meiosis I,GO:0007126~meiotic nuclear division,GO:0007049~cell cycle,GO:0006974~cellular response to DNA damage stimulus,GO:0006338~chromatin remodeling,GO:0006325~chromatin organization,GO:0006310~DNA recombination,GO:0006302~double-strand break repair,GO:0006281~DNA repair,GO:0006259~DNA metabolic process,GO:0000725~recombinational repair,GO:0000724~double-strand break repair via homologous recombination,GO:0000280~nuclear division,GO:0000003~reproduction,												GO:0005654~nucleoplasm,												GO:1901363~heterocyclic compound binding,GO:1901265~nucleoside phosphate binding,GO:0097617~annealing activity,GO:0097367~carbohydrate derivative binding,GO:0097159~organic cyclic compound binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043168~anion binding,GO:0043167~ion binding,GO:0042623~ATPase activity, coupled,GO:0036310~annealing helicase activity,GO:0036094~small molecule binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0017111~nucleoside-triphosphatase activity,GO:0017076~purine nucleotide binding,GO:0016887~ATPase activity,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016462~pyrophosphatase activity,GO:0015616~DNA translocase activity,GO:0008094~DNA-dependent ATPase activity,GO:0005524~ATP binding,GO:0004386~helicase activity,GO:0003676~nucleic acid binding,GO:0000166~nucleotide binding,												IPR038718:SNF2-like_sf,IPR027417:P-loop_NTPase,IPR014001:Helicase_ATP-bd,IPR001650:Helicase_C,IPR000330:SNF2_N,												hsa03440:Homologous recombination,												Adenocarcinoma, colonic, somatic~Adenocarcinoma, colonic, somatic,605027~Lymphoma, non-Hodgkin, somatic,114480~Breast cancer, invasive ductal,													SM00490:HELICc,SM00487:DEXDc,												REGION:Required for chromatin remodeling, strand pairing activities and coupling of ATPase activity,REGION:Disordered,MUTAGEN:S->E: Promotes homologous recombination (HR), but causes RAD51 removal from chromatin.,MUTAGEN:S->A: Defect in homologous recombination (HR).,MUTAGEN:K->R: Unable to rescue the MMS-sensitive phenotype of S cerevisiae rad54delta cells.,MUTAGEN:K->R: Loss of acetylation.,MOTIF:DEGH box,DOMAIN:SNF2 N-terminal,DOMAIN:Helicase C-terminal,DOMAIN:Helicase ATP-binding,COMPBIAS:Polar residues,COMPBIAS:Basic and acidic residues,
33080_s_at	RAP1 GTPase activating protein(RAP1GAP)	Homo sapiens			GO:1990792~cellular response to glial cell derived neurotrophic factor,GO:1990790~response to glial cell derived neurotrophic factor,GO:1990789~thyroid gland epithelial cell proliferation,GO:1904442~negative regulation of thyroid gland epithelial cell proliferation,GO:1904441~regulation of thyroid gland epithelial cell proliferation,GO:1903697~negative regulation of microvillus assembly,GO:1902531~regulation of intracellular signal transduction,GO:0071495~cellular response to endogenous stimulus,GO:0071363~cellular response to growth factor stimulus,GO:0071310~cellular response to organic substance,GO:0070887~cellular response to chemical stimulus,GO:0070848~response to growth factor,GO:0065009~regulation of molecular function,GO:0060491~regulation of cell projection assembly,GO:0060284~regulation of cell development,GO:0051961~negative regulation of nervous system development,GO:0051960~regulation of nervous system development,GO:0051345~positive regulation of hydrolase activity,GO:0051336~regulation of hydrolase activity,GO:0051241~negative regulation of multicellular organismal process,GO:0051129~negative regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051093~negative regulation of developmental process,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0050790~regulation of catalytic activity,GO:0050768~negative regulation of neurogenesis,GO:0050767~regulation of neurogenesis,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0050673~epithelial cell proliferation,GO:0048732~gland development,GO:0048699~generation of neurons,GO:0048468~cell development,GO:0045665~negative regulation of neuron differentiation,GO:0045664~regulation of neuron differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0044093~positive regulation of molecular function,GO:0044087~regulation of cellular component biogenesis,GO:0044085~cellular component biogenesis,GO:0043547~positive regulation of GTPase activity,GO:0043087~regulation of GTPase activity,GO:0043085~positive regulation of catalytic activity,GO:0042127~regulation of cell proliferation,GO:0035556~intracellular signal transduction,GO:0035270~endocrine system development,GO:0032534~regulation of microvillus assembly,GO:0032530~regulation of microvillus organization,GO:0032528~microvillus organization,GO:0031345~negative regulation of cell projection organization,GO:0031344~regulation of cell projection organization,GO:0030878~thyroid gland development,GO:0030182~neuron differentiation,GO:0030033~microvillus assembly,GO:0030031~cell projection assembly,GO:0030030~cell projection organization,GO:0023051~regulation of signaling,GO:0022607~cellular component assembly,GO:0022008~neurogenesis,GO:0010721~negative regulation of cell development,GO:0010646~regulation of cell communication,GO:0010033~response to organic substance,GO:0009966~regulation of signal transduction,GO:0009719~response to endogenous stimulus,GO:0008285~negative regulation of cell proliferation,GO:0008283~cell proliferation,GO:0007399~nervous system development,GO:0006955~immune response,GO:0002250~adaptive immune response,												GO:0097458~neuron part,GO:0044431~Golgi apparatus part,GO:0044297~cell body,GO:0043025~neuronal cell body,GO:0043005~neuron projection,GO:0036477~somatodendritic compartment,GO:0030425~dendrite,GO:0030424~axon,GO:0005829~cytosol,GO:0005794~Golgi apparatus,GO:0005769~early endosome,GO:0005768~endosome,GO:0000139~Golgi membrane,												GO:0098772~molecular function regulator,GO:0060589~nucleoside-triphosphatase regulator activity,GO:0051020~GTPase binding,GO:0046983~protein dimerization activity,GO:0042803~protein homodimerization activity,GO:0042802~identical protein binding,GO:0031267~small GTPase binding,GO:0030695~GTPase regulator activity,GO:0030234~enzyme regulator activity,GO:0019899~enzyme binding,GO:0017111~nucleoside-triphosphatase activity,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016462~pyrophosphatase activity,GO:0008047~enzyme activator activity,GO:0005096~GTPase activator activity,GO:0003924~GTPase activity,												IPR035974:Rap/Ran-GAP_sf,IPR003109:GoLoco_motif,IPR000331:Rap/Ran_GAP_dom,												hsa04015:Rap1 signaling pathway,														SM00390:GoLoco,												REGION:Disordered,MUTAGEN:R->A: Reduces GTPase activation.,MUTAGEN:R->A,P: Reduces GTPase activation.,MUTAGEN:N->A,K: Abolishes GTPase activation.,MUTAGEN:L->E: Impaired dimerization; when associated with E-100.,MUTAGEN:H->A: Abolishes GTPase activation.,MUTAGEN:F->E: Impaired dimerization; when associated with E-173.,MUTAGEN:E->A: Reduces GTPase activation.,MUTAGEN:D->A: Abolishes GTPase activation.,DOMAIN:Rap-GAP,DOMAIN:GoLoco,COMPBIAS:Polar residues,
39187_at	RUNX family transcription factor 2(RUNX2)	Homo sapiens			GO:2001141~regulation of RNA biosynthetic process,GO:2000648~positive regulation of stem cell proliferation,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000027~regulation of organ morphogenesis,GO:1904888~cranial skeletal system development,GO:1904383~response to sodium phosphate,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1902680~positive regulation of RNA biosynthetic process,GO:1902679~negative regulation of RNA biosynthetic process,GO:1902074~response to salt,GO:0097659~nucleic acid-templated transcription,GO:0090287~regulation of cellular response to growth factor stimulus,GO:0072091~regulation of stem cell proliferation,GO:0072089~stem cell proliferation,GO:0071773~cellular response to BMP stimulus,GO:0071772~response to BMP,GO:0071495~cellular response to endogenous stimulus,GO:0071363~cellular response to growth factor stimulus,GO:0071310~cellular response to organic substance,GO:0070887~cellular response to chemical stimulus,GO:0070848~response to growth factor,GO:0061448~connective tissue development,GO:0061036~positive regulation of cartilage development,GO:0061035~regulation of cartilage development,GO:0060395~SMAD protein signal transduction,GO:0060350~endochondral bone morphogenesis,GO:0060349~bone morphogenesis,GO:0060348~bone development,GO:0060173~limb development,GO:0051254~positive regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051216~cartilage development,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051094~positive regulation of developmental process,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0050673~epithelial cell proliferation,GO:0048863~stem cell differentiation,GO:0048736~appendage development,GO:0048706~embryonic skeletal system development,GO:0048705~skeletal system morphogenesis,GO:0048704~embryonic skeletal system morphogenesis,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0048699~generation of neurons,GO:0048598~embryonic morphogenesis,GO:0048585~negative regulation of response to stimulus,GO:0048568~embryonic organ development,GO:0048562~embryonic organ morphogenesis,GO:0048534~hematopoietic or lymphoid organ development,GO:0048469~cell maturation,GO:0048468~cell development,GO:0046649~lymphocyte activation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045879~negative regulation of smoothened signaling pathway,GO:0045778~positive regulation of ossification,GO:0045669~positive regulation of osteoblast differentiation,GO:0045667~regulation of osteoblast differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0045321~leukocyte activation,GO:0045165~cell fate commitment,GO:0043009~chordate embryonic development,GO:0042487~regulation of odontogenesis of dentin-containing tooth,GO:0042481~regulation of odontogenesis,GO:0042476~odontogenesis,GO:0042475~odontogenesis of dentin-containing tooth,GO:0042127~regulation of cell proliferation,GO:0042110~T cell activation,GO:0040036~regulation of fibroblast growth factor receptor signaling pathway,GO:0036076~ligamentous ossification,GO:0036075~replacement ossification,GO:0035136~forelimb morphogenesis,GO:0035115~embryonic forelimb morphogenesis,GO:0035113~embryonic appendage morphogenesis,GO:0035108~limb morphogenesis,GO:0035107~appendage morphogenesis,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0032332~positive regulation of chondrocyte differentiation,GO:0032330~regulation of chondrocyte differentiation,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031324~negative regulation of cellular metabolic process,GO:0031214~biomineral tissue development,GO:0030509~BMP signaling pathway,GO:0030326~embryonic limb morphogenesis,GO:0030282~bone mineralization,GO:0030278~regulation of ossification,GO:0030217~T cell differentiation,GO:0030182~neuron differentiation,GO:0030098~lymphocyte differentiation,GO:0030097~hemopoiesis,GO:0023057~negative regulation of signaling,GO:0023051~regulation of signaling,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022008~neurogenesis,GO:0021700~developmental maturation,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016070~RNA metabolic process,GO:0010648~negative regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010629~negative regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010035~response to inorganic substance,GO:0010033~response to organic substance,GO:0009968~negative regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0009891~positive regulation of biosynthetic process,GO:0009890~negative regulation of biosynthetic process,GO:0009887~animal organ morphogenesis,GO:0009792~embryo development ending in birth or egg hatching,GO:0009790~embryo development,GO:0009719~response to endogenous stimulus,GO:0008589~regulation of smoothened signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0008283~cell proliferation,GO:0007399~nervous system development,GO:0007224~smoothened signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0006366~transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0002521~leukocyte differentiation,GO:0002520~immune system development,GO:0002076~osteoblast development,GO:0002063~chondrocyte development,GO:0002062~chondrocyte differentiation,GO:0002051~osteoblast fate commitment,GO:0001958~endochondral ossification,GO:0001775~cell activation,GO:0001649~osteoblast differentiation,GO:0001503~ossification,GO:0001501~skeletal system development,												GO:0044427~chromosomal part,GO:0005829~cytosol,GO:0005694~chromosome,GO:0005667~transcription factor complex,GO:0005654~nucleoplasm,GO:0000785~chromatin,												GO:1990837~sequence-specific double-stranded DNA binding,GO:1901363~heterocyclic compound binding,GO:1901265~nucleoside phosphate binding,GO:0097367~carbohydrate derivative binding,GO:0097159~organic cyclic compound binding,GO:0044212~transcription regulatory region DNA binding,GO:0043565~sequence-specific DNA binding,GO:0043425~bHLH transcription factor binding,GO:0043168~anion binding,GO:0043167~ion binding,GO:0036094~small molecule binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0031490~chromatin DNA binding,GO:0030554~adenyl nucleotide binding,GO:0019904~protein domain specific binding,GO:0017076~purine nucleotide binding,GO:0008134~transcription factor binding,GO:0005524~ATP binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003690~double-stranded DNA binding,GO:0003682~chromatin binding,GO:0003677~DNA binding,GO:0003676~nucleic acid binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001159~core promoter proximal region DNA binding,GO:0001071~nucleic acid binding transcription factor activity,GO:0001067~regulatory region nucleic acid binding,GO:0001012~RNA polymerase II regulatory region DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000975~regulatory region DNA binding,GO:0000166~nucleotide binding,												IPR027384:Runx_central_dom_sf,IPR016554:TF_Runt-rel_RUNX,IPR013711:RunxI_C_dom,IPR013524:Runt_dom,IPR012346:p53/RUNT-type_TF_DNA-bd_sf,IPR008967:p53-like_TF_DNA-bd_sf,IPR000040:AML1_Runt,												hsa05202:Transcriptional misregulation in cancer,hsa04928:Parathyroid hormone synthesis, secretion and action,												156510~Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly,119600~Cleidocranial dysplasia, forme fruste, with brachydactyly,119600~Cleidocranial dysplasia, forme fruste, dental anomalies only,119600~Cleidocranial dysplasia,												PIRSF009374:TF_Runt-rel_RUNX,													REGION:Required for interaction with FOXO1,REGION:Interaction with KAT6B,REGION:Interaction with KAT6A,REGION:Disordered,MUTAGEN:S->A: Reduced DNA-binding and impaired phosphorylation.,DOMAIN:Runt,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),COMPBIAS:Pro residues,COMPBIAS:Polar residues,COMPBIAS:Basic and acidic residues,
606_at	Rho family GTPase 2(RND2)	Homo sapiens			GO:1902589~single-organism organelle organization,GO:0097435~supramolecular fiber organization,GO:0090066~regulation of anatomical structure size,GO:0061564~axon development,GO:0061387~regulation of extent of cell growth,GO:0060560~developmental growth involved in morphogenesis,GO:0060284~regulation of cell development,GO:0051962~positive regulation of nervous system development,GO:0051960~regulation of nervous system development,GO:0051674~localization of cell,GO:0051493~regulation of cytoskeleton organization,GO:0051240~positive regulation of multicellular organismal process,GO:0051130~positive regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051094~positive regulation of developmental process,GO:0050772~positive regulation of axonogenesis,GO:0050770~regulation of axonogenesis,GO:0050769~positive regulation of neurogenesis,GO:0050767~regulation of neurogenesis,GO:0048870~cell motility,GO:0048858~cell projection morphogenesis,GO:0048812~neuron projection morphogenesis,GO:0048699~generation of neurons,GO:0048672~positive regulation of collateral sprouting,GO:0048670~regulation of collateral sprouting,GO:0048668~collateral sprouting,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048666~neuron development,GO:0048639~positive regulation of developmental growth,GO:0048638~regulation of developmental growth,GO:0048589~developmental growth,GO:0048588~developmental cell growth,GO:0048468~cell development,GO:0045927~positive regulation of growth,GO:0045666~positive regulation of neuron differentiation,GO:0045664~regulation of neuron differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0040011~locomotion,GO:0040008~regulation of growth,GO:0040007~growth,GO:0035556~intracellular signal transduction,GO:0033043~regulation of organelle organization,GO:0032990~cell part morphogenesis,GO:0032989~cellular component morphogenesis,GO:0032970~regulation of actin filament-based process,GO:0032956~regulation of actin cytoskeleton organization,GO:0032535~regulation of cellular component size,GO:0031346~positive regulation of cell projection organization,GO:0031344~regulation of cell projection organization,GO:0031175~neuron projection development,GO:0030307~positive regulation of cell growth,GO:0030182~neuron differentiation,GO:0030036~actin cytoskeleton organization,GO:0030030~cell projection organization,GO:0030029~actin filament-based process,GO:0022604~regulation of cell morphogenesis,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022008~neurogenesis,GO:0016477~cell migration,GO:0016049~cell growth,GO:0010976~positive regulation of neuron projection development,GO:0010975~regulation of neuron projection development,GO:0010770~positive regulation of cell morphogenesis involved in differentiation,GO:0010769~regulation of cell morphogenesis involved in differentiation,GO:0010720~positive regulation of cell development,GO:0008361~regulation of cell size,GO:0007409~axonogenesis,GO:0007399~nervous system development,GO:0007264~small GTPase mediated signal transduction,GO:0007015~actin filament organization,GO:0007010~cytoskeleton organization,GO:0006928~movement of cell or subcellular component,GO:0001558~regulation of cell growth,GO:0000904~cell morphogenesis involved in differentiation,GO:0000902~cell morphogenesis,												GO:0099503~secretory vesicle,GO:0097223~sperm part,GO:0044433~cytoplasmic vesicle part,GO:0030667~secretory granule membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0030141~secretory granule,GO:0012506~vesicle membrane,GO:0005829~cytosol,GO:0005769~early endosome,GO:0005768~endosome,GO:0002080~acrosomal membrane,GO:0001669~acrosomal vesicle,												GO:1901363~heterocyclic compound binding,GO:1901265~nucleoside phosphate binding,GO:0097367~carbohydrate derivative binding,GO:0097159~organic cyclic compound binding,GO:0043168~anion binding,GO:0043167~ion binding,GO:0036094~small molecule binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0032561~guanyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0032550~purine ribonucleoside binding,GO:0032549~ribonucleoside binding,GO:0019901~protein kinase binding,GO:0019900~kinase binding,GO:0019899~enzyme binding,GO:0019001~guanyl nucleotide binding,GO:0017111~nucleoside-triphosphatase activity,GO:0017076~purine nucleotide binding,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016462~pyrophosphatase activity,GO:0005525~GTP binding,GO:0003924~GTPase activity,GO:0001883~purine nucleoside binding,GO:0001882~nucleoside binding,GO:0000166~nucleotide binding,												IPR041842:RhoN,IPR027417:P-loop_NTPase,IPR005225:Small_GTP-bd_dom,IPR003578:Small_GTPase_Rho,IPR001806:Small_GTPase,															SM00175:RAB,SM00174:RHO,SM00173:RAS,												REGION:Disordered,PROPEP:Removed in mature form,MOTIF:Effector region,LIPID:S-geranylgeranyl cysteine,COMPBIAS:Basic and acidic residues,
39908_at	TATA-box binding protein associated factor 6 like(TAF6L)	Homo sapiens			GO:2001141~regulation of RNA biosynthetic process,GO:2001020~regulation of response to DNA damage stimulus,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000036~regulation of stem cell population maintenance,GO:1904672~regulation of somatic stem cell population maintenance,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1902680~positive regulation of RNA biosynthetic process,GO:0098727~maintenance of cell number,GO:0097659~nucleic acid-templated transcription,GO:0080135~regulation of cellular response to stress,GO:0080134~regulation of response to stress,GO:0071824~protein-DNA complex subunit organization,GO:0070897~DNA-templated transcriptional preinitiation complex assembly,GO:0065004~protein-DNA complex assembly,GO:0065003~macromolecular complex assembly,GO:0051276~chromosome organization,GO:0051254~positive regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051123~RNA polymerase II transcriptional preinitiation complex assembly,GO:0051052~regulation of DNA metabolic process,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0044085~cellular component biogenesis,GO:0043933~macromolecular complex subunit organization,GO:0043484~regulation of RNA splicing,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034622~cellular macromolecular complex assembly,GO:0033554~cellular response to stress,GO:0032774~RNA biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0022607~cellular component assembly,GO:0019827~stem cell population maintenance,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016070~RNA metabolic process,GO:0010628~positive regulation of gene expression,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0009893~positive regulation of metabolic process,GO:0009891~positive regulation of biosynthetic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006352~DNA-templated transcription, initiation,GO:0006351~transcription, DNA-templated,GO:0006338~chromatin remodeling,GO:0006325~chromatin organization,GO:0006282~regulation of DNA repair,GO:0006259~DNA metabolic process,												GO:1905368~peptidase complex,GO:1903561~extracellular vesicle,GO:1902493~acetyltransferase complex,GO:0090575~RNA polymerase II transcription factor complex,GO:0070461~SAGA-type complex,GO:0070062~extracellular exosome,GO:0061695~transferase complex, transferring phosphorus-containing groups,GO:0055029~nuclear DNA-directed RNA polymerase complex,GO:0046695~SLIK (SAGA-like) complex,GO:0044798~nuclear transcription factor complex,GO:0044451~nucleoplasm part,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0031248~protein acetyltransferase complex,GO:0030880~RNA polymerase complex,GO:0016591~DNA-directed RNA polymerase II, holoenzyme,GO:0005669~transcription factor TFIID complex,GO:0005667~transcription factor complex,GO:0005654~nucleoplasm,GO:0005576~extracellular region,GO:0000428~DNA-directed RNA polymerase complex,GO:0000124~SAGA complex,GO:0000123~histone acetyltransferase complex,GO:0000118~histone deacetylase complex,												GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0046983~protein dimerization activity,GO:0046982~protein heterodimerization activity,GO:0003713~transcription coactivator activity,GO:0003712~transcription cofactor activity,GO:0003677~DNA binding,GO:0003676~nucleic acid binding,GO:0000989~transcription factor activity, transcription factor binding,GO:0000988~transcription factor activity, protein binding,												IPR046344:TAF6_C_sf,IPR037796:TAF6,IPR011442:TAF6_C,IPR009072:Histone-fold,IPR004823:TAF_TATA-bd_Histone-like_dom,												hsa03022:Basal transcription factors,														SM00803:TAF,												REGION:Disordered,DOMAIN:TATA box binding protein associated factor (TAF) histone-like fold,
41489_at	TLE family member 1, transcriptional corepressor(TLE1)	Homo sapiens		h_wntPathway:WNT Signaling Pathway,												GO:2001141~regulation of RNA biosynthetic process,GO:2000811~negative regulation of anoikis,GO:2000209~regulation of anoikis,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1905114~cell surface receptor signaling pathway involved in cell-cell signaling,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1902679~negative regulation of RNA biosynthetic process,GO:1902532~negative regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:0198738~cell-cell signaling by wnt,GO:0097659~nucleic acid-templated transcription,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0060828~regulation of canonical Wnt signaling pathway,GO:0060548~negative regulation of cell death,GO:0060070~canonical Wnt signaling pathway,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0048585~negative regulation of response to stimulus,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0043276~anoikis,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043122~regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043069~negative regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptotic process,GO:0042981~regulation of apoptotic process,GO:0035556~intracellular signal transduction,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031324~negative regulation of cellular metabolic process,GO:0030178~negative regulation of Wnt signaling pathway,GO:0030111~regulation of Wnt signaling pathway,GO:0023057~negative regulation of signaling,GO:0023051~regulation of signaling,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016070~RNA metabolic process,GO:0016055~Wnt signaling pathway,GO:0012501~programmed cell death,GO:0010941~regulation of cell death,GO:0010648~negative regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010629~negative regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0009968~negative regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0009887~animal organ morphogenesis,GO:0008219~cell death,GO:0007267~cell-cell signaling,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0007166~cell surface receptor signaling pathway,GO:0006915~apoptotic process,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,												GO:1990907~beta-catenin-TCF complex,GO:0090575~RNA polymerase II transcription factor complex,GO:0044798~nuclear transcription factor complex,GO:0005829~cytosol,GO:0005667~transcription factor complex,GO:0005654~nucleoplasm,												GO:0042802~identical protein binding,GO:0003714~transcription corepressor activity,GO:0003712~transcription cofactor activity,GO:0000989~transcription factor activity, transcription factor binding,GO:0000988~transcription factor activity, protein binding,												IPR036322:WD40_repeat_dom_sf,IPR019775:WD40_repeat_CS,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR009146:Groucho_enhance,IPR005617:Groucho/TLE_N,IPR001680:WD40_rpt,												hsa04330:Notch signaling pathway,hsa04310:Wnt signaling pathway,														SM00320:WD40,												REPEAT:WD 6,REPEAT:WD 5,REPEAT:WD 4,REPEAT:WD 3,REPEAT:WD 2,REPEAT:WD 1,REPEAT:WD,REGION:SP domain,REGION:Q domain,REGION:GP domain,REGION:Disordered,REGION:CcN domain,MUTAGEN:Y->H: Abolishes HESX1 binding.,MUTAGEN:V->S: Abolishes HESX1 binding.,MUTAGEN:S->P: Abolishes HESX1 binding.,MUTAGEN:L->S: Abolishes HESX1 binding.,MOTIF:Nuclear localization signal,DOMAIN:Groucho/TLE N-terminal Q-rich,COMPBIAS:Pro residues,COMPBIAS:Polar residues,COMPBIAS:Basic and acidic residues,
1372_at	TNF alpha induced protein 6(TNFAIP6)	Homo sapiens			GO:2001141~regulation of RNA biosynthetic process,GO:2000147~positive regulation of cell motility,GO:2000146~negative regulation of cell motility,GO:2000145~regulation of cell motility,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1990266~neutrophil migration,GO:1905590~fibronectin fibril organization,GO:1905477~positive regulation of protein localization to membrane,GO:1905475~regulation of protein localization to membrane,GO:1903911~positive regulation of receptor clustering,GO:1903909~regulation of receptor clustering,GO:1903829~positive regulation of cellular protein localization,GO:1903827~regulation of cellular protein localization,GO:1903707~negative regulation of hemopoiesis,GO:1903706~regulation of hemopoiesis,GO:1903510~mucopolysaccharide metabolic process,GO:1903506~regulation of nucleic acid-templated transcription,GO:1902623~negative regulation of neutrophil migration,GO:1902622~regulation of neutrophil migration,GO:1902106~negative regulation of leukocyte differentiation,GO:1902105~regulation of leukocyte differentiation,GO:1901135~carbohydrate derivative metabolic process,GO:0097659~nucleic acid-templated transcription,GO:0097530~granulocyte migration,GO:0097529~myeloid leukocyte migration,GO:0097435~supramolecular fiber organization,GO:0090288~negative regulation of cellular response to growth factor stimulus,GO:0090287~regulation of cellular response to growth factor stimulus,GO:0090101~negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0090092~regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0090024~negative regulation of neutrophil chemotaxis,GO:0090022~regulation of neutrophil chemotaxis,GO:0080134~regulation of response to stress,GO:0072657~protein localization to membrane,GO:0071773~cellular response to BMP stimulus,GO:0071772~response to BMP,GO:0071623~negative regulation of granulocyte chemotaxis,GO:0071622~regulation of granulocyte chemotaxis,GO:0071621~granulocyte chemotaxis,GO:0071495~cellular response to endogenous stimulus,GO:0071363~cellular response to growth factor stimulus,GO:0071310~cellular response to organic substance,GO:0070887~cellular response to chemical stimulus,GO:0070848~response to growth factor,GO:0070727~cellular macromolecule localization,GO:0061458~reproductive system development,GO:0060341~regulation of cellular localization,GO:0060326~cell chemotaxis,GO:0051674~localization of cell,GO:0051668~localization within membrane,GO:0051641~cellular localization,GO:0051272~positive regulation of cellular component movement,GO:0051271~negative regulation of cellular component movement,GO:0051270~regulation of cellular component movement,GO:0051252~regulation of RNA metabolic process,GO:0051241~negative regulation of multicellular organismal process,GO:0051093~negative regulation of developmental process,GO:0050922~negative regulation of chemotaxis,GO:0050920~regulation of chemotaxis,GO:0050900~leukocyte migration,GO:0050728~negative regulation of inflammatory response,GO:0050727~regulation of inflammatory response,GO:0048870~cell motility,GO:0048609~multicellular organismal reproductive process,GO:0048608~reproductive structure development,GO:0048589~developmental growth,GO:0048585~negative regulation of response to stimulus,GO:0048534~hematopoietic or lymphoid organ development,GO:0048511~rhythmic process,GO:0048477~oogenesis,GO:0048468~cell development,GO:0048165~fused antrum stage,GO:0046660~female sex differentiation,GO:0046545~development of primary female sexual characteristics,GO:0045671~negative regulation of osteoclast differentiation,GO:0045670~regulation of osteoclast differentiation,GO:0045668~negative regulation of osteoblast differentiation,GO:0045667~regulation of osteoblast differentiation,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0045137~development of primary sexual characteristics,GO:0044703~multi-organism reproductive process,GO:0044702~single organism reproductive process,GO:0043113~receptor clustering,GO:0043062~extracellular structure organization,GO:0042698~ovulation cycle,GO:0042330~taxis,GO:0040017~positive regulation of locomotion,GO:0040013~negative regulation of locomotion,GO:0040012~regulation of locomotion,GO:0040011~locomotion,GO:0040007~growth,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034613~cellular protein localization,GO:0033036~macromolecule localization,GO:0032880~regulation of protein localization,GO:0032774~RNA biosynthetic process,GO:0032504~multicellular organism reproduction,GO:0032102~negative regulation of response to external stimulus,GO:0032101~regulation of response to external stimulus,GO:0031348~negative regulation of defense response,GO:0031347~regulation of defense response,GO:0030595~leukocyte chemotaxis,GO:0030593~neutrophil chemotaxis,GO:0030514~negative regulation of BMP signaling pathway,GO:0030510~regulation of BMP signaling pathway,GO:0030509~BMP signaling pathway,GO:0030336~negative regulation of cell migration,GO:0030335~positive regulation of cell migration,GO:0030334~regulation of cell migration,GO:0030316~osteoclast differentiation,GO:0030279~negative regulation of ossification,GO:0030278~regulation of ossification,GO:0030212~hyaluronan metabolic process,GO:0030203~glycosaminoglycan metabolic process,GO:0030198~extracellular matrix organization,GO:0030099~myeloid cell differentiation,GO:0030097~hemopoiesis,GO:0023057~negative regulation of signaling,GO:0023051~regulation of signaling,GO:0022610~biological adhesion,GO:0022605~oogenesis stage,GO:0022602~ovulation cycle process,GO:0022414~reproductive process,GO:0022412~cellular process involved in reproduction in multicellular organism,GO:0019953~sexual reproduction,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016477~cell migration,GO:0016070~RNA metabolic process,GO:0010648~negative regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010033~response to organic substance,GO:0009968~negative regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009719~response to endogenous stimulus,GO:0009605~response to external stimulus,GO:0008585~female gonad development,GO:0008406~gonad development,GO:0008104~protein localization,GO:0007548~sex differentiation,GO:0007292~female gamete generation,GO:0007281~germ cell development,GO:0007276~gamete generation,GO:0007267~cell-cell signaling,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0007155~cell adhesion,GO:0006954~inflammatory response,GO:0006952~defense response,GO:0006935~chemotaxis,GO:0006928~movement of cell or subcellular component,GO:0006366~transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0006022~aminoglycan metabolic process,GO:0003006~developmental process involved in reproduction,GO:0002762~negative regulation of myeloid leukocyte differentiation,GO:0002761~regulation of myeloid leukocyte differentiation,GO:0002689~negative regulation of leukocyte chemotaxis,GO:0002688~regulation of leukocyte chemotaxis,GO:0002686~negative regulation of leukocyte migration,GO:0002685~regulation of leukocyte migration,GO:0002683~negative regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002573~myeloid leukocyte differentiation,GO:0002521~leukocyte differentiation,GO:0002520~immune system development,GO:0001649~osteoblast differentiation,GO:0001550~ovarian cumulus expansion,GO:0001547~antral ovarian follicle growth,GO:0001541~ovarian follicle development,GO:0001503~ossification,GO:0000003~reproduction,												GO:1904813~ficolin-1-rich granule lumen,GO:1904724~tertiary granule lumen,GO:0101002~ficolin-1-rich granule,GO:0099503~secretory vesicle,GO:0070820~tertiary granule,GO:0044433~cytoplasmic vesicle part,GO:0044421~extracellular region part,GO:0030141~secretory granule,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:0097367~carbohydrate derivative binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0005540~hyaluronic acid binding,GO:0005539~glycosaminoglycan binding,GO:0005509~calcium ion binding,GO:0001968~fibronectin binding,												IPR035914:Sperma_CUB_dom_sf,IPR016187:CTDL_fold,IPR016186:C-type_lectin-like/link_sf,IPR000859:CUB_dom,IPR000538:Link_dom,															SM00445:LINK,SM00042:CUB,												MUTAGEN:Y->F: Abolishes binding to bikunin. Impairs binding to hyaluronan. Retains the ability to bind heavy chains but cannot transfer them onto hyaluronan. Impairs binding of hyaluronan to CD44. Decreases hyaluronan-dependent lymphocyte rolling.,MUTAGEN:Y->F: Abolishes binding to bikunin. Impairs binding of hyaluronan to CD44. Decreases hyaluronan-dependent lymphocyte rolling. Has no effect on transesterification reaction.,MUTAGEN:Y->F: Abolishes binding to bikunin. Has no effect on transesterification reaction.,MUTAGEN:K->Q: Abolishes binding to bikunin.,MUTAGEN:K->E: Decreases binding of hyaluronan to CD44. Decreases hyaluronan-dependent lymphocyte rolling.,MUTAGEN:K->A: Decreases binding to heparin. Has normal binding to bikunin. Impairs binding to heparin; when associated with A-69 and A-76. Has no effect on CXCL8-induced neutrophil transmigration; when associated with A-69 and A-76.,MUTAGEN:K->A: Decreases binding to heparin. Has normal binding to bikunin. Impairs binding to heparin; when associated with A-55 and A-76. Has no effect on CXCL8-induced neutrophil transmigration; when associated with A-55 and A-76.,MUTAGEN:K->A: Decreases binding to heparin. Has normal binding to bikunin. Impairs binding to heparin and decreases the potentiation effect toward bikunin antiprotease activity; when associated with A-55 and A-69. Has no effect on CXCL8-induced neutrophil transmigration; when associated with A-55 and A-69.,MUTAGEN:K->A: Decreases binding to heparin. Has normal binding to bikunin.,MUTAGEN:H->K: Increases binding of hyaluronan to CD44. Has no significant effect on hyaluronan-dependent lymphocyte rolling.,MUTAGEN:H->K: Decreases binding of hyaluronan to CD44. Decreases hyaluronan-dependent lymphocyte rolling.,MUTAGEN:F->V: Impairs binding of hyaluronan to CD44. Decreases hyaluronan-dependent lymphocyte rolling.,MUTAGEN:E->S: Reduces the binding affinity to calcium ions. Abolishes the interaction with heavy chain ITIH1.,MUTAGEN:E->K: Has no significant effect on hyaluronan binding to CD44 or hyaluronan-dependent lymphocyte rolling.,DOMAIN:Link,DOMAIN:CUB,CARBOHYD:N-linked (GlcNAc...) asparagine,
1331_s_at	TNF receptor superfamily member 25(TNFRSF25)	Homo sapiens		h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,												GO:0097190~apoptotic signaling pathway,GO:0071356~cellular response to tumor necrosis factor,GO:0071345~cellular response to cytokine stimulus,GO:0071310~cellular response to organic substance,GO:0070887~cellular response to chemical stimulus,GO:0043067~regulation of programmed cell death,GO:0042981~regulation of apoptotic process,GO:0034612~response to tumor necrosis factor,GO:0034097~response to cytokine,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0019221~cytokine-mediated signaling pathway,GO:0012501~programmed cell death,GO:0010941~regulation of cell death,GO:0010033~response to organic substance,GO:0008219~cell death,GO:0007166~cell surface receptor signaling pathway,GO:0006915~apoptotic process,												GO:0005829~cytosol,GO:0005576~extracellular region,												GO:0099600~transmembrane receptor activity,GO:0060089~molecular transducer activity,GO:0038023~signaling receptor activity,GO:0005035~death receptor activity,GO:0005031~tumor necrosis factor-activated receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0004872~receptor activity,GO:0004871~signal transducer activity,												IPR034050:TNFRSF25_N,IPR022329:TNFR_25,IPR011029:DEATH-like_dom_sf,IPR001368:TNFR/NGFR_Cys_rich_reg,IPR000488:Death_domain,												hsa04060:Cytokine-cytokine receptor interaction,														SM00208:TNFR,SM00005:DEATH,												TRANSMEM:Helical,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,REPEAT:TNFR-Cys 4,REPEAT:TNFR-Cys 3,REPEAT:TNFR-Cys 2,REPEAT:TNFR-Cys 1,REPEAT:TNFR-Cys,MUTAGEN:L->A: Suppresses homodimerization, and TNFR1 interaction.,MUTAGEN:L->A: Suppresses homodimerization, TNFR1 interaction, and apoptosis induction.,MUTAGEN:D->A: Suppresses homodimerization, and TNFR1 interaction.,DOMAIN:TNFR-Cys,DOMAIN:Death,CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:(Microbial infection) N-beta-linked (GlcNAc) arginine,
32680_at	TRAF2 and NCK interacting kinase(TNIK)	Homo sapiens			GO:1990778~protein localization to cell periphery,GO:1905114~cell surface receptor signaling pathway involved in cell-cell signaling,GO:1902589~single-organism organelle organization,GO:1902580~single-organism cellular localization,GO:1902533~positive regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:1901698~response to nitrogen compound,GO:0198738~cell-cell signaling by wnt,GO:0080135~regulation of cellular response to stress,GO:0080134~regulation of response to stress,GO:0072659~protein localization to plasma membrane,GO:0072657~protein localization to membrane,GO:0070727~cellular macromolecule localization,GO:0070304~positive regulation of stress-activated protein kinase signaling cascade,GO:0070302~regulation of stress-activated protein kinase signaling cascade,GO:0061024~membrane organization,GO:0060284~regulation of cell development,GO:0051960~regulation of nervous system development,GO:0051641~cellular localization,GO:0051403~stress-activated MAPK cascade,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051128~regulation of cellular component organization,GO:0050773~regulation of dendrite development,GO:0050767~regulation of neurogenesis,GO:0048858~cell projection morphogenesis,GO:0048814~regulation of dendrite morphogenesis,GO:0048812~neuron projection morphogenesis,GO:0048699~generation of neurons,GO:0048666~neuron development,GO:0048584~positive regulation of response to stimulus,GO:0048468~cell development,GO:0046777~protein autophosphorylation,GO:0046330~positive regulation of JNK cascade,GO:0046328~regulation of JNK cascade,GO:0045937~positive regulation of phosphate metabolic process,GO:0045664~regulation of neuron differentiation,GO:0045595~regulation of cell differentiation,GO:0044802~single-organism membrane organization,GO:0044085~cellular component biogenesis,GO:0043410~positive regulation of MAPK cascade,GO:0043408~regulation of MAPK cascade,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0036211~protein modification process,GO:0035556~intracellular signal transduction,GO:0034613~cellular protein localization,GO:0033554~cellular response to stress,GO:0033036~macromolecule localization,GO:0032990~cell part morphogenesis,GO:0032989~cellular component morphogenesis,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0032872~regulation of stress-activated MAPK cascade,GO:0032528~microvillus organization,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031344~regulation of cell projection organization,GO:0031325~positive regulation of cellular metabolic process,GO:0031175~neuron projection development,GO:0031098~stress-activated protein kinase signaling cascade,GO:0030182~neuron differentiation,GO:0030036~actin cytoskeleton organization,GO:0030033~microvillus assembly,GO:0030031~cell projection assembly,GO:0030030~cell projection organization,GO:0030029~actin filament-based process,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0023014~signal transduction by protein phosphorylation,GO:0022607~cellular component assembly,GO:0022604~regulation of cell morphogenesis,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022008~neurogenesis,GO:0019220~regulation of phosphate metabolic process,GO:0016358~dendrite development,GO:0016310~phosphorylation,GO:0016055~Wnt signaling pathway,GO:0010975~regulation of neuron projection development,GO:0010769~regulation of cell morphogenesis involved in differentiation,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010256~endomembrane system organization,GO:0010243~response to organonitrogen compound,GO:0010033~response to organic substance,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009893~positive regulation of metabolic process,GO:0009719~response to endogenous stimulus,GO:0008104~protein localization,GO:0007399~nervous system development,GO:0007267~cell-cell signaling,GO:0007254~JNK cascade,GO:0007166~cell surface receptor signaling pathway,GO:0007010~cytoskeleton organization,GO:0007009~plasma membrane organization,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0001934~positive regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,GO:0000904~cell morphogenesis involved in differentiation,GO:0000902~cell morphogenesis,GO:0000165~MAPK cascade,												GO:1903561~extracellular vesicle,GO:0099572~postsynaptic specialization,GO:0099092~postsynaptic density, intracellular component,GO:0098984~neuron to neuron synapse,GO:0098978~glutamatergic synapse,GO:0098794~postsynapse,GO:0098793~presynapse,GO:0098590~plasma membrane region,GO:0097458~neuron part,GO:0070062~extracellular exosome,GO:0055037~recycling endosome,GO:0048471~perinuclear region of cytoplasm,GO:0045202~synapse,GO:0045177~apical part of cell,GO:0044456~synapse part,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0032279~asymmetric synapse,GO:0016324~apical plasma membrane,GO:0014069~postsynaptic density,GO:0005829~cytosol,GO:0005768~endosome,GO:0005654~nucleoplasm,GO:0005576~extracellular region,												GO:1901363~heterocyclic compound binding,GO:1901265~nucleoside phosphate binding,GO:0097367~carbohydrate derivative binding,GO:0097159~organic cyclic compound binding,GO:0043168~anion binding,GO:0043167~ion binding,GO:0036094~small molecule binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0017076~purine nucleotide binding,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0016301~kinase activity,GO:0005524~ATP binding,GO:0004674~protein serine/threonine kinase activity,GO:0004672~protein kinase activity,GO:0000166~nucleotide binding,												IPR017441:Protein_kinase_ATP_BS,IPR011009:Kinase-like_dom_sf,IPR008271:Ser/Thr_kinase_AS,IPR001180:CNH_dom,IPR000719:Prot_kinase_dom,													617028~Intellectual developmental disorder, autosomal recessive 54,													SM00220:S_TKc,SM00036:CNH,												REGION:Mediates interaction with NEDD4,REGION:Disordered,MUTAGEN:RD->AA: Loss of autophosphorylation.,MUTAGEN:K->A: Kinase dead. Loss of autophosphorylation and loss of function in cytoskeleton regulation.,MUTAGEN:DF->AA: Loss of autophosphorylation.,DOMAIN:Protein kinase,DOMAIN:CNH,COMPBIAS:Polar residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Acidic residues,ACT_SITE:Proton acceptor,
35213_at	WW domain binding protein 4(WBP4)	Homo sapiens			GO:0045292~mRNA cis splicing, via spliceosome,GO:0016071~mRNA metabolic process,GO:0016070~RNA metabolic process,GO:0010467~gene expression,GO:0008380~RNA splicing,GO:0006397~mRNA processing,GO:0006396~RNA processing,GO:0000398~mRNA splicing, via spliceosome,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000375~RNA splicing, via transesterification reactions,												GO:1990904~ribonucleoprotein complex,GO:0071011~precatalytic spliceosome,GO:0071005~U2-type precatalytic spliceosome,GO:0044451~nucleoplasm part,GO:0030529~intracellular ribonucleoprotein complex,GO:0016607~nuclear speck,GO:0016604~nuclear body,GO:0005684~U2-type spliceosomal complex,GO:0005681~spliceosomal complex,GO:0005654~nucleoplasm,												GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0070064~proline-rich region binding,GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0008270~zinc ion binding,GO:0003723~RNA binding,GO:0003676~nucleic acid binding,												IPR040023:WBP4,IPR036236:Znf_C2H2_sf,IPR036020:WW_dom_sf,IPR013085:U1-CZ_Znf_C2H2,IPR003604:Matrin/U1-like-C_Znf_C2H2,IPR001202:WW_dom,IPR000690:Matrin/U1-C_Znf_C2H2,															SM00456:WW,SM00451:ZnF_U1,												ZN_FING:Matrin-type,REGION:Interaction with SNRNP200,REGION:Disordered,MUTAGEN:W->A: Nearly abolishes activation of pre-mRNA splicing. Abolishes interaction with WBP11.,DOMAIN:WW 2,DOMAIN:WW 1,DOMAIN:WW,DOMAIN:Matrin-type,COMPBIAS:Polar residues,COMPBIAS:Basic and acidic residues,
33684_at	Wnt family member 2B(WNT2B)	Homo sapiens			GO:2000027~regulation of organ morphogenesis,GO:1905332~positive regulation of morphogenesis of an epithelium,GO:1905330~regulation of morphogenesis of an epithelium,GO:1905114~cell surface receptor signaling pathway involved in cell-cell signaling,GO:0198738~cell-cell signaling by wnt,GO:0090596~sensory organ morphogenesis,GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis,GO:0090189~regulation of branching involved in ureteric bud morphogenesis,GO:0090184~positive regulation of kidney development,GO:0090183~regulation of kidney development,GO:0072171~mesonephric tubule morphogenesis,GO:0072164~mesonephric tubule development,GO:0072163~mesonephric epithelium development,GO:0072089~stem cell proliferation,GO:0072088~nephron epithelium morphogenesis,GO:0072080~nephron tubule development,GO:0072078~nephron tubule morphogenesis,GO:0072073~kidney epithelium development,GO:0072028~nephron morphogenesis,GO:0072009~nephron epithelium development,GO:0072006~nephron development,GO:0072001~renal system development,GO:0071496~cellular response to external stimulus,GO:0071425~hematopoietic stem cell proliferation,GO:0061458~reproductive system development,GO:0061448~connective tissue development,GO:0061333~renal tubule morphogenesis,GO:0061326~renal tubule development,GO:0061303~cornea development in camera-type eye,GO:0061217~regulation of mesonephros development,GO:0061213~positive regulation of mesonephros development,GO:0061138~morphogenesis of a branching epithelium,GO:0061072~iris morphogenesis,GO:0061047~positive regulation of branching involved in lung morphogenesis,GO:0061046~regulation of branching involved in lung morphogenesis,GO:0060993~kidney morphogenesis,GO:0060688~regulation of morphogenesis of a branching structure,GO:0060675~ureteric bud morphogenesis,GO:0060638~mesenchymal-epithelial cell signaling,GO:0060562~epithelial tube morphogenesis,GO:0060541~respiratory system development,GO:0060492~lung induction,GO:0060441~epithelial tube branching involved in lung morphogenesis,GO:0060429~epithelium development,GO:0060425~lung morphogenesis,GO:0060322~head development,GO:0060070~canonical Wnt signaling pathway,GO:0051240~positive regulation of multicellular organismal process,GO:0051216~cartilage development,GO:0051094~positive regulation of developmental process,GO:0048754~branching morphogenesis of an epithelial tube,GO:0048729~tissue morphogenesis,GO:0048699~generation of neurons,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048645~animal organ formation,GO:0048608~reproductive structure development,GO:0048593~camera-type eye morphogenesis,GO:0048592~eye morphogenesis,GO:0048534~hematopoietic or lymphoid organ development,GO:0046661~male sex differentiation,GO:0046546~development of primary male sexual characteristics,GO:0045995~regulation of embryonic development,GO:0045165~cell fate commitment,GO:0045137~development of primary sexual characteristics,GO:0044702~single organism reproductive process,GO:0043010~camera-type eye development,GO:0042594~response to starvation,GO:0040019~positive regulation of embryonic development,GO:0035295~tube development,GO:0035239~tube morphogenesis,GO:0033554~cellular response to stress,GO:0031669~cellular response to nutrient levels,GO:0031668~cellular response to extracellular stimulus,GO:0031667~response to nutrient levels,GO:0031128~developmental induction,GO:0030900~forebrain development,GO:0030324~lung development,GO:0030323~respiratory tube development,GO:0030182~neuron differentiation,GO:0030097~hemopoiesis,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022414~reproductive process,GO:0022008~neurogenesis,GO:0021871~forebrain regionalization,GO:0016055~Wnt signaling pathway,GO:0010092~specification of animal organ identity,GO:0009991~response to extracellular stimulus,GO:0009887~animal organ morphogenesis,GO:0009790~embryo development,GO:0009605~response to external stimulus,GO:0009267~cellular response to starvation,GO:0008584~male gonad development,GO:0008406~gonad development,GO:0008283~cell proliferation,GO:0007548~sex differentiation,GO:0007423~sensory organ development,GO:0007420~brain development,GO:0007417~central nervous system development,GO:0007399~nervous system development,GO:0007389~pattern specification process,GO:0007267~cell-cell signaling,GO:0007166~cell surface receptor signaling pathway,GO:0003156~regulation of animal organ formation,GO:0003006~developmental process involved in reproduction,GO:0003002~regionalization,GO:0002520~immune system development,GO:0002088~lens development in camera-type eye,GO:0002062~chondrocyte differentiation,GO:0002009~morphogenesis of an epithelium,GO:0001823~mesonephros development,GO:0001822~kidney development,GO:0001763~morphogenesis of a branching structure,GO:0001759~organ induction,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001657~ureteric bud development,GO:0001655~urogenital system development,GO:0001654~eye development,GO:0001501~skeletal system development,GO:0000003~reproduction,												GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:0005125~cytokine activity,GO:0005109~frizzled binding,GO:0005102~receptor binding,GO:0001664~G-protein coupled receptor binding,												IPR043158:Wnt_C,IPR018161:Wnt_CS,IPR009140:Wnt2,IPR005817:Wnt,												hsa05226:Gastric cancer,hsa05225:Hepatocellular carcinoma,hsa05224:Breast cancer,hsa05217:Basal cell carcinoma,hsa05205:Proteoglycans in cancer,hsa05200:Pathways in cancer,hsa05165:Human papillomavirus infection,hsa05022:Pathways of neurodegeneration - multiple diseases,hsa05010:Alzheimer disease,hsa04934:Cushing syndrome,hsa04916:Melanogenesis,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04390:Hippo signaling pathway,hsa04310:Wnt signaling pathway,hsa04150:mTOR signaling pathway,												618168~Diarrhea 9,													SM00097:WNT1,												LIPID:O-palmitoleoyl serine; by PORCN,CARBOHYD:N-linked (GlcNAc...) asparagine,
2090_i_at	Wnt family member 6(WNT6)	Homo sapiens			GO:2001141~regulation of RNA biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000027~regulation of organ morphogenesis,GO:1905114~cell surface receptor signaling pathway involved in cell-cell signaling,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1902680~positive regulation of RNA biosynthetic process,GO:1901701~cellular response to oxygen-containing compound,GO:1901700~response to oxygen-containing compound,GO:0198738~cell-cell signaling by wnt,GO:0097659~nucleic acid-templated transcription,GO:0072175~epithelial tube formation,GO:0072171~mesonephric tubule morphogenesis,GO:0072164~mesonephric tubule development,GO:0072163~mesonephric epithelium development,GO:0072088~nephron epithelium morphogenesis,GO:0072080~nephron tubule development,GO:0072079~nephron tubule formation,GO:0072078~nephron tubule morphogenesis,GO:0072073~kidney epithelium development,GO:0072028~nephron morphogenesis,GO:0072009~nephron epithelium development,GO:0072006~nephron development,GO:0072001~renal system development,GO:0071396~cellular response to lipid,GO:0071310~cellular response to organic substance,GO:0071300~cellular response to retinoic acid,GO:0071229~cellular response to acid chemical,GO:0070887~cellular response to chemical stimulus,GO:0070172~positive regulation of tooth mineralization,GO:0070170~regulation of tooth mineralization,GO:0070169~positive regulation of biomineral tissue development,GO:0070167~regulation of biomineral tissue development,GO:0061333~renal tubule morphogenesis,GO:0061326~renal tubule development,GO:0061303~cornea development in camera-type eye,GO:0061138~morphogenesis of a branching epithelium,GO:0060993~kidney morphogenesis,GO:0060684~epithelial-mesenchymal cell signaling,GO:0060675~ureteric bud morphogenesis,GO:0060562~epithelial tube morphogenesis,GO:0060429~epithelium development,GO:0060070~canonical Wnt signaling pathway,GO:0051254~positive regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051094~positive regulation of developmental process,GO:0048754~branching morphogenesis of an epithelial tube,GO:0048729~tissue morphogenesis,GO:0048699~generation of neurons,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048598~embryonic morphogenesis,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045165~cell fate commitment,GO:0043010~camera-type eye development,GO:0042482~positive regulation of odontogenesis,GO:0042481~regulation of odontogenesis,GO:0042476~odontogenesis,GO:0042475~odontogenesis of dentin-containing tooth,GO:0035295~tube development,GO:0035239~tube morphogenesis,GO:0035148~tube formation,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034505~tooth mineralization,GO:0033993~response to lipid,GO:0032774~RNA biosynthetic process,GO:0032526~response to retinoic acid,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031214~biomineral tissue development,GO:0030182~neuron differentiation,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022008~neurogenesis,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016331~morphogenesis of embryonic epithelium,GO:0016070~RNA metabolic process,GO:0016055~Wnt signaling pathway,GO:0010628~positive regulation of gene expression,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010033~response to organic substance,GO:0009893~positive regulation of metabolic process,GO:0009891~positive regulation of biosynthetic process,GO:0009887~animal organ morphogenesis,GO:0009798~axis specification,GO:0009790~embryo development,GO:0007423~sensory organ development,GO:0007399~nervous system development,GO:0007389~pattern specification process,GO:0007267~cell-cell signaling,GO:0007166~cell surface receptor signaling pathway,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0002009~morphogenesis of an epithelium,GO:0001838~embryonic epithelial tube formation,GO:0001823~mesonephros development,GO:0001822~kidney development,GO:0001763~morphogenesis of a branching structure,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001657~ureteric bud development,GO:0001655~urogenital system development,GO:0001654~eye development,GO:0001101~response to acid chemical,												GO:1903561~extracellular vesicle,GO:0070062~extracellular exosome,GO:0044433~cytoplasmic vesicle part,GO:0044432~endoplasmic reticulum part,GO:0044431~Golgi apparatus part,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0031012~extracellular matrix,GO:0030666~endocytic vesicle membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0030139~endocytic vesicle,GO:0012506~vesicle membrane,GO:0009986~cell surface,GO:0005796~Golgi lumen,GO:0005794~Golgi apparatus,GO:0005788~endoplasmic reticulum lumen,GO:0005783~endoplasmic reticulum,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:0005125~cytokine activity,GO:0005109~frizzled binding,GO:0005102~receptor binding,GO:0001664~G-protein coupled receptor binding,												IPR043158:Wnt_C,IPR018161:Wnt_CS,IPR009143:Wnt6,IPR005817:Wnt,												hsa05226:Gastric cancer,hsa05225:Hepatocellular carcinoma,hsa05224:Breast cancer,hsa05217:Basal cell carcinoma,hsa05205:Proteoglycans in cancer,hsa05200:Pathways in cancer,hsa05165:Human papillomavirus infection,hsa05022:Pathways of neurodegeneration - multiple diseases,hsa05010:Alzheimer disease,hsa04934:Cushing syndrome,hsa04916:Melanogenesis,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04390:Hippo signaling pathway,hsa04310:Wnt signaling pathway,hsa04150:mTOR signaling pathway,														SM00097:WNT1,												REGION:Disordered,LIPID:O-palmitoleoyl serine; by PORCN,COMPBIAS:Pro residues,CARBOHYD:N-linked (GlcNAc...) asparagine,
37953_s_at	acid sensing ion channel subunit 1(ASIC1)	Homo sapiens			GO:1903531~negative regulation of secretion by cell,GO:1903530~regulation of secretion by cell,GO:1901698~response to nitrogen compound,GO:0099643~signal release from synapse,GO:0099537~trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0099531~presynaptic process involved in chemical synaptic transmission,GO:0098916~anterograde trans-synaptic signaling,GO:0098662~inorganic cation transmembrane transport,GO:0098660~inorganic ion transmembrane transport,GO:0098655~cation transmembrane transport,GO:0072511~divalent inorganic cation transport,GO:0071822~protein complex subunit organization,GO:0071467~cellular response to pH,GO:0071214~cellular response to abiotic stimulus,GO:0070838~divalent metal ion transport,GO:0070588~calcium ion transmembrane transport,GO:0070271~protein complex biogenesis,GO:0070207~protein homotrimerization,GO:0070206~protein trimerization,GO:0065003~macromolecular complex assembly,GO:0060341~regulation of cellular localization,GO:0055085~transmembrane transport,GO:0051649~establishment of localization in cell,GO:0051641~cellular localization,GO:0051589~negative regulation of neurotransmitter transport,GO:0051588~regulation of neurotransmitter transport,GO:0051260~protein homooligomerization,GO:0051259~protein oligomerization,GO:0051051~negative regulation of transport,GO:0051049~regulation of transport,GO:0051048~negative regulation of secretion,GO:0051046~regulation of secretion,GO:0050915~sensory perception of sour taste,GO:0050909~sensory perception of taste,GO:0050890~cognition,GO:0050877~neurological system process,GO:0050805~negative regulation of synaptic transmission,GO:0050804~modulation of synaptic transmission,GO:0046929~negative regulation of neurotransmitter secretion,GO:0046928~regulation of neurotransmitter secretion,GO:0046903~secretion,GO:0044708~single-organism behavior,GO:0044085~cellular component biogenesis,GO:0043933~macromolecular complex subunit organization,GO:0042596~fear response,GO:0042391~regulation of membrane potential,GO:0035725~sodium ion transmembrane transport,GO:0034220~ion transmembrane transport,GO:0033555~multicellular organismal response to stress,GO:0032940~secretion by cell,GO:0030001~metal ion transport,GO:0023061~signal release,GO:0023057~negative regulation of signaling,GO:0023051~regulation of signaling,GO:0022607~cellular component assembly,GO:0015672~monovalent inorganic cation transport,GO:0014075~response to amine,GO:0010648~negative regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010447~response to acidic pH,GO:0010243~response to organonitrogen compound,GO:0010033~response to organic substance,GO:0009719~response to endogenous stimulus,GO:0009628~response to abiotic stimulus,GO:0009268~response to pH,GO:0008306~associative learning,GO:0007613~memory,GO:0007612~learning,GO:0007611~learning or memory,GO:0007610~behavior,GO:0007606~sensory perception of chemical stimulus,GO:0007600~sensory perception,GO:0007269~neurotransmitter secretion,GO:0007268~chemical synaptic transmission,GO:0007267~cell-cell signaling,GO:0006952~defense response,GO:0006836~neurotransmitter transport,GO:0006816~calcium ion transport,GO:0006814~sodium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,GO:0006461~protein complex assembly,GO:0003008~system process,GO:0002209~behavioral defense response,GO:0001975~response to amphetamine,GO:0001662~behavioral fear response,GO:0001505~regulation of neurotransmitter levels,												GO:0098793~presynapse,GO:0097458~neuron part,GO:0045202~synapse,GO:0044456~synapse part,GO:0009986~cell surface,GO:0005794~Golgi apparatus,												GO:0099600~transmembrane receptor activity,GO:0099094~ligand-gated cation channel activity,GO:0060089~molecular transducer activity,GO:0046873~metal ion transmembrane transporter activity,GO:0044736~acid-sensing ion channel activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0022839~ion gated channel activity,GO:0022838~substrate-specific channel activity,GO:0022836~gated channel activity,GO:0022834~ligand-gated channel activity,GO:0022803~passive transmembrane transporter activity,GO:0015280~ligand-gated sodium channel activity,GO:0015276~ligand-gated ion channel activity,GO:0015267~channel activity,GO:0015081~sodium ion transmembrane transporter activity,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0008324~cation transmembrane transporter activity,GO:0005272~sodium channel activity,GO:0005261~cation channel activity,GO:0005216~ion channel activity,GO:0004872~receptor activity,												IPR020903:ENaC_CS,IPR004724:ENaC_chordates,IPR001873:ENaC,												hsa04750:Inflammatory mediator regulation of TRP channels,															TRANSMEM:Helical,TRANSMEM:Discontinuously helical,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,SITE:Key residue for defining the pH sensitivity of ASIC1 (isoform 1),SITE:Important for interaction with the spider venom psalmotoxin-1,SITE:Important for channel gating,SITE:Important for channel desensitizing,MUTAGEN:S->A: No effect on phosphorylation.,MUTAGEN:S->A: Loss of phosphorylation.,MUTAGEN:F->L: Complete loss in the shift of pH for both activation and desensitization by the spider venom psalmotoxin-1.,MUTAGEN:D->A,N: Large decrease in response to pH 6.5 solutions.,MOTIF:Selectivity filter,CARBOHYD:N-linked (GlcNAc...) asparagine,
40317_at	acid sensing ion channel subunit 2(ASIC2)	Homo sapiens			GO:1903522~regulation of blood circulation,GO:0099537~trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0098916~anterograde trans-synaptic signaling,GO:0098662~inorganic cation transmembrane transport,GO:0098660~inorganic ion transmembrane transport,GO:0098655~cation transmembrane transport,GO:0097746~regulation of blood vessel diameter,GO:0090066~regulation of anatomical structure size,GO:0071468~cellular response to acidic pH,GO:0071467~cellular response to pH,GO:0071466~cellular response to xenobiotic stimulus,GO:0071214~cellular response to abiotic stimulus,GO:0070887~cellular response to chemical stimulus,GO:0060548~negative regulation of cell death,GO:0055085~transmembrane transport,GO:0051965~positive regulation of synapse assembly,GO:0051963~regulation of synapse assembly,GO:0051962~positive regulation of nervous system development,GO:0051960~regulation of nervous system development,GO:0051649~establishment of localization in cell,GO:0051641~cellular localization,GO:0051606~detection of stimulus,GO:0051240~positive regulation of multicellular organismal process,GO:0051130~positive regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051094~positive regulation of developmental process,GO:0051049~regulation of transport,GO:0050982~detection of mechanical stimulus,GO:0050974~detection of mechanical stimulus involved in sensory perception,GO:0050954~sensory perception of mechanical stimulus,GO:0050915~sensory perception of sour taste,GO:0050909~sensory perception of taste,GO:0050906~detection of stimulus involved in sensory perception,GO:0050880~regulation of blood vessel size,GO:0050877~neurological system process,GO:0050808~synapse organization,GO:0050807~regulation of synapse organization,GO:0050803~regulation of synapse structure or activity,GO:0044089~positive regulation of cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044085~cellular component biogenesis,GO:0044057~regulation of system process,GO:0043269~regulation of ion transport,GO:0043069~negative regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptotic process,GO:0042981~regulation of apoptotic process,GO:0042391~regulation of membrane potential,GO:0035725~sodium ion transmembrane transport,GO:0035418~protein localization to synapse,GO:0035296~regulation of tube diameter,GO:0035150~regulation of tube size,GO:0034765~regulation of ion transmembrane transport,GO:0034762~regulation of transmembrane transport,GO:0034220~ion transmembrane transport,GO:0033036~macromolecule localization,GO:0030001~metal ion transport,GO:0022607~cellular component assembly,GO:0019229~regulation of vasoconstriction,GO:0015672~monovalent inorganic cation transport,GO:0012501~programmed cell death,GO:0010941~regulation of cell death,GO:0010447~response to acidic pH,GO:0009628~response to abiotic stimulus,GO:0009612~response to mechanical stimulus,GO:0009605~response to external stimulus,GO:0009583~detection of light stimulus,GO:0009582~detection of abiotic stimulus,GO:0009581~detection of external stimulus,GO:0009416~response to light stimulus,GO:0009410~response to xenobiotic stimulus,GO:0009314~response to radiation,GO:0009268~response to pH,GO:0008219~cell death,GO:0008217~regulation of blood pressure,GO:0008104~protein localization,GO:0008015~blood circulation,GO:0007606~sensory perception of chemical stimulus,GO:0007605~sensory perception of sound,GO:0007602~phototransduction,GO:0007600~sensory perception,GO:0007422~peripheral nervous system development,GO:0007417~central nervous system development,GO:0007416~synapse assembly,GO:0007399~nervous system development,GO:0007268~chemical synaptic transmission,GO:0007267~cell-cell signaling,GO:0006915~apoptotic process,GO:0006814~sodium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,GO:0003073~regulation of systemic arterial blood pressure,GO:0003026~regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback,GO:0003025~regulation of systemic arterial blood pressure by baroreceptor feedback,GO:0003018~vascular process in circulatory system,GO:0003013~circulatory system process,GO:0003008~system process,GO:0001976~neurological system process involved in regulation of systemic arterial blood pressure,												GO:0098794~postsynapse,GO:0097458~neuron part,GO:0045202~synapse,GO:0044456~synapse part,GO:0044309~neuron spine,GO:0044297~cell body,GO:0043197~dendritic spine,GO:0043025~neuronal cell body,GO:0043005~neuron projection,GO:0036477~somatodendritic compartment,GO:0030425~dendrite,												GO:1905030~voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,GO:0099600~transmembrane receptor activity,GO:0099094~ligand-gated cation channel activity,GO:0060089~molecular transducer activity,GO:0046873~metal ion transmembrane transporter activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0022839~ion gated channel activity,GO:0022838~substrate-specific channel activity,GO:0022836~gated channel activity,GO:0022834~ligand-gated channel activity,GO:0022832~voltage-gated channel activity,GO:0022803~passive transmembrane transporter activity,GO:0015280~ligand-gated sodium channel activity,GO:0015276~ligand-gated ion channel activity,GO:0015267~channel activity,GO:0015081~sodium ion transmembrane transporter activity,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0008324~cation transmembrane transporter activity,GO:0005272~sodium channel activity,GO:0005261~cation channel activity,GO:0005248~voltage-gated sodium channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005216~ion channel activity,GO:0004872~receptor activity,												IPR020903:ENaC_CS,IPR004724:ENaC_chordates,IPR001873:ENaC,												hsa04750:Inflammatory mediator regulation of TRP channels,hsa04742:Taste transduction,															TRANSMEM:Helical,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,CARBOHYD:N-linked (GlcNAc...) asparagine,
34606_s_at	activating transcription factor 7(ATF7)	Homo sapiens			GO:2001141~regulation of RNA biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1902680~positive regulation of RNA biosynthetic process,GO:1902679~negative regulation of RNA biosynthetic process,GO:0097659~nucleic acid-templated transcription,GO:0051254~positive regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031324~negative regulation of cellular metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016070~RNA metabolic process,GO:0010629~negative regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0009891~positive regulation of biosynthetic process,GO:0009890~negative regulation of biosynthetic process,GO:0006366~transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,												GO:0098687~chromosomal region,GO:0090575~RNA polymerase II transcription factor complex,GO:0044798~nuclear transcription factor complex,GO:0044427~chromosomal part,GO:0005694~chromosome,GO:0005667~transcription factor complex,GO:0005654~nucleoplasm,GO:0000785~chromatin,GO:0000781~chromosome, telomeric region,												GO:1990837~sequence-specific double-stranded DNA binding,GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0051019~mitogen-activated protein kinase binding,GO:0046872~metal ion binding,GO:0044212~transcription regulatory region DNA binding,GO:0043565~sequence-specific DNA binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0035497~cAMP response element binding,GO:0019901~protein kinase binding,GO:0019900~kinase binding,GO:0019899~enzyme binding,GO:0008134~transcription factor binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003690~double-stranded DNA binding,GO:0003677~DNA binding,GO:0003676~nucleic acid binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001223~transcription coactivator binding,GO:0001221~transcription cofactor binding,GO:0001159~core promoter proximal region DNA binding,GO:0001071~nucleic acid binding transcription factor activity,GO:0001067~regulatory region nucleic acid binding,GO:0001012~RNA polymerase II regulatory region DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000975~regulatory region DNA binding,												IPR046347:bZIP_sf,IPR036236:Znf_C2H2_sf,IPR016378:TF_CRE-BP1-typ,IPR013087:Znf_C2H2_type,IPR004827:bZIP,														PIRSF003153:ATF2_CRE-BP1,												SM00355:ZnF_C2H2,SM00338:BRLZ,												ZN_FING:C2H2-type,REGION:Transactivation domain,REGION:Leucine-zipper,REGION:Essential for binding adenovirus 2 E1A,REGION:Disordered,REGION:Basic motif,MUTAGEN:T->G: Some reduction in transactivation but, completely abolishes MAPK9-mediated activation. Abolishes MAPK9-mediated and greatly reduces adenovirus E1A-mediated transactivation; when associated with A-51 and A-53. Abolishes adenovirus 2 E1A-mediated transactivation; when associated with A-14; A-51 and A-53.,MUTAGEN:T->D: Completely abolishes MAPK9- and adenovirus E1A-mediated transactivation; when associated with D-53.,MUTAGEN:T->D: Completely abolishes MAPK9- and adenovirus E1A-mediated transactivation; when associated with D-51.,MUTAGEN:T->A: Severely reduced TAF12-induced transcriptional activity. No effect on MAPK9-mediated phosphorylation; when associated with A-53. Greatly reduces MAPK9- and adenovirus E1A-mediated transactivation; when associated with A-53 and G-101. Abolishes adenovirus 2 E1A-mediated transactivation; when associated with A-14; A-53 and G-101.,MUTAGEN:T->A: Severely reduced TAF12-induced transcriptional activity. No effect on MAPK9-mediated phosphorylation; when associated with A-51. Greatly reduces MAPK9- and adenovirus E1A-mediated transactivation; when associated with A-51 and G-101. Abolishes adenovirus 2 E1A-mediated transactivation; when associated with A-14; A-51 and G-101.,MUTAGEN:T->A: No effect on transactivation; when associated with A-147.,MUTAGEN:T->A: No effect on transactivation; when associated with A-145.,MUTAGEN:M->D: Severely reduced TAF12-induced transcriptional activity; when associated with S-35.,MUTAGEN:L->S: Severely reduced TAF12-induced transcriptional activity; when associated with D-33.,MUTAGEN:K->R: Abolishes sumoylation. Exclusive nucleoplasmic location. Increase in binding the E-selectin promoter.,MUTAGEN:H->N: No effect on binding adenovirus 2 E1A. Abolishes ATF7-mediated E1A responsiveness.,MUTAGEN:D->K: No effect on binding adenovirus 2 E1A. Abolishes ATF7-mediated E1A responsiveness.,MUTAGEN:C->A: Severely reduced TAF12-mediated enhancement of transcriptional activity.,MUTAGEN:C->A: Greatly reduced JNK2- or adenovirus E1A-mediated transactivation. Abolishes adenovirus 2 E1A-mediated transactivation; when associated with A-51; A-53 and G-101.,DOMAIN:bZIP,DOMAIN:C2H2-type,DOMAIN:BZIP,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1),COMPBIAS:Basic and acidic residues,
35648_at	activator of transcription and developmental regulator AUTS2(AUTS2)	Homo sapiens			GO:2001252~positive regulation of chromosome organization,GO:2001141~regulation of RNA biosynthetic process,GO:2000758~positive regulation of peptidyl-lysine acetylation,GO:2000756~regulation of peptidyl-lysine acetylation,GO:2000620~positive regulation of histone H4-K16 acetylation,GO:2000618~regulation of histone H4-K16 acetylation,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1990138~neuron projection extension,GO:1905269~positive regulation of chromatin organization,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1902745~positive regulation of lamellipodium organization,GO:1902743~regulation of lamellipodium organization,GO:1902680~positive regulation of RNA biosynthetic process,GO:1902589~single-organism organelle organization,GO:1902533~positive regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:1902275~regulation of chromatin organization,GO:1901985~positive regulation of protein acetylation,GO:1901983~regulation of protein acetylation,GO:0097659~nucleic acid-templated transcription,GO:0097581~lamellipodium organization,GO:0097484~dendrite extension,GO:0090240~positive regulation of histone H4 acetylation,GO:0090239~regulation of histone H4 acetylation,GO:0061564~axon development,GO:0060560~developmental growth involved in morphogenesis,GO:0060491~regulation of cell projection assembly,GO:0051674~localization of cell,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0051569~regulation of histone H3-K4 methylation,GO:0051568~histone H3-K4 methylation,GO:0051276~chromosome organization,GO:0051254~positive regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051130~positive regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051057~positive regulation of small GTPase mediated signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0048870~cell motility,GO:0048858~cell projection morphogenesis,GO:0048812~neuron projection morphogenesis,GO:0048699~generation of neurons,GO:0048675~axon extension,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048666~neuron development,GO:0048589~developmental growth,GO:0048588~developmental cell growth,GO:0048584~positive regulation of response to stimulus,GO:0048468~cell development,GO:0046579~positive regulation of Ras protein signal transduction,GO:0046578~regulation of Ras protein signal transduction,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0044089~positive regulation of cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044085~cellular component biogenesis,GO:0043984~histone H4-K16 acetylation,GO:0043967~histone H4 acetylation,GO:0043543~protein acylation,GO:0043414~macromolecule methylation,GO:0040011~locomotion,GO:0040007~growth,GO:0036211~protein modification process,GO:0035556~intracellular signal transduction,GO:0035066~positive regulation of histone acetylation,GO:0035065~regulation of histone acetylation,GO:0035022~positive regulation of Rac protein signal transduction,GO:0035020~regulation of Rac protein signal transduction,GO:0034968~histone lysine methylation,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0033044~regulation of chromosome organization,GO:0033043~regulation of organelle organization,GO:0032990~cell part morphogenesis,GO:0032989~cellular component morphogenesis,GO:0032774~RNA biosynthetic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032259~methylation,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031346~positive regulation of cell projection organization,GO:0031344~regulation of cell projection organization,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031175~neuron projection development,GO:0031062~positive regulation of histone methylation,GO:0031060~regulation of histone methylation,GO:0031058~positive regulation of histone modification,GO:0031056~regulation of histone modification,GO:0030182~neuron differentiation,GO:0030036~actin cytoskeleton organization,GO:0030032~lamellipodium assembly,GO:0030031~cell projection assembly,GO:0030030~cell projection organization,GO:0030029~actin filament-based process,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0022607~cellular component assembly,GO:0022008~neurogenesis,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018394~peptidyl-lysine acetylation,GO:0018393~internal peptidyl-lysine acetylation,GO:0018205~peptidyl-lysine modification,GO:0018193~peptidyl-amino acid modification,GO:0018130~heterocycle biosynthetic process,GO:0018022~peptidyl-lysine methylation,GO:0016601~Rac protein signal transduction,GO:0016573~histone acetylation,GO:0016571~histone methylation,GO:0016570~histone modification,GO:0016569~covalent chromatin modification,GO:0016477~cell migration,GO:0016070~RNA metabolic process,GO:0016049~cell growth,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010638~positive regulation of organelle organization,GO:0010628~positive regulation of gene expression,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010592~positive regulation of lamellipodium assembly,GO:0010591~regulation of lamellipodium assembly,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009893~positive regulation of metabolic process,GO:0009891~positive regulation of biosynthetic process,GO:0008213~protein alkylation,GO:0007409~axonogenesis,GO:0007399~nervous system development,GO:0007265~Ras protein signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0007010~cytoskeleton organization,GO:0006928~movement of cell or subcellular component,GO:0006479~protein methylation,GO:0006475~internal protein amino acid acetylation,GO:0006473~protein acetylation,GO:0006464~cellular protein modification process,GO:0006366~transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0006325~chromatin organization,GO:0001764~neuron migration,GO:0000904~cell morphogenesis involved in differentiation,GO:0000902~cell morphogenesis,												GO:0097458~neuron part,GO:0043005~neuron projection,GO:0030427~site of polarized growth,GO:0030426~growth cone,GO:0015629~actin cytoskeleton,												GO:0003682~chromatin binding,												IPR023246:AUTS2,												hsa03083:Polycomb repressive complex,												615834~Intellectual developmental disorder, autosomal dominant 26,														REGION:Important for regulation of lamellipodia formation,REGION:Disordered,COMPBIAS:Pro residues,COMPBIAS:Polar residues,COMPBIAS:Basic and acidic residues,
39511_at	afadin, adherens junction formation factor(AFDN)	Homo sapiens			GO:2000146~negative regulation of cell motility,GO:2000145~regulation of cell motility,GO:2000049~positive regulation of cell-cell adhesion mediated by cadherin,GO:2000047~regulation of cell-cell adhesion mediated by cadherin,GO:0098609~cell-cell adhesion,GO:0098602~single organism cell adhesion,GO:0090557~establishment of endothelial intestinal barrier,GO:0071822~protein complex subunit organization,GO:0070830~bicellular tight junction assembly,GO:0070271~protein complex biogenesis,GO:0065003~macromolecular complex assembly,GO:0061028~establishment of endothelial barrier,GO:0060429~epithelium development,GO:0051674~localization of cell,GO:0051271~negative regulation of cellular component movement,GO:0051270~regulation of cellular component movement,GO:0048870~cell motility,GO:0048468~cell development,GO:0046931~pore complex assembly,GO:0045785~positive regulation of cell adhesion,GO:0045446~endothelial cell differentiation,GO:0045216~cell-cell junction organization,GO:0044331~cell-cell adhesion mediated by cadherin,GO:0044085~cellular component biogenesis,GO:0043933~macromolecular complex subunit organization,GO:0043297~apical junction assembly,GO:0040013~negative regulation of locomotion,GO:0040012~regulation of locomotion,GO:0040011~locomotion,GO:0034330~cell junction organization,GO:0034329~cell junction assembly,GO:0032880~regulation of protein localization,GO:0030855~epithelial cell differentiation,GO:0030336~negative regulation of cell migration,GO:0030334~regulation of cell migration,GO:0030155~regulation of cell adhesion,GO:0022610~biological adhesion,GO:0022607~cellular component assembly,GO:0022409~positive regulation of cell-cell adhesion,GO:0022407~regulation of cell-cell adhesion,GO:0016477~cell migration,GO:0016337~single organismal cell-cell adhesion,GO:0010628~positive regulation of gene expression,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0009893~positive regulation of metabolic process,GO:0007267~cell-cell signaling,GO:0007155~cell adhesion,GO:0007043~cell-cell junction assembly,GO:0006928~movement of cell or subcellular component,GO:0006461~protein complex assembly,GO:0003158~endothelium development,GO:0002064~epithelial cell development,GO:0001885~endothelial cell development,												GO:0070161~anchoring junction,GO:0070160~occluding junction,GO:0046930~pore complex,GO:0044451~nucleoplasm part,GO:0044291~cell-cell contact zone,GO:0030054~cell junction,GO:0016607~nuclear speck,GO:0016604~nuclear body,GO:0005912~adherens junction,GO:0005911~cell-cell junction,GO:0005829~cytosol,GO:0005654~nucleoplasm,												GO:0051020~GTPase binding,GO:0051015~actin filament binding,GO:0050839~cell adhesion molecule binding,GO:0045296~cadherin binding,GO:0044877~macromolecular complex binding,GO:0032403~protein complex binding,GO:0031267~small GTPase binding,GO:0019899~enzyme binding,GO:0008092~cytoskeletal protein binding,GO:0003779~actin binding,												IPR037977:CBD_Afadin,IPR036034:PDZ_sf,IPR029071:Ubiquitin-like_domsf,IPR008984:SMAD_FHA_dom_sf,IPR002710:Dilute_dom,IPR001478:PDZ,IPR000253:FHA_dom,IPR000159:RA_dom,												hsa04670:Leukocyte transendothelial migration,hsa04530:Tight junction,hsa04520:Adherens junction,hsa04024:cAMP signaling pathway,hsa04015:Rap1 signaling pathway,hsa04014:Ras signaling pathway,														SM01132:DIL,SM00314:RA,SM00240:FHA,SM00228:PDZ,												SITE:Breakpoint for translocation to form KMT2A/MLL1-AFDN,REGION:Disordered,DOMAIN:Ras-associating 2,DOMAIN:Ras-associating 1,DOMAIN:Ras-associating,DOMAIN:PDZ,DOMAIN:FHA,DOMAIN:Dilute,COMPBIAS:Pro residues,COMPBIAS:Polar residues,COMPBIAS:Basic and acidic residues,
37983_at	angiotensin II receptor type 1(AGTR1)	Homo sapiens		h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_ace2Pathway:Angiotensin-converting enzyme 2 regulates heart function,												GO:2000858~regulation of aldosterone secretion,GO:2000855~regulation of mineralocorticoid secretion,GO:2000846~regulation of corticosteroid hormone secretion,GO:2000831~regulation of steroid hormone secretion,GO:2000379~positive regulation of reactive oxygen species metabolic process,GO:2000377~regulation of reactive oxygen species metabolic process,GO:2000021~regulation of ion homeostasis,GO:1990776~response to angiotensin,GO:1905952~regulation of lipid localization,GO:1905920~positive regulation of CoA-transferase activity,GO:1905918~regulation of CoA-transferase activity,GO:1904385~cellular response to angiotensin,GO:1904018~positive regulation of vasculature development,GO:1903672~positive regulation of sprouting angiogenesis,GO:1903670~regulation of sprouting angiogenesis,GO:1903589~positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,GO:1903587~regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,GO:1903530~regulation of secretion by cell,GO:1903522~regulation of blood circulation,GO:1901701~cellular response to oxygen-containing compound,GO:1901700~response to oxygen-containing compound,GO:1901699~cellular response to nitrogen compound,GO:1901698~response to nitrogen compound,GO:1901653~cellular response to peptide,GO:1901652~response to peptide,GO:1901342~regulation of vasculature development,GO:0098801~regulation of renal system process,GO:0098771~inorganic ion homeostasis,GO:0097746~regulation of blood vessel diameter,GO:0097006~regulation of plasma lipoprotein particle levels,GO:0090077~foam cell differentiation,GO:0090066~regulation of anatomical structure size,GO:0086097~phospholipase C-activating angiotensin-activated signaling pathway,GO:0080134~regulation of response to stress,GO:0072593~reactive oxygen species metabolic process,GO:0072507~divalent inorganic cation homeostasis,GO:0072503~cellular divalent inorganic cation homeostasis,GO:0072359~circulatory system development,GO:0072358~cardiovascular system development,GO:0072001~renal system development,GO:0071827~plasma lipoprotein particle organization,GO:0071825~protein-lipid complex subunit organization,GO:0071495~cellular response to endogenous stimulus,GO:0071417~cellular response to organonitrogen compound,GO:0071375~cellular response to peptide hormone stimulus,GO:0071310~cellular response to organic substance,GO:0070887~cellular response to chemical stimulus,GO:0065009~regulation of molecular function,GO:0060986~endocrine hormone secretion,GO:0060326~cell chemotaxis,GO:0060193~positive regulation of lipase activity,GO:0060191~regulation of lipase activity,GO:0055082~cellular chemical homeostasis,GO:0055080~cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055065~metal ion homeostasis,GO:0051828~entry into other organism involved in symbiotic interaction,GO:0051806~entry into cell of other organism involved in symbiotic interaction,GO:0051701~interaction with host,GO:0051674~localization of cell,GO:0051480~regulation of cytosolic calcium ion concentration,GO:0051353~positive regulation of oxidoreductase activity,GO:0051347~positive regulation of transferase activity,GO:0051345~positive regulation of hydrolase activity,GO:0051341~regulation of oxidoreductase activity,GO:0051338~regulation of transferase activity,GO:0051336~regulation of hydrolase activity,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051128~regulation of cellular component organization,GO:0051094~positive regulation of developmental process,GO:0051049~regulation of transport,GO:0051046~regulation of secretion,GO:0050886~endocrine process,GO:0050880~regulation of blood vessel size,GO:0050801~ion homeostasis,GO:0050790~regulation of catalytic activity,GO:0050729~positive regulation of inflammatory response,GO:0050727~regulation of inflammatory response,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0050673~epithelial cell proliferation,GO:0048878~chemical homeostasis,GO:0048870~cell motility,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048584~positive regulation of response to stimulus,GO:0048514~blood vessel morphogenesis,GO:0046903~secretion,GO:0046883~regulation of hormone secretion,GO:0046879~hormone secretion,GO:0046718~viral entry into host cell,GO:0045766~positive regulation of angiogenesis,GO:0045765~regulation of angiogenesis,GO:0045597~positive regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0044764~multi-organism cellular process,GO:0044419~interspecies interaction between organisms,GO:0044409~entry into host,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044093~positive regulation of molecular function,GO:0044062~regulation of excretion,GO:0044060~regulation of endocrine process,GO:0044057~regulation of system process,GO:0043933~macromolecular complex subunit organization,GO:0043434~response to peptide hormone,GO:0043085~positive regulation of catalytic activity,GO:0042592~homeostatic process,GO:0042330~taxis,GO:0042127~regulation of cell proliferation,GO:0040011~locomotion,GO:0040008~regulation of growth,GO:0040007~growth,GO:0038166~angiotensin-activated signaling pathway,GO:0035932~aldosterone secretion,GO:0035931~mineralocorticoid secretion,GO:0035930~corticosteroid hormone secretion,GO:0035929~steroid hormone secretion,GO:0035813~regulation of renal sodium excretion,GO:0035556~intracellular signal transduction,GO:0035296~regulation of tube diameter,GO:0035150~regulation of tube size,GO:0034374~low-density lipoprotein particle remodeling,GO:0034369~plasma lipoprotein particle remodeling,GO:0034368~protein-lipid complex remodeling,GO:0034367~macromolecular complex remodeling,GO:0033864~positive regulation of NAD(P)H oxidase activity,GO:0033860~regulation of NAD(P)H oxidase activity,GO:0033036~macromolecule localization,GO:0032940~secretion by cell,GO:0032870~cellular response to hormone stimulus,GO:0032844~regulation of homeostatic process,GO:0032430~positive regulation of phospholipase A2 activity,GO:0032429~regulation of phospholipase A2 activity,GO:0032368~regulation of lipid transport,GO:0032103~positive regulation of response to external stimulus,GO:0032101~regulation of response to external stimulus,GO:0031349~positive regulation of defense response,GO:0031347~regulation of defense response,GO:0031325~positive regulation of cellular metabolic process,GO:0030260~entry into host cell,GO:0030003~cellular cation homeostasis,GO:0023061~signal release,GO:0023051~regulation of signaling,GO:0022603~regulation of anatomical structure morphogenesis,GO:0019932~second-messenger-mediated signaling,GO:0019725~cellular homeostasis,GO:0019722~calcium-mediated signaling,GO:0019229~regulation of vasoconstriction,GO:0019058~viral life cycle,GO:0016477~cell migration,GO:0016032~viral process,GO:0015850~organic hydroxy compound transport,GO:0010876~lipid localization,GO:0010817~regulation of hormone levels,GO:0010744~positive regulation of macrophage derived foam cell differentiation,GO:0010743~regulation of macrophage derived foam cell differentiation,GO:0010742~macrophage derived foam cell differentiation,GO:0010646~regulation of cell communication,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010518~positive regulation of phospholipase activity,GO:0010517~regulation of phospholipase activity,GO:0010243~response to organonitrogen compound,GO:0010033~response to organic substance,GO:0009914~hormone transport,GO:0009893~positive regulation of metabolic process,GO:0009725~response to hormone,GO:0009719~response to endogenous stimulus,GO:0009605~response to external stimulus,GO:0008284~positive regulation of cell proliferation,GO:0008283~cell proliferation,GO:0008217~regulation of blood pressure,GO:0008015~blood circulation,GO:0007588~excretion,GO:0007267~cell-cell signaling,GO:0007266~Rho protein signal transduction,GO:0007265~Ras protein signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0006954~inflammatory response,GO:0006952~defense response,GO:0006935~chemotaxis,GO:0006928~movement of cell or subcellular component,GO:0006875~cellular metal ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006873~cellular ion homeostasis,GO:0006869~lipid transport,GO:0003081~regulation of systemic arterial blood pressure by renin-angiotensin,GO:0003073~regulation of systemic arterial blood pressure,GO:0003072~renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,GO:0003071~renal system process involved in regulation of systemic arterial blood pressure,GO:0003044~regulation of systemic arterial blood pressure mediated by a chemical signal,GO:0003018~vascular process in circulatory system,GO:0003014~renal system process,GO:0003013~circulatory system process,GO:0003008~system process,GO:0002043~blood vessel endothelial cell proliferation involved in sprouting angiogenesis,GO:0002040~sprouting angiogenesis,GO:0002034~regulation of blood vessel diameter by renin-angiotensin,GO:0002018~renin-angiotensin regulation of aldosterone production,GO:0002016~regulation of blood volume by renin-angiotensin,GO:0001990~regulation of systemic arterial blood pressure by hormone,GO:0001944~vasculature development,GO:0001938~positive regulation of endothelial cell proliferation,GO:0001936~regulation of endothelial cell proliferation,GO:0001935~endothelial cell proliferation,GO:0001822~kidney development,GO:0001655~urogenital system development,GO:0001568~blood vessel development,GO:0001558~regulation of cell growth,GO:0001525~angiogenesis,													GO:0099600~transmembrane receptor activity,GO:0060089~molecular transducer activity,GO:0046983~protein dimerization activity,GO:0046982~protein heterodimerization activity,GO:0038023~signaling receptor activity,GO:0031711~bradykinin receptor binding,GO:0008528~G-protein coupled peptide receptor activity,GO:0005102~receptor binding,GO:0004945~angiotensin type II receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0004872~receptor activity,GO:0004871~signal transducer activity,GO:0001664~G-protein coupled receptor binding,GO:0001653~peptide receptor activity,GO:0001596~angiotensin type I receptor activity,GO:0001595~angiotensin receptor activity,												IPR017452:GPCR_Rhodpsn_7TM,IPR000276:GPCR_Rhodpsn,IPR000248:ATII_rcpt,IPR000190:ATII_AT1_rcpt,												hsa05415:Diabetic cardiomyopathy,hsa05200:Pathways in cancer,hsa05171:Coronavirus disease - COVID-19,hsa04934:Cushing syndrome,hsa04933:AGE-RAGE signaling pathway in diabetic complications,hsa04927:Cortisol synthesis and secretion,hsa04925:Aldosterone synthesis and secretion,hsa04924:Renin secretion,hsa04614:Renin-angiotensin system,hsa04371:Apelin signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04080:Neuroactive ligand-receptor interaction,hsa04072:Phospholipase D signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04020:Calcium signaling pathway,												267430~Renal tubular dysgenesis,145500~Hypertension, essential,													SM01381:7TM_GPCR_Srsx,												TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=1,TRANSMEM:Helical,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,REGION:Disordered,MUTAGEN:Y->A: Mimics the disordered side chain induced by angiotensin II-binding; increased affinity for G-protein subunit alpha proteins. Decreased affinity for telmisartan.,MUTAGEN:Y->A: Decreased binding to telmisartan inhibitor.,MUTAGEN:Y->A,F: Abolished binding to angiotensin II; abolished binding to olmesartan inhibitor.,MUTAGEN:W->A,I: Abolished binding to angiotensin II; abolished binding to olmesartan inhibitor.,MUTAGEN:R->A: Abolished binding to angiotensin II; abolished binding to olmesartan inhibitor.,MUTAGEN:P->A: Decreased binding to eprosartan inhibitor.,MUTAGEN:N->G: Induces a conformational change in the angiotensin II-binding pocket, leading to constitutive activation of the receptor.,MUTAGEN:N->A,F,I: Reduced affinity for angiotensin II.,MUTAGEN:M->A: Slightly affects binding to eprosartan inhibitor.,MUTAGEN:L->A: Increased affinity for angiotensin II.,MUTAGEN:K->R,Q: Abolished binding to angiotensin II.,MUTAGEN:K->A: Abolished binding to angiotensin II.,MUTAGEN:I->A: Decreased binding to eprosartan inhibitor.,MUTAGEN:F->A: Reduced binding to angiotensin II without affecting binding to candesartan inhibitor.,LIPID:S-palmitoyl cysteine,DOMAIN:G-protein coupled receptors family 1 profile,COMPBIAS:Polar residues,CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:N-linked (GlcNAc...) (complex) asparagine,
34636_at	arachidonate 15-lipoxygenase(ALOX15)	Homo sapiens			GO:2001303~lipoxin A4 biosynthetic process,GO:2001302~lipoxin A4 metabolic process,GO:2001301~lipoxin biosynthetic process,GO:2001300~lipoxin metabolic process,GO:2000425~regulation of apoptotic cell clearance,GO:1905153~regulation of membrane invagination,GO:1902905~positive regulation of supramolecular fiber organization,GO:1902903~regulation of supramolecular fiber organization,GO:1902589~single-organism organelle organization,GO:1902533~positive regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:1901617~organic hydroxy compound biosynthetic process,GO:1901615~organic hydroxy compound metabolic process,GO:1901570~fatty acid derivative biosynthetic process,GO:1901568~fatty acid derivative metabolic process,GO:1901074~regulation of engulfment of apoptotic cell,GO:0099024~plasma membrane invagination,GO:0097435~supramolecular fiber organization,GO:0090407~organophosphate biosynthetic process,GO:0090066~regulation of anatomical structure size,GO:0080134~regulation of response to stress,GO:0072330~monocarboxylic acid biosynthetic process,GO:0071822~protein complex subunit organization,GO:0071345~cellular response to cytokine stimulus,GO:0071310~cellular response to organic substance,GO:0071277~cellular response to calcium ion,GO:0071248~cellular response to metal ion,GO:0071241~cellular response to inorganic substance,GO:0070887~cellular response to chemical stimulus,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0070371~ERK1 and ERK2 cascade,GO:0070271~protein complex biogenesis,GO:0065003~macromolecular complex assembly,GO:0061024~membrane organization,GO:0060627~regulation of vesicle-mediated transport,GO:0060099~regulation of phagocytosis, engulfment,GO:0055114~oxidation-reduction process,GO:0051592~response to calcium ion,GO:0051495~positive regulation of cytoskeleton organization,GO:0051493~regulation of cytoskeleton organization,GO:0051258~protein polymerization,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051130~positive regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051122~hepoxilin biosynthetic process,GO:0051121~hepoxilin metabolic process,GO:0051049~regulation of transport,GO:0050777~negative regulation of immune response,GO:0050776~regulation of immune response,GO:0050764~regulation of phagocytosis,GO:0050727~regulation of inflammatory response,GO:0048585~negative regulation of response to stimulus,GO:0048584~positive regulation of response to stimulus,GO:0046486~glycerolipid metabolic process,GO:0046474~glycerophospholipid biosynthetic process,GO:0046456~icosanoid biosynthetic process,GO:0046394~carboxylic acid biosynthetic process,GO:0046337~phosphatidylethanolamine metabolic process,GO:0045937~positive regulation of phosphate metabolic process,GO:0045785~positive regulation of cell adhesion,GO:0045017~glycerolipid biosynthetic process,GO:0044283~small molecule biosynthetic process,GO:0044255~cellular lipid metabolic process,GO:0044089~positive regulation of cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044085~cellular component biogenesis,GO:0043933~macromolecular complex subunit organization,GO:0043651~linoleic acid metabolic process,GO:0043623~cellular protein complex assembly,GO:0043436~oxoacid metabolic process,GO:0043410~positive regulation of MAPK cascade,GO:0043408~regulation of MAPK cascade,GO:0043277~apoptotic cell clearance,GO:0043254~regulation of protein complex assembly,GO:0042759~long-chain fatty acid biosynthetic process,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0042060~wound healing,GO:0036211~protein modification process,GO:0035963~cellular response to interleukin-13,GO:0035962~response to interleukin-13,GO:0035556~intracellular signal transduction,GO:0035358~regulation of peroxisome proliferator activated receptor signaling pathway,GO:0034976~response to endoplasmic reticulum stress,GO:0034622~cellular macromolecular complex assembly,GO:0034440~lipid oxidation,GO:0034097~response to cytokine,GO:0033559~unsaturated fatty acid metabolic process,GO:0033554~cellular response to stress,GO:0033043~regulation of organelle organization,GO:0032970~regulation of actin filament-based process,GO:0032956~regulation of actin cytoskeleton organization,GO:0032787~monocarboxylic acid metabolic process,GO:0032535~regulation of cellular component size,GO:0032273~positive regulation of protein polymerization,GO:0032271~regulation of protein polymerization,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032101~regulation of response to external stimulus,GO:0031589~cell-substrate adhesion,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031347~regulation of defense response,GO:0031334~positive regulation of protein complex assembly,GO:0031325~positive regulation of cellular metabolic process,GO:0031214~biomineral tissue development,GO:0030838~positive regulation of actin filament polymerization,GO:0030833~regulation of actin filament polymerization,GO:0030832~regulation of actin filament length,GO:0030282~bone mineralization,GO:0030258~lipid modification,GO:0030155~regulation of cell adhesion,GO:0030100~regulation of endocytosis,GO:0030041~actin filament polymerization,GO:0030036~actin cytoskeleton organization,GO:0030029~actin filament-based process,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0023014~signal transduction by protein phosphorylation,GO:0022610~biological adhesion,GO:0022607~cellular component assembly,GO:0019752~carboxylic acid metabolic process,GO:0019637~organophosphate metabolic process,GO:0019395~fatty acid oxidation,GO:0019372~lipoxygenase pathway,GO:0019369~arachidonic acid metabolic process,GO:0019220~regulation of phosphate metabolic process,GO:0016310~phosphorylation,GO:0016192~vesicle-mediated transport,GO:0016053~organic acid biosynthetic process,GO:0010811~positive regulation of cell-substrate adhesion,GO:0010810~regulation of cell-substrate adhesion,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010638~positive regulation of organelle organization,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010324~membrane invagination,GO:0010038~response to metal ion,GO:0010035~response to inorganic substance,GO:0010033~response to organic substance,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009893~positive regulation of metabolic process,GO:0009611~response to wounding,GO:0009605~response to external stimulus,GO:0008654~phospholipid biosynthetic process,GO:0008610~lipid biosynthetic process,GO:0008154~actin polymerization or depolymerization,GO:0008064~regulation of actin polymerization or depolymerization,GO:0007155~cell adhesion,GO:0007015~actin filament organization,GO:0007010~cytoskeleton organization,GO:0006955~immune response,GO:0006954~inflammatory response,GO:0006952~defense response,GO:0006911~phagocytosis, engulfment,GO:0006909~phagocytosis,GO:0006897~endocytosis,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006690~icosanoid metabolic process,GO:0006650~glycerophospholipid metabolic process,GO:0006646~phosphatidylethanolamine biosynthetic process,GO:0006644~phospholipid metabolic process,GO:0006636~unsaturated fatty acid biosynthetic process,GO:0006633~fatty acid biosynthetic process,GO:0006631~fatty acid metabolic process,GO:0006629~lipid metabolic process,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0006461~protein complex assembly,GO:0006082~organic acid metabolic process,GO:0002820~negative regulation of adaptive immune response,GO:0002819~regulation of adaptive immune response,GO:0002683~negative regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002250~adaptive immune response,GO:0001934~positive regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,GO:0001676~long-chain fatty acid metabolic process,GO:0001503~ossification,GO:0000165~MAPK cascade,												GO:0098562~cytoplasmic side of membrane,GO:0098552~side of membrane,GO:0009898~cytoplasmic side of plasma membrane,GO:0005829~cytosol,GO:0005811~lipid particle,												GO:1902936~phosphatidylinositol bisphosphate binding,GO:1901981~phosphatidylinositol phosphate binding,GO:0051213~dioxygenase activity,GO:0050473~arachidonate 15-lipoxygenase activity,GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043168~anion binding,GO:0043167~ion binding,GO:0035091~phosphatidylinositol binding,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0016701~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,GO:0016165~linoleate 13S-lipoxygenase activity,GO:0008289~lipid binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0005543~phospholipid binding,GO:0005506~iron ion binding,GO:0004052~arachidonate 12-lipoxygenase activity,												IPR042062:PLAT_LOX_verte,IPR036392:PLAT/LH2_dom_sf,IPR036226:LipOase_C_sf,IPR020834:LipOase_CS,IPR020833:LipOase_Fe_BS,IPR013819:LipOase_C,IPR001885:LipOase_mml,IPR001024:PLAT/LH2_dom,IPR000907:LipOase,												hsa04726:Serotonergic synapse,hsa04217:Necroptosis,hsa04216:Ferroptosis,hsa04148:Efferocytosis,hsa01100:Metabolic pathways,hsa00591:Linoleic acid metabolism,hsa00590:Arachidonic acid metabolism,														SM00308:LH2,												SITE:Essential for stabilizing binding to COTL1,MUTAGEN:M->V: Catalyzes 15- and 12-lipoxygenation.,DOMAIN:PLAT,DOMAIN:Lipoxygenase,
33963_at	azurocidin 1(AZU1)	Homo sapiens			GO:1905517~macrophage migration,GO:1903557~positive regulation of tumor necrosis factor superfamily cytokine production,GO:1903555~regulation of tumor necrosis factor superfamily cytokine production,GO:1901701~cellular response to oxygen-containing compound,GO:1901700~response to oxygen-containing compound,GO:0098542~defense response to other organism,GO:0097529~myeloid leukocyte migration,GO:0071706~tumor necrosis factor superfamily cytokine production,GO:0071396~cellular response to lipid,GO:0071310~cellular response to organic substance,GO:0071222~cellular response to lipopolysaccharide,GO:0071219~cellular response to molecule of bacterial origin,GO:0071216~cellular response to biotic stimulus,GO:0070944~neutrophil mediated killing of bacterium,GO:0070943~neutrophil mediated killing of symbiont cell,GO:0070942~neutrophil mediated cytotoxicity,GO:0070887~cellular response to chemical stimulus,GO:0070528~protein kinase C signaling,GO:0065009~regulation of molecular function,GO:0060627~regulation of vesicle-mediated transport,GO:0060548~negative regulation of cell death,GO:0060326~cell chemotaxis,GO:0051883~killing of cells in other organism involved in symbiotic interaction,GO:0051873~killing by host of symbiont cells,GO:0051852~disruption by host of symbiont cells,GO:0051851~modification by host of symbiont morphology or physiology,GO:0051818~disruption of cells of other organism involved in symbiotic interaction,GO:0051817~modification of morphology or physiology of other organism involved in symbiotic interaction,GO:0051707~response to other organism,GO:0051702~interaction with symbiont,GO:0051674~localization of cell,GO:0051607~defense response to virus,GO:0051347~positive regulation of transferase activity,GO:0051338~regulation of transferase activity,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051174~regulation of phosphorus metabolic process,GO:0051130~positive regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051050~positive regulation of transport,GO:0051049~regulation of transport,GO:0050930~induction of positive chemotaxis,GO:0050927~positive regulation of positive chemotaxis,GO:0050926~regulation of positive chemotaxis,GO:0050921~positive regulation of chemotaxis,GO:0050920~regulation of chemotaxis,GO:0050918~positive chemotaxis,GO:0050900~leukocyte migration,GO:0050829~defense response to Gram-negative bacterium,GO:0050790~regulation of catalytic activity,GO:0050766~positive regulation of phagocytosis,GO:0050764~regulation of phagocytosis,GO:0048870~cell motility,GO:0048584~positive regulation of response to stimulus,GO:0048246~macrophage chemotaxis,GO:0045937~positive regulation of phosphate metabolic process,GO:0045860~positive regulation of protein kinase activity,GO:0045859~regulation of protein kinase activity,GO:0045807~positive regulation of endocytosis,GO:0045785~positive regulation of cell adhesion,GO:0045348~positive regulation of MHC class II biosynthetic process,GO:0045346~regulation of MHC class II biosynthetic process,GO:0045342~MHC class II biosynthetic process,GO:0045321~leukocyte activation,GO:0045123~cellular extravasation,GO:0044764~multi-organism cellular process,GO:0044419~interspecies interaction between organisms,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044364~disruption of cells of other organism,GO:0044093~positive regulation of molecular function,GO:0043549~regulation of kinase activity,GO:0043207~response to external biotic stimulus,GO:0043114~regulation of vascular permeability,GO:0043085~positive regulation of catalytic activity,GO:0043069~negative regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptotic process,GO:0042981~regulation of apoptotic process,GO:0042742~defense response to bacterium,GO:0042330~taxis,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0042117~monocyte activation,GO:0042116~macrophage activation,GO:0042063~gliogenesis,GO:0040017~positive regulation of locomotion,GO:0040012~regulation of locomotion,GO:0040011~locomotion,GO:0036211~protein modification process,GO:0035821~modification of morphology or physiology of other organism,GO:0035584~calcium-mediated signaling using intracellular calcium source,GO:0035556~intracellular signal transduction,GO:0033993~response to lipid,GO:0033674~positive regulation of kinase activity,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032732~positive regulation of interleukin-1 production,GO:0032731~positive regulation of interleukin-1 beta production,GO:0032724~positive regulation of fractalkine production,GO:0032722~positive regulation of chemokine production,GO:0032680~regulation of tumor necrosis factor production,GO:0032652~regulation of interleukin-1 production,GO:0032651~regulation of interleukin-1 beta production,GO:0032644~regulation of fractalkine production,GO:0032642~regulation of chemokine production,GO:0032640~tumor necrosis factor production,GO:0032612~interleukin-1 production,GO:0032611~interleukin-1 beta production,GO:0032603~fractalkine production,GO:0032602~chemokine production,GO:0032496~response to lipopolysaccharide,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032103~positive regulation of response to external stimulus,GO:0032101~regulation of response to external stimulus,GO:0031640~killing of cells of other organism,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031325~positive regulation of cellular metabolic process,GO:0030595~leukocyte chemotaxis,GO:0030155~regulation of cell adhesion,GO:0030100~regulation of endocytosis,GO:0022610~biological adhesion,GO:0022008~neurogenesis,GO:0019932~second-messenger-mediated signaling,GO:0019731~antibacterial humoral response,GO:0019730~antimicrobial humoral response,GO:0019722~calcium-mediated signaling,GO:0019220~regulation of phosphate metabolic process,GO:0018210~peptidyl-threonine modification,GO:0018193~peptidyl-amino acid modification,GO:0018107~peptidyl-threonine phosphorylation,GO:0016477~cell migration,GO:0016310~phosphorylation,GO:0016192~vesicle-mediated transport,GO:0016032~viral process,GO:0012501~programmed cell death,GO:0010941~regulation of cell death,GO:0010800~positive regulation of peptidyl-threonine phosphorylation,GO:0010799~regulation of peptidyl-threonine phosphorylation,GO:0010628~positive regulation of gene expression,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010033~response to organic substance,GO:0009893~positive regulation of metabolic process,GO:0009891~positive regulation of biosynthetic process,GO:0009617~response to bacterium,GO:0009615~response to virus,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0008347~glial cell migration,GO:0008219~cell death,GO:0008015~blood circulation,GO:0007399~nervous system development,GO:0007205~protein kinase C-activating G-protein coupled receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007155~cell adhesion,GO:0006959~humoral immune response,GO:0006955~immune response,GO:0006954~inflammatory response,GO:0006952~defense response,GO:0006935~chemotaxis,GO:0006928~movement of cell or subcellular component,GO:0006915~apoptotic process,GO:0006909~phagocytosis,GO:0006897~endocytosis,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006508~proteolysis,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0003018~vascular process in circulatory system,GO:0003013~circulatory system process,GO:0003008~system process,GO:0002446~neutrophil mediated immunity,GO:0002444~myeloid leukocyte mediated immunity,GO:0002443~leukocyte mediated immunity,GO:0002274~myeloid leukocyte activation,GO:0002252~immune effector process,GO:0002237~response to molecule of bacterial origin,GO:0001934~positive regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,GO:0001909~leukocyte mediated cytotoxicity,GO:0001906~cell killing,GO:0001819~positive regulation of cytokine production,GO:0001817~regulation of cytokine production,GO:0001816~cytokine production,GO:0001775~cell activation,GO:0001774~microglial cell activation,												GO:1990904~ribonucleoprotein complex,GO:1903561~extracellular vesicle,GO:0099503~secretory vesicle,GO:0098852~lytic vacuole membrane,GO:0070062~extracellular exosome,GO:0060205~cytoplasmic vesicle lumen,GO:0044437~vacuolar part,GO:0044433~cytoplasmic vesicle part,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0042582~azurophil granule,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0035770~ribonucleoprotein granule,GO:0035578~azurophil granule lumen,GO:0035577~azurophil granule membrane,GO:0034774~secretory granule lumen,GO:0031983~vesicle lumen,GO:0030667~secretory granule membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0030141~secretory granule,GO:0012506~vesicle membrane,GO:0010494~cytoplasmic stress granule,GO:0005775~vacuolar lumen,GO:0005774~vacuolar membrane,GO:0005773~vacuole,GO:0005766~primary lysosome,GO:0005765~lysosomal membrane,GO:0005764~lysosome,GO:0005615~extracellular space,GO:0005576~extracellular region,GO:0000323~lytic vacuole,												GO:1901681~sulfur compound binding,GO:0097367~carbohydrate derivative binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0043395~heparan sulfate proteoglycan binding,GO:0043394~proteoglycan binding,GO:0043168~anion binding,GO:0043167~ion binding,GO:0017171~serine hydrolase activity,GO:0015643~toxic substance binding,GO:0008236~serine-type peptidase activity,GO:0008233~peptidase activity,GO:0008201~heparin binding,GO:0005539~glycosaminoglycan binding,GO:0004252~serine-type endopeptidase activity,GO:0004175~endopeptidase activity,GO:0001948~glycoprotein binding,												IPR043504:Peptidase_S1_PA_chymotrypsin,IPR009003:Peptidase_S1_PA,IPR001314:Peptidase_S1A,IPR001254:Trypsin_dom,												hsa04613:Neutrophil extracellular trap formation,														SM00020:Tryp_SPc,												REGION:Possesses antibiotic activity,PROPEP:Removed in mature form,PROPEP:Dipeptide found in non-mature form,MUTAGEN:C->S: Loss of antibiotic activity.,DOMAIN:Peptidase S1,CARBOHYD:N-linked (GlcNAc...) asparagine; partial,CARBOHYD:N-linked (GlcNAc...) asparagine,
40790_at	basic helix-loop-helix family member e40(BHLHE40)	Homo sapiens			GO:2001141~regulation of RNA biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1902679~negative regulation of RNA biosynthetic process,GO:0097659~nucleic acid-templated transcription,GO:0065009~regulation of molecular function,GO:0060284~regulation of cell development,GO:0051960~regulation of nervous system development,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,GO:0050767~regulation of neurogenesis,GO:0048699~generation of neurons,GO:0048511~rhythmic process,GO:0048468~cell development,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045595~regulation of cell differentiation,GO:0044092~negative regulation of molecular function,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043153~entrainment of circadian clock by photoperiod,GO:0042752~regulation of circadian rhythm,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0032922~circadian regulation of gene expression,GO:0032774~RNA biosynthetic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031324~negative regulation of cellular metabolic process,GO:0022008~neurogenesis,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016070~RNA metabolic process,GO:0010629~negative regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0009952~anterior/posterior pattern specification,GO:0009892~negative regulation of metabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0009649~entrainment of circadian clock,GO:0009648~photoperiodism,GO:0009628~response to abiotic stimulus,GO:0009605~response to external stimulus,GO:0009416~response to light stimulus,GO:0009314~response to radiation,GO:0007623~circadian rhythm,GO:0007399~nervous system development,GO:0007389~pattern specification process,GO:0006366~transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0003002~regionalization,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,												GO:0044451~nucleoplasm part,GO:0044427~chromosomal part,GO:0016604~nuclear body,GO:0005694~chromosome,GO:0005654~nucleoplasm,GO:0000785~chromatin,												GO:1990837~sequence-specific double-stranded DNA binding,GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0070888~E-box binding,GO:0061629~RNA polymerase II sequence-specific DNA binding transcription factor binding,GO:0046983~protein dimerization activity,GO:0046982~protein heterodimerization activity,GO:0044212~transcription regulatory region DNA binding,GO:0043565~sequence-specific DNA binding,GO:0043426~MRF binding,GO:0043425~bHLH transcription factor binding,GO:0042803~protein homodimerization activity,GO:0042802~identical protein binding,GO:0019904~protein domain specific binding,GO:0008134~transcription factor binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003690~double-stranded DNA binding,GO:0003677~DNA binding,GO:0003676~nucleic acid binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001159~core promoter proximal region DNA binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001071~nucleic acid binding transcription factor activity,GO:0001067~regulatory region nucleic acid binding,GO:0001012~RNA polymerase II regulatory region DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000975~regulatory region DNA binding,												IPR036638:HLH_DNA-bd_sf,IPR011598:bHLH_dom,IPR003650:Orange_dom,												hsa04710:Circadian rhythm,														SM00511:ORANGE,SM00353:HLH,												REGION:Necessary for interaction with RXRA and repressor activity against RXRA,REGION:Essential for interaction with BMAL1, E-box binding and repressor activity against the CLOCK-BMAL1 heterodimer,REGION:Disordered,MUTAGEN:R->A: Loss of repressor activity against NR0B2.,MUTAGEN:R->A: Loss of interaction with BMAL1 and E-box binding. Significant reduction in its repressor activity against the CLOCK-BMAL1 heterodimer.,MUTAGEN:P->A: No loss of repressor activity against NR0B2.,MUTAGEN:LL->AA: Abolishes RXRA repression.,MUTAGEN:K->R: Partial loss of sumoylation. Complete loss of sumoylation; when associated with R-279.,MUTAGEN:K->R: Partial loss of sumoylation. Complete loss of sumoylation; when associated with R-159.,MUTAGEN:H->A: No effect on its interaction with BMAL1 or its repressor activity against the CLOCK-BMAL1 heterodimer. Significant reduction in E-box binding.,DOMAIN:bHLH,DOMAIN:Orange,DOMAIN:BHLH,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1, SUMO2 and SUMO3); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1, SUMO2 and SUMO3),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,COMPBIAS:Polar residues,COMPBIAS:Basic and acidic residues,
38201_at	branched chain amino acid transaminase 1(BCAT1)	Homo sapiens			GO:1903047~mitotic cell cycle process,GO:1901607~alpha-amino acid biosynthetic process,GO:1901605~alpha-amino acid metabolic process,GO:1901566~organonitrogen compound biosynthetic process,GO:0046394~carboxylic acid biosynthetic process,GO:0044843~cell cycle G1/S phase transition,GO:0044772~mitotic cell cycle phase transition,GO:0044770~cell cycle phase transition,GO:0044283~small molecule biosynthetic process,GO:0043436~oxoacid metabolic process,GO:0022402~cell cycle process,GO:0019752~carboxylic acid metabolic process,GO:0016053~organic acid biosynthetic process,GO:0009099~valine biosynthetic process,GO:0009098~leucine biosynthetic process,GO:0009082~branched-chain amino acid biosynthetic process,GO:0009081~branched-chain amino acid metabolic process,GO:0008652~cellular amino acid biosynthetic process,GO:0007049~cell cycle,GO:0006629~lipid metabolic process,GO:0006573~valine metabolic process,GO:0006551~leucine metabolic process,GO:0006520~cellular amino acid metabolic process,GO:0006082~organic acid metabolic process,GO:0000278~mitotic cell cycle,GO:0000082~G1/S transition of mitotic cell cycle,												GO:0005829~cytosol,GO:0005739~mitochondrion,												GO:0052656~L-isoleucine transaminase activity,GO:0052655~L-valine transaminase activity,GO:0052654~L-leucine transaminase activity,GO:0050048~L-leucine:2-oxoglutarate aminotransferase activity,GO:0016769~transferase activity, transferring nitrogenous groups,GO:0008483~transaminase activity,GO:0004084~branched-chain-amino-acid transaminase activity,												IPR043132:BCAT-like_C,IPR043131:BCAT-like_N,IPR036038:Aminotransferase-like,IPR033939:BCAT_family,IPR018300:Aminotrans_IV_CS,IPR005786:B_amino_transII,IPR001544:Aminotrans_IV,												hsa01240:Biosynthesis of cofactors,hsa01230:Biosynthesis of amino acids,hsa01210:2-Oxocarboxylic acid metabolism,hsa01100:Metabolic pathways,hsa00770:Pantothenate and CoA biosynthesis,hsa00290:Valine, leucine and isoleucine biosynthesis,hsa00280:Valine, leucine and isoleucine degradation,hsa00270:Cysteine and methionine metabolism,													PIRSF006468:BCAT1,		
39094_at	bromodomain containing 4(BRD4)	Homo sapiens			GO:2001141~regulation of RNA biosynthetic process,GO:2001021~negative regulation of response to DNA damage stimulus,GO:2001020~regulation of response to DNA damage stimulus,GO:2000516~positive regulation of CD4-positive, alpha-beta T cell activation,GO:2000514~regulation of CD4-positive, alpha-beta T cell activation,GO:2000330~positive regulation of T-helper 17 cell lineage commitment,GO:2000328~regulation of T-helper 17 cell lineage commitment,GO:2000321~positive regulation of T-helper 17 cell differentiation,GO:2000319~regulation of T-helper 17 cell differentiation,GO:2000318~positive regulation of T-helper 17 type immune response,GO:2000316~regulation of T-helper 17 type immune response,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000002~negative regulation of DNA damage checkpoint,GO:2000001~regulation of DNA damage checkpoint,GO:1903901~negative regulation of viral life cycle,GO:1903900~regulation of viral life cycle,GO:1903708~positive regulation of hemopoiesis,GO:1903706~regulation of hemopoiesis,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903047~mitotic cell cycle process,GO:1903039~positive regulation of leukocyte cell-cell adhesion,GO:1903037~regulation of leukocyte cell-cell adhesion,GO:1902751~positive regulation of cell cycle G2/M phase transition,GO:1902749~regulation of cell cycle G2/M phase transition,GO:1902680~positive regulation of RNA biosynthetic process,GO:1902679~negative regulation of RNA biosynthetic process,GO:1902533~positive regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:1902107~positive regulation of leukocyte differentiation,GO:1902105~regulation of leukocyte differentiation,GO:1901992~positive regulation of mitotic cell cycle phase transition,GO:1901990~regulation of mitotic cell cycle phase transition,GO:1901989~positive regulation of cell cycle phase transition,GO:1901987~regulation of cell cycle phase transition,GO:1901977~negative regulation of cell cycle checkpoint,GO:1901976~regulation of cell cycle checkpoint,GO:0098609~cell-cell adhesion,GO:0098602~single organism cell adhesion,GO:0097659~nucleic acid-templated transcription,GO:0090068~positive regulation of cell cycle process,GO:0080135~regulation of cellular response to stress,GO:0080134~regulation of response to stress,GO:0072540~T-helper 17 cell lineage commitment,GO:0072539~T-helper 17 cell differentiation,GO:0072538~T-helper 17 type immune response,GO:0052472~modulation by host of symbiont transcription,GO:0052312~modulation of transcription in other organism involved in symbiotic interaction,GO:0051851~modification by host of symbiont morphology or physiology,GO:0051817~modification of morphology or physiology of other organism involved in symbiotic interaction,GO:0051726~regulation of cell cycle,GO:0051702~interaction with symbiont,GO:0051276~chromosome organization,GO:0051254~positive regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051251~positive regulation of lymphocyte activation,GO:0051249~regulation of lymphocyte activation,GO:0051240~positive regulation of multicellular organismal process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051094~positive regulation of developmental process,GO:0050870~positive regulation of T cell activation,GO:0050867~positive regulation of cell activation,GO:0050865~regulation of cell activation,GO:0050863~regulation of T cell activation,GO:0050792~regulation of viral process,GO:0050778~positive regulation of immune response,GO:0050776~regulation of immune response,GO:0050727~regulation of inflammatory response,GO:0048585~negative regulation of response to stimulus,GO:0048584~positive regulation of response to stimulus,GO:0048534~hematopoietic or lymphoid organ development,GO:0048525~negative regulation of viral process,GO:0046782~regulation of viral transcription,GO:0046649~lymphocyte activation,GO:0046638~positive regulation of alpha-beta T cell differentiation,GO:0046637~regulation of alpha-beta T cell differentiation,GO:0046635~positive regulation of alpha-beta T cell activation,GO:0046634~regulation of alpha-beta T cell activation,GO:0046632~alpha-beta T cell differentiation,GO:0046631~alpha-beta T cell activation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045931~positive regulation of mitotic cell cycle,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045787~positive regulation of cell cycle,GO:0045786~negative regulation of cell cycle,GO:0045785~positive regulation of cell adhesion,GO:0045624~positive regulation of T-helper cell differentiation,GO:0045622~regulation of T-helper cell differentiation,GO:0045621~positive regulation of lymphocyte differentiation,GO:0045619~regulation of lymphocyte differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0045582~positive regulation of T cell differentiation,GO:0045580~regulation of T cell differentiation,GO:0045321~leukocyte activation,GO:0045165~cell fate commitment,GO:0045058~T cell selection,GO:0044839~cell cycle G2/M phase transition,GO:0044772~mitotic cell cycle phase transition,GO:0044770~cell cycle phase transition,GO:0044764~multi-organism cellular process,GO:0044419~interspecies interaction between organisms,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044033~multi-organism metabolic process,GO:0043922~negative regulation by host of viral transcription,GO:0043921~modulation by host of viral transcription,GO:0043903~regulation of symbiosis, encompassing mutualism through parasitism,GO:0043901~negative regulation of multi-organism process,GO:0043900~regulation of multi-organism process,GO:0043373~CD4-positive, alpha-beta T cell lineage commitment,GO:0043372~positive regulation of CD4-positive, alpha-beta T cell differentiation,GO:0043370~regulation of CD4-positive, alpha-beta T cell differentiation,GO:0043369~CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,GO:0043368~positive T cell selection,GO:0043367~CD4-positive, alpha-beta T cell differentiation,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043122~regulation of I-kappaB kinase/NF-kappaB signaling,GO:0042110~T cell activation,GO:0042093~T-helper cell differentiation,GO:0035821~modification of morphology or physiology of other organism,GO:0035710~CD4-positive, alpha-beta T cell activation,GO:0035556~intracellular signal transduction,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034243~regulation of transcription elongation from RNA polymerase II promoter,GO:0033554~cellular response to stress,GO:0032968~positive regulation of transcription elongation from RNA polymerase II promoter,GO:0032897~negative regulation of viral transcription,GO:0032786~positive regulation of DNA-templated transcription, elongation,GO:0032784~regulation of DNA-templated transcription, elongation,GO:0032774~RNA biosynthetic process,GO:0032101~regulation of response to external stimulus,GO:0031570~DNA integrity checkpoint,GO:0031347~regulation of defense response,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031324~negative regulation of cellular metabolic process,GO:0030217~T cell differentiation,GO:0030155~regulation of cell adhesion,GO:0030098~lymphocyte differentiation,GO:0030097~hemopoiesis,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0022610~biological adhesion,GO:0022409~positive regulation of cell-cell adhesion,GO:0022407~regulation of cell-cell adhesion,GO:0022402~cell cycle process,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019083~viral transcription,GO:0019080~viral gene expression,GO:0019058~viral life cycle,GO:0018130~heterocycle biosynthetic process,GO:0016337~single organismal cell-cell adhesion,GO:0016070~RNA metabolic process,GO:0016032~viral process,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010629~negative regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010564~regulation of cell cycle process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010455~positive regulation of cell fate commitment,GO:0010453~regulation of cell fate commitment,GO:0010389~regulation of G2/M transition of mitotic cell cycle,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0009891~positive regulation of biosynthetic process,GO:0009890~negative regulation of biosynthetic process,GO:0009605~response to external stimulus,GO:0007346~regulation of mitotic cell cycle,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0007159~leukocyte cell-cell adhesion,GO:0007155~cell adhesion,GO:0007049~cell cycle,GO:0006974~cellular response to DNA damage stimulus,GO:0006955~immune response,GO:0006952~defense response,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006354~DNA-templated transcription, elongation,GO:0006351~transcription, DNA-templated,GO:0006338~chromatin remodeling,GO:0006325~chromatin organization,GO:0002824~positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002822~regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002821~positive regulation of adaptive immune response,GO:0002819~regulation of adaptive immune response,GO:0002699~positive regulation of immune effector process,GO:0002697~regulation of immune effector process,GO:0002696~positive regulation of leukocyte activation,GO:0002694~regulation of leukocyte activation,GO:0002684~positive regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002521~leukocyte differentiation,GO:0002520~immune system development,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002366~leukocyte activation involved in immune response,GO:0002363~alpha-beta T cell lineage commitment,GO:0002360~T cell lineage commitment,GO:0002295~T-helper cell lineage commitment,GO:0002294~CD4-positive, alpha-beta T cell differentiation involved in immune response,GO:0002293~alpha-beta T cell differentiation involved in immune response,GO:0002292~T cell differentiation involved in immune response,GO:0002287~alpha-beta T cell activation involved in immune response,GO:0002286~T cell activation involved in immune response,GO:0002285~lymphocyte activation involved in immune response,GO:0002263~cell activation involved in immune response,GO:0002252~immune effector process,GO:0002250~adaptive immune response,GO:0001775~cell activation,GO:0000278~mitotic cell cycle,GO:0000086~G2/M transition of mitotic cell cycle,GO:0000077~DNA damage checkpoint,GO:0000075~cell cycle checkpoint,												GO:0005694~chromosome,GO:0005654~nucleoplasm,GO:0000794~condensed nuclear chromosome,GO:0000793~condensed chromosome,GO:0000228~nuclear chromosome,												GO:1990837~sequence-specific double-stranded DNA binding,GO:1901363~heterocyclic compound binding,GO:0099122~RNA polymerase II C-terminal domain binding,GO:0097159~organic cyclic compound binding,GO:0070577~lysine-acetylated histone binding,GO:0070063~RNA polymerase binding,GO:0044877~macromolecular complex binding,GO:0044212~transcription regulatory region DNA binding,GO:0043565~sequence-specific DNA binding,GO:0043175~RNA polymerase core enzyme binding,GO:0042393~histone binding,GO:0032403~protein complex binding,GO:0019899~enzyme binding,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0016301~kinase activity,GO:0008353~RNA polymerase II carboxy-terminal domain kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004672~protein kinase activity,GO:0003713~transcription coactivator activity,GO:0003712~transcription cofactor activity,GO:0003690~double-stranded DNA binding,GO:0003682~chromatin binding,GO:0003677~DNA binding,GO:0003676~nucleic acid binding,GO:0002039~p53 binding,GO:0001099~basal RNA polymerase II transcription machinery binding,GO:0001098~basal transcription machinery binding,GO:0001067~regulatory region nucleic acid binding,GO:0000993~RNA polymerase II core binding,GO:0000989~transcription factor activity, transcription factor binding,GO:0000988~transcription factor activity, protein binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000975~regulatory region DNA binding,												IPR043509:Bromo_Brdt_II,IPR043508:Bromo_Brdt_I,IPR038336:NET_sf,IPR036427:Bromodomain-like_sf,IPR031354:BRD4_CDT,IPR027353:NET_dom,IPR018359:Bromodomain_CS,IPR001487:Bromodomain,													620568~Cornelia de Lange syndrome 6,													SM00297:BROMO,												SITE:Breakpoint for translocation to form BDR4-NUTM1 fusion protein,SITE:Acetylated histone binding,REGION:NPS region,REGION:Disordered,REGION:C-terminal (CTD) region,REGION:BID region,MUTAGEN:SST->AAA: Impaired phosphorylation by CK2 and binding to acetylated histones.,MUTAGEN:SSS->ASA: Impaired phosphorylation by CK2 and binding to acetylated histones.,MUTAGEN:S->A: Impaired phosphorylation by CK2 and binding to acetylated histones.,MUTAGEN:N->A: Abolishes binding to acetylated histones.,MUTAGEN:EIE->AIA: Decreases interaction with JMJD6 and NSD3.No effect on interaction with histone 4 acetylated.,DOMAIN:NET,DOMAIN:Bromo 2,DOMAIN:Bromo 1,DOMAIN:Bromo,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,COMPBIAS:Pro residues,COMPBIAS:Polar residues,COMPBIAS:Basic residues,COMPBIAS:Basic and acidic residues,
37172_at	carboxypeptidase B2(CPB2)	Homo sapiens		h_fibrinolysisPathway:Fibrinolysis Pathway,												GO:2000346~negative regulation of hepatocyte proliferation,GO:2000345~regulation of hepatocyte proliferation,GO:2000027~regulation of organ morphogenesis,GO:1903532~positive regulation of secretion by cell,GO:1903530~regulation of secretion by cell,GO:1903318~negative regulation of protein maturation,GO:1903317~regulation of protein maturation,GO:1903055~positive regulation of extracellular matrix organization,GO:1903053~regulation of extracellular matrix organization,GO:1903036~positive regulation of response to wounding,GO:1903035~negative regulation of response to wounding,GO:1903034~regulation of response to wounding,GO:1901701~cellular response to oxygen-containing compound,GO:1901700~response to oxygen-containing compound,GO:1900048~positive regulation of hemostasis,GO:1900047~negative regulation of hemostasis,GO:1900046~regulation of hemostasis,GO:0097421~liver regeneration,GO:0090303~positive regulation of wound healing,GO:0080134~regulation of response to stress,GO:0072576~liver morphogenesis,GO:0072575~epithelial cell proliferation involved in liver morphogenesis,GO:0072574~hepatocyte proliferation,GO:0071333~cellular response to glucose stimulus,GO:0071331~cellular response to hexose stimulus,GO:0071326~cellular response to monosaccharide stimulus,GO:0071322~cellular response to carbohydrate stimulus,GO:0071310~cellular response to organic substance,GO:0070887~cellular response to chemical stimulus,GO:0070613~regulation of protein processing,GO:0070278~extracellular matrix constituent secretion,GO:0061045~negative regulation of wound healing,GO:0061041~regulation of wound healing,GO:0061008~hepaticobiliary system development,GO:0055082~cellular chemical homeostasis,GO:0051918~negative regulation of fibrinolysis,GO:0051917~regulation of fibrinolysis,GO:0051604~protein maturation,GO:0051248~negative regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051241~negative regulation of multicellular organismal process,GO:0051240~positive regulation of multicellular organismal process,GO:0051130~positive regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051093~negative regulation of developmental process,GO:0051050~positive regulation of transport,GO:0051049~regulation of transport,GO:0051047~positive regulation of secretion,GO:0051046~regulation of secretion,GO:0050878~regulation of body fluid levels,GO:0050820~positive regulation of coagulation,GO:0050819~negative regulation of coagulation,GO:0050818~regulation of coagulation,GO:0050817~coagulation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0050673~epithelial cell proliferation,GO:0048878~chemical homeostasis,GO:0048732~gland development,GO:0048585~negative regulation of response to stimulus,GO:0048584~positive regulation of response to stimulus,GO:0046903~secretion,GO:0045861~negative regulation of proteolysis,GO:0043062~extracellular structure organization,GO:0042730~fibrinolysis,GO:0042593~glucose homeostasis,GO:0042592~homeostatic process,GO:0042127~regulation of cell proliferation,GO:0042060~wound healing,GO:0034284~response to monosaccharide,GO:0033500~carbohydrate homeostasis,GO:0032940~secretion by cell,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032103~positive regulation of response to external stimulus,GO:0032102~negative regulation of response to external stimulus,GO:0032101~regulation of response to external stimulus,GO:0031639~plasminogen activation,GO:0031638~zymogen activation,GO:0031324~negative regulation of cellular metabolic process,GO:0031100~animal organ regeneration,GO:0031099~regeneration,GO:0030198~extracellular matrix organization,GO:0030195~negative regulation of blood coagulation,GO:0030194~positive regulation of blood coagulation,GO:0030193~regulation of blood coagulation,GO:0030163~protein catabolic process,GO:0030162~regulation of proteolysis,GO:0022612~gland morphogenesis,GO:0022603~regulation of anatomical structure morphogenesis,GO:0019725~cellular homeostasis,GO:0016485~protein processing,GO:0010955~negative regulation of protein processing,GO:0010757~negative regulation of plasminogen activation,GO:0010755~regulation of plasminogen activation,GO:0010629~negative regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010033~response to organic substance,GO:0009892~negative regulation of metabolic process,GO:0009887~animal organ morphogenesis,GO:0009749~response to glucose,GO:0009746~response to hexose,GO:0009743~response to carbohydrate,GO:0009611~response to wounding,GO:0009605~response to external stimulus,GO:0009410~response to xenobiotic stimulus,GO:0009057~macromolecule catabolic process,GO:0008285~negative regulation of cell proliferation,GO:0008283~cell proliferation,GO:0007599~hemostasis,GO:0007596~blood coagulation,GO:0006508~proteolysis,GO:0003331~positive regulation of extracellular matrix constituent secretion,GO:0003330~regulation of extracellular matrix constituent secretion,GO:0001889~liver development,GO:0001678~cellular glucose homeostasis,												GO:1903561~extracellular vesicle,GO:0070062~extracellular exosome,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0008270~zinc ion binding,GO:0008238~exopeptidase activity,GO:0008237~metallopeptidase activity,GO:0008235~metalloexopeptidase activity,GO:0008233~peptidase activity,GO:0004181~metallocarboxypeptidase activity,GO:0004180~carboxypeptidase activity,												IPR036990:M14A-like_propep,IPR033849:CPB2,IPR003146:M14A_act_pep,IPR000834:Peptidase_M14,												hsa04974:Protein digestion and absorption,hsa04972:Pancreatic secretion,hsa04610:Complement and coagulation cascades,														SM00631:Zn_pept,												SITE:Cleavage; by thrombin,PROPEP:Activation peptide,DOMAIN:Peptidase M14 carboxypeptidase A,DOMAIN:Peptidase M14,DOMAIN:Carboxypeptidase activation peptide,CARBOHYD:N-linked (GlcNAc...) asparagine; partial,CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:N-linked (GlcNAc...) (complex) asparagine,ACT_SITE:Proton donor/acceptor,
37105_at	cathepsin G(CTSG)	Homo sapiens
679_at	cathepsin G(CTSG)	Homo sapiens			GO:1903038~negative regulation of leukocyte cell-cell adhesion,GO:1903037~regulation of leukocyte cell-cell adhesion,GO:1903036~positive regulation of response to wounding,GO:1903034~regulation of response to wounding,GO:1901731~positive regulation of platelet aggregation,GO:1901701~cellular response to oxygen-containing compound,GO:1901700~response to oxygen-containing compound,GO:1900048~positive regulation of hemostasis,GO:1900046~regulation of hemostasis,GO:0098786~biofilm matrix disassembly,GO:0098784~biofilm matrix organization,GO:0098609~cell-cell adhesion,GO:0098602~single organism cell adhesion,GO:0098542~defense response to other organism,GO:0097529~myeloid leukocyte migration,GO:0090330~regulation of platelet aggregation,GO:0090303~positive regulation of wound healing,GO:0080134~regulation of response to stress,GO:0071674~mononuclear cell migration,GO:0071396~cellular response to lipid,GO:0071345~cellular response to cytokine stimulus,GO:0071310~cellular response to organic substance,GO:0071222~cellular response to lipopolysaccharide,GO:0071219~cellular response to molecule of bacterial origin,GO:0071216~cellular response to biotic stimulus,GO:0070946~neutrophil mediated killing of gram-positive bacterium,GO:0070944~neutrophil mediated killing of bacterium,GO:0070943~neutrophil mediated killing of symbiont cell,GO:0070942~neutrophil mediated cytotoxicity,GO:0070887~cellular response to chemical stimulus,GO:0070527~platelet aggregation,GO:0061041~regulation of wound healing,GO:0060326~cell chemotaxis,GO:0060177~regulation of angiotensin metabolic process,GO:0051883~killing of cells in other organism involved in symbiotic interaction,GO:0051873~killing by host of symbiont cells,GO:0051852~disruption by host of symbiont cells,GO:0051851~modification by host of symbiont morphology or physiology,GO:0051818~disruption of cells of other organism involved in symbiotic interaction,GO:0051817~modification of morphology or physiology of other organism involved in symbiotic interaction,GO:0051707~response to other organism,GO:0051702~interaction with symbiont,GO:0051674~localization of cell,GO:0051604~protein maturation,GO:0051250~negative regulation of lymphocyte activation,GO:0051249~regulation of lymphocyte activation,GO:0051246~regulation of protein metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0050900~leukocyte migration,GO:0050886~endocrine process,GO:0050878~regulation of body fluid levels,GO:0050868~negative regulation of T cell activation,GO:0050867~positive regulation of cell activation,GO:0050866~negative regulation of cell activation,GO:0050865~regulation of cell activation,GO:0050863~regulation of T cell activation,GO:0050832~defense response to fungus,GO:0050830~defense response to Gram-positive bacterium,GO:0050829~defense response to Gram-negative bacterium,GO:0050820~positive regulation of coagulation,GO:0050818~regulation of coagulation,GO:0050817~coagulation,GO:0050778~positive regulation of immune response,GO:0050776~regulation of immune response,GO:0048870~cell motility,GO:0048584~positive regulation of response to stimulus,GO:0046649~lymphocyte activation,GO:0045785~positive regulation of cell adhesion,GO:0045321~leukocyte activation,GO:0044419~interspecies interaction between organisms,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044364~disruption of cells of other organism,GO:0043603~cellular amide metabolic process,GO:0043207~response to external biotic stimulus,GO:0043062~extracellular structure organization,GO:0042742~defense response to bacterium,GO:0042445~hormone metabolic process,GO:0042330~taxis,GO:0042119~neutrophil activation,GO:0042110~T cell activation,GO:0042060~wound healing,GO:0040011~locomotion,GO:0036230~granulocyte activation,GO:0036211~protein modification process,GO:0035821~modification of morphology or physiology of other organism,GO:0035590~purinergic nucleotide receptor signaling pathway,GO:0035587~purinergic receptor signaling pathway,GO:0034112~positive regulation of homotypic cell-cell adhesion,GO:0034110~regulation of homotypic cell-cell adhesion,GO:0034109~homotypic cell-cell adhesion,GO:0034097~response to cytokine,GO:0033993~response to lipid,GO:0032496~response to lipopolysaccharide,GO:0032101~regulation of response to external stimulus,GO:0031640~killing of cells of other organism,GO:0030595~leukocyte chemotaxis,GO:0030198~extracellular matrix organization,GO:0030194~positive regulation of blood coagulation,GO:0030193~regulation of blood coagulation,GO:0030168~platelet activation,GO:0030155~regulation of cell adhesion,GO:0022617~extracellular matrix disassembly,GO:0022610~biological adhesion,GO:0022411~cellular component disassembly,GO:0022409~positive regulation of cell-cell adhesion,GO:0022408~negative regulation of cell-cell adhesion,GO:0022407~regulation of cell-cell adhesion,GO:0019731~antibacterial humoral response,GO:0019730~antimicrobial humoral response,GO:0019221~cytokine-mediated signaling pathway,GO:0016486~peptide hormone processing,GO:0016485~protein processing,GO:0016477~cell migration,GO:0016337~single organismal cell-cell adhesion,GO:0016310~phosphorylation,GO:0010817~regulation of hormone levels,GO:0010572~positive regulation of platelet activation,GO:0010543~regulation of platelet activation,GO:0010467~gene expression,GO:0010033~response to organic substance,GO:0009620~response to fungus,GO:0009617~response to bacterium,GO:0009611~response to wounding,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0008217~regulation of blood pressure,GO:0008015~blood circulation,GO:0007599~hemostasis,GO:0007596~blood coagulation,GO:0007166~cell surface receptor signaling pathway,GO:0007162~negative regulation of cell adhesion,GO:0007159~leukocyte cell-cell adhesion,GO:0007155~cell adhesion,GO:0006959~humoral immune response,GO:0006955~immune response,GO:0006952~defense response,GO:0006935~chemotaxis,GO:0006928~movement of cell or subcellular component,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006518~peptide metabolic process,GO:0006508~proteolysis,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0003081~regulation of systemic arterial blood pressure by renin-angiotensin,GO:0003073~regulation of systemic arterial blood pressure,GO:0003044~regulation of systemic arterial blood pressure mediated by a chemical signal,GO:0003013~circulatory system process,GO:0003008~system process,GO:0002695~negative regulation of leukocyte activation,GO:0002694~regulation of leukocyte activation,GO:0002684~positive regulation of immune system process,GO:0002683~negative regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002548~monocyte chemotaxis,GO:0002446~neutrophil mediated immunity,GO:0002444~myeloid leukocyte mediated immunity,GO:0002443~leukocyte mediated immunity,GO:0002274~myeloid leukocyte activation,GO:0002252~immune effector process,GO:0002237~response to molecule of bacterial origin,GO:0002003~angiotensin maturation,GO:0002002~regulation of angiotensin levels in blood,GO:0001991~regulation of systemic arterial blood pressure by circulatory renin-angiotensin,GO:0001990~regulation of systemic arterial blood pressure by hormone,GO:0001909~leukocyte mediated cytotoxicity,GO:0001906~cell killing,GO:0001775~cell activation,												GO:1990904~ribonucleoprotein complex,GO:1903561~extracellular vesicle,GO:0099503~secretory vesicle,GO:0070062~extracellular exosome,GO:0060205~cytoplasmic vesicle lumen,GO:0044437~vacuolar part,GO:0044433~cytoplasmic vesicle part,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0042582~azurophil granule,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0035770~ribonucleoprotein granule,GO:0035578~azurophil granule lumen,GO:0034774~secretory granule lumen,GO:0031983~vesicle lumen,GO:0030529~intracellular ribonucleoprotein complex,GO:0030141~secretory granule,GO:0010494~cytoplasmic stress granule,GO:0005829~cytosol,GO:0005775~vacuolar lumen,GO:0005773~vacuole,GO:0005766~primary lysosome,GO:0005764~lysosome,GO:0005615~extracellular space,GO:0005576~extracellular region,GO:0000323~lytic vacuole,												GO:1901681~sulfur compound binding,GO:0098772~molecular function regulator,GO:0097367~carbohydrate derivative binding,GO:0089720~caspase binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0048018~receptor agonist activity,GO:0043168~anion binding,GO:0043167~ion binding,GO:0030546~receptor activator activity,GO:0030545~receptor regulator activity,GO:0019899~enzyme binding,GO:0017171~serine hydrolase activity,GO:0008236~serine-type peptidase activity,GO:0008233~peptidase activity,GO:0008201~heparin binding,GO:0005539~glycosaminoglycan binding,GO:0005102~receptor binding,GO:0004871~signal transducer activity,GO:0004252~serine-type endopeptidase activity,GO:0004175~endopeptidase activity,GO:0002020~protease binding,												IPR043504:Peptidase_S1_PA_chymotrypsin,IPR033116:TRYPSIN_SER,IPR018114:TRYPSIN_HIS,IPR009003:Peptidase_S1_PA,IPR001314:Peptidase_S1A,IPR001254:Trypsin_dom,												hsa05322:Systemic lupus erythematosus,hsa05146:Amoebiasis,hsa04614:Renin-angiotensin system,hsa04613:Neutrophil extracellular trap formation,hsa04142:Lysosome,hsa04080:Neuroactive ligand-receptor interaction,														SM00020:Tryp_SPc,												REGION:Important for antimicrobial activity,PROPEP:Activation peptide,MUTAGEN:N->A: No effect on proteolytic processing, enzyme activation or sorting to cytoplasmic granules.,DOMAIN:Peptidase S1,CARBOHYD:N-linked (GlcNAc...) (paucimannose) asparagine; alternate,CARBOHYD:N-linked (GlcNAc...) (complex) asparagine; alternate,ACT_SITE:Charge relay system,
37061_at	chitinase 1(CHIT1)	Homo sapiens			GO:1901565~organonitrogen compound catabolic process,GO:1901136~carbohydrate derivative catabolic process,GO:1901135~carbohydrate derivative metabolic process,GO:1901072~glucosamine-containing compound catabolic process,GO:1901071~glucosamine-containing compound metabolic process,GO:0051707~response to other organism,GO:0046348~amino sugar catabolic process,GO:0044245~polysaccharide digestion,GO:0043207~response to external biotic stimulus,GO:0016052~carbohydrate catabolic process,GO:0009617~response to bacterium,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0009057~macromolecule catabolic process,GO:0007586~digestion,GO:0006955~immune response,GO:0006040~amino sugar metabolic process,GO:0006032~chitin catabolic process,GO:0006030~chitin metabolic process,GO:0006026~aminoglycan catabolic process,GO:0006022~aminoglycan metabolic process,GO:0005976~polysaccharide metabolic process,GO:0005975~carbohydrate metabolic process,GO:0000272~polysaccharide catabolic process,												GO:1904724~tertiary granule lumen,GO:0099503~secretory vesicle,GO:0070820~tertiary granule,GO:0060205~cytoplasmic vesicle lumen,GO:0044433~cytoplasmic vesicle part,GO:0044421~extracellular region part,GO:0042581~specific granule,GO:0035580~specific granule lumen,GO:0034774~secretory granule lumen,GO:0031983~vesicle lumen,GO:0030141~secretory granule,GO:0005773~vacuole,GO:0005764~lysosome,GO:0005615~extracellular space,GO:0005576~extracellular region,GO:0000323~lytic vacuole,												GO:0097367~carbohydrate derivative binding,GO:0016798~hydrolase activity, acting on glycosyl bonds,GO:0008843~endochitinase activity,GO:0008061~chitin binding,GO:0004568~chitinase activity,GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,												IPR036508:Chitin-bd_dom_sf,IPR029070:Chitinase_insertion_sf,IPR017853:Glycoside_hydrolase_SF,IPR011583:Chitinase_II,IPR002557:Chitin-bd_dom,IPR001579:Glyco_hydro_18_chit_AS,IPR001223:Glyco_hydro18_cat,												hsa01100:Metabolic pathways,hsa00520:Amino sugar and nucleotide sugar metabolism,												614122~Chitotriosidase deficiency,													SM00636:Glyco_18,SM00494:ChtBD2,												REGION:Disordered,DOMAIN:GH18,DOMAIN:Chitin-binding type-2,CARBOHYD:N-linked (GlcNAc...) asparagine; in variant S-102,ACT_SITE:Proton donor,
38482_at	claudin 7(CLDN7)	Homo sapiens			GO:2000147~positive regulation of cell motility,GO:2000145~regulation of cell motility,GO:1901700~response to oxygen-containing compound,GO:0098742~cell-cell adhesion via plasma-membrane adhesion molecules,GO:0098609~cell-cell adhesion,GO:0097305~response to alcohol,GO:0071822~protein complex subunit organization,GO:0070830~bicellular tight junction assembly,GO:0070271~protein complex biogenesis,GO:0065003~macromolecular complex assembly,GO:0060548~negative regulation of cell death,GO:0051674~localization of cell,GO:0051272~positive regulation of cellular component movement,GO:0051270~regulation of cellular component movement,GO:0051129~negative regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0048870~cell motility,GO:0045471~response to ethanol,GO:0045216~cell-cell junction organization,GO:0044087~regulation of cellular component biogenesis,GO:0044085~cellular component biogenesis,GO:0043933~macromolecular complex subunit organization,GO:0043297~apical junction assembly,GO:0043254~regulation of protein complex assembly,GO:0043069~negative regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptotic process,GO:0042981~regulation of apoptotic process,GO:0042127~regulation of cell proliferation,GO:0040017~positive regulation of locomotion,GO:0040012~regulation of locomotion,GO:0040011~locomotion,GO:0034330~cell junction organization,GO:0034329~cell junction assembly,GO:0031333~negative regulation of protein complex assembly,GO:0030155~regulation of cell adhesion,GO:0022610~biological adhesion,GO:0022607~cellular component assembly,GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,GO:0012501~programmed cell death,GO:0010941~regulation of cell death,GO:0010033~response to organic substance,GO:0008284~positive regulation of cell proliferation,GO:0008283~cell proliferation,GO:0008219~cell death,GO:0007162~negative regulation of cell adhesion,GO:0007155~cell adhesion,GO:0007043~cell-cell junction assembly,GO:0006928~movement of cell or subcellular component,GO:0006915~apoptotic process,GO:0006461~protein complex assembly,												GO:0098590~plasma membrane region,GO:0070160~occluding junction,GO:0043296~apical junction complex,GO:0030054~cell junction,GO:0016328~lateral plasma membrane,GO:0016327~apicolateral plasma membrane,GO:0016323~basolateral plasma membrane,GO:0005923~bicellular tight junction,GO:0005911~cell-cell junction,												GO:0050839~cell adhesion molecule binding,GO:0042802~identical protein binding,GO:0019904~protein domain specific binding,GO:0005198~structural molecule activity,												IPR017974:Claudin_CS,IPR006187:Claudin,IPR004031:PMP22/EMP/MP20/Claudin,IPR003552:Claudin7,												hsa05160:Hepatitis C,hsa05130:Pathogenic Escherichia coli infection,hsa04670:Leukocyte transendothelial migration,hsa04530:Tight junction,hsa04514:Cell adhesion molecules,															TRANSMEM:Helical,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,REGION:Interactions with TJP1, TJP2 and TJP3,MUTAGEN:M->I: Interacts with CD81, and exhibits HCV infection susceptibility in cell culture.,MUTAGEN:K->E: Interacts with CD81, and exhibits HCV infection susceptibility in cell culture.,
35169_at	collagen type XVI alpha 1 chain(COL16A1)	Homo sapiens			GO:1903393~positive regulation of adherens junction organization,GO:1903391~regulation of adherens junction organization,GO:1901890~positive regulation of cell junction assembly,GO:1901888~regulation of cell junction assembly,GO:1901701~cellular response to oxygen-containing compound,GO:1901700~response to oxygen-containing compound,GO:1901699~cellular response to nitrogen compound,GO:1901698~response to nitrogen compound,GO:0090109~regulation of cell-substrate junction assembly,GO:0071822~protein complex subunit organization,GO:0071495~cellular response to endogenous stimulus,GO:0071417~cellular response to organonitrogen compound,GO:0071310~cellular response to organic substance,GO:0071230~cellular response to amino acid stimulus,GO:0071229~cellular response to acid chemical,GO:0070887~cellular response to chemical stimulus,GO:0070271~protein complex biogenesis,GO:0065003~macromolecular complex assembly,GO:0051894~positive regulation of focal adhesion assembly,GO:0051893~regulation of focal adhesion assembly,GO:0051130~positive regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0048041~focal adhesion assembly,GO:0045785~positive regulation of cell adhesion,GO:0045216~cell-cell junction organization,GO:0044706~multi-multicellular organism process,GO:0044703~multi-organism reproductive process,GO:0044089~positive regulation of cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044085~cellular component biogenesis,GO:0043933~macromolecular complex subunit organization,GO:0043200~response to amino acid,GO:0043062~extracellular structure organization,GO:0034333~adherens junction assembly,GO:0034332~adherens junction organization,GO:0034330~cell junction organization,GO:0034329~cell junction assembly,GO:0033627~cell adhesion mediated by integrin,GO:0033622~integrin activation,GO:0031589~cell-substrate adhesion,GO:0030198~extracellular matrix organization,GO:0030155~regulation of cell adhesion,GO:0022610~biological adhesion,GO:0022607~cellular component assembly,GO:0022414~reproductive process,GO:0010811~positive regulation of cell-substrate adhesion,GO:0010810~regulation of cell-substrate adhesion,GO:0010243~response to organonitrogen compound,GO:0010033~response to organic substance,GO:0009719~response to endogenous stimulus,GO:0007565~female pregnancy,GO:0007229~integrin-mediated signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0007160~cell-matrix adhesion,GO:0007155~cell adhesion,GO:0007045~cell-substrate adherens junction assembly,GO:0007044~cell-substrate junction assembly,GO:0006461~protein complex assembly,GO:0001954~positive regulation of cell-matrix adhesion,GO:0001952~regulation of cell-matrix adhesion,GO:0001101~response to acid chemical,GO:0000003~reproduction,												GO:0044432~endoplasmic reticulum part,GO:0044421~extracellular region part,GO:0005788~endoplasmic reticulum lumen,GO:0005783~endoplasmic reticulum,GO:0005615~extracellular space,GO:0005597~collagen type XVI trimer,GO:0005594~collagen type IX trimer,GO:0005593~FACIT collagen trimer,GO:0005581~collagen trimer,GO:0005576~extracellular region,												GO:0050839~cell adhesion molecule binding,GO:0044877~macromolecular complex binding,GO:0032403~protein complex binding,GO:0030020~extracellular matrix structural constituent conferring tensile strength,GO:0005201~extracellular matrix structural constituent,GO:0005198~structural molecule activity,GO:0005178~integrin binding,GO:0005102~receptor binding,												IPR048287:TSPN-like_N,IPR013320:ConA-like_dom_sf,IPR008160:Collagen,												hsa04974:Protein digestion and absorption,														SM00210:TSPN,												REGION:Triple-helical region 9 (COL9) with 3 imperfections,REGION:Triple-helical region 8 (COL8) with 1 imperfection,REGION:Triple-helical region 7 (COL7) with 1 imperfection,REGION:Triple-helical region 6 (COL6) with 1 imperfection,REGION:Triple-helical region 5 (COL5) with 3 imperfections,REGION:Triple-helical region 4 (COL4) with 2 imperfections,REGION:Triple-helical region 3 (COL3),REGION:Triple-helical region 2 (COL2) with 2 imperfections,REGION:Triple-helical region 1 (COL1) with 2 imperfections,REGION:Nonhelical region 9 (NC9),REGION:Nonhelical region 8 (NC8),REGION:Nonhelical region 7 (NC7),REGION:Nonhelical region 6 (NC6),REGION:Nonhelical region 5 (NC5),REGION:Nonhelical region 4 (NC4),REGION:Nonhelical region 3 (NC3),REGION:Nonhelical region 2 (NC2),REGION:Nonhelical region 10 (NC10),REGION:Nonhelical region 1 (NC1),REGION:Disordered,MOTIF:Cell attachment site,DOMAIN:Thrombospondin-like N-terminal,DOMAIN:Laminin G-like,DOMAIN:Collagen-like 8,DOMAIN:Collagen-like 7,DOMAIN:Collagen-like 6,DOMAIN:Collagen-like 5,DOMAIN:Collagen-like 4,DOMAIN:Collagen-like 3,DOMAIN:Collagen-like 2,DOMAIN:Collagen-like 1,COMPBIAS:Pro residues,CARBOHYD:N-linked (GlcNAc...) asparagine,
32250_at	complement factor H(CFH)	Homo sapiens			GO:2000257~regulation of protein activation cascade,GO:1903659~regulation of complement-dependent cytotoxicity,GO:1903317~regulation of protein maturation,GO:0080134~regulation of response to stress,GO:0072376~protein activation cascade,GO:0070613~regulation of protein processing,GO:0051604~protein maturation,GO:0051246~regulation of protein metabolic process,GO:0050778~positive regulation of immune response,GO:0050776~regulation of immune response,GO:0050727~regulation of inflammatory response,GO:0048584~positive regulation of response to stimulus,GO:0045088~regulation of innate immune response,GO:0045087~innate immune response,GO:0032101~regulation of response to external stimulus,GO:0031347~regulation of defense response,GO:0031341~regulation of cell killing,GO:0030451~regulation of complement activation, alternative pathway,GO:0030449~regulation of complement activation,GO:0030162~regulation of proteolysis,GO:0016485~protein processing,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0009605~response to external stimulus,GO:0006959~humoral immune response,GO:0006957~complement activation, alternative pathway,GO:0006956~complement activation,GO:0006955~immune response,GO:0006954~inflammatory response,GO:0006952~defense response,GO:0006508~proteolysis,GO:0002920~regulation of humoral immune response,GO:0002697~regulation of immune effector process,GO:0002684~positive regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002673~regulation of acute inflammatory response,GO:0002526~acute inflammatory response,GO:0002253~activation of immune response,GO:0002252~immune effector process,GO:0001906~cell killing,												GO:1905370~serine-type endopeptidase complex,GO:1905369~endopeptidase complex,GO:1905368~peptidase complex,GO:1905286~serine-type peptidase complex,GO:1903561~extracellular vesicle,GO:0072562~blood microparticle,GO:0070062~extracellular exosome,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:1901681~sulfur compound binding,GO:0097367~carbohydrate derivative binding,GO:0043395~heparan sulfate proteoglycan binding,GO:0043394~proteoglycan binding,GO:0043168~anion binding,GO:0043167~ion binding,GO:0042802~identical protein binding,GO:0008201~heparin binding,GO:0005539~glycosaminoglycan binding,GO:0001948~glycoprotein binding,GO:0001851~complement component C3b binding,GO:0001848~complement binding,GO:0001846~opsonin binding,												IPR035976:Sushi/SCR/CCP_sf,IPR000436:Sushi_SCR_CCP_dom,												hsa05150:Staphylococcus aureus infection,hsa04610:Complement and coagulation cascades,												610698~Macular degeneration, age-related, 4,609814~Complement factor H deficiency,235400~Hemolytic uremic syndrome, atypical, susceptibility to, 1,126700~Basal laminar drusen,													SM00032:CCP,												MUTAGEN:W->L: About 40% loss of C3b binding.,MUTAGEN:R->A: About 50% loss of C3b binding.,MUTAGEN:R->A: About 20% loss of heparin-binding.,MUTAGEN:K->A: About 50% loss of C3b binding.,MUTAGEN:K->A: About 20% loss of C3b binding.,MUTAGEN:H->A: About 10% loss of heparin-binding.,MUTAGEN:E->A: About 30% loss of C3b binding.,DOMAIN:Sushi 9,DOMAIN:Sushi 8,DOMAIN:Sushi 7,DOMAIN:Sushi 6,DOMAIN:Sushi 5,DOMAIN:Sushi 4,DOMAIN:Sushi 3,DOMAIN:Sushi 20,DOMAIN:Sushi 2,DOMAIN:Sushi 19,DOMAIN:Sushi 18,DOMAIN:Sushi 17,DOMAIN:Sushi 16,DOMAIN:Sushi 15,DOMAIN:Sushi 14,DOMAIN:Sushi 13,DOMAIN:Sushi 12,DOMAIN:Sushi 11,DOMAIN:Sushi 10,DOMAIN:Sushi 1,DOMAIN:Sushi,CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:N-linked (GlcNAc...) (complex) asparagine,
36317_at	coronin 2A(CORO2A)	Homo sapiens			GO:0035556~intracellular signal transduction,												GO:0017053~transcriptional repressor complex,												GO:0051015~actin filament binding,GO:0044877~macromolecular complex binding,GO:0032403~protein complex binding,GO:0008092~cytoskeletal protein binding,GO:0003779~actin binding,												IPR036322:WD40_repeat_dom_sf,IPR019775:WD40_repeat_CS,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR015505:Coronin,IPR015048:DUF1899,IPR001680:WD40_rpt,															SM01167:DUF1900,SM01166:DUF1899,SM00320:WD40,												REPEAT:WD 7,REPEAT:WD 6,REPEAT:WD 5,REPEAT:WD 4,REPEAT:WD 3,REPEAT:WD 2,REPEAT:WD 1,REPEAT:WD,DOMAIN:DUF1899,
1983_at	cyclin D2(CCND2)	Homo sapiens		h_cellcyclePathway:Cyclins and Cell Cycle Regulation,												GO:2000045~regulation of G1/S transition of mitotic cell cycle,GO:1904031~positive regulation of cyclin-dependent protein kinase activity,GO:1904029~regulation of cyclin-dependent protein kinase activity,GO:1903047~mitotic cell cycle process,GO:1902808~positive regulation of cell cycle G1/S phase transition,GO:1902806~regulation of cell cycle G1/S phase transition,GO:1901992~positive regulation of mitotic cell cycle phase transition,GO:1901990~regulation of mitotic cell cycle phase transition,GO:1901989~positive regulation of cell cycle phase transition,GO:1901987~regulation of cell cycle phase transition,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,GO:0090068~positive regulation of cell cycle process,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:0071900~regulation of protein serine/threonine kinase activity,GO:0071481~cellular response to X-ray,GO:0071479~cellular response to ionizing radiation,GO:0071478~cellular response to radiation,GO:0071214~cellular response to abiotic stimulus,GO:0065009~regulation of molecular function,GO:0060548~negative regulation of cell death,GO:0051726~regulation of cell cycle,GO:0051347~positive regulation of transferase activity,GO:0051338~regulation of transferase activity,GO:0051301~cell division,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0050890~cognition,GO:0050877~neurological system process,GO:0050790~regulation of catalytic activity,GO:0045937~positive regulation of phosphate metabolic process,GO:0045931~positive regulation of mitotic cell cycle,GO:0045860~positive regulation of protein kinase activity,GO:0045859~regulation of protein kinase activity,GO:0045787~positive regulation of cell cycle,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0044843~cell cycle G1/S phase transition,GO:0044772~mitotic cell cycle phase transition,GO:0044770~cell cycle phase transition,GO:0044708~single-organism behavior,GO:0044093~positive regulation of molecular function,GO:0043549~regulation of kinase activity,GO:0043085~positive regulation of catalytic activity,GO:0043069~negative regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptotic process,GO:0042981~regulation of apoptotic process,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0042127~regulation of cell proliferation,GO:0036211~protein modification process,GO:0033674~positive regulation of kinase activity,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031325~positive regulation of cellular metabolic process,GO:0030534~adult behavior,GO:0022402~cell cycle process,GO:0019220~regulation of phosphate metabolic process,GO:0016310~phosphorylation,GO:0012501~programmed cell death,GO:0010941~regulation of cell death,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010564~regulation of cell cycle process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010212~response to ionizing radiation,GO:0010165~response to X-ray,GO:0009893~positive regulation of metabolic process,GO:0009628~response to abiotic stimulus,GO:0009314~response to radiation,GO:0008344~adult locomotory behavior,GO:0008284~positive regulation of cell proliferation,GO:0008283~cell proliferation,GO:0008219~cell death,GO:0007626~locomotory behavior,GO:0007616~long-term memory,GO:0007613~memory,GO:0007611~learning or memory,GO:0007610~behavior,GO:0007346~regulation of mitotic cell cycle,GO:0007049~cell cycle,GO:0006915~apoptotic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0003008~system process,GO:0001934~positive regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,GO:0000278~mitotic cell cycle,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,												GO:1902911~protein kinase complex,GO:1902554~serine/threonine protein kinase complex,GO:0097129~cyclin D2-CDK4 complex,GO:0061695~transferase complex, transferring phosphorus-containing groups,GO:0044427~chromosomal part,GO:0031975~envelope,GO:0031967~organelle envelope,GO:0031965~nuclear membrane,GO:0015630~microtubule cytoskeleton,GO:0005829~cytosol,GO:0005815~microtubule organizing center,GO:0005813~centrosome,GO:0005730~nucleolus,GO:0005694~chromosome,GO:0005654~nucleoplasm,GO:0005635~nuclear envelope,GO:0000785~chromatin,GO:0000307~cyclin-dependent protein kinase holoenzyme complex,												GO:0098772~molecular function regulator,GO:0061575~cyclin-dependent protein serine/threonine kinase activator activity,GO:0043539~protein serine/threonine kinase activator activity,GO:0030295~protein kinase activator activity,GO:0030234~enzyme regulator activity,GO:0019901~protein kinase binding,GO:0019900~kinase binding,GO:0019899~enzyme binding,GO:0019887~protein kinase regulator activity,GO:0019209~kinase activator activity,GO:0019207~kinase regulator activity,GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,GO:0008047~enzyme activator activity,												IPR048258:Cyclins_cyclin-box,IPR039361:Cyclin,IPR036915:Cyclin-like_sf,IPR013763:Cyclin-like_dom,IPR006671:Cyclin_N,IPR004367:Cyclin_C-dom,												hsa05206:MicroRNAs in cancer,hsa05203:Viral carcinogenesis,hsa05202:Transcriptional misregulation in cancer,hsa05200:Pathways in cancer,hsa05169:Epstein-Barr virus infection,hsa05166:Human T-cell leukemia virus 1 infection,hsa05165:Human papillomavirus infection,hsa05162:Measles,hsa04917:Prolactin signaling pathway,hsa04630:JAK-STAT signaling pathway,hsa04510:Focal adhesion,hsa04390:Hippo signaling pathway,hsa04340:Hedgehog signaling pathway,hsa04310:Wnt signaling pathway,hsa04218:Cellular senescence,hsa04151:PI3K-Akt signaling pathway,hsa04115:p53 signaling pathway,hsa04110:Cell cycle,hsa04068:FoxO signaling pathway,												615938~Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3,													SM01332:Cyclin_C,SM00385:CYCLIN,												REGION:Disordered,DOMAIN:Cyclin-like,DOMAIN:Cyclin N-terminal,DOMAIN:Cyclin C-terminal,COMPBIAS:Basic and acidic residues,
38229_at	cytochrome P450 family 3 subfamily A member 5(CYP3A5)	Homo sapiens			GO:1901615~organic hydroxy compound metabolic process,GO:1901565~organonitrogen compound catabolic process,GO:1901376~organic heteropentacyclic compound metabolic process,GO:0071466~cellular response to xenobiotic stimulus,GO:0070989~oxidative demethylation,GO:0070988~demethylation,GO:0070887~cellular response to chemical stimulus,GO:0055114~oxidation-reduction process,GO:0046222~aflatoxin metabolic process,GO:0044270~cellular nitrogen compound catabolic process,GO:0044255~cellular lipid metabolic process,GO:0043436~oxoacid metabolic process,GO:0043385~mycotoxin metabolic process,GO:0042573~retinoic acid metabolic process,GO:0042572~retinol metabolic process,GO:0042445~hormone metabolic process,GO:0042178~xenobiotic catabolic process,GO:0034754~cellular hormone metabolic process,GO:0034308~primary alcohol metabolic process,GO:0032787~monocarboxylic acid metabolic process,GO:0030258~lipid modification,GO:0019752~carboxylic acid metabolic process,GO:0019748~secondary metabolic process,GO:0016101~diterpenoid metabolic process,GO:0010817~regulation of hormone levels,GO:0009822~alkaloid catabolic process,GO:0009820~alkaloid metabolic process,GO:0009410~response to xenobiotic stimulus,GO:0009404~toxin metabolic process,GO:0008210~estrogen metabolic process,GO:0008202~steroid metabolic process,GO:0006805~xenobiotic metabolic process,GO:0006721~terpenoid metabolic process,GO:0006720~isoprenoid metabolic process,GO:0006629~lipid metabolic process,GO:0006082~organic acid metabolic process,GO:0006066~alcohol metabolic process,GO:0002933~lipid hydroxylation,GO:0001523~retinoid metabolic process,												GO:0044432~endoplasmic reticulum part,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0005789~endoplasmic reticulum membrane,GO:0005783~endoplasmic reticulum,												GO:1901363~heterocyclic compound binding,GO:0101020~estrogen 16-alpha-hydroxylase activity,GO:0097159~organic cyclic compound binding,GO:0070330~aromatase activity,GO:0050649~testosterone 6-beta-hydroxylase activity,GO:0046914~transition metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0020037~heme binding,GO:0019825~oxygen binding,GO:0016712~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,GO:0008401~retinoic acid 4-hydroxylase activity,GO:0008395~steroid hydroxylase activity,GO:0005506~iron ion binding,GO:0004497~monooxygenase activity,												IPR036396:Cyt_P450_sf,IPR017972:Cyt_P450_CS,IPR008072:Cyt_P450_E_CYP3A,IPR002403:Cyt_P450_E_grp-IV,IPR002402:Cyt_P450_E_grp-II,IPR002401:Cyt_P450_E_grp-I,IPR001128:Cyt_P450,												hsa05204:Chemical carcinogenesis - DNA adducts,hsa01100:Metabolic pathways,hsa00982:Drug metabolism - cytochrome P450,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00830:Retinol metabolism,hsa00140:Steroid hormone biosynthesis,												145500~Hypertension, salt-sensitive essential, susceptibility to,														TRANSMEM:Helical,BINDING:axial binding residue,
1391_s_at	cytochrome P450 family 4 subfamily A member 11(CYP4A11)	Homo sapiens		h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,												GO:2000193~positive regulation of fatty acid transport,GO:2000191~regulation of fatty acid transport,GO:1905954~positive regulation of lipid localization,GO:1905952~regulation of lipid localization,GO:1903793~positive regulation of anion transport,GO:1901616~organic hydroxy compound catabolic process,GO:1901615~organic hydroxy compound metabolic process,GO:1901571~fatty acid derivative transport,GO:1901570~fatty acid derivative biosynthetic process,GO:1901569~fatty acid derivative catabolic process,GO:1901568~fatty acid derivative metabolic process,GO:1901523~icosanoid catabolic process,GO:0098771~inorganic ion homeostasis,GO:0097267~omega-hydroxylase P450 pathway,GO:0072330~monocarboxylic acid biosynthetic process,GO:0072329~monocarboxylic acid catabolic process,GO:0072001~renal system development,GO:0071715~icosanoid transport,GO:0055080~cation homeostasis,GO:0055078~sodium ion homeostasis,GO:0055067~monovalent inorganic cation homeostasis,GO:0055065~metal ion homeostasis,GO:0051791~medium-chain fatty acid metabolic process,GO:0051050~positive regulation of transport,GO:0051049~regulation of transport,GO:0051047~positive regulation of secretion,GO:0051046~regulation of secretion,GO:0050891~multicellular organismal water homeostasis,GO:0050878~regulation of body fluid levels,GO:0050801~ion homeostasis,GO:0048878~chemical homeostasis,GO:0048871~multicellular organismal homeostasis,GO:0048252~lauric acid metabolic process,GO:0046942~carboxylic acid transport,GO:0046903~secretion,GO:0046717~acid secretion,GO:0046456~icosanoid biosynthetic process,GO:0046395~carboxylic acid catabolic process,GO:0046394~carboxylic acid biosynthetic process,GO:0044712~single-organism catabolic process,GO:0044283~small molecule biosynthetic process,GO:0044282~small molecule catabolic process,GO:0044255~cellular lipid metabolic process,GO:0044242~cellular lipid catabolic process,GO:0044070~regulation of anion transport,GO:0043651~linoleic acid metabolic process,GO:0043436~oxoacid metabolic process,GO:0043270~positive regulation of ion transport,GO:0043269~regulation of ion transport,GO:0042758~long-chain fatty acid catabolic process,GO:0042592~homeostatic process,GO:0036102~leukotriene B4 metabolic process,GO:0036101~leukotriene B4 catabolic process,GO:0036100~leukotriene catabolic process,GO:0033559~unsaturated fatty acid metabolic process,GO:0033036~macromolecule localization,GO:0032892~positive regulation of organic acid transport,GO:0032890~regulation of organic acid transport,GO:0032787~monocarboxylic acid metabolic process,GO:0032370~positive regulation of lipid transport,GO:0032368~regulation of lipid transport,GO:0032309~icosanoid secretion,GO:0032305~positive regulation of icosanoid secretion,GO:0032303~regulation of icosanoid secretion,GO:0031408~oxylipin biosynthetic process,GO:0031407~oxylipin metabolic process,GO:0030104~water homeostasis,GO:0019752~carboxylic acid metabolic process,GO:0019373~epoxygenase P450 pathway,GO:0019369~arachidonic acid metabolic process,GO:0016054~organic acid catabolic process,GO:0016053~organic acid biosynthetic process,GO:0016042~lipid catabolic process,GO:0015908~fatty acid transport,GO:0015849~organic acid transport,GO:0015718~monocarboxylic acid transport,GO:0015711~organic anion transport,GO:0010876~lipid localization,GO:0009062~fatty acid catabolic process,GO:0008610~lipid biosynthetic process,GO:0008217~regulation of blood pressure,GO:0008015~blood circulation,GO:0006869~lipid transport,GO:0006820~anion transport,GO:0006811~ion transport,GO:0006691~leukotriene metabolic process,GO:0006690~icosanoid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0006631~fatty acid metabolic process,GO:0006629~lipid metabolic process,GO:0006082~organic acid metabolic process,GO:0003095~pressure natriuresis,GO:0003091~renal water homeostasis,GO:0003073~regulation of systemic arterial blood pressure,GO:0003071~renal system process involved in regulation of systemic arterial blood pressure,GO:0003014~renal system process,GO:0003013~circulatory system process,GO:0003008~system process,GO:0001977~renal system process involved in regulation of blood volume,GO:0001822~kidney development,GO:0001676~long-chain fatty acid metabolic process,GO:0001655~urogenital system development,												GO:0098590~plasma membrane region,GO:0045177~apical part of cell,GO:0044432~endoplasmic reticulum part,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0016324~apical plasma membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005783~endoplasmic reticulum,												GO:1901363~heterocyclic compound binding,GO:0102033~cytochrome P450 fatty acid omega-hydroxylase activity,GO:0097159~organic cyclic compound binding,GO:0070330~aromatase activity,GO:0050051~leukotriene-B4 20-monooxygenase activity,GO:0046914~transition metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0020037~heme binding,GO:0018685~alkane 1-monooxygenase activity,GO:0016790~thiolester hydrolase activity,GO:0016713~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,GO:0016712~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,GO:0016709~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,GO:0008392~arachidonic acid epoxygenase activity,GO:0008391~arachidonic acid monooxygenase activity,GO:0005506~iron ion binding,GO:0004497~monooxygenase activity,												IPR036396:Cyt_P450_sf,IPR017972:Cyt_P450_CS,IPR002402:Cyt_P450_E_grp-II,IPR002401:Cyt_P450_E_grp-I,IPR001128:Cyt_P450,																TRANSMEM:Helical,REGION:Disordered,MUTAGEN:G->S: Loss of activity.,MUTAGEN:E->A: Loss of covalent heme binding.,COMPBIAS:Polar residues,BINDING:covalent,BINDING:axial binding residue,
31793_at	defensin alpha 1(DEFA1)	Homo sapiens
31506_s_at	defensin alpha 1(DEFA1)	Homo sapiens			GO:1901701~cellular response to oxygen-containing compound,GO:1901700~response to oxygen-containing compound,GO:0098542~defense response to other organism,GO:0072678~T cell migration,GO:0072676~lymphocyte migration,GO:0071495~cellular response to endogenous stimulus,GO:0071407~cellular response to organic cyclic compound,GO:0071396~cellular response to lipid,GO:0071383~cellular response to steroid hormone stimulus,GO:0071310~cellular response to organic substance,GO:0071222~cellular response to lipopolysaccharide,GO:0071219~cellular response to molecule of bacterial origin,GO:0071216~cellular response to biotic stimulus,GO:0070887~cellular response to chemical stimulus,GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide,GO:0060326~cell chemotaxis,GO:0051883~killing of cells in other organism involved in symbiotic interaction,GO:0051873~killing by host of symbiont cells,GO:0051852~disruption by host of symbiont cells,GO:0051851~modification by host of symbiont morphology or physiology,GO:0051818~disruption of cells of other organism involved in symbiotic interaction,GO:0051817~modification of morphology or physiology of other organism involved in symbiotic interaction,GO:0051707~response to other organism,GO:0051702~interaction with symbiont,GO:0051674~localization of cell,GO:0051673~membrane disruption in other organism,GO:0051607~defense response to virus,GO:0050900~leukocyte migration,GO:0050832~defense response to fungus,GO:0050830~defense response to Gram-positive bacterium,GO:0050829~defense response to Gram-negative bacterium,GO:0048870~cell motility,GO:0048545~response to steroid hormone,GO:0048247~lymphocyte chemotaxis,GO:0045087~innate immune response,GO:0044764~multi-organism cellular process,GO:0044419~interspecies interaction between organisms,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044364~disruption of cells of other organism,GO:0043401~steroid hormone mediated signaling pathway,GO:0043207~response to external biotic stimulus,GO:0042832~defense response to protozoan,GO:0042742~defense response to bacterium,GO:0042330~taxis,GO:0040011~locomotion,GO:0035821~modification of morphology or physiology of other organism,GO:0033993~response to lipid,GO:0032870~cellular response to hormone stimulus,GO:0032496~response to lipopolysaccharide,GO:0031640~killing of cells of other organism,GO:0030595~leukocyte chemotaxis,GO:0030522~intracellular receptor signaling pathway,GO:0030520~intracellular estrogen receptor signaling pathway,GO:0030518~intracellular steroid hormone receptor signaling pathway,GO:0019731~antibacterial humoral response,GO:0019730~antimicrobial humoral response,GO:0016477~cell migration,GO:0016032~viral process,GO:0014070~response to organic cyclic compound,GO:0010818~T cell chemotaxis,GO:0010033~response to organic substance,GO:0009755~hormone-mediated signaling pathway,GO:0009725~response to hormone,GO:0009719~response to endogenous stimulus,GO:0009620~response to fungus,GO:0009617~response to bacterium,GO:0009615~response to virus,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0006959~humoral immune response,GO:0006955~immune response,GO:0006952~defense response,GO:0006935~chemotaxis,GO:0006928~movement of cell or subcellular component,GO:0002385~mucosal immune response,GO:0002252~immune effector process,GO:0002251~organ or tissue specific immune response,GO:0002237~response to molecule of bacterial origin,GO:0002227~innate immune response in mucosa,GO:0001906~cell killing,GO:0001562~response to protozoan,												GO:1903561~extracellular vesicle,GO:0099503~secretory vesicle,GO:0070062~extracellular exosome,GO:0060205~cytoplasmic vesicle lumen,GO:0044437~vacuolar part,GO:0044433~cytoplasmic vesicle part,GO:0044431~Golgi apparatus part,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0042582~azurophil granule,GO:0035578~azurophil granule lumen,GO:0034774~secretory granule lumen,GO:0031983~vesicle lumen,GO:0030141~secretory granule,GO:0005796~Golgi lumen,GO:0005794~Golgi apparatus,GO:0005775~vacuolar lumen,GO:0005773~vacuole,GO:0005766~primary lysosome,GO:0005764~lysosome,GO:0005615~extracellular space,GO:0005576~extracellular region,GO:0000323~lytic vacuole,													IPR016327:Alpha-defensin,IPR006081:Alpha-defensin_C,IPR006080:Beta/alpha-defensin_C,IPR002366:Alpha-defensin_N,												hsa05202:Transcriptional misregulation in cancer,hsa05150:Staphylococcus aureus infection,hsa04621:NOD-like receptor signaling pathway,													PIRSF001875:Alpha-defensin,												SM01418:Defensin_propep,SM00048:DEFSN,												PEPTIDE:Neutrophil defensin 2,PEPTIDE:Neutrophil defensin 1,MUTAGEN:W->A: Almost complete loss of bactericidal activity.,
34546_at	defensin alpha 4(DEFA4)	Homo sapiens			GO:1901701~cellular response to oxygen-containing compound,GO:1901700~response to oxygen-containing compound,GO:0098542~defense response to other organism,GO:0071396~cellular response to lipid,GO:0071310~cellular response to organic substance,GO:0071222~cellular response to lipopolysaccharide,GO:0071219~cellular response to molecule of bacterial origin,GO:0071216~cellular response to biotic stimulus,GO:0070887~cellular response to chemical stimulus,GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide,GO:0051707~response to other organism,GO:0051673~membrane disruption in other organism,GO:0050832~defense response to fungus,GO:0050830~defense response to Gram-positive bacterium,GO:0050829~defense response to Gram-negative bacterium,GO:0045087~innate immune response,GO:0044364~disruption of cells of other organism,GO:0043207~response to external biotic stimulus,GO:0042742~defense response to bacterium,GO:0035821~modification of morphology or physiology of other organism,GO:0033993~response to lipid,GO:0032496~response to lipopolysaccharide,GO:0031640~killing of cells of other organism,GO:0019732~antifungal humoral response,GO:0019731~antibacterial humoral response,GO:0019730~antimicrobial humoral response,GO:0010033~response to organic substance,GO:0009620~response to fungus,GO:0009617~response to bacterium,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0006959~humoral immune response,GO:0006955~immune response,GO:0006952~defense response,GO:0002385~mucosal immune response,GO:0002251~organ or tissue specific immune response,GO:0002237~response to molecule of bacterial origin,GO:0002227~innate immune response in mucosa,GO:0001906~cell killing,												GO:0099503~secretory vesicle,GO:0060205~cytoplasmic vesicle lumen,GO:0044433~cytoplasmic vesicle part,GO:0044431~Golgi apparatus part,GO:0044421~extracellular region part,GO:0042582~azurophil granule,GO:0042581~specific granule,GO:0035580~specific granule lumen,GO:0034774~secretory granule lumen,GO:0031983~vesicle lumen,GO:0030141~secretory granule,GO:0030133~transport vesicle,GO:0005796~Golgi lumen,GO:0005794~Golgi apparatus,GO:0005773~vacuole,GO:0005766~primary lysosome,GO:0005764~lysosome,GO:0005615~extracellular space,GO:0005576~extracellular region,GO:0000323~lytic vacuole,												GO:0046983~protein dimerization activity,GO:0042803~protein homodimerization activity,GO:0042802~identical protein binding,												IPR016327:Alpha-defensin,IPR006081:Alpha-defensin_C,IPR006080:Beta/alpha-defensin_C,IPR002366:Alpha-defensin_N,												hsa05202:Transcriptional misregulation in cancer,hsa05150:Staphylococcus aureus infection,hsa04621:NOD-like receptor signaling pathway,													PIRSF001875:Alpha-defensin,												SM01418:Defensin_propep,SM00048:DEFSN,												PEPTIDE:Defensin alpha 4,MUTAGEN:Y->A: Slight decrease in antibacterial activity against E.coli and S.aureus.,MUTAGEN:R->A: Slight decrease in antibacterial activity against E.coli and S.aureus.,MUTAGEN:R->A: Decreased antibacterial activity against E.coli. Weakens interaction with B.anthracis lef and with HIV-1 gp120.,MUTAGEN:R->A: Decreased antibacterial activity against E.coli and S.aureus. Weakens interaction with B.anthracis lef and with HIV-1 gp120.,MUTAGEN:L->A: Slight decrease in antibacterial activity against E.coli.,MUTAGEN:F->A: Impaired homodimerization. Decreased antibacterial activity against S.aureus. Disrupts interaction with B.anthracis lef and with HIV-1 gp120.,MUTAGEN:F->A: Decreased antibacterial activity against S.aureus.,MUTAGEN:C->A: Impairs bactericidal activity against E.coli and S.aureus; when associated with Ala-67, Ala-72, Ala-82, Ala-92 and Ala-93.,MUTAGEN:C->A: Impairs bactericidal activity against E.coli and S.aureus; when associated with Ala-65, Ala-72, Ala-82, Ala-92 and Ala-93.,MUTAGEN:C->A: Impairs bactericidal activity against E.coli and S.aureus; when associated with Ala-65, Ala-67, Ala-82, Ala-92 and Ala-93.,MUTAGEN:C->A: Impairs bactericidal activity against E.coli and S.aureus; when associated with Ala-65, Ala-67, Ala-72, Ala-92 and Ala-93.,MUTAGEN:C->A: Impairs bactericidal activity against E.coli and S.aureus; when associated with Ala-65, Ala-67, Ala-72, Ala-82 and Ala-93.,MUTAGEN:C->A: Impairs bactericidal activity against E.coli and S.aureus; when associated with Ala-65, Ala-67, Ala-72, Ala-82 and Ala-92.,
34623_at	defensin alpha 5(DEFA5)	Homo sapiens			GO:1905710~positive regulation of membrane permeability,GO:1901701~cellular response to oxygen-containing compound,GO:1901700~response to oxygen-containing compound,GO:0098542~defense response to other organism,GO:0090559~regulation of membrane permeability,GO:0071822~protein complex subunit organization,GO:0071396~cellular response to lipid,GO:0071310~cellular response to organic substance,GO:0071222~cellular response to lipopolysaccharide,GO:0071219~cellular response to molecule of bacterial origin,GO:0071216~cellular response to biotic stimulus,GO:0070887~cellular response to chemical stimulus,GO:0070271~protein complex biogenesis,GO:0065003~macromolecular complex assembly,GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide,GO:0051883~killing of cells in other organism involved in symbiotic interaction,GO:0051873~killing by host of symbiont cells,GO:0051852~disruption by host of symbiont cells,GO:0051851~modification by host of symbiont morphology or physiology,GO:0051818~disruption of cells of other organism involved in symbiotic interaction,GO:0051817~modification of morphology or physiology of other organism involved in symbiotic interaction,GO:0051707~response to other organism,GO:0051702~interaction with symbiont,GO:0051673~membrane disruption in other organism,GO:0051289~protein homotetramerization,GO:0051262~protein tetramerization,GO:0051260~protein homooligomerization,GO:0051259~protein oligomerization,GO:0051240~positive regulation of multicellular organismal process,GO:0050832~defense response to fungus,GO:0050830~defense response to Gram-positive bacterium,GO:0050829~defense response to Gram-negative bacterium,GO:0045087~innate immune response,GO:0044419~interspecies interaction between organisms,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044364~disruption of cells of other organism,GO:0044085~cellular component biogenesis,GO:0043933~macromolecular complex subunit organization,GO:0043207~response to external biotic stimulus,GO:0042742~defense response to bacterium,GO:0035821~modification of morphology or physiology of other organism,GO:0033993~response to lipid,GO:0032757~positive regulation of interleukin-8 production,GO:0032677~regulation of interleukin-8 production,GO:0032637~interleukin-8 production,GO:0032496~response to lipopolysaccharide,GO:0031640~killing of cells of other organism,GO:0022607~cellular component assembly,GO:0019731~antibacterial humoral response,GO:0019730~antimicrobial humoral response,GO:0010033~response to organic substance,GO:0009620~response to fungus,GO:0009617~response to bacterium,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0006959~humoral immune response,GO:0006955~immune response,GO:0006952~defense response,GO:0006461~protein complex assembly,GO:0002385~mucosal immune response,GO:0002251~organ or tissue specific immune response,GO:0002237~response to molecule of bacterial origin,GO:0002227~innate immune response in mucosa,GO:0001906~cell killing,GO:0001819~positive regulation of cytokine production,GO:0001817~regulation of cytokine production,GO:0001816~cytokine production,												GO:0099503~secretory vesicle,GO:0060205~cytoplasmic vesicle lumen,GO:0044433~cytoplasmic vesicle part,GO:0044431~Golgi apparatus part,GO:0044421~extracellular region part,GO:0034774~secretory granule lumen,GO:0031983~vesicle lumen,GO:0030496~midbody,GO:0030141~secretory granule,GO:0030133~transport vesicle,GO:0005796~Golgi lumen,GO:0005794~Golgi apparatus,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:0046983~protein dimerization activity,GO:0042803~protein homodimerization activity,GO:0042802~identical protein binding,												IPR016327:Alpha-defensin,IPR006081:Alpha-defensin_C,IPR006080:Beta/alpha-defensin_C,IPR002366:Alpha-defensin_N,												hsa05202:Transcriptional misregulation in cancer,hsa05150:Staphylococcus aureus infection,hsa04621:NOD-like receptor signaling pathway,													PIRSF001875:Alpha-defensin,												SM01418:Defensin_propep,SM00048:DEFSN,												PEPTIDE:HD5(63-94),PEPTIDE:HD5(56-94),PEPTIDE:HD5(29-94),PEPTIDE:HD5(23-94),PEPTIDE:Defensin alpha 5,MUTAGEN:Y->A: Disrupts homodimer-formation. Reduced interaction with B.antracis lef/lethal factor and reduced killing of S.aureus. Reduced enhancement of S.flexneri infection.,MUTAGEN:T->R: Enhanced antibacterial activity against both E.coli and S.aureus. Enhanced membrane binding and membrane disintegration abilities, as well as further increased antibacterial activity; when associated with R-83.,MUTAGEN:S->R: Enhanced antibacterial activity against both E.coli and S.aureus.,MUTAGEN:S->A: Increased interaction with B.antracis lef/lethal factor.,MUTAGEN:R->K: Impairs antimicrobial activity against S. aureus; when associated with K-90. Reduced induction of IL-8 secretion; when associated with K-90.,MUTAGEN:R->K: Impairs antimicrobial activity against S. aureus; when associated with K-71. Reduced induction of IL-8 secretion; when associated with K-71.,MUTAGEN:R->K: Does not impair antimicrobial activity against E.coli, E.aerogenes, S.aureus and B.cereus; when associated with K-94. Reduced induction of IL-8 secretion; when associated with K-90.,MUTAGEN:R->K: Does not impair antimicrobial activity against E.coli, E.aerogenes, S.aureus and B.cereus; when associated with K-75. Reduced induction of IL-8 secretion; when associated with K-75.,MUTAGEN:R->A: Reduced killing of S.aureus and E.coli. Impairs antimicrobial activity against E.coli, E.aerogenes, S.aureus and B.cereus; when associated with A-90. Reduced induction of IL-8 secretion; when associated with A-90.,MUTAGEN:R->A: Impairs antimicrobial activity against E.coli, E.aerogenes, S.aureus and B.cereus; when associated with A-94. Reduced induction of IL-8 secretion; when associated with A-94.,MUTAGEN:R->A: Impairs antimicrobial activity against E.coli, E.aerogenes, S.aureus and B.cereus; when associated with A-75. Reduced induction of IL-8 secretion; when associated with A-75.,MUTAGEN:R->A: Does not disrupt homodimer-formation. Reduced enhancement of S.flexneri infection. Impairs antimicrobial activity against E.coli, E.aerogenes, S.aureus and B.cereus; when associated with A-71. Reduced induction of IL-8 secretion; when associated with A-71.,MUTAGEN:L->A: Reduced interaction with B.antracis lef/lethal factor. Reduced enhancement of S.flexneri infection.,MUTAGEN:L->A: Reduced interaction with B.antracis lef/lethal factor and decreased bactericidal activity against E.coli and S.aureus. Reduced enhancement of S.flexneri infection.,MUTAGEN:G->R: Enhanced antibacterial activity against both E.coli and S.aureus.,MUTAGEN:E->R: Enhanced antibacterial activity against both E.coli and S.aureus. Disrupts homodimerization. Enhanced membrane binding and membrane disintegration abilities, as well further increased antibacterial activity; when associated with R-69.,MUTAGEN:C->S: Prohibits tetramer formation; when associated with S-93.,MUTAGEN:C->S: Prohibits tetramer formation; when associated with S-92.,MUTAGEN:C->S: Prohibits tetramer formation; when associated with S-72.,MUTAGEN:C->S: Prohibits tetramer formation; when associated with S-67.,
40186_at	dual specificity phosphatase 9(DUSP9)	Homo sapiens		h_dspPathway:Regulation of MAP Kinase Pathways Through Dual Specificity Phosphatases,												GO:1902532~negative regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:0070371~ERK1 and ERK2 cascade,GO:0051403~stress-activated MAPK cascade,GO:0051248~negative regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0048585~negative regulation of response to stimulus,GO:0045936~negative regulation of phosphate metabolic process,GO:0043409~negative regulation of MAPK cascade,GO:0043408~regulation of MAPK cascade,GO:0042326~negative regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0036211~protein modification process,GO:0035556~intracellular signal transduction,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0033554~cellular response to stress,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0031400~negative regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031324~negative regulation of cellular metabolic process,GO:0031098~stress-activated protein kinase signaling cascade,GO:0023057~negative regulation of signaling,GO:0023051~regulation of signaling,GO:0023014~signal transduction by protein phosphorylation,GO:0019220~regulation of phosphate metabolic process,GO:0016311~dephosphorylation,GO:0016310~phosphorylation,GO:0010648~negative regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010563~negative regulation of phosphorus metabolic process,GO:0009968~negative regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009892~negative regulation of metabolic process,GO:0007254~JNK cascade,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006470~protein dephosphorylation,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0001933~negative regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,GO:0000165~MAPK cascade,												GO:0005829~cytosol,												GO:0042578~phosphoric ester hydrolase activity,GO:0033550~MAP kinase tyrosine phosphatase activity,GO:0033549~MAP kinase phosphatase activity,GO:0017018~myosin phosphatase activity,GO:0017017~MAP kinase tyrosine/serine/threonine phosphatase activity,GO:0016791~phosphatase activity,GO:0008330~protein tyrosine/threonine phosphatase activity,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0004721~phosphoprotein phosphatase activity,												IPR036873:Rhodanese-like_dom_sf,IPR029021:Prot-tyrosine_phosphatase-like,IPR020422:TYR_PHOSPHATASE_DUAL_dom,IPR008343:MKP,IPR001763:Rhodanese-like_dom,IPR000387:Tyr_Pase_dom,IPR000340:Dual-sp_phosphatase_cat-dom,												hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04010:MAPK signaling pathway,													PIRSF000939:MAPK_Ptase,												SM00450:RHOD,SM00195:DSPc,												REGION:Disordered,DOMAIN:Tyrosine-protein phosphatase,DOMAIN:Tyrosine specific protein phosphatases,DOMAIN:Rhodanese,COMPBIAS:Polar residues,ACT_SITE:Phosphocysteine intermediate,
34972_s_at	dynein axonemal heavy chain 17(DNAH17)	Homo sapiens			GO:1902589~single-organism organelle organization,GO:0071822~protein complex subunit organization,GO:0070925~organelle assembly,GO:0070286~axonemal dynein complex assembly,GO:0070271~protein complex biogenesis,GO:0065003~macromolecular complex assembly,GO:0060294~cilium movement involved in cell motility,GO:0060285~cilium-dependent cell motility,GO:0060271~cilium assembly,GO:0051674~localization of cell,GO:0048870~cell motility,GO:0044782~cilium organization,GO:0044085~cellular component biogenesis,GO:0043933~macromolecular complex subunit organization,GO:0043623~cellular protein complex assembly,GO:0040011~locomotion,GO:0036158~outer dynein arm assembly,GO:0035082~axoneme assembly,GO:0034622~cellular macromolecular complex assembly,GO:0030031~cell projection assembly,GO:0030030~cell projection organization,GO:0022607~cellular component assembly,GO:0007018~microtubule-based movement,GO:0007017~microtubule-based process,GO:0007010~cytoskeleton organization,GO:0006928~movement of cell or subcellular component,GO:0006461~protein complex assembly,GO:0003341~cilium movement,GO:0001578~microtubule bundle formation,GO:0001539~cilium or flagellum-dependent cell motility,GO:0000226~microtubule cytoskeleton organization,												GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0099081~supramolecular polymer,GO:0099080~supramolecular complex,GO:0097729~9+2 motile cilium,GO:0097223~sperm part,GO:0097014~ciliary plasm,GO:0044447~axoneme part,GO:0044441~ciliary part,GO:0036157~outer dynein arm,GO:0036126~sperm flagellum,GO:0031514~motile cilium,GO:0030286~dynein complex,GO:0015630~microtubule cytoskeleton,GO:0005930~axoneme,GO:0005929~cilium,GO:0005875~microtubule associated complex,GO:0005874~microtubule,GO:0005858~axonemal dynein complex,												GO:1990939~ATP-dependent microtubule motor activity,GO:1901363~heterocyclic compound binding,GO:1901265~nucleoside phosphate binding,GO:0097367~carbohydrate derivative binding,GO:0097159~organic cyclic compound binding,GO:0051959~dynein light intermediate chain binding,GO:0045505~dynein intermediate chain binding,GO:0043168~anion binding,GO:0043167~ion binding,GO:0036094~small molecule binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0017111~nucleoside-triphosphatase activity,GO:0017076~purine nucleotide binding,GO:0016887~ATPase activity,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016462~pyrophosphatase activity,GO:0008569~ATP-dependent microtubule motor activity, minus-end-directed,GO:0005524~ATP binding,GO:0003777~microtubule motor activity,GO:0003774~motor activity,GO:0000166~nucleotide binding,												IPR043160:Dynein_C_barrel,IPR043157:Dynein_AAA1S,IPR042228:Dynein_linker_3,IPR042222:Dynein_2_N,IPR042219:AAA_lid_11_sf,IPR041658:AAA_lid_11,IPR041589:DNAH3_AAA_lid_1,IPR041466:Dynein_AAA5_ext,IPR041228:Dynein_C,IPR035706:AAA_9,IPR035699:AAA_6,IPR027417:P-loop_NTPase,IPR026983:DHC_fam,IPR024743:Dynein_HC_stalk,IPR024317:Dynein_heavy_chain_D4_dom,IPR013602:Dynein_heavy_linker,IPR013594:Dynein_heavy_tail,IPR004273:Dynein_heavy_D6_P-loop,												hsa05022:Pathways of neurodegeneration - multiple diseases,hsa05016:Huntington disease,hsa05014:Amyotrophic lateral sclerosis,hsa04814:Motor proteins,												618643~Spermatogenic failure 39,														REPEAT:TPR 3,REPEAT:TPR 2,REPEAT:TPR 1,REGION:Stem,REGION:Stalk,REGION:AAA 6,REGION:AAA 5,REGION:AAA 4,REGION:AAA 3,REGION:AAA 2,REGION:AAA 1,DOMAIN:Dynein heavy chain region D6 P-loop,DOMAIN:Dynein heavy chain coiled coil stalk,DOMAIN:Dynein heavy chain C-terminal,DOMAIN:Dynein heavy chain ATP-binding dynein motor region,DOMAIN:Dynein heavy chain AAA module D4,DOMAIN:Dynein heavy chain AAA lid,
37096_at	elastase, neutrophil expressed(ELANE)	Homo sapiens		h_pepiPathway:Proepithelin Conversion to Epithelin and Wound Repair Control,												GO:2001141~regulation of RNA biosynthetic process,GO:2000147~positive regulation of cell motility,GO:2000145~regulation of cell motility,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1904996~positive regulation of leukocyte adhesion to vascular endothelial cell,GO:1904994~regulation of leukocyte adhesion to vascular endothelial cell,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903238~positive regulation of leukocyte tethering or rolling,GO:1903236~regulation of leukocyte tethering or rolling,GO:1903039~positive regulation of leukocyte cell-cell adhesion,GO:1903037~regulation of leukocyte cell-cell adhesion,GO:1902679~negative regulation of RNA biosynthetic process,GO:1902533~positive regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:1901700~response to oxygen-containing compound,GO:1901566~organonitrogen compound biosynthetic process,GO:0098771~inorganic ion homeostasis,GO:0098609~cell-cell adhesion,GO:0098602~single organism cell adhesion,GO:0098542~defense response to other organism,GO:0097659~nucleic acid-templated transcription,GO:0080134~regulation of response to stress,GO:0072507~divalent inorganic cation homeostasis,GO:0072503~cellular divalent inorganic cation homeostasis,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:0071900~regulation of protein serine/threonine kinase activity,GO:0070947~neutrophil mediated killing of fungus,GO:0070945~neutrophil mediated killing of gram-negative bacterium,GO:0070944~neutrophil mediated killing of bacterium,GO:0070943~neutrophil mediated killing of symbiont cell,GO:0070942~neutrophil mediated cytotoxicity,GO:0070269~pyroptosis,GO:0065009~regulation of molecular function,GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide,GO:0061756~leukocyte adhesion to vascular endothelial cell,GO:0055082~cellular chemical homeostasis,GO:0055080~cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055065~metal ion homeostasis,GO:0051883~killing of cells in other organism involved in symbiotic interaction,GO:0051873~killing by host of symbiont cells,GO:0051852~disruption by host of symbiont cells,GO:0051851~modification by host of symbiont morphology or physiology,GO:0051818~disruption of cells of other organism involved in symbiotic interaction,GO:0051817~modification of morphology or physiology of other organism involved in symbiotic interaction,GO:0051707~response to other organism,GO:0051702~interaction with symbiont,GO:0051674~localization of cell,GO:0051347~positive regulation of transferase activity,GO:0051338~regulation of transferase activity,GO:0051272~positive regulation of cellular component movement,GO:0051270~regulation of cellular component movement,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051241~negative regulation of multicellular organismal process,GO:0051240~positive regulation of multicellular organismal process,GO:0051174~regulation of phosphorus metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0050922~negative regulation of chemotaxis,GO:0050920~regulation of chemotaxis,GO:0050901~leukocyte tethering or rolling,GO:0050900~leukocyte migration,GO:0050832~defense response to fungus,GO:0050829~defense response to Gram-negative bacterium,GO:0050801~ion homeostasis,GO:0050790~regulation of catalytic activity,GO:0050778~positive regulation of immune response,GO:0050776~regulation of immune response,GO:0050728~negative regulation of inflammatory response,GO:0050727~regulation of inflammatory response,GO:0048878~chemical homeostasis,GO:0048870~cell motility,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048659~smooth muscle cell proliferation,GO:0048585~negative regulation of response to stimulus,GO:0048584~positive regulation of response to stimulus,GO:0045937~positive regulation of phosphate metabolic process,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045860~positive regulation of protein kinase activity,GO:0045859~regulation of protein kinase activity,GO:0045785~positive regulation of cell adhesion,GO:0045123~cellular extravasation,GO:0044419~interspecies interaction between organisms,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044364~disruption of cells of other organism,GO:0044093~positive regulation of molecular function,GO:0043604~amide biosynthetic process,GO:0043603~cellular amide metabolic process,GO:0043549~regulation of kinase activity,GO:0043410~positive regulation of MAPK cascade,GO:0043408~regulation of MAPK cascade,GO:0043406~positive regulation of MAP kinase activity,GO:0043405~regulation of MAP kinase activity,GO:0043207~response to external biotic stimulus,GO:0043085~positive regulation of catalytic activity,GO:0043062~extracellular structure organization,GO:0043043~peptide biosynthetic process,GO:0042742~defense response to bacterium,GO:0042592~homeostatic process,GO:0042330~taxis,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0042127~regulation of cell proliferation,GO:0040017~positive regulation of locomotion,GO:0040013~negative regulation of locomotion,GO:0040012~regulation of locomotion,GO:0040011~locomotion,GO:0036211~protein modification process,GO:0035821~modification of morphology or physiology of other organism,GO:0035556~intracellular signal transduction,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0033993~response to lipid,GO:0033674~positive regulation of kinase activity,GO:0033002~muscle cell proliferation,GO:0032774~RNA biosynthetic process,GO:0032757~positive regulation of interleukin-8 production,GO:0032717~negative regulation of interleukin-8 production,GO:0032682~negative regulation of chemokine production,GO:0032677~regulation of interleukin-8 production,GO:0032642~regulation of chemokine production,GO:0032637~interleukin-8 production,GO:0032602~chemokine production,GO:0032496~response to lipopolysaccharide,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032102~negative regulation of response to external stimulus,GO:0032101~regulation of response to external stimulus,GO:0031640~killing of cells of other organism,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031348~negative regulation of defense response,GO:0031347~regulation of defense response,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031324~negative regulation of cellular metabolic process,GO:0030335~positive regulation of cell migration,GO:0030334~regulation of cell migration,GO:0030198~extracellular matrix organization,GO:0030163~protein catabolic process,GO:0030155~regulation of cell adhesion,GO:0030003~cellular cation homeostasis,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0023014~signal transduction by protein phosphorylation,GO:0022617~extracellular matrix disassembly,GO:0022610~biological adhesion,GO:0022411~cellular component disassembly,GO:0022409~positive regulation of cell-cell adhesion,GO:0022407~regulation of cell-cell adhesion,GO:0019731~antibacterial humoral response,GO:0019730~antimicrobial humoral response,GO:0019725~cellular homeostasis,GO:0019438~aromatic compound biosynthetic process,GO:0019220~regulation of phosphate metabolic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016477~cell migration,GO:0016337~single organismal cell-cell adhesion,GO:0016310~phosphorylation,GO:0016192~vesicle-mediated transport,GO:0016070~RNA metabolic process,GO:0012501~programmed cell death,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010629~negative regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010033~response to organic substance,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0009628~response to abiotic stimulus,GO:0009620~response to fungus,GO:0009617~response to bacterium,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0009416~response to light stimulus,GO:0009411~response to UV,GO:0009314~response to radiation,GO:0009057~macromolecule catabolic process,GO:0008284~positive regulation of cell proliferation,GO:0008283~cell proliferation,GO:0008219~cell death,GO:0007159~leukocyte cell-cell adhesion,GO:0007155~cell adhesion,GO:0006959~humoral immune response,GO:0006955~immune response,GO:0006954~inflammatory response,GO:0006952~defense response,GO:0006935~chemotaxis,GO:0006928~movement of cell or subcellular component,GO:0006909~phagocytosis,GO:0006897~endocytosis,GO:0006875~cellular metal ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006873~cellular ion homeostasis,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006518~peptide metabolic process,GO:0006508~proteolysis,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0006366~transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0002812~biosynthetic process of antibacterial peptides active against Gram-negative bacteria,GO:0002780~antibacterial peptide biosynthetic process,GO:0002778~antibacterial peptide production,GO:0002777~antimicrobial peptide biosynthetic process,GO:0002775~antimicrobial peptide production,GO:0002693~positive regulation of cellular extravasation,GO:0002691~regulation of cellular extravasation,GO:0002687~positive regulation of leukocyte migration,GO:0002685~regulation of leukocyte migration,GO:0002684~positive regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002526~acute inflammatory response,GO:0002523~leukocyte migration involved in inflammatory response,GO:0002446~neutrophil mediated immunity,GO:0002444~myeloid leukocyte mediated immunity,GO:0002443~leukocyte mediated immunity,GO:0002440~production of molecular mediator of immune response,GO:0002438~acute inflammatory response to antigenic stimulus,GO:0002437~inflammatory response to antigenic stimulus,GO:0002252~immune effector process,GO:0002237~response to molecule of bacterial origin,GO:0001934~positive regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,GO:0001909~leukocyte mediated cytotoxicity,GO:0001906~cell killing,GO:0001878~response to yeast,GO:0001819~positive regulation of cytokine production,GO:0001818~negative regulation of cytokine production,GO:0001817~regulation of cytokine production,GO:0001816~cytokine production,GO:0000165~MAPK cascade,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,												GO:1903561~extracellular vesicle,GO:0099503~secretory vesicle,GO:0070062~extracellular exosome,GO:0060205~cytoplasmic vesicle lumen,GO:0045335~phagocytic vesicle,GO:0044437~vacuolar part,GO:0044433~cytoplasmic vesicle part,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0042582~azurophil granule,GO:0042581~specific granule,GO:0035580~specific granule lumen,GO:0035578~azurophil granule lumen,GO:0034774~secretory granule lumen,GO:0031983~vesicle lumen,GO:0030141~secretory granule,GO:0030139~endocytic vesicle,GO:0017053~transcriptional repressor complex,GO:0009986~cell surface,GO:0005829~cytosol,GO:0005775~vacuolar lumen,GO:0005773~vacuole,GO:0005766~primary lysosome,GO:0005764~lysosome,GO:0005615~extracellular space,GO:0005576~extracellular region,GO:0000323~lytic vacuole,												GO:1901681~sulfur compound binding,GO:0097367~carbohydrate derivative binding,GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0043168~anion binding,GO:0043167~ion binding,GO:0019955~cytokine binding,GO:0019899~enzyme binding,GO:0017171~serine hydrolase activity,GO:0008236~serine-type peptidase activity,GO:0008233~peptidase activity,GO:0008201~heparin binding,GO:0005539~glycosaminoglycan binding,GO:0004252~serine-type endopeptidase activity,GO:0004175~endopeptidase activity,GO:0003714~transcription corepressor activity,GO:0003712~transcription cofactor activity,GO:0002020~protease binding,GO:0000989~transcription factor activity, transcription factor binding,GO:0000988~transcription factor activity, protein binding,												IPR043504:Peptidase_S1_PA_chymotrypsin,IPR033116:TRYPSIN_SER,IPR018114:TRYPSIN_HIS,IPR009003:Peptidase_S1_PA,IPR001314:Peptidase_S1A,IPR001254:Trypsin_dom,												hsa05322:Systemic lupus erythematosus,hsa05202:Transcriptional misregulation in cancer,hsa04613:Neutrophil extracellular trap formation,												202700~Neutropenia, severe congenital 1, autosomal dominant,162800~Neutropenia, cyclic,													SM00020:Tryp_SPc,												DOMAIN:Peptidase S1,CARBOHYD:N-linked (GlcNAc...) asparagine,ACT_SITE:Charge relay system,
31621_s_at	elastin(ELN)	Homo sapiens			GO:1905314~semi-lunar valve development,GO:1902903~regulation of supramolecular fiber organization,GO:1902589~single-organism organelle organization,GO:0097435~supramolecular fiber organization,GO:0090066~regulation of anatomical structure size,GO:0085029~extracellular matrix assembly,GO:0072359~circulatory system development,GO:0071822~protein complex subunit organization,GO:0070271~protein complex biogenesis,GO:0065003~macromolecular complex assembly,GO:0061572~actin filament bundle organization,GO:0061061~muscle structure development,GO:0060538~skeletal muscle organ development,GO:0060537~muscle tissue development,GO:0051493~regulation of cytoskeleton organization,GO:0051258~protein polymerization,GO:0051128~regulation of cellular component organization,GO:0051017~actin filament bundle assembly,GO:0048660~regulation of smooth muscle cell proliferation,GO:0044087~regulation of cellular component biogenesis,GO:0044085~cellular component biogenesis,GO:0043933~macromolecular complex subunit organization,GO:0043623~cellular protein complex assembly,GO:0043254~regulation of protein complex assembly,GO:0043149~stress fiber assembly,GO:0043062~extracellular structure organization,GO:0042127~regulation of cell proliferation,GO:0034622~cellular macromolecular complex assembly,GO:0033043~regulation of organelle organization,GO:0032970~regulation of actin filament-based process,GO:0032956~regulation of actin cytoskeleton organization,GO:0032535~regulation of cellular component size,GO:0032271~regulation of protein polymerization,GO:0031032~actomyosin structure organization,GO:0030833~regulation of actin filament polymerization,GO:0030832~regulation of actin filament length,GO:0030198~extracellular matrix organization,GO:0030038~contractile actin filament bundle assembly,GO:0030036~actin cytoskeleton organization,GO:0030029~actin filament-based process,GO:0022607~cellular component assembly,GO:0014706~striated muscle tissue development,GO:0009887~animal organ morphogenesis,GO:0008283~cell proliferation,GO:0008154~actin polymerization or depolymerization,GO:0008064~regulation of actin polymerization or depolymerization,GO:0008015~blood circulation,GO:0007585~respiratory gaseous exchange,GO:0007519~skeletal muscle tissue development,GO:0007517~muscle organ development,GO:0007507~heart development,GO:0007015~actin filament organization,GO:0007010~cytoskeleton organization,GO:0006461~protein complex assembly,GO:0003180~aortic valve morphogenesis,GO:0003179~heart valve morphogenesis,GO:0003176~aortic valve development,GO:0003170~heart valve development,GO:0003151~outflow tract morphogenesis,GO:0003013~circulatory system process,GO:0003008~system process,GO:0003007~heart morphogenesis,												GO:0071953~elastic fiber,GO:0044421~extracellular region part,GO:0044420~extracellular matrix component,GO:0031012~extracellular matrix,GO:0005576~extracellular region,												GO:0097493~structural molecule activity conferring elasticity,GO:0050840~extracellular matrix binding,GO:0030023~extracellular matrix constituent conferring elasticity,GO:0005201~extracellular matrix structural constituent,GO:0005198~structural molecule activity,												IPR003979:Tropoelastin,												hsa04974:Protein digestion and absorption,												185500~Supravalvar aortic stenosis,123700~Cutis laxa, autosomal dominant,														REGION:Disordered,COMPBIAS:Polar residues,
1901_s_at	erb-b2 receptor tyrosine kinase 2(ERBB2)	Homo sapiens		h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,												GO:2001141~regulation of RNA biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1990778~protein localization to cell periphery,GO:1905477~positive regulation of protein localization to membrane,GO:1905475~regulation of protein localization to membrane,GO:1904951~positive regulation of establishment of protein localization,GO:1903829~positive regulation of cellular protein localization,GO:1903827~regulation of cellular protein localization,GO:1903707~negative regulation of hemopoiesis,GO:1903706~regulation of hemopoiesis,GO:1903539~protein localization to postsynaptic membrane,GO:1903533~regulation of protein targeting,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903038~negative regulation of leukocyte cell-cell adhesion,GO:1903037~regulation of leukocyte cell-cell adhesion,GO:1902680~positive regulation of RNA biosynthetic process,GO:1902533~positive regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:1902106~negative regulation of leukocyte differentiation,GO:1902105~regulation of leukocyte differentiation,GO:1901566~organonitrogen compound biosynthetic process,GO:1901342~regulation of vasculature development,GO:0099645~neurotransmitter receptor localization to postsynaptic specialization membrane,GO:0099633~protein localization to postsynaptic specialization membrane,GO:0099072~regulation of postsynaptic specialization membrane neurotransmitter receptor levels,GO:0098609~cell-cell adhesion,GO:0098602~single organism cell adhesion,GO:0097659~nucleic acid-templated transcription,GO:0097485~neuron projection guidance,GO:0090316~positive regulation of intracellular protein transport,GO:0090314~positive regulation of protein targeting to membrane,GO:0090313~regulation of protein targeting to membrane,GO:0090150~establishment of protein localization to membrane,GO:0090087~regulation of peptide transport,GO:0072657~protein localization to membrane,GO:0072359~circulatory system development,GO:0072358~cardiovascular system development,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:0071900~regulation of protein serine/threonine kinase activity,GO:0071705~nitrogen compound transport,GO:0071526~semaphorin-plexin signaling pathway,GO:0071495~cellular response to endogenous stimulus,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0071363~cellular response to growth factor stimulus,GO:0071310~cellular response to organic substance,GO:0070887~cellular response to chemical stimulus,GO:0070849~response to epidermal growth factor,GO:0070848~response to growth factor,GO:0070727~cellular macromolecule localization,GO:0070664~negative regulation of leukocyte proliferation,GO:0070663~regulation of leukocyte proliferation,GO:0070661~leukocyte proliferation,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0070201~regulation of establishment of protein localization,GO:0065009~regulation of molecular function,GO:0061564~axon development,GO:0060548~negative regulation of cell death,GO:0060341~regulation of cellular localization,GO:0051649~establishment of localization in cell,GO:0051641~cellular localization,GO:0051347~positive regulation of transferase activity,GO:0051338~regulation of transferase activity,GO:0051254~positive regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051250~negative regulation of lymphocyte activation,GO:0051249~regulation of lymphocyte activation,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051241~negative regulation of multicellular organismal process,GO:0051223~regulation of protein transport,GO:0051222~positive regulation of protein transport,GO:0051174~regulation of phosphorus metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051128~regulation of cellular component organization,GO:0051093~negative regulation of developmental process,GO:0051057~positive regulation of small GTPase mediated signal transduction,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0051050~positive regulation of transport,GO:0051049~regulation of transport,GO:0050868~negative regulation of T cell activation,GO:0050866~negative regulation of cell activation,GO:0050865~regulation of cell activation,GO:0050863~regulation of T cell activation,GO:0050808~synapse organization,GO:0050790~regulation of catalytic activity,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0050673~epithelial cell proliferation,GO:0050672~negative regulation of lymphocyte proliferation,GO:0050670~regulation of lymphocyte proliferation,GO:0048858~cell projection morphogenesis,GO:0048812~neuron projection morphogenesis,GO:0048709~oligodendrocyte differentiation,GO:0048699~generation of neurons,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048666~neuron development,GO:0048584~positive regulation of response to stimulus,GO:0048534~hematopoietic or lymphoid organ development,GO:0048468~cell development,GO:0046907~intracellular transport,GO:0046651~lymphocyte proliferation,GO:0046649~lymphocyte activation,GO:0046579~positive regulation of Ras protein signal transduction,GO:0046578~regulation of Ras protein signal transduction,GO:0045943~positive regulation of transcription from RNA polymerase I promoter,GO:0045937~positive regulation of phosphate metabolic process,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045927~positive regulation of growth,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045860~positive regulation of protein kinase activity,GO:0045859~regulation of protein kinase activity,GO:0045785~positive regulation of cell adhesion,GO:0045765~regulation of angiogenesis,GO:0045727~positive regulation of translation,GO:0045620~negative regulation of lymphocyte differentiation,GO:0045619~regulation of lymphocyte differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0045581~negative regulation of T cell differentiation,GO:0045580~regulation of T cell differentiation,GO:0045321~leukocyte activation,GO:0045184~establishment of protein localization,GO:0044093~positive regulation of molecular function,GO:0043604~amide biosynthetic process,GO:0043603~cellular amide metabolic process,GO:0043549~regulation of kinase activity,GO:0043491~protein kinase B signaling,GO:0043410~positive regulation of MAPK cascade,GO:0043408~regulation of MAPK cascade,GO:0043406~positive regulation of MAP kinase activity,GO:0043405~regulation of MAP kinase activity,GO:0043085~positive regulation of catalytic activity,GO:0043069~negative regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptotic process,GO:0043043~peptide biosynthetic process,GO:0042981~regulation of apoptotic process,GO:0042886~amide transport,GO:0042552~myelination,GO:0042330~taxis,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0042130~negative regulation of T cell proliferation,GO:0042129~regulation of T cell proliferation,GO:0042127~regulation of cell proliferation,GO:0042110~T cell activation,GO:0042098~T cell proliferation,GO:0042063~gliogenesis,GO:0042060~wound healing,GO:0040011~locomotion,GO:0040008~regulation of growth,GO:0040007~growth,GO:0038135~ERBB2-ERBB4 signaling pathway,GO:0038134~ERBB2-EGFR signaling pathway,GO:0038133~ERBB2-ERBB3 signaling pathway,GO:0038130~ERBB4 signaling pathway,GO:0038129~ERBB3 signaling pathway,GO:0038128~ERBB2 signaling pathway,GO:0038127~ERBB signaling pathway,GO:0036211~protein modification process,GO:0035556~intracellular signal transduction,GO:0035418~protein localization to synapse,GO:0035025~positive regulation of Rho protein signal transduction,GO:0035023~regulation of Rho protein signal transduction,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034613~cellular protein localization,GO:0034250~positive regulation of cellular amide metabolic process,GO:0034248~regulation of cellular amide metabolic process,GO:0033674~positive regulation of kinase activity,GO:0033365~protein localization to organelle,GO:0033157~regulation of intracellular protein transport,GO:0033088~negative regulation of immature T cell proliferation in thymus,GO:0033087~negative regulation of immature T cell proliferation,GO:0033085~negative regulation of T cell differentiation in thymus,GO:0033084~regulation of immature T cell proliferation in thymus,GO:0033083~regulation of immature T cell proliferation,GO:0033081~regulation of T cell differentiation in thymus,GO:0033080~immature T cell proliferation in thymus,GO:0033079~immature T cell proliferation,GO:0033077~T cell differentiation in thymus,GO:0033036~macromolecule localization,GO:0032990~cell part morphogenesis,GO:0032989~cellular component morphogenesis,GO:0032945~negative regulation of mononuclear cell proliferation,GO:0032944~regulation of mononuclear cell proliferation,GO:0032943~mononuclear cell proliferation,GO:0032886~regulation of microtubule-based process,GO:0032880~regulation of protein localization,GO:0032774~RNA biosynthetic process,GO:0032388~positive regulation of intracellular transport,GO:0032386~regulation of intracellular transport,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031175~neuron projection development,GO:0030307~positive regulation of cell growth,GO:0030217~T cell differentiation,GO:0030182~neuron differentiation,GO:0030155~regulation of cell adhesion,GO:0030098~lymphocyte differentiation,GO:0030097~hemopoiesis,GO:0030030~cell projection organization,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0023014~signal transduction by protein phosphorylation,GO:0022610~biological adhesion,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022408~negative regulation of cell-cell adhesion,GO:0022407~regulation of cell-cell adhesion,GO:0022008~neurogenesis,GO:0021782~glial cell development,GO:0019438~aromatic compound biosynthetic process,GO:0019220~regulation of phosphate metabolic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018212~peptidyl-tyrosine modification,GO:0018193~peptidyl-amino acid modification,GO:0018130~heterocycle biosynthetic process,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0016337~single organismal cell-cell adhesion,GO:0016310~phosphorylation,GO:0016070~RNA metabolic process,GO:0016049~cell growth,GO:0015833~peptide transport,GO:0015031~protein transport,GO:0014044~Schwann cell development,GO:0014037~Schwann cell differentiation,GO:0012501~programmed cell death,GO:0010941~regulation of cell death,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010628~positive regulation of gene expression,GO:0010608~posttranscriptional regulation of gene expression,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010033~response to organic substance,GO:0010001~glial cell differentiation,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009893~positive regulation of metabolic process,GO:0009891~positive regulation of biosynthetic process,GO:0009719~response to endogenous stimulus,GO:0009611~response to wounding,GO:0009605~response to external stimulus,GO:0008366~axon ensheathment,GO:0008285~negative regulation of cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008283~cell proliferation,GO:0008219~cell death,GO:0008104~protein localization,GO:0008045~motor neuron axon guidance,GO:0007528~neuromuscular junction development,GO:0007507~heart development,GO:0007422~peripheral nervous system development,GO:0007417~central nervous system development,GO:0007411~axon guidance,GO:0007409~axonogenesis,GO:0007399~nervous system development,GO:0007272~ensheathment of neurons,GO:0007266~Rho protein signal transduction,GO:0007265~Ras protein signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0007162~negative regulation of cell adhesion,GO:0007159~leukocyte cell-cell adhesion,GO:0007155~cell adhesion,GO:0006935~chemotaxis,GO:0006928~movement of cell or subcellular component,GO:0006915~apoptotic process,GO:0006886~intracellular protein transport,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006612~protein targeting to membrane,GO:0006605~protein targeting,GO:0006518~peptide metabolic process,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0006417~regulation of translation,GO:0006412~translation,GO:0006360~transcription from RNA polymerase I promoter,GO:0006356~regulation of transcription from RNA polymerase I promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0002695~negative regulation of leukocyte activation,GO:0002694~regulation of leukocyte activation,GO:0002683~negative regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002521~leukocyte differentiation,GO:0002520~immune system development,GO:0001944~vasculature development,GO:0001934~positive regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,GO:0001775~cell activation,GO:0001558~regulation of cell growth,GO:0000904~cell morphogenesis involved in differentiation,GO:0000902~cell morphogenesis,GO:0000165~MAPK cascade,												GO:0098802~plasma membrane receptor complex,GO:0098793~presynapse,GO:0098590~plasma membrane region,GO:0097458~neuron part,GO:0097060~synaptic membrane,GO:0048471~perinuclear region of cytoplasm,GO:0045202~synapse,GO:0045178~basal part of cell,GO:0045177~apical part of cell,GO:0044456~synapse part,GO:0044440~endosomal part,GO:0044433~cytoplasmic vesicle part,GO:0043235~receptor complex,GO:0043209~myelin sheath,GO:0042734~presynaptic membrane,GO:0038143~ERBB3:ERBB2 complex,GO:0032587~ruffle membrane,GO:0031594~neuromuscular junction,GO:0031256~leading edge membrane,GO:0031253~cell projection membrane,GO:0031252~cell leading edge,GO:0016324~apical plasma membrane,GO:0016323~basolateral plasma membrane,GO:0010008~endosome membrane,GO:0009925~basal plasma membrane,GO:0005829~cytosol,GO:0005769~early endosome,GO:0005768~endosome,GO:0005654~nucleoplasm,GO:0002116~semaphorin receptor complex,GO:0001726~ruffle,												GO:1990782~protein tyrosine kinase binding,GO:1901363~heterocyclic compound binding,GO:1901265~nucleoside phosphate binding,GO:0099600~transmembrane receptor activity,GO:0097367~carbohydrate derivative binding,GO:0097159~organic cyclic compound binding,GO:0070063~RNA polymerase binding,GO:0060089~molecular transducer activity,GO:0046983~protein dimerization activity,GO:0046982~protein heterodimerization activity,GO:0043175~RNA polymerase core enzyme binding,GO:0043168~anion binding,GO:0043167~ion binding,GO:0043125~ErbB-3 class receptor binding,GO:0042802~identical protein binding,GO:0038023~signaling receptor activity,GO:0036094~small molecule binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030971~receptor tyrosine kinase binding,GO:0030554~adenyl nucleotide binding,GO:0019901~protein kinase binding,GO:0019900~kinase binding,GO:0019899~enzyme binding,GO:0019838~growth factor binding,GO:0019199~transmembrane receptor protein kinase activity,GO:0017076~purine nucleotide binding,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0016301~kinase activity,GO:0015026~coreceptor activity,GO:0005524~ATP binding,GO:0005102~receptor binding,GO:0004888~transmembrane signaling receptor activity,GO:0004872~receptor activity,GO:0004871~signal transducer activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004672~protein kinase activity,GO:0001042~RNA polymerase I core binding,GO:0000166~nucleotide binding,												IPR049328:TM_ErbB1,IPR036941:Rcpt_L-dom_sf,IPR032778:GF_recep_IV,IPR020635:Tyr_kinase_cat_dom,IPR017441:Protein_kinase_ATP_BS,IPR016245:Tyr_kinase_EGF/ERB/XmrK_rcpt,IPR011009:Kinase-like_dom_sf,IPR009030:Growth_fac_rcpt_cys_sf,IPR008266:Tyr_kinase_AS,IPR006212:Furin_repeat,IPR006211:Furin-like_Cys-rich_dom,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR000719:Prot_kinase_dom,IPR000494:Rcpt_L-dom,												hsa05230:Central carbon metabolism in cancer,hsa05226:Gastric cancer,hsa05224:Breast cancer,hsa05223:Non-small cell lung cancer,hsa05219:Bladder cancer,hsa05215:Prostate cancer,hsa05213:Endometrial cancer,hsa05212:Pancreatic cancer,hsa05206:MicroRNAs in cancer,hsa05205:Proteoglycans in cancer,hsa05200:Pathways in cancer,hsa04530:Tight junction,hsa04520:Adherens junction,hsa04510:Focal adhesion,hsa04151:PI3K-Akt signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04020:Calcium signaling pathway,hsa04012:ErbB signaling pathway,hsa04010:MAPK signaling pathway,hsa01524:Platinum drug resistance,hsa01522:Endocrine resistance,hsa01521:EGFR tyrosine kinase inhibitor resistance,												619465~Visceral neuropathy, familial, 2, autosomal recessive,613659~Gastric cancer, somatic,211980~Adenocarcinoma of lung, somatic,167000~Ovarian cancer, somatic,137800~Glioblastoma, somatic,												PIRSF000619:TyrPK_EGF-R,												SM00261:FU,SM00219:TyrKc,												TRANSMEM:Helical,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,REGION:Required for interaction with KPNB1 and EEA1,REGION:Interaction with PIK3C2B,REGION:Disordered,MUTAGEN:M->A: Prevents synthesis of isoform 3.,MUTAGEN:M->A: Prevents synthesis of isoform 2.,MUTAGEN:M->A: No effect on isoform production.,MUTAGEN:LH->AA: Reduces dimerization with ERBB3.,MOTIF:Nuclear localization signal,DOMAIN:Serine-threonine/tyrosine-protein kinase catalytic,DOMAIN:Receptor L-domain,DOMAIN:Protein kinase,DOMAIN:Growth factor receptor,DOMAIN:Furin-like cysteine-rich,DOMAIN:Epidermal growth factor receptor-like transmembrane-juxtamembrane segment,COMPBIAS:Pro residues,CARBOHYD:N-linked (GlcNAc...) asparagine,ACT_SITE:Proton acceptor,
36234_at	eukaryotic translation initiation factor 4A1(EIF4A1)	Homo sapiens		h_mtorPathway:mTOR Signaling Pathway,h_iresPathway:Internal Ribosome entry pathway,h_eifPathway:Eukaryotic protein translation,h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,												GO:1901566~organonitrogen compound biosynthetic process,GO:0043604~amide biosynthetic process,GO:0043603~cellular amide metabolic process,GO:0043043~peptide biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0010467~gene expression,GO:0006518~peptide metabolic process,GO:0006413~translational initiation,GO:0006412~translation,GO:0002183~cytoplasmic translational initiation,GO:0002181~cytoplasmic translation,												GO:1903561~extracellular vesicle,GO:0070062~extracellular exosome,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0016281~eukaryotic translation initiation factor 4F complex,GO:0005829~cytosol,GO:0005576~extracellular region,												GO:1901363~heterocyclic compound binding,GO:1901265~nucleoside phosphate binding,GO:0097367~carbohydrate derivative binding,GO:0097159~organic cyclic compound binding,GO:0043168~anion binding,GO:0043167~ion binding,GO:0036094~small molecule binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0017111~nucleoside-triphosphatase activity,GO:0017076~purine nucleotide binding,GO:0016887~ATPase activity,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016462~pyrophosphatase activity,GO:0008135~translation factor activity, RNA binding,GO:0005524~ATP binding,GO:0004386~helicase activity,GO:0003743~translation initiation factor activity,GO:0003729~mRNA binding,GO:0003725~double-stranded RNA binding,GO:0003724~RNA helicase activity,GO:0003723~RNA binding,GO:0003676~nucleic acid binding,GO:0000339~RNA cap binding,GO:0000166~nucleotide binding,												IPR044728:EIF4A_DEADc,IPR027417:P-loop_NTPase,IPR014014:RNA_helicase_DEAD_Q_motif,IPR014001:Helicase_ATP-bd,IPR011545:DEAD/DEAH_box_helicase_dom,IPR001650:Helicase_C,IPR000629:RNA-helicase_DEAD-box_CS,															SM00490:HELICc,SM00487:DEXDc,												REGION:Disordered,MOTIF:Q motif,MOTIF:DEAD box,DOMAIN:Helicase C-terminal,DOMAIN:Helicase ATP-binding,DOMAIN:DEAD-box RNA helicase Q,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),
1855_at	fibroblast growth factor 3(FGF3)	Homo sapiens			GO:2000145~regulation of cell motility,GO:1901862~negative regulation of muscle tissue development,GO:1901861~regulation of muscle tissue development,GO:0072359~circulatory system development,GO:0071774~response to fibroblast growth factor,GO:0071495~cellular response to endogenous stimulus,GO:0071363~cellular response to growth factor stimulus,GO:0071310~cellular response to organic substance,GO:0070887~cellular response to chemical stimulus,GO:0070848~response to growth factor,GO:0061061~muscle structure development,GO:0060537~muscle tissue development,GO:0055026~negative regulation of cardiac muscle tissue development,GO:0055024~regulation of cardiac muscle tissue development,GO:0051781~positive regulation of cell division,GO:0051674~localization of cell,GO:0051302~regulation of cell division,GO:0051301~cell division,GO:0051270~regulation of cellular component movement,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051241~negative regulation of multicellular organismal process,GO:0051174~regulation of phosphorus metabolic process,GO:0051093~negative regulation of developmental process,GO:0048870~cell motility,GO:0048738~cardiac muscle tissue development,GO:0048635~negative regulation of muscle organ development,GO:0048634~regulation of muscle organ development,GO:0045937~positive regulation of phosphate metabolic process,GO:0045843~negative regulation of striated muscle tissue development,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0042127~regulation of cell proliferation,GO:0040012~regulation of locomotion,GO:0040011~locomotion,GO:0036211~protein modification process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031325~positive regulation of cellular metabolic process,GO:0030334~regulation of cell migration,GO:0019220~regulation of phosphate metabolic process,GO:0016310~phosphorylation,GO:0016202~regulation of striated muscle tissue development,GO:0014706~striated muscle tissue development,GO:0010628~positive regulation of gene expression,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010033~response to organic substance,GO:0009893~positive regulation of metabolic process,GO:0009887~animal organ morphogenesis,GO:0009719~response to endogenous stimulus,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0008283~cell proliferation,GO:0007517~muscle organ development,GO:0007507~heart development,GO:0007267~cell-cell signaling,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0006928~movement of cell or subcellular component,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0001934~positive regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,												GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:0070851~growth factor receptor binding,GO:0008083~growth factor activity,GO:0005104~fibroblast growth factor receptor binding,GO:0005102~receptor binding,												IPR008996:IL1/FGF,IPR002209:Fibroblast_GF_fam,												hsa05226:Gastric cancer,hsa05224:Breast cancer,hsa05218:Melanoma,hsa05207:Chemical carcinogenesis - receptor activation,hsa05200:Pathways in cancer,hsa04810:Regulation of actin cytoskeleton,hsa04151:PI3K-Akt signaling pathway,hsa04020:Calcium signaling pathway,hsa04015:Rap1 signaling pathway,hsa04014:Ras signaling pathway,hsa04010:MAPK signaling pathway,												610706~Deafness, congenital with inner ear agenesis, microtia, and microdontia,													SM00442:FGF,												REGION:Disordered,COMPBIAS:Polar residues,CARBOHYD:N-linked (GlcNAc...) asparagine,
35367_at	galectin 3(LGALS3)	Homo sapiens			GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,GO:2001236~regulation of extrinsic apoptotic signaling pathway,GO:2001234~negative regulation of apoptotic signaling pathway,GO:2001233~regulation of apoptotic signaling pathway,GO:2001189~negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,GO:2001188~regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,GO:2000521~negative regulation of immunological synapse formation,GO:2000520~regulation of immunological synapse formation,GO:2000147~positive regulation of cell motility,GO:2000145~regulation of cell motility,GO:2000106~regulation of leukocyte apoptotic process,GO:1990778~protein localization to cell periphery,GO:1990266~neutrophil migration,GO:1905517~macrophage migration,GO:1905477~positive regulation of protein localization to membrane,GO:1905475~regulation of protein localization to membrane,GO:1904377~positive regulation of protein localization to cell periphery,GO:1904375~regulation of protein localization to cell periphery,GO:1903829~positive regulation of cellular protein localization,GO:1903827~regulation of cellular protein localization,GO:1903729~regulation of plasma membrane organization,GO:1903614~negative regulation of protein tyrosine phosphatase activity,GO:1903613~regulation of protein tyrosine phosphatase activity,GO:1903078~positive regulation of protein localization to plasma membrane,GO:1903076~regulation of protein localization to plasma membrane,GO:1903038~negative regulation of leukocyte cell-cell adhesion,GO:1903037~regulation of leukocyte cell-cell adhesion,GO:1902580~single-organism cellular localization,GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:0098609~cell-cell adhesion,GO:0098602~single organism cell adhesion,GO:0097530~granulocyte migration,GO:0097529~myeloid leukocyte migration,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097190~apoptotic signaling pathway,GO:0090280~positive regulation of calcium ion import,GO:0090279~regulation of calcium ion import,GO:0072677~eosinophil migration,GO:0072659~protein localization to plasma membrane,GO:0072657~protein localization to membrane,GO:0072511~divalent inorganic cation transport,GO:0071887~leukocyte apoptotic process,GO:0071822~protein complex subunit organization,GO:0071677~positive regulation of mononuclear cell migration,GO:0071675~regulation of mononuclear cell migration,GO:0071674~mononuclear cell migration,GO:0071621~granulocyte chemotaxis,GO:0070887~cellular response to chemical stimulus,GO:0070838~divalent metal ion transport,GO:0070727~cellular macromolecule localization,GO:0070663~regulation of leukocyte proliferation,GO:0070661~leukocyte proliferation,GO:0070509~calcium ion import,GO:0070271~protein complex biogenesis,GO:0070232~regulation of T cell apoptotic process,GO:0070228~regulation of lymphocyte apoptotic process,GO:0070227~lymphocyte apoptotic process,GO:0065009~regulation of molecular function,GO:0065003~macromolecular complex assembly,GO:0061024~membrane organization,GO:0060627~regulation of vesicle-mediated transport,GO:0060548~negative regulation of cell death,GO:0060429~epithelium development,GO:0060341~regulation of cellular localization,GO:0060326~cell chemotaxis,GO:0051928~positive regulation of calcium ion transport,GO:0051924~regulation of calcium ion transport,GO:0051674~localization of cell,GO:0051641~cellular localization,GO:0051346~negative regulation of hydrolase activity,GO:0051336~regulation of hydrolase activity,GO:0051272~positive regulation of cellular component movement,GO:0051270~regulation of cellular component movement,GO:0051250~negative regulation of lymphocyte activation,GO:0051249~regulation of lymphocyte activation,GO:0051248~negative regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051130~positive regulation of cellular component organization,GO:0051129~negative regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051051~negative regulation of transport,GO:0051050~positive regulation of transport,GO:0051049~regulation of transport,GO:0050918~positive chemotaxis,GO:0050900~leukocyte migration,GO:0050868~negative regulation of T cell activation,GO:0050866~negative regulation of cell activation,GO:0050865~regulation of cell activation,GO:0050863~regulation of T cell activation,GO:0050860~negative regulation of T cell receptor signaling pathway,GO:0050858~negative regulation of antigen receptor-mediated signaling pathway,GO:0050856~regulation of T cell receptor signaling pathway,GO:0050854~regulation of antigen receptor-mediated signaling pathway,GO:0050852~T cell receptor signaling pathway,GO:0050851~antigen receptor-mediated signaling pathway,GO:0050790~regulation of catalytic activity,GO:0050778~positive regulation of immune response,GO:0050777~negative regulation of immune response,GO:0050776~regulation of immune response,GO:0050670~regulation of lymphocyte proliferation,GO:0048870~cell motility,GO:0048585~negative regulation of response to stimulus,GO:0048584~positive regulation of response to stimulus,GO:0048246~macrophage chemotaxis,GO:0048245~eosinophil chemotaxis,GO:0046651~lymphocyte proliferation,GO:0046649~lymphocyte activation,GO:0045936~negative regulation of phosphate metabolic process,GO:0045806~negative regulation of endocytosis,GO:0045321~leukocyte activation,GO:0045087~innate immune response,GO:0044802~single-organism membrane organization,GO:0044092~negative regulation of molecular function,GO:0044089~positive regulation of cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044085~cellular component biogenesis,GO:0043933~macromolecular complex subunit organization,GO:0043666~regulation of phosphoprotein phosphatase activity,GO:0043270~positive regulation of ion transport,GO:0043269~regulation of ion transport,GO:0043254~regulation of protein complex assembly,GO:0043086~negative regulation of catalytic activity,GO:0043069~negative regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptotic process,GO:0042981~regulation of apoptotic process,GO:0042330~taxis,GO:0042129~regulation of T cell proliferation,GO:0042127~regulation of cell proliferation,GO:0042110~T cell activation,GO:0040017~positive regulation of locomotion,GO:0040012~regulation of locomotion,GO:0040011~locomotion,GO:0036211~protein modification process,GO:0035308~negative regulation of protein dephosphorylation,GO:0035305~negative regulation of dephosphorylation,GO:0035304~regulation of protein dephosphorylation,GO:0035303~regulation of dephosphorylation,GO:0034613~cellular protein localization,GO:0033036~macromolecule localization,GO:0032944~regulation of mononuclear cell proliferation,GO:0032943~mononuclear cell proliferation,GO:0032880~regulation of protein localization,GO:0032515~negative regulation of phosphoprotein phosphatase activity,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0031400~negative regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031334~positive regulation of protein complex assembly,GO:0031324~negative regulation of cellular metabolic process,GO:0030855~epithelial cell differentiation,GO:0030595~leukocyte chemotaxis,GO:0030593~neutrophil chemotaxis,GO:0030335~positive regulation of cell migration,GO:0030334~regulation of cell migration,GO:0030155~regulation of cell adhesion,GO:0030100~regulation of endocytosis,GO:0030001~metal ion transport,GO:0023057~negative regulation of signaling,GO:0023051~regulation of signaling,GO:0022610~biological adhesion,GO:0022607~cellular component assembly,GO:0022408~negative regulation of cell-cell adhesion,GO:0022407~regulation of cell-cell adhesion,GO:0019220~regulation of phosphate metabolic process,GO:0016477~cell migration,GO:0016337~single organismal cell-cell adhesion,GO:0016311~dephosphorylation,GO:0016192~vesicle-mediated transport,GO:0016071~mRNA metabolic process,GO:0016070~RNA metabolic process,GO:0012501~programmed cell death,GO:0010959~regulation of metal ion transport,GO:0010941~regulation of cell death,GO:0010923~negative regulation of phosphatase activity,GO:0010921~regulation of phosphatase activity,GO:0010648~negative regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010563~negative regulation of phosphorus metabolic process,GO:0010467~gene expression,GO:0010256~endomembrane system organization,GO:0009988~cell-cell recognition,GO:0009968~negative regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009892~negative regulation of metabolic process,GO:0009605~response to external stimulus,GO:0008380~RNA splicing,GO:0008283~cell proliferation,GO:0008219~cell death,GO:0008104~protein localization,GO:0008037~cell recognition,GO:0007166~cell surface receptor signaling pathway,GO:0007162~negative regulation of cell adhesion,GO:0007159~leukocyte cell-cell adhesion,GO:0007155~cell adhesion,GO:0007009~plasma membrane organization,GO:0006955~immune response,GO:0006952~defense response,GO:0006935~chemotaxis,GO:0006928~movement of cell or subcellular component,GO:0006915~apoptotic process,GO:0006897~endocytosis,GO:0006816~calcium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006470~protein dephosphorylation,GO:0006464~cellular protein modification process,GO:0006461~protein complex assembly,GO:0006397~mRNA processing,GO:0006396~RNA processing,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0002764~immune response-regulating signaling pathway,GO:0002757~immune response-activating signal transduction,GO:0002698~negative regulation of immune effector process,GO:0002697~regulation of immune effector process,GO:0002695~negative regulation of leukocyte activation,GO:0002694~regulation of leukocyte activation,GO:0002687~positive regulation of leukocyte migration,GO:0002685~regulation of leukocyte migration,GO:0002684~positive regulation of immune system process,GO:0002683~negative regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002548~monocyte chemotaxis,GO:0002429~immune response-activating cell surface receptor signaling pathway,GO:0002366~leukocyte activation involved in immune response,GO:0002291~T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,GO:0002286~T cell activation involved in immune response,GO:0002285~lymphocyte activation involved in immune response,GO:0002263~cell activation involved in immune response,GO:0002253~activation of immune response,GO:0002252~immune effector process,GO:0001775~cell activation,GO:0001771~immunological synapse formation,												GO:1990904~ribonucleoprotein complex,GO:1903561~extracellular vesicle,GO:0101003~ficolin-1-rich granule membrane,GO:0099503~secretory vesicle,GO:0070820~tertiary granule,GO:0070062~extracellular exosome,GO:0044433~cytoplasmic vesicle part,GO:0044429~mitochondrial part,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0031975~envelope,GO:0031967~organelle envelope,GO:0031966~mitochondrial membrane,GO:0030667~secretory granule membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0030141~secretory granule,GO:0019866~organelle inner membrane,GO:0012506~vesicle membrane,GO:0009986~cell surface,GO:0005829~cytosol,GO:0005743~mitochondrial inner membrane,GO:0005740~mitochondrial envelope,GO:0005739~mitochondrion,GO:0005681~spliceosomal complex,GO:0005654~nucleoplasm,GO:0005615~extracellular space,GO:0005576~extracellular region,GO:0001772~immunological synapse,												GO:1901363~heterocyclic compound binding,GO:0098772~molecular function regulator,GO:0097159~organic cyclic compound binding,GO:0070492~oligosaccharide binding,GO:0050840~extracellular matrix binding,GO:0048030~disaccharide binding,GO:0044877~macromolecular complex binding,GO:0043236~laminin binding,GO:0042056~chemoattractant activity,GO:0032403~protein complex binding,GO:0030246~carbohydrate binding,GO:0030234~enzyme regulator activity,GO:0019903~protein phosphatase binding,GO:0019902~phosphatase binding,GO:0019899~enzyme binding,GO:0019888~protein phosphatase regulator activity,GO:0019865~immunoglobulin binding,GO:0019863~IgE binding,GO:0019212~phosphatase inhibitor activity,GO:0019208~phosphatase regulator activity,GO:0004864~protein phosphatase inhibitor activity,GO:0004857~enzyme inhibitor activity,GO:0003723~RNA binding,GO:0003676~nucleic acid binding,												IPR044156:Galectin-like,IPR013320:ConA-like_dom_sf,IPR001079:Galectin_CRD,															SM00908:Gal-bind_lectin,SM00276:GLECT,												REPEAT:8; approximate,REPEAT:7; approximate,REPEAT:6; approximate,REPEAT:5,REPEAT:4; approximate,REPEAT:3,REPEAT:2,REPEAT:1,REGION:Disordered,REGION:8 X 9 AA tandem repeats of Y-P-G-X(3)-P-G-A,MOTIF:Nuclear export signal,DOMAIN:Galectin,DISULFID:Interchain,COMPBIAS:Pro residues,COMPBIAS:Polar residues,
32279_at	glutamate decarboxylase 2(GAD2)	Homo sapiens			GO:1901606~alpha-amino acid catabolic process,GO:1901605~alpha-amino acid metabolic process,GO:1901566~organonitrogen compound biosynthetic process,GO:1901565~organonitrogen compound catabolic process,GO:0099537~trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0098916~anterograde trans-synaptic signaling,GO:0072330~monocarboxylic acid biosynthetic process,GO:0046395~carboxylic acid catabolic process,GO:0046394~carboxylic acid biosynthetic process,GO:0044712~single-organism catabolic process,GO:0044283~small molecule biosynthetic process,GO:0044282~small molecule catabolic process,GO:0043649~dicarboxylic acid catabolic process,GO:0043648~dicarboxylic acid metabolic process,GO:0043436~oxoacid metabolic process,GO:0032787~monocarboxylic acid metabolic process,GO:0019752~carboxylic acid metabolic process,GO:0016054~organic acid catabolic process,GO:0016053~organic acid biosynthetic process,GO:0009449~gamma-aminobutyric acid biosynthetic process,GO:0009448~gamma-aminobutyric acid metabolic process,GO:0009410~response to xenobiotic stimulus,GO:0009065~glutamine family amino acid catabolic process,GO:0009064~glutamine family amino acid metabolic process,GO:0009063~cellular amino acid catabolic process,GO:0008652~cellular amino acid biosynthetic process,GO:0007268~chemical synaptic transmission,GO:0007267~cell-cell signaling,GO:0006540~glutamate decarboxylation to succinate,GO:0006538~glutamate catabolic process,GO:0006536~glutamate metabolic process,GO:0006520~cellular amino acid metabolic process,GO:0006105~succinate metabolic process,GO:0006082~organic acid metabolic process,												GO:0099503~secretory vesicle,GO:0099501~exocytic vesicle membrane,GO:0098982~GABA-ergic synapse,GO:0098793~presynapse,GO:0098590~plasma membrane region,GO:0097458~neuron part,GO:0097060~synaptic membrane,GO:0070382~exocytic vesicle,GO:0061202~clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,GO:0061200~clathrin-sculpted gamma-aminobutyric acid transport vesicle,GO:0060198~clathrin-sculpted vesicle,GO:0060077~inhibitory synapse,GO:0048471~perinuclear region of cytoplasm,GO:0045202~synapse,GO:0044456~synapse part,GO:0044433~cytoplasmic vesicle part,GO:0044431~Golgi apparatus part,GO:0043005~neuron projection,GO:0042734~presynaptic membrane,GO:0030672~synaptic vesicle membrane,GO:0030665~clathrin-coated vesicle membrane,GO:0030662~coated vesicle membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0030658~transport vesicle membrane,GO:0030424~axon,GO:0030136~clathrin-coated vesicle,GO:0030135~coated vesicle,GO:0030133~transport vesicle,GO:0012506~vesicle membrane,GO:0008021~synaptic vesicle,GO:0005829~cytosol,GO:0005794~Golgi apparatus,GO:0000139~Golgi membrane,												GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0070279~vitamin B6 binding,GO:0048037~cofactor binding,GO:0044877~macromolecular complex binding,GO:0043177~organic acid binding,GO:0043168~anion binding,GO:0043167~ion binding,GO:0036094~small molecule binding,GO:0031406~carboxylic acid binding,GO:0030170~pyridoxal phosphate binding,GO:0019842~vitamin binding,GO:0016831~carboxy-lyase activity,GO:0016830~carbon-carbon lyase activity,GO:0016597~amino acid binding,GO:0016595~glutamate binding,GO:0004351~glutamate decarboxylase activity,												IPR021115:Pyridoxal-P_BS,IPR015424:PyrdxlP-dep_Trfase,IPR015421:PyrdxlP-dep_Trfase_major,IPR002129:PyrdxlP-dep_de-COase,												hsa04940:Type I diabetes mellitus,hsa04727:GABAergic synapse,hsa01100:Metabolic pathways,hsa00650:Butanoate metabolism,hsa00430:Taurine and hypotaurine metabolism,hsa00410:beta-Alanine metabolism,hsa00250:Alanine, aspartate and glutamate metabolism,															REGION:Disordered,MUTAGEN:SPGSGFWSFGS->APGAGFWAFGA: No effect on glutamate decarboxylase activity.,LIPID:S-palmitoyl cysteine,
38236_at	glutamate ionotropic receptor NMDA type subunit 2A(GRIN2A)	Homo sapiens		h_nos1Pathway:Nitric Oxide Signaling Pathway,												GO:2001056~positive regulation of cysteine-type endopeptidase activity,GO:2000463~positive regulation of excitatory postsynaptic potential,GO:2000116~regulation of cysteine-type endopeptidase activity,GO:1990778~protein localization to cell periphery,GO:1905114~cell surface receptor signaling pathway involved in cell-cell signaling,GO:1904062~regulation of cation transmembrane transport,GO:1903539~protein localization to postsynaptic membrane,GO:1902656~calcium ion import into cytosol,GO:1901700~response to oxygen-containing compound,GO:1901698~response to nitrogen compound,GO:1901615~organic hydroxy compound metabolic process,GO:1901160~primary amino compound metabolic process,GO:0099565~chemical synaptic transmission, postsynaptic,GO:0099537~trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0098976~excitatory chemical synaptic transmission,GO:0098916~anterograde trans-synaptic signaling,GO:0098815~modulation of excitatory postsynaptic potential,GO:0098771~inorganic ion homeostasis,GO:0098662~inorganic cation transmembrane transport,GO:0098660~inorganic ion transmembrane transport,GO:0098655~cation transmembrane transport,GO:0097553~calcium ion transmembrane import into cytosol,GO:0097305~response to alcohol,GO:0097202~activation of cysteine-type endopeptidase activity,GO:0097164~ammonium ion metabolic process,GO:0072657~protein localization to membrane,GO:0072511~divalent inorganic cation transport,GO:0072507~divalent inorganic cation homeostasis,GO:0072503~cellular divalent inorganic cation homeostasis,GO:0070838~divalent metal ion transport,GO:0070727~cellular macromolecule localization,GO:0070588~calcium ion transmembrane transport,GO:0070509~calcium ion import,GO:0065009~regulation of molecular function,GO:0060402~calcium ion transport into cytosol,GO:0060401~cytosolic calcium ion transport,GO:0060322~head development,GO:0060291~long-term synaptic potentiation,GO:0060079~excitatory postsynaptic potential,GO:0060078~regulation of postsynaptic membrane potential,GO:0055085~transmembrane transport,GO:0055082~cellular chemical homeostasis,GO:0055080~cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055065~metal ion homeostasis,GO:0052548~regulation of endopeptidase activity,GO:0052547~regulation of peptidase activity,GO:0051968~positive regulation of synaptic transmission, glutamatergic,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0051649~establishment of localization in cell,GO:0051641~cellular localization,GO:0051604~protein maturation,GO:0051480~regulation of cytosolic calcium ion concentration,GO:0051345~positive regulation of hydrolase activity,GO:0051336~regulation of hydrolase activity,GO:0051248~negative regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051049~regulation of transport,GO:0050905~neuromuscular process,GO:0050890~cognition,GO:0050877~neurological system process,GO:0050806~positive regulation of synaptic transmission,GO:0050804~modulation of synaptic transmission,GO:0050801~ion homeostasis,GO:0050790~regulation of catalytic activity,GO:0048878~chemical homeostasis,GO:0048584~positive regulation of response to stimulus,GO:0048168~regulation of neuronal synaptic plasticity,GO:0048167~regulation of synaptic plasticity,GO:0045862~positive regulation of proteolysis,GO:0045471~response to ethanol,GO:0044708~single-organism behavior,GO:0044093~positive regulation of molecular function,GO:0043269~regulation of ion transport,GO:0043085~positive regulation of catalytic activity,GO:0043068~positive regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043065~positive regulation of apoptotic process,GO:0042981~regulation of apoptotic process,GO:0042592~homeostatic process,GO:0042430~indole-containing compound metabolic process,GO:0042428~serotonin metabolic process,GO:0042417~dopamine metabolic process,GO:0042391~regulation of membrane potential,GO:0042177~negative regulation of protein catabolic process,GO:0042176~regulation of protein catabolic process,GO:0040011~locomotion,GO:0035556~intracellular signal transduction,GO:0035418~protein localization to synapse,GO:0035249~synaptic transmission, glutamatergic,GO:0035235~ionotropic glutamate receptor signaling pathway,GO:0034765~regulation of ion transmembrane transport,GO:0034762~regulation of transmembrane transport,GO:0034613~cellular protein localization,GO:0034220~ion transmembrane transport,GO:0033058~directional locomotion,GO:0033036~macromolecule localization,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0031638~zymogen activation,GO:0031325~positive regulation of cellular metabolic process,GO:0030431~sleep,GO:0030163~protein catabolic process,GO:0030162~regulation of proteolysis,GO:0030003~cellular cation homeostasis,GO:0030001~metal ion transport,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0022008~neurogenesis,GO:0019932~second-messenger-mediated signaling,GO:0019725~cellular homeostasis,GO:0019722~calcium-mediated signaling,GO:0019233~sensory perception of pain,GO:0018958~phenol-containing compound metabolic process,GO:0016485~protein processing,GO:0014075~response to amine,GO:0012501~programmed cell death,GO:0010952~positive regulation of peptidase activity,GO:0010950~positive regulation of endopeptidase activity,GO:0010942~positive regulation of cell death,GO:0010941~regulation of cell death,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010467~gene expression,GO:0010243~response to organonitrogen compound,GO:0010033~response to organic substance,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009895~negative regulation of catabolic process,GO:0009894~regulation of catabolic process,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0009719~response to endogenous stimulus,GO:0009712~catechol-containing compound metabolic process,GO:0009628~response to abiotic stimulus,GO:0009611~response to wounding,GO:0009605~response to external stimulus,GO:0009416~response to light stimulus,GO:0009410~response to xenobiotic stimulus,GO:0009314~response to radiation,GO:0009057~macromolecule catabolic process,GO:0008542~visual learning,GO:0008306~associative learning,GO:0008219~cell death,GO:0008104~protein localization,GO:0007632~visual behavior,GO:0007613~memory,GO:0007612~learning,GO:0007611~learning or memory,GO:0007610~behavior,GO:0007600~sensory perception,GO:0007420~brain development,GO:0007417~central nervous system development,GO:0007399~nervous system development,GO:0007270~neuron-neuron synaptic transmission,GO:0007268~chemical synaptic transmission,GO:0007267~cell-cell signaling,GO:0007215~glutamate receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007166~cell surface receptor signaling pathway,GO:0006915~apoptotic process,GO:0006875~cellular metal ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006873~cellular ion homeostasis,GO:0006816~calcium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,GO:0006584~catecholamine metabolic process,GO:0006508~proteolysis,GO:0003008~system process,GO:0001975~response to amphetamine,GO:0001964~startle response,												GO:1990351~transporter complex,GO:1902495~transmembrane transporter complex,GO:0099634~postsynaptic specialization membrane,GO:0099572~postsynaptic specialization,GO:0099503~secretory vesicle,GO:0098984~neuron to neuron synapse,GO:0098978~glutamatergic synapse,GO:0098878~neurotransmitter receptor complex,GO:0098839~postsynaptic density membrane,GO:0098802~plasma membrane receptor complex,GO:0098794~postsynapse,GO:0098793~presynapse,GO:0098590~plasma membrane region,GO:0097458~neuron part,GO:0097060~synaptic membrane,GO:0070382~exocytic vesicle,GO:0045211~postsynaptic membrane,GO:0045202~synapse,GO:0044456~synapse part,GO:0044433~cytoplasmic vesicle part,GO:0044432~endoplasmic reticulum part,GO:0044309~neuron spine,GO:0043235~receptor complex,GO:0043197~dendritic spine,GO:0043005~neuron projection,GO:0042734~presynaptic membrane,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0036477~somatodendritic compartment,GO:0034703~cation channel complex,GO:0034702~ion channel complex,GO:0032279~asymmetric synapse,GO:0031226~intrinsic component of plasma membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0030425~dendrite,GO:0030133~transport vesicle,GO:0017146~NMDA selective glutamate receptor complex,GO:0014069~postsynaptic density,GO:0012506~vesicle membrane,GO:0009986~cell surface,GO:0008328~ionotropic glutamate receptor complex,GO:0008021~synaptic vesicle,GO:0005887~integral component of plasma membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005783~endoplasmic reticulum,												GO:1904315~transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,GO:0099604~ligand-gated calcium channel activity,GO:0099600~transmembrane receptor activity,GO:0099529~neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,GO:0099094~ligand-gated cation channel activity,GO:0098960~postsynaptic neurotransmitter receptor activity,GO:0072509~divalent inorganic cation transmembrane transporter activity,GO:0060089~molecular transducer activity,GO:0046914~transition metal ion binding,GO:0046873~metal ion transmembrane transporter activity,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0042277~peptide binding,GO:0038023~signaling receptor activity,GO:0033218~amide binding,GO:0030594~neurotransmitter receptor activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0022849~glutamate-gated calcium ion channel activity,GO:0022838~substrate-specific channel activity,GO:0022836~gated channel activity,GO:0022835~transmitter-gated channel activity,GO:0022834~ligand-gated channel activity,GO:0022832~voltage-gated channel activity,GO:0022824~transmitter-gated ion channel activity,GO:0022803~passive transmembrane transporter activity,GO:0015276~ligand-gated ion channel activity,GO:0015267~channel activity,GO:0015085~calcium ion transmembrane transporter activity,GO:0008324~cation transmembrane transporter activity,GO:0008270~zinc ion binding,GO:0008066~glutamate receptor activity,GO:0005262~calcium channel activity,GO:0005261~cation channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005230~extracellular ligand-gated ion channel activity,GO:0005216~ion channel activity,GO:0004972~NMDA glutamate receptor activity,GO:0004970~ionotropic glutamate receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0004872~receptor activity,GO:0004871~signal transducer activity,GO:0001540~beta-amyloid binding,												IPR028082:Peripla_BP_I,IPR019594:Glu/Gly-bd,IPR018884:NMDAR2_C,IPR015683:Ionotropic_Glu_rcpt,IPR001828:ANF_lig-bd_rcpt,IPR001638:Solute-binding_3/MltF_N,IPR001508:Iono_Glu_rcpt_met,IPR001320:Iontro_rcpt_C,												hsa05322:Systemic lupus erythematosus,hsa05034:Alcoholism,hsa05033:Nicotine addiction,hsa05031:Amphetamine addiction,hsa05030:Cocaine addiction,hsa05022:Pathways of neurodegeneration - multiple diseases,hsa05020:Prion disease,hsa05017:Spinocerebellar ataxia,hsa05014:Amyotrophic lateral sclerosis,hsa05010:Alzheimer disease,hsa04728:Dopaminergic synapse,hsa04724:Glutamatergic synapse,hsa04720:Long-term potentiation,hsa04713:Circadian entrainment,hsa04080:Neuroactive ligand-receptor interaction,hsa04024:cAMP signaling pathway,hsa04020:Calcium signaling pathway,hsa04015:Rap1 signaling pathway,hsa04014:Ras signaling pathway,												245570~Epilepsy, focal, with speech disorder and with or without impaired intellectual development,													SM00918:Lig_chan-Glu_bd,SM00079:PBPe,												TRANSMEM:Helical,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,SITE:Functional determinant of NMDA receptors,REGION:Pore-forming,REGION:Disordered,MUTAGEN:P->Q: No effect on localization to the cell membrane. Changed glutamate-gated calcium ion channel activity characterized by decreased response amplitude and changed desensitization without effect on response rise time or deactivation time course.,MUTAGEN:P->L: No effect on localization to the cell membrane. Changed glutamate-gated calcium ion channel activity characterized by increased desensitization.,MUTAGEN:P->K: Changed glutamate-gated calcium ion channel activity characterized by increased glutamate and glycine potency with delay in rise time and slower deactivation time course.,MUTAGEN:P->I: Changed glutamate-gated calcium ion channel activity characterized by increased desensitization.,MUTAGEN:P->G: Changed glutamate-gated calcium ion channel activity characterized by accelerated response activation time and increased desensitization.,MUTAGEN:P->A: Changed glutamate-gated calcium ion channel activity characterized by increased desensitization.,MOTIF:PDZ-binding,INTRAMEM:Discontinuously helical,DOMAIN:Receptor ligand binding region,DOMAIN:Ionotropic glutamate receptor L-glutamate and glycine-binding,DOMAIN:Ionotropic glutamate receptor C-terminal,COMPBIAS:Polar residues,COMPBIAS:Basic and acidic residues,CARBOHYD:N-linked (GlcNAc...) asparagine,
36479_at	growth arrest specific 8(GAS8)	Homo sapiens			GO:1904526~regulation of microtubule binding,GO:1903829~positive regulation of cellular protein localization,GO:1903827~regulation of cellular protein localization,GO:1903566~positive regulation of protein localization to cilium,GO:1903564~regulation of protein localization to cilium,GO:1902589~single-organism organelle organization,GO:0097722~sperm motility,GO:0070925~organelle assembly,GO:0070727~cellular macromolecule localization,GO:0065009~regulation of molecular function,GO:0061512~protein localization to cilium,GO:0060341~regulation of cellular localization,GO:0060322~head development,GO:0060294~cilium movement involved in cell motility,GO:0060285~cilium-dependent cell motility,GO:0060271~cilium assembly,GO:0051674~localization of cell,GO:0051649~establishment of localization in cell,GO:0051641~cellular localization,GO:0051098~regulation of binding,GO:0048870~cell motility,GO:0048584~positive regulation of response to stimulus,GO:0045880~positive regulation of smoothened signaling pathway,GO:0044782~cilium organization,GO:0044085~cellular component biogenesis,GO:0043393~regulation of protein binding,GO:0042127~regulation of cell proliferation,GO:0040011~locomotion,GO:0035082~axoneme assembly,GO:0034613~cellular protein localization,GO:0033365~protein localization to organelle,GO:0033036~macromolecule localization,GO:0032880~regulation of protein localization,GO:0030317~flagellated sperm motility,GO:0030031~cell projection assembly,GO:0030030~cell projection organization,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0022607~cellular component assembly,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009855~determination of bilateral symmetry,GO:0009799~specification of symmetry,GO:0008589~regulation of smoothened signaling pathway,GO:0008285~negative regulation of cell proliferation,GO:0008283~cell proliferation,GO:0008104~protein localization,GO:0007420~brain development,GO:0007417~central nervous system development,GO:0007399~nervous system development,GO:0007389~pattern specification process,GO:0007368~determination of left/right symmetry,GO:0007224~smoothened signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0007018~microtubule-based movement,GO:0007017~microtubule-based process,GO:0007010~cytoskeleton organization,GO:0006928~movement of cell or subcellular component,GO:0003351~epithelial cilium movement,GO:0003341~cilium movement,GO:0001578~microtubule bundle formation,GO:0001539~cilium or flagellum-dependent cell motility,GO:0000226~microtubule cytoskeleton organization,												GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0099081~supramolecular polymer,GO:0099080~supramolecular complex,GO:0097729~9+2 motile cilium,GO:0097223~sperm part,GO:0097014~ciliary plasm,GO:0044441~ciliary part,GO:0036126~sperm flagellum,GO:0036064~ciliary basal body,GO:0031514~motile cilium,GO:0015630~microtubule cytoskeleton,GO:0005930~axoneme,GO:0005929~cilium,GO:0005874~microtubule,GO:0005829~cytosol,GO:0005815~microtubule organizing center,GO:0005794~Golgi apparatus,GO:0005576~extracellular region,												GO:0051020~GTPase binding,GO:0031267~small GTPase binding,GO:0019899~enzyme binding,GO:0015631~tubulin binding,GO:0008092~cytoskeletal protein binding,GO:0008017~microtubule binding,												IPR039308:GAS8,IPR025593:GAS8_dom,													616726~Ciliary dyskinesia, primary, 33,														REGION:Regulates microtubule-binding,REGION:Microtubule-binding,REGION:Interaction with SMO,REGION:Disordered,DOMAIN:Growth arrest-specific protein 8,
1890_at	growth differentiation factor 15(GDF15)	Homo sapiens			GO:1902533~positive regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:1901741~positive regulation of myoblast fusion,GO:1901739~regulation of myoblast fusion,GO:1901701~cellular response to oxygen-containing compound,GO:1901700~response to oxygen-containing compound,GO:1901699~cellular response to nitrogen compound,GO:1901698~response to nitrogen compound,GO:1901653~cellular response to peptide,GO:1901652~response to peptide,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0071559~response to transforming growth factor beta,GO:0071495~cellular response to endogenous stimulus,GO:0071417~cellular response to organonitrogen compound,GO:0071378~cellular response to growth hormone stimulus,GO:0071375~cellular response to peptide hormone stimulus,GO:0071363~cellular response to growth factor stimulus,GO:0071310~cellular response to organic substance,GO:0070887~cellular response to chemical stimulus,GO:0070848~response to growth factor,GO:0061061~muscle structure development,GO:0060416~response to growth hormone,GO:0060400~negative regulation of growth hormone receptor signaling pathway,GO:0060398~regulation of growth hormone receptor signaling pathway,GO:0060396~growth hormone receptor signaling pathway,GO:0060395~SMAD protein signal transduction,GO:0060143~positive regulation of syncytium formation by plasma membrane fusion,GO:0060142~regulation of syncytium formation by plasma membrane fusion,GO:0051897~positive regulation of protein kinase B signaling,GO:0051896~regulation of protein kinase B signaling,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051241~negative regulation of multicellular organismal process,GO:0051174~regulation of phosphorus metabolic process,GO:0051155~positive regulation of striated muscle cell differentiation,GO:0051153~regulation of striated muscle cell differentiation,GO:0051149~positive regulation of muscle cell differentiation,GO:0051147~regulation of muscle cell differentiation,GO:0051146~striated muscle cell differentiation,GO:0051130~positive regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051094~positive regulation of developmental process,GO:0051093~negative regulation of developmental process,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048640~negative regulation of developmental growth,GO:0048638~regulation of developmental growth,GO:0048589~developmental growth,GO:0048585~negative regulation of response to stimulus,GO:0048584~positive regulation of response to stimulus,GO:0045937~positive regulation of phosphate metabolic process,GO:0045926~negative regulation of growth,GO:0045597~positive regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0043491~protein kinase B signaling,GO:0043434~response to peptide hormone,GO:0043410~positive regulation of MAPK cascade,GO:0043408~regulation of MAPK cascade,GO:0042755~eating behavior,GO:0042692~muscle cell differentiation,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0040015~negative regulation of multicellular organism growth,GO:0040014~regulation of multicellular organism growth,GO:0040008~regulation of growth,GO:0040007~growth,GO:0036211~protein modification process,GO:0035860~glial cell-derived neurotrophic factor receptor signaling pathway,GO:0035556~intracellular signal transduction,GO:0035264~multicellular organism growth,GO:0032870~cellular response to hormone stimulus,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0031667~response to nutrient levels,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031325~positive regulation of cellular metabolic process,GO:0023057~negative regulation of signaling,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0023014~signal transduction by protein phosphorylation,GO:0022603~regulation of anatomical structure morphogenesis,GO:0019220~regulation of phosphate metabolic process,GO:0016310~phosphorylation,GO:0014902~myotube differentiation,GO:0010831~positive regulation of myotube differentiation,GO:0010830~regulation of myotube differentiation,GO:0010648~negative regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010243~response to organonitrogen compound,GO:0010033~response to organic substance,GO:0009991~response to extracellular stimulus,GO:0009968~negative regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009893~positive regulation of metabolic process,GO:0009725~response to hormone,GO:0009719~response to endogenous stimulus,GO:0009605~response to external stimulus,GO:0007631~feeding behavior,GO:0007610~behavior,GO:0007520~myoblast fusion,GO:0007267~cell-cell signaling,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0006949~syncytium formation,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0002023~reduction of food intake in response to dietary excess,GO:0002021~response to dietary excess,GO:0001934~positive regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,GO:0000768~syncytium formation by plasma membrane fusion,GO:0000165~MAPK cascade,												GO:1903561~extracellular vesicle,GO:0070062~extracellular exosome,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0005794~Golgi apparatus,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:0046983~protein dimerization activity,GO:0042803~protein homodimerization activity,GO:0042802~identical protein binding,GO:0008083~growth factor activity,GO:0005125~cytokine activity,GO:0005102~receptor binding,												IPR029034:Cystine-knot_cytokine,IPR015615:TGF-beta-rel,IPR001839:TGF-b_C,												hsa04060:Cytokine-cytokine receptor interaction,												620730~Hyperemesis gravidarum, susceptibility to,													SM00204:TGFB,												REGION:Disordered,MUTAGEN:W->A: No effect on interaction with GFRAL. Attenuates GDF15-mediated food-intake inhibition.,MUTAGEN:V->R: Abolishes interaction with GFRAL. Abolishes RET phosphorylation and cellular signaling mediated by GFRAL and RET.,MUTAGEN:V->A: Reduces cellular signaling mediated by GFRAL and RET.,MUTAGEN:I->A: Reduces cellular signaling mediated by GFRAL and RET. Abolishes interaction with GFRAL and GDF15-mediated food-intake inhibition.,DISULFID:Interchain,COMPBIAS:Polar residues,CARBOHYD:N-linked (GlcNAc...) asparagine,
31525_s_at	hemoglobin subunit alpha 1(HBA1)	Homo sapiens		h_ahspPathway:Hemoglobin's Chaperone,												GO:1990748~cellular detoxification,GO:1901700~response to oxygen-containing compound,GO:0098869~cellular oxidant detoxification,GO:0098754~detoxification,GO:0072593~reactive oxygen species metabolic process,GO:0071705~nitrogen compound transport,GO:0042744~hydrogen peroxide catabolic process,GO:0042743~hydrogen peroxide metabolic process,GO:0042542~response to hydrogen peroxide,GO:0030185~nitric oxide transport,GO:0019755~one-carbon compound transport,GO:0015671~oxygen transport,GO:0015670~carbon dioxide transport,GO:0015669~gas transport,GO:0010035~response to inorganic substance,GO:0009636~response to toxic substance,GO:0006979~response to oxidative stress,GO:0000302~response to reactive oxygen species,												GO:1903561~extracellular vesicle,GO:0072562~blood microparticle,GO:0071682~endocytic vesicle lumen,GO:0070062~extracellular exosome,GO:0060205~cytoplasmic vesicle lumen,GO:0044445~cytosolic part,GO:0044433~cytoplasmic vesicle part,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0031983~vesicle lumen,GO:0031838~haptoglobin-hemoglobin complex,GO:0030139~endocytic vesicle,GO:0005833~hemoglobin complex,GO:0005829~cytosol,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0046914~transition metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046872~metal ion binding,GO:0043177~organic acid binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0036094~small molecule binding,GO:0031720~haptoglobin binding,GO:0020037~heme binding,GO:0019825~oxygen binding,GO:0016684~oxidoreductase activity, acting on peroxide as acceptor,GO:0016209~antioxidant activity,GO:0005506~iron ion binding,GO:0005344~oxygen transporter activity,GO:0004601~peroxidase activity,												IPR012292:Globin/Proto,IPR009050:Globin-like_sf,IPR002339:Hemoglobin_pi,IPR002338:Hemoglobin_a-typ,IPR000971:Globin,												hsa05144:Malaria,hsa05143:African trypanosomiasis,												617981~Erythrocytosis, familial, 7,617973~Methemoglobinemia, alpha type,613978~Hemoglobin H disease, nondeletional,604131~Thalassemias, alpha-,140700~Heinz body anemias, alpha-,														SITE:Not glycated,SITE:(Microbial infection) Cleavage; by N.americanus apr-2,PEPTIDE:Hemopressin,DOMAIN:Globin family profile,CARBOHYD:N-linked (Glc) (glycation) lysine; alternate,CARBOHYD:N-linked (Glc) (glycation) lysine,BINDING:proximal binding residue,BINDING:distal binding residue,
31687_f_at	hemoglobin subunit beta(HBB)	Homo sapiens		h_ahspPathway:Hemoglobin's Chaperone,												GO:2001057~reactive nitrogen species metabolic process,GO:2000379~positive regulation of reactive oxygen species metabolic process,GO:2000377~regulation of reactive oxygen species metabolic process,GO:1990748~cellular detoxification,GO:1904407~positive regulation of nitric oxide metabolic process,GO:1903428~positive regulation of reactive oxygen species biosynthetic process,GO:1903426~regulation of reactive oxygen species biosynthetic process,GO:1903409~reactive oxygen species biosynthetic process,GO:1901700~response to oxygen-containing compound,GO:0098869~cellular oxidant detoxification,GO:0098754~detoxification,GO:0098609~cell-cell adhesion,GO:0098602~single organism cell adhesion,GO:0097746~regulation of blood vessel diameter,GO:0090066~regulation of anatomical structure size,GO:0072593~reactive oxygen species metabolic process,GO:0071705~nitrogen compound transport,GO:0070527~platelet aggregation,GO:0070293~renal absorption,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0050880~regulation of blood vessel size,GO:0050878~regulation of body fluid levels,GO:0050817~coagulation,GO:0046209~nitric oxide metabolic process,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045428~regulation of nitric oxide biosynthetic process,GO:0042744~hydrogen peroxide catabolic process,GO:0042743~hydrogen peroxide metabolic process,GO:0042542~response to hydrogen peroxide,GO:0042060~wound healing,GO:0035296~regulation of tube diameter,GO:0035150~regulation of tube size,GO:0034109~homotypic cell-cell adhesion,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0030185~nitric oxide transport,GO:0030168~platelet activation,GO:0022610~biological adhesion,GO:0019755~one-carbon compound transport,GO:0016337~single organismal cell-cell adhesion,GO:0015671~oxygen transport,GO:0015670~carbon dioxide transport,GO:0015669~gas transport,GO:0010035~response to inorganic substance,GO:0009893~positive regulation of metabolic process,GO:0009891~positive regulation of biosynthetic process,GO:0009636~response to toxic substance,GO:0009611~response to wounding,GO:0008217~regulation of blood pressure,GO:0008015~blood circulation,GO:0007599~hemostasis,GO:0007596~blood coagulation,GO:0007155~cell adhesion,GO:0006979~response to oxidative stress,GO:0006809~nitric oxide biosynthetic process,GO:0003018~vascular process in circulatory system,GO:0003014~renal system process,GO:0003013~circulatory system process,GO:0003008~system process,GO:0001775~cell activation,GO:0000302~response to reactive oxygen species,												GO:1904813~ficolin-1-rich granule lumen,GO:1904724~tertiary granule lumen,GO:1903561~extracellular vesicle,GO:0101002~ficolin-1-rich granule,GO:0099503~secretory vesicle,GO:0072562~blood microparticle,GO:0071682~endocytic vesicle lumen,GO:0070820~tertiary granule,GO:0070062~extracellular exosome,GO:0060205~cytoplasmic vesicle lumen,GO:0044445~cytosolic part,GO:0044433~cytoplasmic vesicle part,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0031983~vesicle lumen,GO:0031838~haptoglobin-hemoglobin complex,GO:0030141~secretory granule,GO:0030139~endocytic vesicle,GO:0005833~hemoglobin complex,GO:0005829~cytosol,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0046906~tetrapyrrole binding,GO:0046872~metal ion binding,GO:0043177~organic acid binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0036094~small molecule binding,GO:0031721~hemoglobin alpha binding,GO:0031720~haptoglobin binding,GO:0030492~hemoglobin binding,GO:0020037~heme binding,GO:0019825~oxygen binding,GO:0016684~oxidoreductase activity, acting on peroxide as acceptor,GO:0016209~antioxidant activity,GO:0005344~oxygen transporter activity,GO:0004601~peroxidase activity,												IPR012292:Globin/Proto,IPR009050:Globin-like_sf,IPR002337:Hemoglobin_b,IPR000971:Globin,												hsa05144:Malaria,hsa05143:African trypanosomiasis,												617980~Erythrocytosis, familial, 6,617971~Methemoglobinemia, beta type,613985~Thalassemia, beta,611162~Malaria, resistance to,603903~Sickle cell disease,603902~Thalassemia-beta, dominant inclusion-body,141749~Hereditary persistence of fetal hemoglobin,141749~Delta-beta thalassemia,140700~Heinz body anemia,														TRANSMEM:Helical,SITE:Not glycated,SITE:(Microbial infection) Cleavage; by N.americanus apr-2,REGION:Disordered,PEPTIDE:Spinorphin,PEPTIDE:LVV-hemorphin-7,DOMAIN:Globin family profile,CARBOHYD:N-linked (Glc) (glycation) valine; in Hb A1c,CARBOHYD:N-linked (Glc) (glycation) lysine; alternate,CARBOHYD:N-linked (Glc) (glycation) lysine,BINDING:proximal binding residue,BINDING:distal binding residue,
33516_at	hemoglobin subunit delta(HBD)	Homo sapiens			GO:1990748~cellular detoxification,GO:0098869~cellular oxidant detoxification,GO:0098754~detoxification,GO:0072593~reactive oxygen species metabolic process,GO:0042744~hydrogen peroxide catabolic process,GO:0042743~hydrogen peroxide metabolic process,GO:0019755~one-carbon compound transport,GO:0015671~oxygen transport,GO:0015670~carbon dioxide transport,GO:0015669~gas transport,GO:0009636~response to toxic substance,												GO:0072562~blood microparticle,GO:0044445~cytosolic part,GO:0044421~extracellular region part,GO:0031838~haptoglobin-hemoglobin complex,GO:0005833~hemoglobin complex,GO:0005829~cytosol,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0046906~tetrapyrrole binding,GO:0046872~metal ion binding,GO:0043177~organic acid binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0036094~small molecule binding,GO:0031721~hemoglobin alpha binding,GO:0031720~haptoglobin binding,GO:0030492~hemoglobin binding,GO:0020037~heme binding,GO:0019825~oxygen binding,GO:0016684~oxidoreductase activity, acting on peroxide as acceptor,GO:0016209~antioxidant activity,GO:0005344~oxygen transporter activity,GO:0004601~peroxidase activity,												IPR012292:Globin/Proto,IPR009050:Globin-like_sf,IPR002337:Hemoglobin_b,IPR000971:Globin,													Thalassemia, delta-~Thalassemia, delta-,Thalassemia due to Hb Lepore~Thalassemia due to Hb Lepore,														TRANSMEM:Helical,DOMAIN:Globin family profile,BINDING:proximal binding residue,BINDING:distal binding residue,
40735_at	histidine ammonia-lyase(HAL)	Homo sapiens			GO:1901606~alpha-amino acid catabolic process,GO:1901605~alpha-amino acid metabolic process,GO:1901565~organonitrogen compound catabolic process,GO:1901361~organic cyclic compound catabolic process,GO:0052805~imidazole-containing compound catabolic process,GO:0052803~imidazole-containing compound metabolic process,GO:0046700~heterocycle catabolic process,GO:0046395~carboxylic acid catabolic process,GO:0044712~single-organism catabolic process,GO:0044282~small molecule catabolic process,GO:0044270~cellular nitrogen compound catabolic process,GO:0043648~dicarboxylic acid metabolic process,GO:0043606~formamide metabolic process,GO:0043603~cellular amide metabolic process,GO:0043436~oxoacid metabolic process,GO:0032787~monocarboxylic acid metabolic process,GO:0019752~carboxylic acid metabolic process,GO:0019557~histidine catabolic process to glutamate and formate,GO:0019556~histidine catabolic process to glutamate and formamide,GO:0019439~aromatic compound catabolic process,GO:0016054~organic acid catabolic process,GO:0015942~formate metabolic process,GO:0009064~glutamine family amino acid metabolic process,GO:0009063~cellular amino acid catabolic process,GO:0006548~histidine catabolic process,GO:0006547~histidine metabolic process,GO:0006536~glutamate metabolic process,GO:0006520~cellular amino acid metabolic process,GO:0006082~organic acid metabolic process,												GO:0005829~cytosol,												GO:0016841~ammonia-lyase activity,GO:0016840~carbon-nitrogen lyase activity,GO:0004397~histidine ammonia-lyase activity,												IPR024083:Fumarase/histidase_N,IPR022313:Phe/His_NH3-lyase_AS,IPR021922:Par3/HAL_N,IPR008948:L-Aspartase-like,IPR005921:HutH,IPR001106:Aromatic_Lyase,												hsa01100:Metabolic pathways,hsa00340:Histidine metabolism,												235800~Histidinemia,														DOMAIN:Par3/HAL N-terminal,CROSSLNK:5-imidazolinone (Ala-Gly),
31512_at	immunoglobulin kappa variable 1-13(IGKV1-13)	Homo sapiens			GO:0006955~immune response,GO:0002440~production of molecular mediator of immune response,GO:0002377~immunoglobulin production,GO:0002250~adaptive immune response,												GO:0044421~extracellular region part,GO:0019814~immunoglobulin complex,GO:0005615~extracellular space,GO:0005576~extracellular region,													IPR036179:Ig-like_dom_sf,IPR013783:Ig-like_fold,IPR013106:Ig_V-set,IPR007110:Ig-like_dom,IPR003599:Ig_sub,															SM00409:IG,SM00406:IGv,												DOMAIN:Ig-like,
35915_at	inhibin subunit beta C(INHBC)	Homo sapiens				GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:0008083~growth factor activity,GO:0005179~hormone activity,GO:0005160~transforming growth factor beta receptor binding,GO:0005126~cytokine receptor binding,GO:0005125~cytokine activity,GO:0005102~receptor binding,												IPR029034:Cystine-knot_cytokine,IPR017948:TGFb_CS,IPR015615:TGF-beta-rel,IPR001839:TGF-b_C,IPR001318:Inhibin_betaC,												hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04350:TGF-beta signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,														SM00204:TGFB,												DOMAIN:TGF-beta family profile,DISULFID:Interchain,CARBOHYD:N-linked (GlcNAc...) asparagine,
38674_at	kelch like family member 9(KLHL9)	Homo sapiens			GO:0070647~protein modification by small protein conjugation or removal,GO:0051726~regulation of cell cycle,GO:0051302~regulation of cell division,GO:0051301~cell division,GO:0036211~protein modification process,GO:0032465~regulation of cytokinesis,GO:0032446~protein modification by small protein conjugation,GO:0022402~cell cycle process,GO:0016567~protein ubiquitination,GO:0010564~regulation of cell cycle process,GO:0007049~cell cycle,GO:0006464~cellular protein modification process,												GO:0031463~Cul3-RING ubiquitin ligase complex,GO:0031461~cullin-RING ubiquitin ligase complex,GO:0030496~midbody,GO:0005829~cytosol,GO:0000151~ubiquitin ligase complex,												GO:0097602~cullin family protein binding,GO:0019787~ubiquitin-like protein transferase activity,GO:0004842~ubiquitin-protein transferase activity,												IPR017096:BTB-kelch_protein,IPR015915:Kelch-typ_b-propeller,IPR011705:BACK,IPR011333:SKP1/BTB/POZ_sf,IPR006652:Kelch_1,IPR000210:BTB/POZ_dom,												hsa04120:Ubiquitin mediated proteolysis,													PIRSF037037:Kelch-like_protein_gigaxonin,												SM00875:BACK,SM00612:Kelch,SM00225:BTB,												REPEAT:Kelch 6,REPEAT:Kelch 5,REPEAT:Kelch 4,REPEAT:Kelch 3,REPEAT:Kelch 2,REPEAT:Kelch 1,REGION:Disordered,DOMAIN:BTB,DOMAIN:BACK,
34012_at	keratin, type I cuticular Ha4(LOC100653049)	Homo sapiens			GO:1902589~single-organism organelle organization,GO:0097435~supramolecular fiber organization,GO:0060429~epithelium development,GO:0045109~intermediate filament organization,GO:0045104~intermediate filament cytoskeleton organization,GO:0045103~intermediate filament-based process,GO:0030855~epithelial cell differentiation,GO:0008544~epidermis development,GO:0007010~cytoskeleton organization,												GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0099081~supramolecular polymer,GO:0099080~supramolecular complex,GO:0045111~intermediate filament cytoskeleton,GO:0044421~extracellular region part,GO:0005882~intermediate filament,GO:0005829~cytosol,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:0005198~structural molecule activity,												IPR039008:IF_rod_dom,IPR018039:IF_conserved,IPR002957:Keratin_I,												hsa05150:Staphylococcus aureus infection,hsa04915:Estrogen signaling pathway,														SM01391:Filament,												SITE:Stutter,REGION:Tail,REGION:Linker 12,REGION:Linker 1,REGION:Head,REGION:Coil 2,REGION:Coil 1B,REGION:Coil 1A,DOMAIN:IF rod,
36436_at	leukocyte cell derived chemotaxin 2(LECT2)	Homo sapiens			GO:0042330~taxis,GO:0040011~locomotion,GO:0009605~response to external stimulus,GO:0006935~chemotaxis,GO:0001501~skeletal system development,												GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0042802~identical protein binding,												IPR017381:LECT2_chordata,IPR016047:Peptidase_M23,IPR011055:Dup_hybrid_motif,IPR008663:LECT2,														PIRSF038085:LECT3,													MUTAGEN:Y->H: No metalloendopeptidase activity.,
32073_at	lysine demethylase 4A(KDM4A)	Homo sapiens			GO:2001141~regulation of RNA biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1902679~negative regulation of RNA biosynthetic process,GO:0097659~nucleic acid-templated transcription,GO:0097194~execution phase of apoptosis,GO:0071103~DNA conformation change,GO:0060284~regulation of cell development,GO:0051962~positive regulation of nervous system development,GO:0051961~negative regulation of nervous system development,GO:0051960~regulation of nervous system development,GO:0051276~chromosome organization,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051241~negative regulation of multicellular organismal process,GO:0051240~positive regulation of multicellular organismal process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051094~positive regulation of developmental process,GO:0051093~negative regulation of developmental process,GO:0050769~positive regulation of neurogenesis,GO:0050768~negative regulation of neurogenesis,GO:0050767~regulation of neurogenesis,GO:0048712~negative regulation of astrocyte differentiation,GO:0048710~regulation of astrocyte differentiation,GO:0048708~astrocyte differentiation,GO:0048699~generation of neurons,GO:0048468~cell development,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045686~negative regulation of glial cell differentiation,GO:0045685~regulation of glial cell differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045664~regulation of neuron differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0043500~muscle adaptation,GO:0042063~gliogenesis,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0031667~response to nutrient levels,GO:0031330~negative regulation of cellular catabolic process,GO:0031329~regulation of cellular catabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031324~negative regulation of cellular metabolic process,GO:0030263~apoptotic chromosome condensation,GO:0030262~apoptotic nuclear changes,GO:0030261~chromosome condensation,GO:0030182~neuron differentiation,GO:0022411~cellular component disassembly,GO:0022008~neurogenesis,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016070~RNA metabolic process,GO:0014898~cardiac muscle hypertrophy in response to stress,GO:0014897~striated muscle hypertrophy,GO:0014896~muscle hypertrophy,GO:0014888~striated muscle adaptation,GO:0014887~cardiac muscle adaptation,GO:0014014~negative regulation of gliogenesis,GO:0014013~regulation of gliogenesis,GO:0012501~programmed cell death,GO:0010721~negative regulation of cell development,GO:0010720~positive regulation of cell development,GO:0010629~negative regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010507~negative regulation of autophagy,GO:0010506~regulation of autophagy,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010001~glial cell differentiation,GO:0009991~response to extracellular stimulus,GO:0009895~negative regulation of catabolic process,GO:0009894~regulation of catabolic process,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0009605~response to external stimulus,GO:0008219~cell death,GO:0007417~central nervous system development,GO:0007399~nervous system development,GO:0006921~cellular component disassembly involved in execution phase of apoptosis,GO:0006915~apoptotic process,GO:0006914~autophagy,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0006338~chromatin remodeling,GO:0006325~chromatin organization,GO:0006323~DNA packaging,GO:0003300~cardiac muscle hypertrophy,GO:0003299~muscle hypertrophy in response to stress,GO:0003012~muscle system process,GO:0003008~system process,												GO:0098687~chromosomal region,GO:0044452~nucleolar part,GO:0044427~chromosomal part,GO:0005829~cytosol,GO:0005730~nucleolus,GO:0005721~pericentric heterochromatin,GO:0005694~chromosome,GO:0005654~nucleoplasm,GO:0001650~fibrillar center,GO:0000792~heterochromatin,GO:0000785~chromatin,GO:0000775~chromosome, centromeric region,												GO:0051864~histone demethylase activity (H3-K36 specific),GO:0051213~dioxygenase activity,GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0044389~ubiquitin-like protein ligase binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0042393~histone binding,GO:0035064~methylated histone binding,GO:0032454~histone demethylase activity (H3-K9 specific),GO:0032452~histone demethylase activity,GO:0032451~demethylase activity,GO:0031625~ubiquitin protein ligase binding,GO:0019899~enzyme binding,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0008270~zinc ion binding,												IPR047482:JMJD2A_ePHD,IPR047481:Tudor_KDM4A_rpt2,IPR047479:Tudor_KDM4A_rpt1,IPR040477:KDM4-like_Tudor,IPR034732:EPHD,IPR013083:Znf_RING/FYVE/PHD,IPR011011:Znf_FYVE_PHD,IPR003349:JmjN,IPR003347:JmjC_dom,IPR002999:Tudor,IPR001965:Znf_PHD,															SM00558:JmjC,SM00545:JmjN,SM00333:TUDOR,SM00249:PHD,												ZN_FING:PHD-type 2,ZN_FING:PHD-type 1,ZN_FING:C2HC pre-PHD-type,SITE:Histone H3K4me3 binding,REGION:Interaction with NCOR1,REGION:Disordered,MUTAGEN:Y->A: Abolishes binding to H3K4me3.,MUTAGEN:W->H: Abolishes binding to H3K4me3.,MUTAGEN:ST->TV,NV,GG: Abolishes histone demethylase activity.,MUTAGEN:ST->AI: Displays histone demethylase activity for both dimethylated and H3-K9Me3.,MUTAGEN:H->A: Abolishes histone demethylase activity without affecting ability to bind H4K20me2.,MUTAGEN:G->A: Abolishes histone demethylase activity; when associated with A-165.,MUTAGEN:G->A: Abolishes histone demethylase activity; when associated with A-138.,MUTAGEN:D->R: Impairs binding to H4K20me2, promoting partial recruitment of TP53BP1.,MUTAGEN:D->R: Abolishes binding to H3K4me3.,MUTAGEN:D->A: Impairs binding to H3K4me3.,DOMAIN:Tudor 2,DOMAIN:Tudor 1,DOMAIN:JmjN,DOMAIN:JmjC,COMPBIAS:Polar residues,
37408_at	mannose receptor C type 2(MRC2)	Homo sapiens			GO:0044712~single-organism catabolic process,GO:0044259~multicellular organismal macromolecule metabolic process,GO:0044243~multicellular organismal catabolic process,GO:0044236~multicellular organism metabolic process,GO:0032963~collagen metabolic process,GO:0030574~collagen catabolic process,GO:0016192~vesicle-mediated transport,GO:0006897~endocytosis,GO:0001649~osteoblast differentiation,GO:0001503~ossification,												GO:0070161~anchoring junction,GO:0030055~cell-substrate junction,GO:0030054~cell junction,GO:0005925~focal adhesion,GO:0005924~cell-substrate adherens junction,GO:0005912~adherens junction,												GO:0060089~molecular transducer activity,GO:0044877~macromolecular complex binding,GO:0038023~signaling receptor activity,GO:0032403~protein complex binding,GO:0030246~carbohydrate binding,GO:0005518~collagen binding,GO:0004872~receptor activity,GO:0004871~signal transducer activity,												IPR036943:FN_type2_sf,IPR035992:Ricin_B-like_lectins,IPR033989:CD209-like_CTLD,IPR018378:C-type_lectin_CS,IPR016187:CTDL_fold,IPR016186:C-type_lectin-like/link_sf,IPR013806:Kringle-like,IPR001304:C-type_lectin-like,IPR000772:Ricin_B_lectin,IPR000562:FN_type2_dom,												hsa05152:Tuberculosis,hsa04145:Phagosome,														SM00458:RICIN,SM00059:FN2,SM00034:CLECT,												TRANSMEM:Helical,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,REGION:Disordered,MUTAGEN:Y->A: No alteration of distribution and trafficking.,MUTAGEN:N->D: Reduced sugar-binding activity.,MUTAGEN:LV->AA: Reduction of endocytotic activity; distribution almost restricted to the cell surface.,MUTAGEN:E->A: Increased cell surface distribution.,DOMAIN:Ricin B-type lectin,DOMAIN:Fibronectin type-II,DOMAIN:C-type lectin 8,DOMAIN:C-type lectin 7,DOMAIN:C-type lectin 6,DOMAIN:C-type lectin 5,DOMAIN:C-type lectin 4,DOMAIN:C-type lectin 3,DOMAIN:C-type lectin 2,DOMAIN:C-type lectin 1,DOMAIN:C-type lectin,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1),COMPBIAS:Polar residues,CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:N-linked (GlcNAc...) (complex) asparagine,
38945_at	metal regulatory transcription factor 1(MTF1)	Homo sapiens			GO:2001141~regulation of RNA biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1990079~cartilage homeostasis,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1902680~positive regulation of RNA biosynthetic process,GO:0097659~nucleic acid-templated transcription,GO:0071294~cellular response to zinc ion,GO:0071248~cellular response to metal ion,GO:0071241~cellular response to inorganic substance,GO:0070887~cellular response to chemical stimulus,GO:0060249~anatomical structure homeostasis,GO:0051254~positive regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0048871~multicellular organismal homeostasis,GO:0046686~response to cadmium ion,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0042592~homeostatic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016070~RNA metabolic process,GO:0010628~positive regulation of gene expression,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010043~response to zinc ion,GO:0010038~response to metal ion,GO:0010035~response to inorganic substance,GO:0009893~positive regulation of metabolic process,GO:0009891~positive regulation of biosynthetic process,GO:0007417~central nervous system development,GO:0007399~nervous system development,GO:0006979~response to oxidative stress,GO:0006366~transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0001894~tissue homeostasis,												GO:0005654~nucleoplasm,												GO:1990837~sequence-specific double-stranded DNA binding,GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0046872~metal ion binding,GO:0044212~transcription regulatory region DNA binding,GO:0043565~sequence-specific DNA binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0035035~histone acetyltransferase binding,GO:0019899~enzyme binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003690~double-stranded DNA binding,GO:0003677~DNA binding,GO:0003676~nucleic acid binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001159~core promoter proximal region DNA binding,GO:0001071~nucleic acid binding transcription factor activity,GO:0001067~regulatory region nucleic acid binding,GO:0001012~RNA polymerase II regulatory region DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000975~regulatory region DNA binding,												IPR036236:Znf_C2H2_sf,IPR013087:Znf_C2H2_type,															SM00355:ZnF_C2H2,												ZN_FING:C2H2-type 6,ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 1,REGION:Disordered,MOTIF:Nuclear localization signal,COMPBIAS:Pro residues,COMPBIAS:Polar residues,
41280_r_at	mitogen-activated protein kinase 8 interacting protein 1(MAPK8IP1)	Homo sapiens			GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,GO:2001242~regulation of intrinsic apoptotic signaling pathway,GO:2001234~negative regulation of apoptotic signaling pathway,GO:2001233~regulation of apoptotic signaling pathway,GO:2001185~regulation of CD8-positive, alpha-beta T cell activation,GO:2001141~regulation of RNA biosynthetic process,GO:2000564~regulation of CD8-positive, alpha-beta T cell proliferation,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903037~regulation of leukocyte cell-cell adhesion,GO:1902533~positive regulation of intracellular signal transduction,GO:1902532~negative regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:0098609~cell-cell adhesion,GO:0098602~single organism cell adhesion,GO:0097659~nucleic acid-templated transcription,GO:0097193~intrinsic apoptotic signaling pathway,GO:0097190~apoptotic signaling pathway,GO:0080135~regulation of cellular response to stress,GO:0080134~regulation of response to stress,GO:0071901~negative regulation of protein serine/threonine kinase activity,GO:0071900~regulation of protein serine/threonine kinase activity,GO:0070663~regulation of leukocyte proliferation,GO:0070661~leukocyte proliferation,GO:0070304~positive regulation of stress-activated protein kinase signaling cascade,GO:0070303~negative regulation of stress-activated protein kinase signaling cascade,GO:0070302~regulation of stress-activated protein kinase signaling cascade,GO:0065009~regulation of molecular function,GO:0060548~negative regulation of cell death,GO:0051403~stress-activated MAPK cascade,GO:0051348~negative regulation of transferase activity,GO:0051338~regulation of transferase activity,GO:0051252~regulation of RNA metabolic process,GO:0051249~regulation of lymphocyte activation,GO:0051248~negative regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0050865~regulation of cell activation,GO:0050863~regulation of T cell activation,GO:0050790~regulation of catalytic activity,GO:0050670~regulation of lymphocyte proliferation,GO:0048585~negative regulation of response to stimulus,GO:0048584~positive regulation of response to stimulus,GO:0046651~lymphocyte proliferation,GO:0046649~lymphocyte activation,GO:0046640~regulation of alpha-beta T cell proliferation,GO:0046634~regulation of alpha-beta T cell activation,GO:0046633~alpha-beta T cell proliferation,GO:0046631~alpha-beta T cell activation,GO:0046330~positive regulation of JNK cascade,GO:0046329~negative regulation of JNK cascade,GO:0046328~regulation of JNK cascade,GO:0045937~positive regulation of phosphate metabolic process,GO:0045936~negative regulation of phosphate metabolic process,GO:0045859~regulation of protein kinase activity,GO:0045321~leukocyte activation,GO:0044092~negative regulation of molecular function,GO:0043549~regulation of kinase activity,GO:0043508~negative regulation of JUN kinase activity,GO:0043506~regulation of JUN kinase activity,GO:0043410~positive regulation of MAPK cascade,GO:0043409~negative regulation of MAPK cascade,GO:0043408~regulation of MAPK cascade,GO:0043407~negative regulation of MAP kinase activity,GO:0043405~regulation of MAP kinase activity,GO:0043086~negative regulation of catalytic activity,GO:0043069~negative regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptotic process,GO:0042981~regulation of apoptotic process,GO:0042327~positive regulation of phosphorylation,GO:0042326~negative regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0042129~regulation of T cell proliferation,GO:0042127~regulation of cell proliferation,GO:0042110~T cell activation,GO:0042098~T cell proliferation,GO:0036211~protein modification process,GO:0036037~CD8-positive, alpha-beta T cell activation,GO:0035556~intracellular signal transduction,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0033673~negative regulation of kinase activity,GO:0033554~cellular response to stress,GO:0032944~regulation of mononuclear cell proliferation,GO:0032943~mononuclear cell proliferation,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0032873~negative regulation of stress-activated MAPK cascade,GO:0032872~regulation of stress-activated MAPK cascade,GO:0032774~RNA biosynthetic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0031401~positive regulation of protein modification process,GO:0031400~negative regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031325~positive regulation of cellular metabolic process,GO:0031324~negative regulation of cellular metabolic process,GO:0031098~stress-activated protein kinase signaling cascade,GO:0030155~regulation of cell adhesion,GO:0023057~negative regulation of signaling,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0023014~signal transduction by protein phosphorylation,GO:0022610~biological adhesion,GO:0022407~regulation of cell-cell adhesion,GO:0019438~aromatic compound biosynthetic process,GO:0019220~regulation of phosphate metabolic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016337~single organismal cell-cell adhesion,GO:0016310~phosphorylation,GO:0016192~vesicle-mediated transport,GO:0016070~RNA metabolic process,GO:0012501~programmed cell death,GO:0010941~regulation of cell death,GO:0010648~negative regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010563~negative regulation of phosphorus metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0009968~negative regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0008283~cell proliferation,GO:0008219~cell death,GO:0007254~JNK cascade,GO:0007159~leukocyte cell-cell adhesion,GO:0007155~cell adhesion,GO:0006915~apoptotic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006469~negative regulation of protein kinase activity,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0006355~regulation of transcription, DNA-templated,GO:0002694~regulation of leukocyte activation,GO:0002682~regulation of immune system process,GO:0001934~positive regulation of protein phosphorylation,GO:0001933~negative regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,GO:0001775~cell activation,GO:0000165~MAPK cascade,												GO:0097458~neuron part,GO:0048471~perinuclear region of cytoplasm,GO:0045202~synapse,GO:0044432~endoplasmic reticulum part,GO:0044429~mitochondrial part,GO:0044302~dentate gyrus mossy fiber,GO:0044297~cell body,GO:0043025~neuronal cell body,GO:0043005~neuron projection,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0036477~somatodendritic compartment,GO:0031975~envelope,GO:0031967~organelle envelope,GO:0031966~mitochondrial membrane,GO:0030425~dendrite,GO:0030424~axon,GO:0005829~cytosol,GO:0005789~endoplasmic reticulum membrane,GO:0005783~endoplasmic reticulum,GO:0005740~mitochondrial envelope,GO:0005739~mitochondrion,												GO:0098772~molecular function regulator,GO:0060090~binding, bridging,GO:0035591~signaling adaptor activity,GO:0032947~protein complex scaffold,GO:0030234~enzyme regulator activity,GO:0019901~protein kinase binding,GO:0019900~kinase binding,GO:0019899~enzyme binding,GO:0019894~kinesin binding,GO:0019887~protein kinase regulator activity,GO:0019210~kinase inhibitor activity,GO:0019207~kinase regulator activity,GO:0016301~kinase activity,GO:0008432~JUN kinase binding,GO:0008092~cytoskeletal protein binding,GO:0005198~structural molecule activity,GO:0005078~MAP-kinase scaffold activity,GO:0004860~protein kinase inhibitor activity,GO:0004857~enzyme inhibitor activity,												IPR047178:JIP1_scaffold,IPR036028:SH3-like_dom_sf,IPR035638:JIP1_SH3,IPR011993:PH-like_dom_sf,IPR006020:PTB/PI_dom,IPR001452:SH3_domain,												hsa04010:MAPK signaling pathway,												125853~Diabetes mellitus, noninsulin-dependent,													SM00462:PTB,SM00326:SH3,												REGION:Minimal inhibitory domain (MID),REGION:JNK-binding domain (JBD),REGION:Interaction with VRK2,REGION:Interaction with MAP3K7,REGION:Disordered,MUTAGEN:Y->A: Abolishes KNS2 binding.,MUTAGEN:R->G: Abolishes MAPK9 interaction.,MUTAGEN:P->G: Abolishes MAPK9 interaction.,MUTAGEN:P->A: No effect on KNS2 binding.,MOTIF:D-box 2,MOTIF:D-box 1,DOMAIN:SH3,DOMAIN:PID,COMPBIAS:Polar residues,COMPBIAS:Basic and acidic residues,
33284_at	myeloperoxidase(MPO)	Homo sapiens			GO:1990748~cellular detoxification,GO:1990268~response to gold nanoparticle,GO:1990267~response to transition metal nanoparticle,GO:1903409~reactive oxygen species biosynthetic process,GO:1901701~cellular response to oxygen-containing compound,GO:1901700~response to oxygen-containing compound,GO:0098869~cellular oxidant detoxification,GO:0098754~detoxification,GO:0098542~defense response to other organism,GO:0097006~regulation of plasma lipoprotein particle levels,GO:0072593~reactive oxygen species metabolic process,GO:0071827~plasma lipoprotein particle organization,GO:0071825~protein-lipid complex subunit organization,GO:0071451~cellular response to superoxide,GO:0071450~cellular response to oxygen radical,GO:0070887~cellular response to chemical stimulus,GO:0060548~negative regulation of cell death,GO:0051707~response to other organism,GO:0050832~defense response to fungus,GO:0045730~respiratory burst,GO:0044283~small molecule biosynthetic process,GO:0043933~macromolecular complex subunit organization,GO:0043436~oxoacid metabolic process,GO:0043207~response to external biotic stimulus,GO:0043069~negative regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptotic process,GO:0042981~regulation of apoptotic process,GO:0042744~hydrogen peroxide catabolic process,GO:0042743~hydrogen peroxide metabolic process,GO:0042742~defense response to bacterium,GO:0034614~cellular response to reactive oxygen species,GO:0034599~cellular response to oxidative stress,GO:0034374~low-density lipoprotein particle remodeling,GO:0034369~plasma lipoprotein particle remodeling,GO:0034368~protein-lipid complex remodeling,GO:0034367~macromolecular complex remodeling,GO:0033993~response to lipid,GO:0033554~cellular response to stress,GO:0032496~response to lipopolysaccharide,GO:0032094~response to food,GO:0031667~response to nutrient levels,GO:0019430~removal of superoxide radicals,GO:0012501~programmed cell death,GO:0010941~regulation of cell death,GO:0010035~response to inorganic substance,GO:0010033~response to organic substance,GO:0009991~response to extracellular stimulus,GO:0009636~response to toxic substance,GO:0009628~response to abiotic stimulus,GO:0009620~response to fungus,GO:0009617~response to bacterium,GO:0009612~response to mechanical stimulus,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0008219~cell death,GO:0006979~response to oxidative stress,GO:0006952~defense response,GO:0006915~apoptotic process,GO:0006801~superoxide metabolic process,GO:0006082~organic acid metabolic process,GO:0002679~respiratory burst involved in defense response,GO:0002252~immune effector process,GO:0002237~response to molecule of bacterial origin,GO:0002149~hypochlorous acid biosynthetic process,GO:0002148~hypochlorous acid metabolic process,GO:0001878~response to yeast,GO:0000305~response to oxygen radical,GO:0000303~response to superoxide,GO:0000302~response to reactive oxygen species,												GO:1903561~extracellular vesicle,GO:0099503~secretory vesicle,GO:0097013~phagocytic vesicle lumen,GO:0071682~endocytic vesicle lumen,GO:0070062~extracellular exosome,GO:0060205~cytoplasmic vesicle lumen,GO:0045335~phagocytic vesicle,GO:0044437~vacuolar part,GO:0044433~cytoplasmic vesicle part,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0042582~azurophil granule,GO:0035578~azurophil granule lumen,GO:0034774~secretory granule lumen,GO:0031983~vesicle lumen,GO:0030141~secretory granule,GO:0030139~endocytic vesicle,GO:0005775~vacuolar lumen,GO:0005773~vacuole,GO:0005766~primary lysosome,GO:0005764~lysosome,GO:0005654~nucleoplasm,GO:0005615~extracellular space,GO:0005576~extracellular region,GO:0000323~lytic vacuole,												GO:1901681~sulfur compound binding,GO:1901363~heterocyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:0097159~organic cyclic compound binding,GO:0046906~tetrapyrrole binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043168~anion binding,GO:0043167~ion binding,GO:0020037~heme binding,GO:0016684~oxidoreductase activity, acting on peroxide as acceptor,GO:0016209~antioxidant activity,GO:0008201~heparin binding,GO:0005539~glycosaminoglycan binding,GO:0004601~peroxidase activity,GO:0003682~chromatin binding,												IPR037120:Haem_peroxidase_sf_animal,IPR019791:Haem_peroxidase_animal,IPR010255:Haem_peroxidase_sf,												hsa05221:Acute myeloid leukemia,hsa05202:Transcriptional misregulation in cancer,hsa04613:Neutrophil extracellular trap formation,hsa04145:Phagosome,hsa00983:Drug metabolism - other enzymes,												Lung cancer, protection against, in smokers~Lung cancer, protection against, in smokers,254600~Myeloperoxidase deficiency,104300~Alzheimer disease, susceptibility to,														SITE:Transition state stabilizer,DISULFID:Interchain,CARBOHYD:N-linked (GlcNAc...) asparagine,BINDING:covalent,BINDING:axial binding residue,ACT_SITE:Proton acceptor,
37711_at	myocyte enhancer factor 2C(MEF2C)	Homo sapiens		h_pgc1aPathway:Regulation of PGC-1a,h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_mitrPathway:Signal Dependent Regulation of Myogenesis by Corepressor MITR,h_mapkPathway:MAPKinase Signaling Pathway,h_hdacPathway:Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK),h_erk5Pathway:Role of Erk5 in Neuronal Survival,h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_alkPathway:ALK in cardiac myocytes,												GO:2001257~regulation of cation channel activity,GO:2001141~regulation of RNA biosynthetic process,GO:2001016~positive regulation of skeletal muscle cell differentiation,GO:2001014~regulation of skeletal muscle cell differentiation,GO:2001013~epithelial cell proliferation involved in renal tubule morphogenesis,GO:2000987~positive regulation of behavioral fear response,GO:2000822~regulation of behavioral fear response,GO:2000727~positive regulation of cardiac muscle cell differentiation,GO:2000725~regulation of cardiac muscle cell differentiation,GO:2000311~regulation of AMPA receptor activity,GO:2000310~regulation of NMDA receptor activity,GO:2000146~negative regulation of cell motility,GO:2000145~regulation of cell motility,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000111~positive regulation of macrophage apoptotic process,GO:2000109~regulation of macrophage apoptotic process,GO:2000108~positive regulation of leukocyte apoptotic process,GO:2000106~regulation of leukocyte apoptotic process,GO:1990874~vascular smooth muscle cell proliferation,GO:1905563~negative regulation of vascular endothelial cell proliferation,GO:1905562~regulation of vascular endothelial cell proliferation,GO:1905209~positive regulation of cardiocyte differentiation,GO:1905207~regulation of cardiocyte differentiation,GO:1905114~cell surface receptor signaling pathway involved in cell-cell signaling,GO:1904753~negative regulation of vascular associated smooth muscle cell migration,GO:1904752~regulation of vascular associated smooth muscle cell migration,GO:1904738~vascular associated smooth muscle cell migration,GO:1904706~negative regulation of vascular smooth muscle cell proliferation,GO:1904705~regulation of vascular smooth muscle cell proliferation,GO:1904062~regulation of cation transmembrane transport,GO:1903706~regulation of hemopoiesis,GO:1903530~regulation of secretion by cell,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903367~positive regulation of fear response,GO:1903365~regulation of fear response,GO:1902680~positive regulation of RNA biosynthetic process,GO:1902679~negative regulation of RNA biosynthetic process,GO:1902533~positive regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:1901863~positive regulation of muscle tissue development,GO:1901861~regulation of muscle tissue development,GO:1901701~cellular response to oxygen-containing compound,GO:1901700~response to oxygen-containing compound,GO:1901699~cellular response to nitrogen compound,GO:1901698~response to nitrogen compound,GO:1901215~negative regulation of neuron death,GO:1901214~regulation of neuron death,GO:1900449~regulation of glutamate receptor signaling pathway,GO:0101023~vascular endothelial cell proliferation,GO:0099601~regulation of neurotransmitter receptor activity,GO:0099565~chemical synaptic transmission, postsynaptic,GO:0099537~trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0098916~anterograde trans-synaptic signaling,GO:0098655~cation transmembrane transport,GO:0097659~nucleic acid-templated transcription,GO:0090132~epithelium migration,GO:0090130~tissue migration,GO:0080134~regulation of response to stress,GO:0072359~circulatory system development,GO:0072358~cardiovascular system development,GO:0072160~nephron tubule epithelial cell differentiation,GO:0072102~glomerulus morphogenesis,GO:0072080~nephron tubule development,GO:0072073~kidney epithelium development,GO:0072009~nephron epithelium development,GO:0072006~nephron development,GO:0072001~renal system development,GO:0071888~macrophage apoptotic process,GO:0071887~leukocyte apoptotic process,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0071559~response to transforming growth factor beta,GO:0071498~cellular response to fluid shear stress,GO:0071495~cellular response to endogenous stimulus,GO:0071466~cellular response to xenobiotic stimulus,GO:0071417~cellular response to organonitrogen compound,GO:0071407~cellular response to organic cyclic compound,GO:0071396~cellular response to lipid,GO:0071374~cellular response to parathyroid hormone stimulus,GO:0071363~cellular response to growth factor stimulus,GO:0071310~cellular response to organic substance,GO:0071277~cellular response to calcium ion,GO:0071248~cellular response to metal ion,GO:0071241~cellular response to inorganic substance,GO:0071236~cellular response to antibiotic,GO:0071222~cellular response to lipopolysaccharide,GO:0071219~cellular response to molecule of bacterial origin,GO:0071216~cellular response to biotic stimulus,GO:0071107~response to parathyroid hormone,GO:0070997~neuron death,GO:0070887~cellular response to chemical stimulus,GO:0070848~response to growth factor,GO:0070665~positive regulation of leukocyte proliferation,GO:0070663~regulation of leukocyte proliferation,GO:0070661~leukocyte proliferation,GO:0070169~positive regulation of biomineral tissue development,GO:0070167~regulation of biomineral tissue development,GO:0065009~regulation of molecular function,GO:0061448~connective tissue development,GO:0061371~determination of heart left/right asymmetry,GO:0061333~renal tubule morphogenesis,GO:0061326~renal tubule development,GO:0061061~muscle structure development,GO:0061005~cell differentiation involved in kidney development,GO:0060998~regulation of dendritic spine development,GO:0060914~heart formation,GO:0060562~epithelial tube morphogenesis,GO:0060548~negative regulation of cell death,GO:0060538~skeletal muscle organ development,GO:0060537~muscle tissue development,GO:0060485~mesenchyme development,GO:0060429~epithelium development,GO:0060421~positive regulation of heart growth,GO:0060420~regulation of heart growth,GO:0060419~heart growth,GO:0060350~endochondral bone morphogenesis,GO:0060349~bone morphogenesis,GO:0060348~bone development,GO:0060341~regulation of cellular localization,GO:0060284~regulation of cell development,GO:0060079~excitatory postsynaptic potential,GO:0060078~regulation of postsynaptic membrane potential,GO:0060045~positive regulation of cardiac muscle cell proliferation,GO:0060043~regulation of cardiac muscle cell proliferation,GO:0060038~cardiac muscle cell proliferation,GO:0060025~regulation of synaptic activity,GO:0055085~transmembrane transport,GO:0055025~positive regulation of cardiac muscle tissue development,GO:0055024~regulation of cardiac muscle tissue development,GO:0055023~positive regulation of cardiac muscle tissue growth,GO:0055021~regulation of cardiac muscle tissue growth,GO:0055017~cardiac muscle tissue growth,GO:0055012~ventricular cardiac muscle cell differentiation,GO:0055007~cardiac muscle cell differentiation,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0051963~regulation of synapse assembly,GO:0051962~positive regulation of nervous system development,GO:0051960~regulation of nervous system development,GO:0051707~response to other organism,GO:0051674~localization of cell,GO:0051641~cellular localization,GO:0051592~response to calcium ion,GO:0051588~regulation of neurotransmitter transport,GO:0051402~neuron apoptotic process,GO:0051345~positive regulation of hydrolase activity,GO:0051336~regulation of hydrolase activity,GO:0051271~negative regulation of cellular component movement,GO:0051270~regulation of cellular component movement,GO:0051254~positive regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051251~positive regulation of lymphocyte activation,GO:0051249~regulation of lymphocyte activation,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051241~negative regulation of multicellular organismal process,GO:0051240~positive regulation of multicellular organismal process,GO:0051216~cartilage development,GO:0051174~regulation of phosphorus metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051155~positive regulation of striated muscle cell differentiation,GO:0051153~regulation of striated muscle cell differentiation,GO:0051149~positive regulation of muscle cell differentiation,GO:0051147~regulation of muscle cell differentiation,GO:0051146~striated muscle cell differentiation,GO:0051145~smooth muscle cell differentiation,GO:0051128~regulation of cellular component organization,GO:0051094~positive regulation of developmental process,GO:0051049~regulation of transport,GO:0051046~regulation of secretion,GO:0050931~pigment cell differentiation,GO:0050890~cognition,GO:0050877~neurological system process,GO:0050871~positive regulation of B cell activation,GO:0050867~positive regulation of cell activation,GO:0050865~regulation of cell activation,GO:0050864~regulation of B cell activation,GO:0050853~B cell receptor signaling pathway,GO:0050851~antigen receptor-mediated signaling pathway,GO:0050808~synapse organization,GO:0050807~regulation of synapse organization,GO:0050804~modulation of synaptic transmission,GO:0050803~regulation of synapse structure or activity,GO:0050795~regulation of behavior,GO:0050790~regulation of catalytic activity,GO:0050778~positive regulation of immune response,GO:0050776~regulation of immune response,GO:0050773~regulation of dendrite development,GO:0050769~positive regulation of neurogenesis,GO:0050767~regulation of neurogenesis,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0050673~epithelial cell proliferation,GO:0050671~positive regulation of lymphocyte proliferation,GO:0050670~regulation of lymphocyte proliferation,GO:0048872~homeostasis of number of cells,GO:0048870~cell motility,GO:0048863~stem cell differentiation,GO:0048771~tissue remodeling,GO:0048762~mesenchymal cell differentiation,GO:0048738~cardiac muscle tissue development,GO:0048729~tissue morphogenesis,GO:0048705~skeletal system morphogenesis,GO:0048699~generation of neurons,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048666~neuron development,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048659~smooth muscle cell proliferation,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048645~animal organ formation,GO:0048643~positive regulation of skeletal muscle tissue development,GO:0048641~regulation of skeletal muscle tissue development,GO:0048639~positive regulation of developmental growth,GO:0048638~regulation of developmental growth,GO:0048636~positive regulation of muscle organ development,GO:0048634~regulation of muscle organ development,GO:0048598~embryonic morphogenesis,GO:0048589~developmental growth,GO:0048584~positive regulation of response to stimulus,GO:0048568~embryonic organ development,GO:0048562~embryonic organ morphogenesis,GO:0048534~hematopoietic or lymphoid organ development,GO:0048520~positive regulation of behavior,GO:0048468~cell development,GO:0048167~regulation of synaptic plasticity,GO:0048066~developmental pigmentation,GO:0046928~regulation of neurotransmitter secretion,GO:0046903~secretion,GO:0046677~response to antibiotic,GO:0046651~lymphocyte proliferation,GO:0046649~lymphocyte activation,GO:0046622~positive regulation of organ growth,GO:0046620~regulation of organ growth,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045937~positive regulation of phosphate metabolic process,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045927~positive regulation of growth,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045844~positive regulation of striated muscle tissue development,GO:0045778~positive regulation of ossification,GO:0045669~positive regulation of osteoblast differentiation,GO:0045667~regulation of osteoblast differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045664~regulation of neuron differentiation,GO:0045663~positive regulation of myoblast differentiation,GO:0045661~regulation of myoblast differentiation,GO:0045652~regulation of megakaryocyte differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0045445~myoblast differentiation,GO:0045321~leukocyte activation,GO:0045165~cell fate commitment,GO:0044708~single-organism behavior,GO:0044093~positive regulation of molecular function,GO:0044087~regulation of cellular component biogenesis,GO:0044085~cellular component biogenesis,GO:0043542~endothelial cell migration,GO:0043537~negative regulation of blood vessel endothelial cell migration,GO:0043535~regulation of blood vessel endothelial cell migration,GO:0043534~blood vessel endothelial cell migration,GO:0043524~negative regulation of neuron apoptotic process,GO:0043523~regulation of neuron apoptotic process,GO:0043473~pigmentation,GO:0043410~positive regulation of MAPK cascade,GO:0043408~regulation of MAPK cascade,GO:0043269~regulation of ion transport,GO:0043207~response to external biotic stimulus,GO:0043085~positive regulation of catalytic activity,GO:0043069~negative regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0042981~regulation of apoptotic process,GO:0042693~muscle cell fate commitment,GO:0042692~muscle cell differentiation,GO:0042596~fear response,GO:0042592~homeostatic process,GO:0042391~regulation of membrane potential,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0042127~regulation of cell proliferation,GO:0042113~B cell activation,GO:0042100~B cell proliferation,GO:0040013~negative regulation of locomotion,GO:0040012~regulation of locomotion,GO:0040011~locomotion,GO:0040008~regulation of growth,GO:0040007~growth,GO:0036344~platelet morphogenesis,GO:0036211~protein modification process,GO:0036075~replacement ossification,GO:0035984~cellular response to trichostatin A,GO:0035983~response to trichostatin A,GO:0035914~skeletal muscle cell differentiation,GO:0035850~epithelial cell differentiation involved in kidney development,GO:0035556~intracellular signal transduction,GO:0035306~positive regulation of dephosphorylation,GO:0035303~regulation of dephosphorylation,GO:0035295~tube development,GO:0035265~organ growth,GO:0035239~tube morphogenesis,GO:0035051~cardiocyte differentiation,GO:0035050~embryonic heart tube development,GO:0034765~regulation of ion transmembrane transport,GO:0034762~regulation of transmembrane transport,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034405~response to fluid shear stress,GO:0034220~ion transmembrane transport,GO:0033993~response to lipid,GO:0033555~multicellular organismal response to stress,GO:0033554~cellular response to stress,GO:0033034~positive regulation of myeloid cell apoptotic process,GO:0033032~regulation of myeloid cell apoptotic process,GO:0033028~myeloid cell apoptotic process,GO:0033002~muscle cell proliferation,GO:0032989~cellular component morphogenesis,GO:0032946~positive regulation of mononuclear cell proliferation,GO:0032944~regulation of mononuclear cell proliferation,GO:0032943~mononuclear cell proliferation,GO:0032940~secretion by cell,GO:0032870~cellular response to hormone stimulus,GO:0032835~glomerulus development,GO:0032774~RNA biosynthetic process,GO:0032496~response to lipopolysaccharide,GO:0032412~regulation of ion transmembrane transporter activity,GO:0032409~regulation of transporter activity,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031349~positive regulation of defense response,GO:0031347~regulation of defense response,GO:0031344~regulation of cell projection organization,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031324~negative regulation of cellular metabolic process,GO:0031214~biomineral tissue development,GO:0031175~neuron projection development,GO:0030890~positive regulation of B cell proliferation,GO:0030888~regulation of B cell proliferation,GO:0030855~epithelial cell differentiation,GO:0030501~positive regulation of bone mineralization,GO:0030500~regulation of bone mineralization,GO:0030336~negative regulation of cell migration,GO:0030334~regulation of cell migration,GO:0030318~melanocyte differentiation,GO:0030282~bone mineralization,GO:0030279~negative regulation of ossification,GO:0030278~regulation of ossification,GO:0030220~platelet formation,GO:0030182~neuron differentiation,GO:0030099~myeloid cell differentiation,GO:0030097~hemopoiesis,GO:0030030~cell projection organization,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0023014~signal transduction by protein phosphorylation,GO:0022898~regulation of transmembrane transporter activity,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022008~neurogenesis,GO:0019438~aromatic compound biosynthetic process,GO:0019220~regulation of phosphate metabolic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016477~cell migration,GO:0016358~dendrite development,GO:0016311~dephosphorylation,GO:0016310~phosphorylation,GO:0016202~regulation of striated muscle tissue development,GO:0016070~RNA metabolic process,GO:0014912~negative regulation of smooth muscle cell migration,GO:0014910~regulation of smooth muscle cell migration,GO:0014909~smooth muscle cell migration,GO:0014902~myotube differentiation,GO:0014855~striated muscle cell proliferation,GO:0014812~muscle cell migration,GO:0014706~striated muscle tissue development,GO:0014070~response to organic cyclic compound,GO:0014033~neural crest cell differentiation,GO:0012501~programmed cell death,GO:0010975~regulation of neuron projection development,GO:0010942~positive regulation of cell death,GO:0010941~regulation of cell death,GO:0010922~positive regulation of phosphatase activity,GO:0010921~regulation of phosphatase activity,GO:0010720~positive regulation of cell development,GO:0010694~positive regulation of alkaline phosphatase activity,GO:0010692~regulation of alkaline phosphatase activity,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010633~negative regulation of epithelial cell migration,GO:0010632~regulation of epithelial cell migration,GO:0010631~epithelial cell migration,GO:0010629~negative regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010596~negative regulation of endothelial cell migration,GO:0010594~regulation of endothelial cell migration,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010469~regulation of receptor activity,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010243~response to organonitrogen compound,GO:0010092~specification of animal organ identity,GO:0010038~response to metal ion,GO:0010035~response to inorganic substance,GO:0010033~response to organic substance,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0009891~positive regulation of biosynthetic process,GO:0009890~negative regulation of biosynthetic process,GO:0009887~animal organ morphogenesis,GO:0009855~determination of bilateral symmetry,GO:0009799~specification of symmetry,GO:0009790~embryo development,GO:0009725~response to hormone,GO:0009719~response to endogenous stimulus,GO:0009617~response to bacterium,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0009410~response to xenobiotic stimulus,GO:0008285~negative regulation of cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008283~cell proliferation,GO:0008219~cell death,GO:0007611~learning or memory,GO:0007610~behavior,GO:0007521~muscle cell fate determination,GO:0007519~skeletal muscle tissue development,GO:0007517~muscle organ development,GO:0007507~heart development,GO:0007399~nervous system development,GO:0007389~pattern specification process,GO:0007368~determination of left/right symmetry,GO:0007268~chemical synaptic transmission,GO:0007267~cell-cell signaling,GO:0007215~glutamate receptor signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0006959~humoral immune response,GO:0006955~immune response,GO:0006952~defense response,GO:0006928~movement of cell or subcellular component,GO:0006925~inflammatory cell apoptotic process,GO:0006915~apoptotic process,GO:0006836~neurotransmitter transport,GO:0006812~cation transport,GO:0006811~ion transport,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0006366~transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0003231~cardiac ventricle development,GO:0003211~cardiac ventricle formation,GO:0003208~cardiac ventricle morphogenesis,GO:0003207~cardiac chamber formation,GO:0003206~cardiac chamber morphogenesis,GO:0003205~cardiac chamber development,GO:0003185~sinoatrial valve morphogenesis,GO:0003179~heart valve morphogenesis,GO:0003172~sinoatrial valve development,GO:0003170~heart valve development,GO:0003151~outflow tract morphogenesis,GO:0003143~embryonic heart tube morphogenesis,GO:0003139~secondary heart field specification,GO:0003138~primary heart field specification,GO:0003128~heart field specification,GO:0003008~system process,GO:0003007~heart morphogenesis,GO:0003002~regionalization,GO:0002931~response to ischemia,GO:0002822~regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002819~regulation of adaptive immune response,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0002764~immune response-regulating signaling pathway,GO:0002757~immune response-activating signal transduction,GO:0002696~positive regulation of leukocyte activation,GO:0002694~regulation of leukocyte activation,GO:0002684~positive regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002634~regulation of germinal center formation,GO:0002520~immune system development,GO:0002467~germinal center formation,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002429~immune response-activating cell surface receptor signaling pathway,GO:0002260~lymphocyte homeostasis,GO:0002253~activation of immune response,GO:0002250~adaptive immune response,GO:0002237~response to molecule of bacterial origin,GO:0002209~behavioral defense response,GO:0002062~chondrocyte differentiation,GO:0002009~morphogenesis of an epithelium,GO:0001974~blood vessel remodeling,GO:0001958~endochondral ossification,GO:0001947~heart looping,GO:0001944~vasculature development,GO:0001937~negative regulation of endothelial cell proliferation,GO:0001936~regulation of endothelial cell proliferation,GO:0001935~endothelial cell proliferation,GO:0001934~positive regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,GO:0001822~kidney development,GO:0001782~B cell homeostasis,GO:0001776~leukocyte homeostasis,GO:0001775~cell activation,GO:0001764~neuron migration,GO:0001709~cell fate determination,GO:0001667~ameboidal-type cell migration,GO:0001662~behavioral fear response,GO:0001655~urogenital system development,GO:0001649~osteoblast differentiation,GO:0001568~blood vessel development,GO:0001505~regulation of neurotransmitter levels,GO:0001503~ossification,GO:0001501~skeletal system development,GO:0000904~cell morphogenesis involved in differentiation,GO:0000902~cell morphogenesis,GO:0000165~MAPK cascade,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,												GO:0098794~postsynapse,GO:0045202~synapse,GO:0044456~synapse part,GO:0044451~nucleoplasm part,GO:0044427~chromosomal part,GO:0016607~nuclear speck,GO:0016604~nuclear body,GO:0016528~sarcoplasm,GO:0005829~cytosol,GO:0005694~chromosome,GO:0005654~nucleoplasm,GO:0000785~chromatin,												GO:1990837~sequence-specific double-stranded DNA binding,GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0061629~RNA polymerase II sequence-specific DNA binding transcription factor binding,GO:0046983~protein dimerization activity,GO:0046982~protein heterodimerization activity,GO:0044212~transcription regulatory region DNA binding,GO:0043565~sequence-specific DNA binding,GO:0042826~histone deacetylase binding,GO:0019899~enzyme binding,GO:0008134~transcription factor binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003690~double-stranded DNA binding,GO:0003680~AT DNA binding,GO:0003677~DNA binding,GO:0003676~nucleic acid binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001159~core promoter proximal region DNA binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001071~nucleic acid binding transcription factor activity,GO:0001067~regulatory region nucleic acid binding,GO:0001012~RNA polymerase II regulatory region DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000975~regulatory region DNA binding,												IPR036879:TF_MADSbox_sf,IPR033896:MADS_MEF2-like,IPR022102:HJURP_C,IPR002100:TF_MADSbox,												hsa05418:Fluid shear stress and atherosclerosis,hsa05202:Transcriptional misregulation in cancer,hsa04928:Parathyroid hormone synthesis, secretion and action,hsa04921:Oxytocin signaling pathway,hsa04371:Apelin signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04010:MAPK signaling pathway,												613443~Neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language,613443~Chromosome 5q14.3 deletion syndrome,													SM00432:MADS,												SITE:Cleavage,REGION:Transcription repressor,REGION:Disordered,REGION:Beta domain,MUTAGEN:T->A: Abolishes MAPK14-mediated phosphorylation. No effect on MAPK7-mediated phosphorylation; when associated with A-300.,MUTAGEN:T->A: Abolishes MAPK14-mediated phosphorylation. No effect on MAPK7-mediated phosphorylation; when associated with A-293.,MUTAGEN:S->E: No effect on sumoylation. No effect on transcriptional activity.,MUTAGEN:S->A: No effect on transcriptional activation.,MUTAGEN:S->A: No effect on MAPK14-mediated phosphorylation. Abolishes MAPK7-mediated phosphorylation and reduces transactivation activity.,MUTAGEN:S->A: No change in transactivational activation for isoforms with or without the beta domain.,MUTAGEN:S->A,C: Abolishes sumoylation. Enhanced transcriptional activity.,MUTAGEN:K->R: Reduced acetylation. Further reduction in acetylation; when associated with R-119. Complete loss of acetylation, 15% less transactivation activity and slightly reduced DNA binding; when associated with R-119; R-234; R-239; R-252 and R-262.,MUTAGEN:K->R: Reduced acetylation. Further reduction in acetylation; when associated with R-119. Complete loss of acetylation, 15% less transactivation activity and slightly reduced DNA binding; when associated with R-116; R-234; R-239; R-252 and R-262.,MUTAGEN:K->R: Reduced acetylation. Complete loss of acetylation, 15% less transactivation activity and slightly reduced DNA binding; when associated with R-116; R-119; R-239; R-252 and R-264.,MUTAGEN:K->R: Reduced acetylation. Complete loss of acetylation, 15% less transactivation activity and slightly reduced DNA binding; when associated with R-116; R-119; R-234; R-252 and R-264.,MUTAGEN:K->R: Reduced acetylation. Complete loss of acetylation, 15% less transactivation activity and slightly reduced DNA binding; when associated with R-116; R-119; R-234; R-239 and R-264.,MUTAGEN:K->R: Reduced acetylation. Complete loss of acetylation, 15% less transactivation activity and slightly reduced DNA binding; when associated with R-116; R-119; R-234; R-239 and R-252.,MUTAGEN:K->R: Abolishes sumoylation.,MUTAGEN:E->Q: Reduced transcriptional activation. Completely abolishes transcriptional activation; when associated with N-273 and N-275.,MUTAGEN:D->N: Reduced transcriptional activation. Completely abolishes transcriptional activation; when associated with Q-272 and N-275.,MUTAGEN:D->N: Reduced transcriptional activation. Completely abolishes transcriptional activation; when associated with Q-272 and N-273.,MUTAGEN:D->A: Abolishes cleavage by caspase 7.,DOMAIN:MADS-box,DNA_BIND:Mef2-type,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),COMPBIAS:Polar residues,COMPBIAS:Basic and acidic residues,
35038_at	myosin binding protein C3(MYBPC3)	Homo sapiens			GO:1903115~regulation of actin filament-based movement,GO:1902589~single-organism organelle organization,GO:0097435~supramolecular fiber organization,GO:0090257~regulation of muscle system process,GO:0072359~circulatory system development,GO:0070925~organelle assembly,GO:0065009~regulation of molecular function,GO:0061061~muscle structure development,GO:0060537~muscle tissue development,GO:0060415~muscle tissue morphogenesis,GO:0060341~regulation of cellular localization,GO:0060048~cardiac muscle contraction,GO:0060047~heart contraction,GO:0055010~ventricular cardiac muscle tissue morphogenesis,GO:0055008~cardiac muscle tissue morphogenesis,GO:0055002~striated muscle cell development,GO:0055001~muscle cell development,GO:0051649~establishment of localization in cell,GO:0051641~cellular localization,GO:0051345~positive regulation of hydrolase activity,GO:0051336~regulation of hydrolase activity,GO:0051270~regulation of cellular component movement,GO:0051146~striated muscle cell differentiation,GO:0051049~regulation of transport,GO:0050790~regulation of catalytic activity,GO:0048738~cardiac muscle tissue development,GO:0048729~tissue morphogenesis,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048644~muscle organ morphogenesis,GO:0048468~cell development,GO:0046907~intracellular transport,GO:0045214~sarcomere organization,GO:0044093~positive regulation of molecular function,GO:0044085~cellular component biogenesis,GO:0044057~regulation of system process,GO:0043462~regulation of ATPase activity,GO:0043085~positive regulation of catalytic activity,GO:0042692~muscle cell differentiation,GO:0032989~cellular component morphogenesis,GO:0032971~regulation of muscle filament sliding,GO:0032970~regulation of actin filament-based process,GO:0032781~positive regulation of ATPase activity,GO:0032386~regulation of intracellular transport,GO:0031032~actomyosin structure organization,GO:0030239~myofibril assembly,GO:0030048~actin filament-based movement,GO:0030036~actin cytoskeleton organization,GO:0030029~actin filament-based process,GO:0022610~biological adhesion,GO:0022607~cellular component assembly,GO:0014706~striated muscle tissue development,GO:0010927~cellular component assembly involved in morphogenesis,GO:0009887~animal organ morphogenesis,GO:0008015~blood circulation,GO:0007517~muscle organ development,GO:0007507~heart development,GO:0007155~cell adhesion,GO:0007010~cytoskeleton organization,GO:0006942~regulation of striated muscle contraction,GO:0006941~striated muscle contraction,GO:0006937~regulation of muscle contraction,GO:0006936~muscle contraction,GO:0006928~movement of cell or subcellular component,GO:0003231~cardiac ventricle development,GO:0003229~ventricular cardiac muscle tissue development,GO:0003208~cardiac ventricle morphogenesis,GO:0003206~cardiac chamber morphogenesis,GO:0003205~cardiac chamber development,GO:0003015~heart process,GO:0003013~circulatory system process,GO:0003012~muscle system process,GO:0003008~system process,GO:0003007~heart morphogenesis,												GO:0099512~supramolecular fiber,GO:0099081~supramolecular polymer,GO:0099080~supramolecular complex,GO:0097512~cardiac myofibril,GO:0044449~contractile fiber part,GO:0043292~contractile fiber,GO:0036379~myofilament,GO:0032982~myosin filament,GO:0031672~A band,GO:0031430~M band,GO:0030017~sarcomere,GO:0030016~myofibril,GO:0016460~myosin II complex,GO:0016459~myosin complex,GO:0015629~actin cytoskeleton,GO:0014705~C zone,GO:0005863~striated muscle myosin thick filament,GO:0005859~muscle myosin complex,GO:0005829~cytosol,												GO:0098772~molecular function regulator,GO:0060590~ATPase regulator activity,GO:0060589~nucleoside-triphosphatase regulator activity,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0042802~identical protein binding,GO:0032036~myosin heavy chain binding,GO:0031432~titin binding,GO:0030234~enzyme regulator activity,GO:0017022~myosin binding,GO:0008307~structural constituent of muscle,GO:0008092~cytoskeletal protein binding,GO:0008047~enzyme activator activity,GO:0005198~structural molecule activity,GO:0003779~actin binding,GO:0001671~ATPase activator activity,												IPR040849:MyBP-C_THB,IPR036179:Ig-like_dom_sf,IPR036116:FN3_sf,IPR013783:Ig-like_fold,IPR013098:Ig_I-set,IPR007110:Ig-like_dom,IPR003961:FN3_dom,IPR003599:Ig_sub,IPR003598:Ig_sub2,												hsa05414:Dilated cardiomyopathy,hsa05410:Hypertrophic cardiomyopathy,												615396~Left ventricular noncompaction 10,615396~Cardiomyopathy, dilated, 1MM,115197~Cardiomyopathy, hypertrophic, 4,													SM00409:IG,SM00408:IGc2,SM00060:FN3,												REGION:Disordered,DOMAIN:MyBP-C tri-helix bundle,DOMAIN:Immunoglobulin I-set,DOMAIN:Ig-like C2-type 7,DOMAIN:Ig-like C2-type 6,DOMAIN:Ig-like C2-type 5,DOMAIN:Ig-like C2-type 4,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like,DOMAIN:Fibronectin type-III 3,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III,
37968_at	natural cytotoxicity triggering receptor 3(NCR3)	Homo sapiens			GO:0080134~regulation of response to stress,GO:0050778~positive regulation of immune response,GO:0050776~regulation of immune response,GO:0048584~positive regulation of response to stimulus,GO:0046649~lymphocyte activation,GO:0045954~positive regulation of natural killer cell mediated cytotoxicity,GO:0045321~leukocyte activation,GO:0045089~positive regulation of innate immune response,GO:0045088~regulation of innate immune response,GO:0045087~innate immune response,GO:0042269~regulation of natural killer cell mediated cytotoxicity,GO:0042267~natural killer cell mediated cytotoxicity,GO:0031349~positive regulation of defense response,GO:0031347~regulation of defense response,GO:0031343~positive regulation of cell killing,GO:0031341~regulation of cell killing,GO:0030101~natural killer cell activation,GO:0008037~cell recognition,GO:0007166~cell surface receptor signaling pathway,GO:0006955~immune response,GO:0006954~inflammatory response,GO:0006952~defense response,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0002764~immune response-regulating signaling pathway,GO:0002757~immune response-activating signal transduction,GO:0002717~positive regulation of natural killer cell mediated immunity,GO:0002715~regulation of natural killer cell mediated immunity,GO:0002708~positive regulation of lymphocyte mediated immunity,GO:0002706~regulation of lymphocyte mediated immunity,GO:0002705~positive regulation of leukocyte mediated immunity,GO:0002703~regulation of leukocyte mediated immunity,GO:0002699~positive regulation of immune effector process,GO:0002697~regulation of immune effector process,GO:0002684~positive regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002449~lymphocyte mediated immunity,GO:0002443~leukocyte mediated immunity,GO:0002429~immune response-activating cell surface receptor signaling pathway,GO:0002253~activation of immune response,GO:0002252~immune effector process,GO:0002228~natural killer cell mediated immunity,GO:0001912~positive regulation of leukocyte mediated cytotoxicity,GO:0001910~regulation of leukocyte mediated cytotoxicity,GO:0001909~leukocyte mediated cytotoxicity,GO:0001906~cell killing,GO:0001775~cell activation,													GO:0042802~identical protein binding,												IPR043226:NCR3,IPR036179:Ig-like_dom_sf,IPR013783:Ig-like_fold,IPR013151:Immunoglobulin,IPR013106:Ig_V-set,IPR007110:Ig-like_dom,IPR003599:Ig_sub,												hsa04650:Natural killer cell mediated cytotoxicity,												609148~Malaria, mild, susceptibility to,													SM00409:IG,												TRANSMEM:Helical,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,DOMAIN:Ig-like,CARBOHYD:N-linked (GlcNAc...) asparagine,
34233_i_at	natural killer cell triggering receptor(NKTR)	Homo sapiens			GO:0036211~protein modification process,GO:0018208~peptidyl-proline modification,GO:0018193~peptidyl-amino acid modification,GO:0006464~cellular protein modification process,GO:0006457~protein folding,GO:0000413~protein peptidyl-prolyl isomerization,												GO:0005739~mitochondrion,												GO:0042277~peptide binding,GO:0033218~amide binding,GO:0016859~cis-trans isomerase activity,GO:0016853~isomerase activity,GO:0016018~cyclosporin A binding,GO:0008144~drug binding,GO:0003755~peptidyl-prolyl cis-trans isomerase activity,												IPR029000:Cyclophilin-like_dom_sf,IPR020892:Cyclophilin-type_PPIase_CS,IPR002130:Cyclophilin-type_PPIase_dom,																REGION:Disordered,REGION:Arg/Ser tandem repeat-rich,DOMAIN:PPIase cyclophilin-type,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate,COMPBIAS:Polar residues,COMPBIAS:Basic residues,COMPBIAS:Basic and acidic residues,
1112_g_at	neural cell adhesion molecule 1(NCAM1)	Homo sapiens		h_PDZsPathway:Synaptic Proteins at the Synaptic Junction,												GO:2001260~regulation of semaphorin-plexin signaling pathway,GO:0097485~neuron projection guidance,GO:0071679~commissural neuron axon guidance,GO:0061564~axon development,GO:0060485~mesenchyme development,GO:0051828~entry into other organism involved in symbiotic interaction,GO:0051806~entry into cell of other organism involved in symbiotic interaction,GO:0051701~interaction with host,GO:0048858~cell projection morphogenesis,GO:0048812~neuron projection morphogenesis,GO:0048762~mesenchymal cell differentiation,GO:0048699~generation of neurons,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048666~neuron development,GO:0048468~cell development,GO:0046718~viral entry into host cell,GO:0044764~multi-organism cellular process,GO:0044419~interspecies interaction between organisms,GO:0044409~entry into host,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0042330~taxis,GO:0040011~locomotion,GO:0032990~cell part morphogenesis,GO:0032989~cellular component morphogenesis,GO:0031175~neuron projection development,GO:0030260~entry into host cell,GO:0030182~neuron differentiation,GO:0030030~cell projection organization,GO:0023051~regulation of signaling,GO:0022610~biological adhesion,GO:0022008~neurogenesis,GO:0019058~viral life cycle,GO:0016032~viral process,GO:0010646~regulation of cell communication,GO:0009966~regulation of signal transduction,GO:0009605~response to external stimulus,GO:0007411~axon guidance,GO:0007409~axonogenesis,GO:0007399~nervous system development,GO:0007155~cell adhesion,GO:0006935~chemotaxis,GO:0006928~movement of cell or subcellular component,GO:0001837~epithelial to mesenchymal transition,GO:0000904~cell morphogenesis involved in differentiation,GO:0000902~cell morphogenesis,												GO:0098552~side of membrane,GO:0044431~Golgi apparatus part,GO:0009986~cell surface,GO:0009897~external side of plasma membrane,GO:0005829~cytosol,GO:0005794~Golgi apparatus,GO:0005576~extracellular region,GO:0000139~Golgi membrane,												GO:0060089~molecular transducer activity,GO:0004872~receptor activity,GO:0001618~virus receptor activity,												IPR036179:Ig-like_dom_sf,IPR036116:FN3_sf,IPR013783:Ig-like_fold,IPR013098:Ig_I-set,IPR009138:Neural_cell_adh,IPR007110:Ig-like_dom,IPR003961:FN3_dom,IPR003599:Ig_sub,IPR003598:Ig_sub2,												hsa05020:Prion disease,hsa04514:Cell adhesion molecules,hsa03265:Virion - Ebolavirus and Lyssavirus,														SM00409:IG,SM00408:IGc2,SM00060:FN3,												TRANSMEM:Helical,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,REGION:Disordered,LIPID:GPI-anchor amidated asparagine,DOMAIN:Ig-like C2-type 5,DOMAIN:Ig-like C2-type 4,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 1,DOMAIN:Fibronectin type-III,COMPBIAS:Pro residues,COMPBIAS:Polar residues,COMPBIAS:Basic and acidic residues,CARBOHYD:N-linked (GlcNAc...) asparagine,
32717_at	neuralized E3 ubiquitin protein ligase 1(NEURL1)	Homo sapiens			GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1902589~single-organism organelle organization,GO:1901701~cellular response to oxygen-containing compound,GO:1901700~response to oxygen-containing compound,GO:1901699~cellular response to nitrogen compound,GO:1901698~response to nitrogen compound,GO:1900006~positive regulation of dendrite development,GO:0099537~trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0098916~anterograde trans-synaptic signaling,GO:0097722~sperm motility,GO:0090129~positive regulation of synapse maturation,GO:0090128~regulation of synapse maturation,GO:0071495~cellular response to endogenous stimulus,GO:0071417~cellular response to organonitrogen compound,GO:0071310~cellular response to organic substance,GO:0071230~cellular response to amino acid stimulus,GO:0071229~cellular response to acid chemical,GO:0070925~organelle assembly,GO:0070887~cellular response to chemical stimulus,GO:0070647~protein modification by small protein conjugation or removal,GO:0061061~muscle structure development,GO:0060999~positive regulation of dendritic spine development,GO:0060998~regulation of dendritic spine development,GO:0060996~dendritic spine development,GO:0060538~skeletal muscle organ development,GO:0060537~muscle tissue development,GO:0060491~regulation of cell projection assembly,GO:0060284~regulation of cell development,GO:0060271~cilium assembly,GO:0060074~synapse maturation,GO:0051962~positive regulation of nervous system development,GO:0051960~regulation of nervous system development,GO:0051674~localization of cell,GO:0051491~positive regulation of filopodium assembly,GO:0051489~regulation of filopodium assembly,GO:0051246~regulation of protein metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051130~positive regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051094~positive regulation of developmental process,GO:0050878~regulation of body fluid levels,GO:0050808~synapse organization,GO:0050807~regulation of synapse organization,GO:0050804~modulation of synaptic transmission,GO:0050803~regulation of synapse structure or activity,GO:0050773~regulation of dendrite development,GO:0050769~positive regulation of neurogenesis,GO:0050767~regulation of neurogenesis,GO:0048870~cell motility,GO:0048732~gland development,GO:0048699~generation of neurons,GO:0048666~neuron development,GO:0048609~multicellular organismal reproductive process,GO:0048585~negative regulation of response to stimulus,GO:0048515~spermatid differentiation,GO:0048468~cell development,GO:0048232~male gamete generation,GO:0048170~positive regulation of long-term neuronal synaptic plasticity,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0048168~regulation of neuronal synaptic plasticity,GO:0048167~regulation of synaptic plasticity,GO:0046903~secretion,GO:0046847~filopodium assembly,GO:0045746~negative regulation of Notch signaling pathway,GO:0045666~positive regulation of neuron differentiation,GO:0045664~regulation of neuron differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0044782~cilium organization,GO:0044703~multi-organism reproductive process,GO:0044702~single organism reproductive process,GO:0044089~positive regulation of cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044085~cellular component biogenesis,GO:0043603~cellular amide metabolic process,GO:0043200~response to amino acid,GO:0043068~positive regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043065~positive regulation of apoptotic process,GO:0042981~regulation of apoptotic process,GO:0042127~regulation of cell proliferation,GO:0040011~locomotion,GO:0036211~protein modification process,GO:0035082~axoneme assembly,GO:0034645~cellular macromolecule biosynthetic process,GO:0034248~regulation of cellular amide metabolic process,GO:0032504~multicellular organism reproduction,GO:0032446~protein modification by small protein conjugation,GO:0032268~regulation of cellular protein metabolic process,GO:0031346~positive regulation of cell projection organization,GO:0031344~regulation of cell projection organization,GO:0031175~neuron projection development,GO:0030879~mammary gland development,GO:0030317~flagellated sperm motility,GO:0030182~neuron differentiation,GO:0030031~cell projection assembly,GO:0030030~cell projection organization,GO:0023057~negative regulation of signaling,GO:0023051~regulation of signaling,GO:0022607~cellular component assembly,GO:0022414~reproductive process,GO:0022412~cellular process involved in reproduction in multicellular organism,GO:0022008~neurogenesis,GO:0021700~developmental maturation,GO:0019953~sexual reproduction,GO:0016567~protein ubiquitination,GO:0016358~dendrite development,GO:0014706~striated muscle tissue development,GO:0012501~programmed cell death,GO:0010976~positive regulation of neuron projection development,GO:0010975~regulation of neuron projection development,GO:0010942~positive regulation of cell death,GO:0010941~regulation of cell death,GO:0010720~positive regulation of cell development,GO:0010648~negative regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010608~posttranscriptional regulation of gene expression,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010243~response to organonitrogen compound,GO:0010033~response to organic substance,GO:0009968~negative regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009719~response to endogenous stimulus,GO:0008593~regulation of Notch signaling pathway,GO:0008285~negative regulation of cell proliferation,GO:0008283~cell proliferation,GO:0008219~cell death,GO:0007595~lactation,GO:0007589~body fluid secretion,GO:0007519~skeletal muscle tissue development,GO:0007517~muscle organ development,GO:0007399~nervous system development,GO:0007288~sperm axoneme assembly,GO:0007286~spermatid development,GO:0007283~spermatogenesis,GO:0007281~germ cell development,GO:0007276~gamete generation,GO:0007268~chemical synaptic transmission,GO:0007267~cell-cell signaling,GO:0007219~Notch signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0007017~microtubule-based process,GO:0007010~cytoskeleton organization,GO:0006928~movement of cell or subcellular component,GO:0006915~apoptotic process,GO:0006513~protein monoubiquitination,GO:0006464~cellular protein modification process,GO:0006417~regulation of translation,GO:0003006~developmental process involved in reproduction,GO:0001578~microtubule bundle formation,GO:0001101~response to acid chemical,GO:0000226~microtubule cytoskeleton organization,GO:0000003~reproduction,												GO:0099572~postsynaptic specialization,GO:0098984~neuron to neuron synapse,GO:0098794~postsynapse,GO:0097458~neuron part,GO:0097440~apical dendrite,GO:0048471~perinuclear region of cytoplasm,GO:0045202~synapse,GO:0044456~synapse part,GO:0044309~neuron spine,GO:0044297~cell body,GO:0043204~perikaryon,GO:0043197~dendritic spine,GO:0043025~neuronal cell body,GO:0043005~neuron projection,GO:0036477~somatodendritic compartment,GO:0032279~asymmetric synapse,GO:0030425~dendrite,GO:0014069~postsynaptic density,												GO:0061659~ubiquitin-like protein ligase activity,GO:0061630~ubiquitin protein ligase activity,GO:0046872~metal ion binding,GO:0045183~translation factor activity, non-nucleic acid binding,GO:0045182~translation regulator activity,GO:0043169~cation binding,GO:0043167~ion binding,GO:0019787~ubiquitin-like protein transferase activity,GO:0004842~ubiquitin-protein transferase activity,												IPR043136:B30.2/SPRY_sf,IPR037962:Neuralized,IPR013083:Znf_RING/FYVE/PHD,IPR006573:NHR_dom,IPR001841:Znf_RING,															SM00588:NEUZ,												ZN_FING:RING-type,REGION:Disordered,LIPID:N-myristoyl glycine,DOMAIN:RING-type,DOMAIN:NHR 2,DOMAIN:NHR 1,DOMAIN:NHR,
35091_at	neuregulin 2(NRG2)	Homo sapiens
35090_g_at	neuregulin 2(NRG2)	Homo sapiens		h_erbb4Pathway:g-Secretase mediated ErbB4 Signaling Pathway ,h_agrPathway:Agrin in Postsynaptic Differentiation,												GO:0035556~intracellular signal transduction,GO:0007399~nervous system development,												GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:0008083~growth factor activity,GO:0005102~receptor binding,												IPR040180:Neuregulin,IPR036179:Ig-like_dom_sf,IPR013783:Ig-like_fold,IPR013098:Ig_I-set,IPR007110:Ig-like_dom,IPR003599:Ig_sub,IPR003598:Ig_sub2,IPR002154:Neuregulin_C,IPR000742:EGF-like_dom,												hsa05014:Amyotrophic lateral sclerosis,hsa04012:ErbB signaling pathway,hsa01521:EGFR tyrosine kinase inhibitor resistance,														SM00409:IG,SM00408:IGc2,												TRANSMEM:Helical; Note=Internal signal sequence,TRANSMEM:Helical,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,REGION:Disordered,DOMAIN:Ig-like C2-type,DOMAIN:Ig-like,DOMAIN:EGF-like,COMPBIAS:Pro residues,COMPBIAS:Polar residues,CARBOHYD:N-linked (GlcNAc...) asparagine,
936_s_at	neuronal vesicle trafficking associated 1(NSG1)	Homo sapiens			GO:1990778~protein localization to cell periphery,GO:1990126~retrograde transport, endosome to plasma membrane,GO:1903540~establishment of protein localization to postsynaptic membrane,GO:1903539~protein localization to postsynaptic membrane,GO:1902580~single-organism cellular localization,GO:1900271~regulation of long-term synaptic potentiation,GO:0099639~neurotransmitter receptor transport, endosome to plasma membrane,GO:0099638~endosome to plasma membrane protein transport,GO:0099637~neurotransmitter receptor transport,GO:0099630~postsynaptic neurotransmitter receptor cycle,GO:0099627~neurotransmitter receptor cycle,GO:0099537~trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0099003~vesicle-mediated transport in synapse,GO:0098969~neurotransmitter receptor transport to postsynaptic membrane,GO:0098916~anterograde trans-synaptic signaling,GO:0098887~neurotransmitter receptor transport, endosome to postsynaptic membrane,GO:0098877~neurotransmitter receptor transport to plasma membrane,GO:0098876~vesicle-mediated transport to the plasma membrane,GO:0098814~spontaneous synaptic transmission,GO:0090150~establishment of protein localization to membrane,GO:0090002~establishment of protein localization to plasma membrane,GO:0072659~protein localization to plasma membrane,GO:0072657~protein localization to membrane,GO:0071822~protein complex subunit organization,GO:0071705~nitrogen compound transport,GO:0070727~cellular macromolecule localization,GO:0070271~protein complex biogenesis,GO:0065003~macromolecular complex assembly,GO:0061024~membrane organization,GO:0051649~establishment of localization in cell,GO:0051641~cellular localization,GO:0050804~modulation of synaptic transmission,GO:0048268~clathrin coat assembly,GO:0048167~regulation of synaptic plasticity,GO:0045184~establishment of protein localization,GO:0044802~single-organism membrane organization,GO:0044085~cellular component biogenesis,GO:0043933~macromolecular complex subunit organization,GO:0043623~cellular protein complex assembly,GO:0043112~receptor metabolic process,GO:0042982~amyloid precursor protein metabolic process,GO:0042886~amide transport,GO:0035418~protein localization to synapse,GO:0034622~cellular macromolecular complex assembly,GO:0034613~cellular protein localization,GO:0033036~macromolecule localization,GO:0031325~positive regulation of cellular metabolic process,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0022607~cellular component assembly,GO:0016197~endosomal transport,GO:0016192~vesicle-mediated transport,GO:0015833~peptide transport,GO:0015031~protein transport,GO:0012501~programmed cell death,GO:0010646~regulation of cell communication,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010256~endomembrane system organization,GO:0009893~positive regulation of metabolic process,GO:0008219~cell death,GO:0008104~protein localization,GO:0007268~chemical synaptic transmission,GO:0007267~cell-cell signaling,GO:0007212~dopamine receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007009~plasma membrane organization,GO:0006915~apoptotic process,GO:0006461~protein complex assembly,GO:0001921~positive regulation of receptor recycling,GO:0001919~regulation of receptor recycling,GO:0001881~receptor recycling,												GO:0098978~glutamatergic synapse,GO:0098845~postsynaptic endosome,GO:0098794~postsynapse,GO:0098791~Golgi subcompartment,GO:0098590~plasma membrane region,GO:0097458~neuron part,GO:0097060~synaptic membrane,GO:0055038~recycling endosome membrane,GO:0055037~recycling endosome,GO:0045211~postsynaptic membrane,GO:0045202~synapse,GO:0044456~synapse part,GO:0044440~endosomal part,GO:0044437~vacuolar part,GO:0044433~cytoplasmic vesicle part,GO:0044432~endoplasmic reticulum part,GO:0044431~Golgi apparatus part,GO:0043202~lysosomal lumen,GO:0043005~neuron projection,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0036477~somatodendritic compartment,GO:0032588~trans-Golgi network membrane,GO:0032585~multivesicular body membrane,GO:0032580~Golgi cisterna membrane,GO:0031985~Golgi cisterna,GO:0031984~organelle subcompartment,GO:0031902~late endosome membrane,GO:0031901~early endosome membrane,GO:0030425~dendrite,GO:0016328~lateral plasma membrane,GO:0010008~endosome membrane,GO:0005802~trans-Golgi network,GO:0005795~Golgi stack,GO:0005794~Golgi apparatus,GO:0005789~endoplasmic reticulum membrane,GO:0005783~endoplasmic reticulum,GO:0005775~vacuolar lumen,GO:0005773~vacuole,GO:0005771~multivesicular body,GO:0005770~late endosome,GO:0005769~early endosome,GO:0005768~endosome,GO:0005764~lysosome,GO:0000323~lytic vacuole,GO:0000139~Golgi membrane,												GO:0035255~ionotropic glutamate receptor binding,GO:0035254~glutamate receptor binding,GO:0032051~clathrin light chain binding,GO:0030276~clathrin binding,GO:0005102~receptor binding,												IPR009431:NSG,														PIRSF002383:Calcyon,													TRANSMEM:Helical; Signal-anchor for type II membrane protein,TRANSMEM:Helical,TOPO_DOM:Lumenal,TOPO_DOM:Cytoplasmic,REGION:Required for GRIP1 interaction,
38604_at	neuropeptide Y(NPY)	Homo sapiens			GO:0099538~synaptic signaling via neuropeptide,GO:0099537~trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0098916~anterograde trans-synaptic signaling,GO:0060575~intestinal epithelial cell differentiation,GO:0060429~epithelium development,GO:0060322~head development,GO:0055123~digestive system development,GO:0048699~generation of neurons,GO:0048666~neuron development,GO:0048584~positive regulation of response to stimulus,GO:0048565~digestive tract development,GO:0048468~cell development,GO:0044708~single-organism behavior,GO:0035295~tube development,GO:0032109~positive regulation of response to nutrient levels,GO:0032107~regulation of response to nutrient levels,GO:0032106~positive regulation of response to extracellular stimulus,GO:0032104~regulation of response to extracellular stimulus,GO:0032103~positive regulation of response to external stimulus,GO:0032101~regulation of response to external stimulus,GO:0032100~positive regulation of appetite,GO:0032098~regulation of appetite,GO:0032097~positive regulation of response to food,GO:0032095~regulation of response to food,GO:0032094~response to food,GO:0031667~response to nutrient levels,GO:0031175~neuron projection development,GO:0030900~forebrain development,GO:0030855~epithelial cell differentiation,GO:0030534~adult behavior,GO:0030182~neuron differentiation,GO:0030030~cell projection organization,GO:0022008~neurogenesis,GO:0021987~cerebral cortex development,GO:0021954~central nervous system neuron development,GO:0021953~central nervous system neuron differentiation,GO:0021543~pallium development,GO:0021537~telencephalon development,GO:0009991~response to extracellular stimulus,GO:0009605~response to external stimulus,GO:0008343~adult feeding behavior,GO:0008217~regulation of blood pressure,GO:0008015~blood circulation,GO:0007631~feeding behavior,GO:0007610~behavior,GO:0007420~brain development,GO:0007417~central nervous system development,GO:0007399~nervous system development,GO:0007268~chemical synaptic transmission,GO:0007267~cell-cell signaling,GO:0007218~neuropeptide signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007186~G-protein coupled receptor signaling pathway,GO:0003013~circulatory system process,GO:0003008~system process,GO:0002065~columnar/cuboidal epithelial cell differentiation,												GO:0099503~secretory vesicle,GO:0098992~neuronal dense core vesicle,GO:0098982~GABA-ergic synapse,GO:0097458~neuron part,GO:0045202~synapse,GO:0044421~extracellular region part,GO:0031045~dense core granule,GO:0030141~secretory granule,GO:0005794~Golgi apparatus,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:0099600~transmembrane receptor activity,GO:0099106~ion channel regulator activity,GO:0098772~molecular function regulator,GO:0071855~neuropeptide receptor binding,GO:0060089~molecular transducer activity,GO:0038023~signaling receptor activity,GO:0031841~neuropeptide Y receptor binding,GO:0016247~channel regulator activity,GO:0005246~calcium channel regulator activity,GO:0005184~neuropeptide hormone activity,GO:0005179~hormone activity,GO:0005102~receptor binding,GO:0004930~G-protein coupled receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0004872~receptor activity,GO:0004871~signal transducer activity,GO:0001664~G-protein coupled receptor binding,												IPR020392:Pancreatic_hormone-like_CS,IPR001955:Pancreatic_hormone-like,												hsa05034:Alcoholism,hsa04923:Regulation of lipolysis in adipocytes,hsa04920:Adipocytokine signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04024:cAMP signaling pathway,														SM00309:PAH,												SITE:Cleavage; by FAP,PEPTIDE:Neuropeptide Y,PEPTIDE:C-flanking peptide of NPY,
1355_g_at	neurotrophic receptor tyrosine kinase 2(NTRK2)	Homo sapiens			GO:2000811~negative regulation of anoikis,GO:2000209~regulation of anoikis,GO:1990416~cellular response to brain-derived neurotrophic factor stimulus,GO:1990090~cellular response to nerve growth factor stimulus,GO:1990089~response to nerve growth factor,GO:1902992~negative regulation of amyloid precursor protein catabolic process,GO:1902991~regulation of amyloid precursor protein catabolic process,GO:1902533~positive regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:1902430~negative regulation of beta-amyloid formation,GO:1902003~regulation of beta-amyloid formation,GO:1901701~cellular response to oxygen-containing compound,GO:1901700~response to oxygen-containing compound,GO:1901699~cellular response to nitrogen compound,GO:1901698~response to nitrogen compound,GO:1901215~negative regulation of neuron death,GO:1901214~regulation of neuron death,GO:0099551~trans-synaptic signaling by neuropeptide, modulating synaptic transmission,GO:0099550~trans-synaptic signalling, modulating synaptic transmission,GO:0099540~trans-synaptic signaling by neuropeptide,GO:0099538~synaptic signaling via neuropeptide,GO:0099537~trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0098916~anterograde trans-synaptic signaling,GO:0098870~action potential propagation,GO:0090596~sensory organ morphogenesis,GO:0072359~circulatory system development,GO:0072358~cardiovascular system development,GO:0071705~nitrogen compound transport,GO:0071495~cellular response to endogenous stimulus,GO:0071417~cellular response to organonitrogen compound,GO:0071363~cellular response to growth factor stimulus,GO:0071310~cellular response to organic substance,GO:0071230~cellular response to amino acid stimulus,GO:0071229~cellular response to acid chemical,GO:0070997~neuron death,GO:0070887~cellular response to chemical stimulus,GO:0070848~response to growth factor,GO:0065009~regulation of molecular function,GO:0061564~axon development,GO:0060548~negative regulation of cell death,GO:0060322~head development,GO:0060291~long-term synaptic potentiation,GO:0060284~regulation of cell development,GO:0051965~positive regulation of synapse assembly,GO:0051963~regulation of synapse assembly,GO:0051962~positive regulation of nervous system development,GO:0051960~regulation of nervous system development,GO:0051897~positive regulation of protein kinase B signaling,GO:0051896~regulation of protein kinase B signaling,GO:0051674~localization of cell,GO:0051402~neuron apoptotic process,GO:0051347~positive regulation of transferase activity,GO:0051338~regulation of transferase activity,GO:0051336~regulation of hydrolase activity,GO:0051248~negative regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051174~regulation of phosphorus metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051130~positive regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051094~positive regulation of developmental process,GO:0050890~cognition,GO:0050877~neurological system process,GO:0050808~synapse organization,GO:0050807~regulation of synapse organization,GO:0050806~positive regulation of synaptic transmission,GO:0050804~modulation of synaptic transmission,GO:0050803~regulation of synapse structure or activity,GO:0050790~regulation of catalytic activity,GO:0050772~positive regulation of axonogenesis,GO:0050770~regulation of axonogenesis,GO:0050769~positive regulation of neurogenesis,GO:0050767~regulation of neurogenesis,GO:0050435~beta-amyloid metabolic process,GO:0048935~peripheral nervous system neuron development,GO:0048934~peripheral nervous system neuron differentiation,GO:0048870~cell motility,GO:0048858~cell projection morphogenesis,GO:0048812~neuron projection morphogenesis,GO:0048709~oligodendrocyte differentiation,GO:0048699~generation of neurons,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048666~neuron development,GO:0048592~eye morphogenesis,GO:0048584~positive regulation of response to stimulus,GO:0048514~blood vessel morphogenesis,GO:0048511~rhythmic process,GO:0048468~cell development,GO:0048167~regulation of synaptic plasticity,GO:0046942~carboxylic acid transport,GO:0046903~secretion,GO:0046777~protein autophosphorylation,GO:0046717~acid secretion,GO:0046548~retinal rod cell development,GO:0046530~photoreceptor cell differentiation,GO:0045937~positive regulation of phosphate metabolic process,GO:0045666~positive regulation of neuron differentiation,GO:0045664~regulation of neuron differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0044708~single-organism behavior,GO:0044093~positive regulation of molecular function,GO:0044089~positive regulation of cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044085~cellular component biogenesis,GO:0043603~cellular amide metabolic process,GO:0043549~regulation of kinase activity,GO:0043524~negative regulation of neuron apoptotic process,GO:0043523~regulation of neuron apoptotic process,GO:0043491~protein kinase B signaling,GO:0043410~positive regulation of MAPK cascade,GO:0043408~regulation of MAPK cascade,GO:0043276~anoikis,GO:0043200~response to amino acid,GO:0043087~regulation of GTPase activity,GO:0043085~positive regulation of catalytic activity,GO:0043069~negative regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptotic process,GO:0042987~amyloid precursor protein catabolic process,GO:0042982~amyloid precursor protein metabolic process,GO:0042981~regulation of apoptotic process,GO:0042552~myelination,GO:0042490~mechanoreceptor differentiation,GO:0042462~eye photoreceptor cell development,GO:0042461~photoreceptor cell development,GO:0042391~regulation of membrane potential,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0042127~regulation of cell proliferation,GO:0042063~gliogenesis,GO:0040011~locomotion,GO:0038179~neurotrophin signaling pathway,GO:0036211~protein modification process,GO:0035637~multicellular organismal signaling,GO:0035556~intracellular signal transduction,GO:0034249~negative regulation of cellular amide metabolic process,GO:0034248~regulation of cellular amide metabolic process,GO:0034205~beta-amyloid formation,GO:0033674~positive regulation of kinase activity,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0033135~regulation of peptidyl-serine phosphorylation,GO:0032990~cell part morphogenesis,GO:0032989~cellular component morphogenesis,GO:0032940~secretion by cell,GO:0032292~peripheral nervous system axon ensheathment,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0031547~brain-derived neurotrophic factor receptor signaling pathway,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031346~positive regulation of cell projection organization,GO:0031344~regulation of cell projection organization,GO:0031325~positive regulation of cellular metabolic process,GO:0031324~negative regulation of cellular metabolic process,GO:0031175~neuron projection development,GO:0030900~forebrain development,GO:0030182~neuron differentiation,GO:0030030~cell projection organization,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0023014~signal transduction by protein phosphorylation,GO:0022607~cellular component assembly,GO:0022604~regulation of cell morphogenesis,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022011~myelination in peripheral nervous system,GO:0022008~neurogenesis,GO:0021987~cerebral cortex development,GO:0021954~central nervous system neuron development,GO:0021953~central nervous system neuron differentiation,GO:0021782~glial cell development,GO:0021543~pallium development,GO:0021537~telencephalon development,GO:0019227~neuronal action potential propagation,GO:0019226~transmission of nerve impulse,GO:0019220~regulation of phosphate metabolic process,GO:0018209~peptidyl-serine modification,GO:0018193~peptidyl-amino acid modification,GO:0018105~peptidyl-serine phosphorylation,GO:0016477~cell migration,GO:0016310~phosphorylation,GO:0015849~organic acid transport,GO:0015711~organic anion transport,GO:0014047~glutamate secretion,GO:0014044~Schwann cell development,GO:0014037~Schwann cell differentiation,GO:0012501~programmed cell death,GO:0010976~positive regulation of neuron projection development,GO:0010975~regulation of neuron projection development,GO:0010941~regulation of cell death,GO:0010770~positive regulation of cell morphogenesis involved in differentiation,GO:0010769~regulation of cell morphogenesis involved in differentiation,GO:0010720~positive regulation of cell development,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010628~positive regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010243~response to organonitrogen compound,GO:0010033~response to organic substance,GO:0010001~glial cell differentiation,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0009887~animal organ morphogenesis,GO:0009719~response to endogenous stimulus,GO:0008366~axon ensheathment,GO:0008284~positive regulation of cell proliferation,GO:0008283~cell proliferation,GO:0008219~cell death,GO:0007631~feeding behavior,GO:0007623~circadian rhythm,GO:0007612~learning,GO:0007611~learning or memory,GO:0007610~behavior,GO:0007423~sensory organ development,GO:0007422~peripheral nervous system development,GO:0007420~brain development,GO:0007417~central nervous system development,GO:0007416~synapse assembly,GO:0007409~axonogenesis,GO:0007399~nervous system development,GO:0007272~ensheathment of neurons,GO:0007268~chemical synaptic transmission,GO:0007267~cell-cell signaling,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0006928~movement of cell or subcellular component,GO:0006915~apoptotic process,GO:0006865~amino acid transport,GO:0006835~dicarboxylic acid transport,GO:0006820~anion transport,GO:0006811~ion transport,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006518~peptide metabolic process,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0003008~system process,GO:0001944~vasculature development,GO:0001934~positive regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,GO:0001764~neuron migration,GO:0001754~eye photoreceptor cell differentiation,GO:0001654~eye development,GO:0001570~vasculogenesis,GO:0001568~blood vessel development,GO:0001508~action potential,GO:0001101~response to acid chemical,GO:0000904~cell morphogenesis involved in differentiation,GO:0000902~cell morphogenesis,GO:0000165~MAPK cascade,												GO:0099572~postsynaptic specialization,GO:0098984~neuron to neuron synapse,GO:0098794~postsynapse,GO:0098793~presynapse,GO:0097458~neuron part,GO:0048471~perinuclear region of cytoplasm,GO:0045202~synapse,GO:0044456~synapse part,GO:0044440~endosomal part,GO:0044433~cytoplasmic vesicle part,GO:0044309~neuron spine,GO:0044306~neuron projection terminus,GO:0043679~axon terminus,GO:0043235~receptor complex,GO:0043197~dendritic spine,GO:0043195~terminal bouton,GO:0043005~neuron projection,GO:0036477~somatodendritic compartment,GO:0033267~axon part,GO:0032279~asymmetric synapse,GO:0031901~early endosome membrane,GO:0030425~dendrite,GO:0030424~axon,GO:0014069~postsynaptic density,GO:0010008~endosome membrane,GO:0005829~cytosol,GO:0005769~early endosome,GO:0005768~endosome,												GO:1901363~heterocyclic compound binding,GO:1901265~nucleoside phosphate binding,GO:0099600~transmembrane receptor activity,GO:0097367~carbohydrate derivative binding,GO:0097159~organic cyclic compound binding,GO:0060175~brain-derived neurotrophic factor-activated receptor activity,GO:0060089~molecular transducer activity,GO:0048403~brain-derived neurotrophic factor binding,GO:0046983~protein dimerization activity,GO:0043168~anion binding,GO:0043167~ion binding,GO:0043121~neurotrophin binding,GO:0042803~protein homodimerization activity,GO:0042802~identical protein binding,GO:0038023~signaling receptor activity,GO:0036094~small molecule binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0019899~enzyme binding,GO:0019838~growth factor binding,GO:0019199~transmembrane receptor protein kinase activity,GO:0017076~purine nucleotide binding,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0016301~kinase activity,GO:0005524~ATP binding,GO:0005030~neurotrophin receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0004872~receptor activity,GO:0004871~signal transducer activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004672~protein kinase activity,GO:0002020~protease binding,GO:0000166~nucleotide binding,												IPR036179:Ig-like_dom_sf,IPR032675:LRR_dom_sf,IPR031635:NTRK_LRRCT,IPR020777:NTRK,IPR020635:Tyr_kinase_cat_dom,IPR020455:NTRK2,IPR017441:Protein_kinase_ATP_BS,IPR013783:Ig-like_fold,IPR013098:Ig_I-set,IPR011009:Kinase-like_dom_sf,IPR008266:Tyr_kinase_AS,IPR007110:Ig-like_dom,IPR003599:Ig_sub,IPR003598:Ig_sub2,IPR002011:Tyr_kinase_rcpt_2_CS,IPR001611:Leu-rich_rpt,IPR001245:Ser-Thr/Tyr_kinase_cat_dom,IPR000719:Prot_kinase_dom,IPR000483:Cys-rich_flank_reg_C,IPR000372:LRRNT,												hsa05034:Alcoholism,hsa04722:Neurotrophin signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04020:Calcium signaling pathway,hsa04014:Ras signaling pathway,hsa04010:MAPK signaling pathway,												617830~Developmental and epileptic encephalopathy 58,613886~Obesity, hyperphagia, and developmental delay,												PIRSF000615:TyrPK_CSF1-R,												SM00409:IG,SM00408:IGc2,SM00219:TyrKc,SM00082:LRRCT,SM00013:LRRNT,												TRANSMEM:Helical,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,SITE:Interaction with SHC1,SITE:Interaction with SH2D1A,SITE:Interaction with PLCG1,REPEAT:LRR 2,REPEAT:LRR 1,REGION:Interaction with MAPK8IP3/JIP3,REGION:Disordered,DOMAIN:Protein kinase,DOMAIN:LRRNT,DOMAIN:LRRCT,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like,COMPBIAS:Polar residues,CARBOHYD:N-linked (GlcNAc...) asparagine,ACT_SITE:Proton acceptor,
1419_g_at	nitric oxide synthase 2(NOS2)	Homo sapiens	8.MonocytesIFNF_IL4,												h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells,												GO:2001057~reactive nitrogen species metabolic process,GO:1903530~regulation of secretion by cell,GO:1903409~reactive oxygen species biosynthetic process,GO:1901701~cellular response to oxygen-containing compound,GO:1901700~response to oxygen-containing compound,GO:1901606~alpha-amino acid catabolic process,GO:1901605~alpha-amino acid metabolic process,GO:1901571~fatty acid derivative transport,GO:1901566~organonitrogen compound biosynthetic process,GO:1901565~organonitrogen compound catabolic process,GO:1901293~nucleoside phosphate biosynthetic process,GO:1901137~carbohydrate derivative biosynthetic process,GO:1901135~carbohydrate derivative metabolic process,GO:1900544~positive regulation of purine nucleotide metabolic process,GO:1900542~regulation of purine nucleotide metabolic process,GO:1900373~positive regulation of purine nucleotide biosynthetic process,GO:1900371~regulation of purine nucleotide biosynthetic process,GO:1900015~regulation of cytokine production involved in inflammatory response,GO:0098542~defense response to other organism,GO:0090407~organophosphate biosynthetic process,GO:0090276~regulation of peptide hormone secretion,GO:0090087~regulation of peptide transport,GO:0080134~regulation of response to stress,GO:0072593~reactive oxygen species metabolic process,GO:0072522~purine-containing compound biosynthetic process,GO:0072521~purine-containing compound metabolic process,GO:0071715~icosanoid transport,GO:0071705~nitrogen compound transport,GO:0071466~cellular response to xenobiotic stimulus,GO:0071396~cellular response to lipid,GO:0071346~cellular response to interferon-gamma,GO:0071345~cellular response to cytokine stimulus,GO:0071310~cellular response to organic substance,GO:0071222~cellular response to lipopolysaccharide,GO:0071219~cellular response to molecule of bacterial origin,GO:0071216~cellular response to biotic stimulus,GO:0070887~cellular response to chemical stimulus,GO:0070482~response to oxygen levels,GO:0070201~regulation of establishment of protein localization,GO:0065009~regulation of molecular function,GO:0055086~nucleobase-containing small molecule metabolic process,GO:0052652~cyclic purine nucleotide metabolic process,GO:0051712~positive regulation of killing of cells of other organism,GO:0051709~regulation of killing of cells of other organism,GO:0051707~response to other organism,GO:0051349~positive regulation of lyase activity,GO:0051339~regulation of lyase activity,GO:0051248~negative regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051223~regulation of protein transport,GO:0051174~regulation of phosphorus metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051049~regulation of transport,GO:0051046~regulation of secretion,GO:0050829~defense response to Gram-negative bacterium,GO:0050796~regulation of insulin secretion,GO:0050790~regulation of catalytic activity,GO:0050727~regulation of inflammatory response,GO:0050708~regulation of protein secretion,GO:0048511~rhythmic process,GO:0046942~carboxylic acid transport,GO:0046903~secretion,GO:0046883~regulation of hormone secretion,GO:0046879~hormone secretion,GO:0046717~acid secretion,GO:0046395~carboxylic acid catabolic process,GO:0046390~ribose phosphate biosynthetic process,GO:0046209~nitric oxide metabolic process,GO:0046068~cGMP metabolic process,GO:0045981~positive regulation of nucleotide metabolic process,GO:0045937~positive regulation of phosphate metabolic process,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045776~negative regulation of blood pressure,GO:0045454~cell redox homeostasis,GO:0045184~establishment of protein localization,GO:0045087~innate immune response,GO:0044712~single-organism catabolic process,GO:0044364~disruption of cells of other organism,GO:0044282~small molecule catabolic process,GO:0044093~positive regulation of molecular function,GO:0043902~positive regulation of multi-organism process,GO:0043900~regulation of multi-organism process,GO:0043467~regulation of generation of precursor metabolites and energy,GO:0043457~regulation of cellular respiration,GO:0043436~oxoacid metabolic process,GO:0043207~response to external biotic stimulus,GO:0043085~positive regulation of catalytic activity,GO:0042886~amide transport,GO:0042742~defense response to bacterium,GO:0042592~homeostatic process,GO:0042177~negative regulation of protein catabolic process,GO:0042176~regulation of protein catabolic process,GO:0042127~regulation of cell proliferation,GO:0036293~response to decreased oxygen levels,GO:0036211~protein modification process,GO:0035821~modification of morphology or physiology of other organism,GO:0035556~intracellular signal transduction,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034341~response to interferon-gamma,GO:0034097~response to cytokine,GO:0033993~response to lipid,GO:0033036~macromolecule localization,GO:0032940~secretion by cell,GO:0032880~regulation of protein localization,GO:0032757~positive regulation of interleukin-8 production,GO:0032755~positive regulation of interleukin-6 production,GO:0032677~regulation of interleukin-8 production,GO:0032675~regulation of interleukin-6 production,GO:0032637~interleukin-8 production,GO:0032635~interleukin-6 production,GO:0032496~response to lipopolysaccharide,GO:0032310~prostaglandin secretion,GO:0032309~icosanoid secretion,GO:0032101~regulation of response to external stimulus,GO:0031640~killing of cells of other organism,GO:0031347~regulation of defense response,GO:0031343~positive regulation of cell killing,GO:0031341~regulation of cell killing,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031284~positive regulation of guanylate cyclase activity,GO:0031282~regulation of guanylate cyclase activity,GO:0031281~positive regulation of cyclase activity,GO:0031279~regulation of cyclase activity,GO:0030828~positive regulation of cGMP biosynthetic process,GO:0030826~regulation of cGMP biosynthetic process,GO:0030825~positive regulation of cGMP metabolic process,GO:0030823~regulation of cGMP metabolic process,GO:0030810~positive regulation of nucleotide biosynthetic process,GO:0030808~regulation of nucleotide biosynthetic process,GO:0030804~positive regulation of cyclic nucleotide biosynthetic process,GO:0030802~regulation of cyclic nucleotide biosynthetic process,GO:0030801~positive regulation of cyclic nucleotide metabolic process,GO:0030799~regulation of cyclic nucleotide metabolic process,GO:0030163~protein catabolic process,GO:0030072~peptide hormone secretion,GO:0023061~signal release,GO:0023051~regulation of signaling,GO:0019932~second-messenger-mediated signaling,GO:0019752~carboxylic acid metabolic process,GO:0019725~cellular homeostasis,GO:0019693~ribose phosphate metabolic process,GO:0019637~organophosphate metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0019220~regulation of phosphate metabolic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018198~peptidyl-cysteine modification,GO:0018193~peptidyl-amino acid modification,GO:0018130~heterocycle biosynthetic process,GO:0018119~peptidyl-cysteine S-nitrosylation,GO:0017014~protein nitrosylation,GO:0016054~organic acid catabolic process,GO:0015908~fatty acid transport,GO:0015849~organic acid transport,GO:0015833~peptide transport,GO:0015732~prostaglandin transport,GO:0015718~monocarboxylic acid transport,GO:0015711~organic anion transport,GO:0015031~protein transport,GO:0010876~lipid localization,GO:0010817~regulation of hormone levels,GO:0010646~regulation of cell communication,GO:0010629~negative regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010033~response to organic substance,GO:0009914~hormone transport,GO:0009895~negative regulation of catabolic process,GO:0009894~regulation of catabolic process,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0009891~positive regulation of biosynthetic process,GO:0009725~response to hormone,GO:0009719~response to endogenous stimulus,GO:0009628~response to abiotic stimulus,GO:0009617~response to bacterium,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0009410~response to xenobiotic stimulus,GO:0009306~protein secretion,GO:0009260~ribonucleotide biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009190~cyclic nucleotide biosynthetic process,GO:0009187~cyclic nucleotide metabolic process,GO:0009165~nucleotide biosynthetic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009117~nucleotide metabolic process,GO:0009065~glutamine family amino acid catabolic process,GO:0009064~glutamine family amino acid metabolic process,GO:0009063~cellular amino acid catabolic process,GO:0009057~macromolecule catabolic process,GO:0008217~regulation of blood pressure,GO:0008104~protein localization,GO:0008015~blood circulation,GO:0007623~circadian rhythm,GO:0007267~cell-cell signaling,GO:0007263~nitric oxide mediated signal transduction,GO:0006955~immune response,GO:0006954~inflammatory response,GO:0006952~defense response,GO:0006869~lipid transport,GO:0006820~anion transport,GO:0006811~ion transport,GO:0006809~nitric oxide biosynthetic process,GO:0006801~superoxide metabolic process,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006753~nucleoside phosphate metabolic process,GO:0006527~arginine catabolic process,GO:0006525~arginine metabolic process,GO:0006520~cellular amino acid metabolic process,GO:0006464~cellular protein modification process,GO:0006182~cGMP biosynthetic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006163~purine nucleotide metabolic process,GO:0006140~regulation of nucleotide metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006082~organic acid metabolic process,GO:0003013~circulatory system process,GO:0003008~system process,GO:0002791~regulation of peptide secretion,GO:0002790~peptide secretion,GO:0002385~mucosal immune response,GO:0002251~organ or tissue specific immune response,GO:0002237~response to molecule of bacterial origin,GO:0002227~innate immune response in mucosa,GO:0001912~positive regulation of leukocyte mediated cytotoxicity,GO:0001910~regulation of leukocyte mediated cytotoxicity,GO:0001909~leukocyte mediated cytotoxicity,GO:0001906~cell killing,GO:0001819~positive regulation of cytokine production,GO:0001817~regulation of cytokine production,GO:0001816~cytokine production,GO:0001666~response to hypoxia,												GO:0099568~cytoplasmic region,GO:0048471~perinuclear region of cytoplasm,GO:0044448~cell cortex part,GO:0044439~peroxisomal part,GO:0044438~microbody part,GO:0042579~microbody,GO:0031907~microbody lumen,GO:0030863~cortical cytoskeleton,GO:0005938~cell cortex,GO:0005829~cytosol,GO:0005782~peroxisomal matrix,GO:0005777~peroxisome,GO:0005654~nucleoplasm,												GO:1901363~heterocyclic compound binding,GO:1901265~nucleoside phosphate binding,GO:0097367~carbohydrate derivative binding,GO:0097159~organic cyclic compound binding,GO:0050662~coenzyme binding,GO:0050661~NADP binding,GO:0050660~flavin adenine dinucleotide binding,GO:0048037~cofactor binding,GO:0046983~protein dimerization activity,GO:0046906~tetrapyrrole binding,GO:0046872~metal ion binding,GO:0043177~organic acid binding,GO:0043169~cation binding,GO:0043168~anion binding,GO:0043167~ion binding,GO:0042803~protein homodimerization activity,GO:0042802~identical protein binding,GO:0036094~small molecule binding,GO:0034618~arginine binding,GO:0034617~tetrahydrobiopterin binding,GO:0032553~ribonucleotide binding,GO:0031406~carboxylic acid binding,GO:0020037~heme binding,GO:0016709~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,GO:0016597~amino acid binding,GO:0010181~FMN binding,GO:0005516~calmodulin binding,GO:0004517~nitric-oxide synthase activity,GO:0004497~monooxygenase activity,GO:0000166~nucleotide binding,												IPR044944:NOS_dom_3,IPR044943:NOS_dom_1,IPR044940:NOS_dom_2,IPR039261:FNR_nucleotide-bd,IPR036119:NOS_N_sf,IPR029039:Flavoprotein-like_sf,IPR023173:NADPH_Cyt_P450_Rdtase_alpha,IPR017938:Riboflavin_synthase-like_b-brl,IPR017927:FAD-bd_FR_type,IPR012144:NOS_euk,IPR008254:Flavodoxin/NO_synth,IPR004030:NOS_N,IPR003097:CysJ-like_FAD-binding,IPR001709:Flavoprot_Pyr_Nucl_cyt_Rdtase,IPR001433:OxRdtase_FAD/NAD-bd,IPR001094:Flavdoxin-like,												hsa05222:Small cell lung cancer,hsa05200:Pathways in cancer,hsa05152:Tuberculosis,hsa05146:Amoebiasis,hsa05145:Toxoplasmosis,hsa05142:Chagas disease,hsa05140:Leishmaniasis,hsa05133:Pertussis,hsa05022:Pathways of neurodegeneration - multiple diseases,hsa05014:Amyotrophic lateral sclerosis,hsa05010:Alzheimer disease,hsa04926:Relaxin signaling pathway,hsa04371:Apelin signaling pathway,hsa04146:Peroxisome,hsa04066:HIF-1 signaling pathway,hsa04020:Calcium signaling pathway,hsa01100:Metabolic pathways,hsa00330:Arginine and proline metabolism,hsa00220:Arginine biosynthesis,												611162~Malaria, resistance to,												PIRSF000333:NOS,													REGION:Disordered,REGION:Calmodulin-binding,MUTAGEN:N->A: Loss of interaction with SPSB1 and SPSB4.,MOTIF:DINNN-motif; mediates interaction with SPSB1, SPSB2 and SPSB4,DOMAIN:Nitric oxide synthase (NOS),DOMAIN:Flavodoxin-like,DOMAIN:FAD-binding FR-type,COMPBIAS:Polar residues,BINDING:axial binding residue,
34720_at	nuclear factor I B(NFIB)	Homo sapiens			GO:2001141~regulation of RNA biosynthetic process,GO:2000795~negative regulation of epithelial cell proliferation involved in lung morphogenesis,GO:2000794~regulation of epithelial cell proliferation involved in lung morphogenesis,GO:2000791~negative regulation of mesenchymal cell proliferation involved in lung development,GO:2000790~regulation of mesenchymal cell proliferation involved in lung development,GO:2000647~negative regulation of stem cell proliferation,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000027~regulation of organ morphogenesis,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903047~mitotic cell cycle process,GO:1902894~negative regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1902893~regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1902680~positive regulation of RNA biosynthetic process,GO:1902679~negative regulation of RNA biosynthetic process,GO:0098727~maintenance of cell number,GO:0097659~nucleic acid-templated transcription,GO:0097485~neuron projection guidance,GO:0072201~negative regulation of mesenchymal cell proliferation,GO:0072091~regulation of stem cell proliferation,GO:0072089~stem cell proliferation,GO:0071679~commissural neuron axon guidance,GO:0065009~regulation of molecular function,GO:0061614~pri-miRNA transcription from RNA polymerase II promoter,GO:0061564~axon development,GO:0061448~connective tissue development,GO:0061351~neural precursor cell proliferation,GO:0061141~lung ciliated cell differentiation,GO:0061140~lung secretory cell differentiation,GO:0060916~mesenchymal cell proliferation involved in lung development,GO:0060689~cell differentiation involved in salivary gland development,GO:0060662~salivary gland cavitation,GO:0060605~tube lumen cavitation,GO:0060541~respiratory system development,GO:0060510~Type II pneumocyte differentiation,GO:0060509~Type I pneumocyte differentiation,GO:0060502~epithelial cell proliferation involved in lung morphogenesis,GO:0060487~lung epithelial cell differentiation,GO:0060486~Clara cell differentiation,GO:0060479~lung cell differentiation,GO:0060429~epithelium development,GO:0060428~lung epithelium development,GO:0060425~lung morphogenesis,GO:0060322~head development,GO:0060249~anatomical structure homeostasis,GO:0060041~retina development in camera-type eye,GO:0051707~response to other organism,GO:0051254~positive regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051241~negative regulation of multicellular organismal process,GO:0051216~cartilage development,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051101~regulation of DNA binding,GO:0051100~negative regulation of binding,GO:0051098~regulation of binding,GO:0051093~negative regulation of developmental process,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0050673~epithelial cell proliferation,GO:0048871~multicellular organismal homeostasis,GO:0048858~cell projection morphogenesis,GO:0048857~neural nucleus development,GO:0048812~neuron projection morphogenesis,GO:0048732~gland development,GO:0048699~generation of neurons,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048666~neuron development,GO:0048665~neuron fate specification,GO:0048663~neuron fate commitment,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048468~cell development,GO:0048285~organelle fission,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045165~cell fate commitment,GO:0044772~mitotic cell cycle phase transition,GO:0044770~cell cycle phase transition,GO:0044092~negative regulation of molecular function,GO:0043392~negative regulation of DNA binding,GO:0043207~response to external biotic stimulus,GO:0043010~camera-type eye development,GO:0042592~homeostatic process,GO:0042330~taxis,GO:0042127~regulation of cell proliferation,GO:0042063~gliogenesis,GO:0040011~locomotion,GO:0035295~tube development,GO:0035272~exocrine system development,GO:0035239~tube morphogenesis,GO:0035148~tube formation,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0032990~cell part morphogenesis,GO:0032989~cellular component morphogenesis,GO:0032774~RNA biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031324~negative regulation of cellular metabolic process,GO:0031175~neuron projection development,GO:0031099~regeneration,GO:0030902~hindbrain development,GO:0030900~forebrain development,GO:0030855~epithelial cell differentiation,GO:0030324~lung development,GO:0030323~respiratory tube development,GO:0030182~neuron differentiation,GO:0030030~cell projection organization,GO:0022612~gland morphogenesis,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022402~cell cycle process,GO:0022008~neurogenesis,GO:0021960~anterior commissure morphogenesis,GO:0021955~central nervous system neuron axonogenesis,GO:0021954~central nervous system neuron development,GO:0021953~central nervous system neuron differentiation,GO:0021952~central nervous system projection neuron axonogenesis,GO:0021846~cell proliferation in forebrain,GO:0021781~glial cell fate commitment,GO:0021780~glial cell fate specification,GO:0021740~principal sensory nucleus of trigeminal nerve development,GO:0021730~trigeminal sensory nucleus development,GO:0021537~telencephalon development,GO:0019827~stem cell population maintenance,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016070~RNA metabolic process,GO:0014009~glial cell proliferation,GO:0010629~negative regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010464~regulation of mesenchymal cell proliferation,GO:0010463~mesenchymal cell proliferation,GO:0010458~exit from mitosis,GO:0010001~glial cell differentiation,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0009891~positive regulation of biosynthetic process,GO:0009890~negative regulation of biosynthetic process,GO:0009887~animal organ morphogenesis,GO:0009617~response to bacterium,GO:0009611~response to wounding,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0008285~negative regulation of cell proliferation,GO:0008283~cell proliferation,GO:0007435~salivary gland morphogenesis,GO:0007431~salivary gland development,GO:0007423~sensory organ development,GO:0007420~brain development,GO:0007417~central nervous system development,GO:0007411~axon guidance,GO:0007409~axonogenesis,GO:0007399~nervous system development,GO:0007067~mitotic nuclear division,GO:0007049~cell cycle,GO:0006935~chemotaxis,GO:0006928~movement of cell or subcellular component,GO:0006366~transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0006260~DNA replication,GO:0006259~DNA metabolic process,GO:0002067~glandular epithelial cell differentiation,GO:0002065~columnar/cuboidal epithelial cell differentiation,GO:0002062~chondrocyte differentiation,GO:0001894~tissue homeostasis,GO:0001708~cell fate specification,GO:0001654~eye development,GO:0001501~skeletal system development,GO:0000904~cell morphogenesis involved in differentiation,GO:0000902~cell morphogenesis,GO:0000280~nuclear division,GO:0000278~mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,												GO:0097458~neuron part,GO:0044452~nucleolar part,GO:0044427~chromosomal part,GO:0044300~cerebellar mossy fiber,GO:0043005~neuron projection,GO:0030424~axon,GO:0005730~nucleolus,GO:0005694~chromosome,GO:0005654~nucleoplasm,GO:0001650~fibrillar center,GO:0000785~chromatin,												GO:1990837~sequence-specific double-stranded DNA binding,GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0044212~transcription regulatory region DNA binding,GO:0043565~sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003690~double-stranded DNA binding,GO:0003677~DNA binding,GO:0003676~nucleic acid binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001159~core promoter proximal region DNA binding,GO:0001071~nucleic acid binding transcription factor activity,GO:0001067~regulatory region nucleic acid binding,GO:0001012~RNA polymerase II regulatory region DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000975~regulatory region DNA binding,												IPR020604:CTF/NFI_DNA-bd-dom,IPR019739:CTF/NFI_DNA-bd_CS,IPR019548:CTF/NFI_DNA-bd_N,IPR003619:MAD_homology1_Dwarfin-type,IPR000647:CTF/NFI,													618286~Macrocephaly, acquired, with impaired intellectual development,													SM00523:DWA,												REGION:Disordered,MOTIF:9aaTAD,DOMAIN:CTF/NF-I,DNA_BIND:CTF/NF-I,COMPBIAS:Pro residues,COMPBIAS:Polar residues,
40271_at	nucleoporin 93(NUP93)	Homo sapiens			GO:1904951~positive regulation of establishment of protein localization,GO:1904591~positive regulation of protein import,GO:1904589~regulation of protein import,GO:1903829~positive regulation of cellular protein localization,GO:1903827~regulation of cellular protein localization,GO:1903533~regulation of protein targeting,GO:1902593~single-organism nuclear import,GO:1902582~single-organism intracellular transport,GO:1902580~single-organism cellular localization,GO:1900182~positive regulation of protein localization to nucleus,GO:1900180~regulation of protein localization to nucleus,GO:0090316~positive regulation of intracellular protein transport,GO:0090100~positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0090092~regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0090087~regulation of peptide transport,GO:0072594~establishment of protein localization to organelle,GO:0071822~protein complex subunit organization,GO:0071705~nitrogen compound transport,GO:0071427~mRNA-containing ribonucleoprotein complex export from nucleus,GO:0071426~ribonucleoprotein complex export from nucleus,GO:0071166~ribonucleoprotein complex localization,GO:0070727~cellular macromolecule localization,GO:0070271~protein complex biogenesis,GO:0070201~regulation of establishment of protein localization,GO:0065003~macromolecular complex assembly,GO:0061024~membrane organization,GO:0060391~positive regulation of SMAD protein import into nucleus,GO:0060390~regulation of SMAD protein import into nucleus,GO:0060341~regulation of cellular localization,GO:0051649~establishment of localization in cell,GO:0051641~cellular localization,GO:0051292~nuclear pore complex assembly,GO:0051236~establishment of RNA localization,GO:0051223~regulation of protein transport,GO:0051222~positive regulation of protein transport,GO:0051170~nuclear import,GO:0051169~nuclear transport,GO:0051168~nuclear export,GO:0051050~positive regulation of transport,GO:0051049~regulation of transport,GO:0051028~mRNA transport,GO:0050658~RNA transport,GO:0050657~nucleic acid transport,GO:0048584~positive regulation of response to stimulus,GO:0046931~pore complex assembly,GO:0046907~intracellular transport,GO:0046824~positive regulation of nucleocytoplasmic transport,GO:0046822~regulation of nucleocytoplasmic transport,GO:0045184~establishment of protein localization,GO:0044802~single-organism membrane organization,GO:0044744~protein targeting to nucleus,GO:0044085~cellular component biogenesis,GO:0043933~macromolecular complex subunit organization,GO:0043623~cellular protein complex assembly,GO:0042886~amide transport,GO:0042307~positive regulation of protein import into nucleus,GO:0042306~regulation of protein import into nucleus,GO:0034622~cellular macromolecular complex assembly,GO:0034613~cellular protein localization,GO:0034504~protein localization to nucleus,GO:0033365~protein localization to organelle,GO:0033157~regulation of intracellular protein transport,GO:0033036~macromolecule localization,GO:0032880~regulation of protein localization,GO:0032388~positive regulation of intracellular transport,GO:0032386~regulation of intracellular transport,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0022607~cellular component assembly,GO:0017038~protein import,GO:0016973~poly(A)+ mRNA export from nucleus,GO:0015931~nucleobase-containing compound transport,GO:0015833~peptide transport,GO:0015031~protein transport,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010467~gene expression,GO:0010256~endomembrane system organization,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0008104~protein localization,GO:0007184~SMAD protein import into nucleus,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0006999~nuclear pore organization,GO:0006998~nuclear envelope organization,GO:0006997~nucleus organization,GO:0006913~nucleocytoplasmic transport,GO:0006886~intracellular protein transport,GO:0006611~protein export from nucleus,GO:0006606~protein import into nucleus,GO:0006605~protein targeting,GO:0006461~protein complex assembly,GO:0006406~mRNA export from nucleus,GO:0006405~RNA export from nucleus,GO:0006403~RNA localization,												GO:0034399~nuclear periphery,GO:0031975~envelope,GO:0031967~organelle envelope,GO:0031965~nuclear membrane,GO:0015630~microtubule cytoskeleton,GO:0005829~cytosol,GO:0005815~microtubule organizing center,GO:0005813~centrosome,GO:0005643~nuclear pore,GO:0005635~nuclear envelope,												GO:0017056~structural constituent of nuclear pore,GO:0005198~structural molecule activity,												IPR007231:Nucleoporin_int_Nup93/Nic96,												hsa05014:Amyotrophic lateral sclerosis,hsa03013:Nucleocytoplasmic transport,												616892~Nephrotic syndrome, type 12,			
35903_at	oligodendrocyte myelin glycoprotein(OMG)	Homo sapiens			GO:0048699~generation of neurons,GO:0048666~neuron development,GO:0048468~cell development,GO:0033554~cellular response to stress,GO:0031175~neuron projection development,GO:0031102~neuron projection regeneration,GO:0031099~regeneration,GO:0030182~neuron differentiation,GO:0030030~cell projection organization,GO:0022610~biological adhesion,GO:0022008~neurogenesis,GO:0007399~nervous system development,GO:0007155~cell adhesion,												GO:0098552~side of membrane,													IPR032675:LRR_dom_sf,IPR003591:Leu-rich_rpt_typical-subtyp,IPR001611:Leu-rich_rpt,IPR000372:LRRNT,															SM00369:LRR_TYP,SM00013:LRRNT,												REPEAT:Ser/Thr-rich,REPEAT:LRR 8,REPEAT:LRR 7,REPEAT:LRR 6,REPEAT:LRR 5,REPEAT:LRR 4,REPEAT:LRR 3,REPEAT:LRR 2,REPEAT:LRR 1,PROPEP:Removed in mature form,LIPID:GPI-anchor amidated serine,DOMAIN:LRRNT,CARBOHYD:N-linked (GlcNAc...) asparagine,
32418_at	phosphodiesterase 1C(PDE1C)	Homo sapiens			GO:0035556~intracellular signal transduction,GO:0019935~cyclic-nucleotide-mediated signaling,GO:0019933~cAMP-mediated signaling,GO:0019932~second-messenger-mediated signaling,												GO:0097458~neuron part,GO:0044297~cell body,GO:0043025~neuronal cell body,GO:0036477~somatodendritic compartment,GO:0005829~cytosol,GO:0005773~vacuole,GO:0005764~lysosome,GO:0000323~lytic vacuole,												GO:0048101~calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity,GO:0047555~3',5'-cyclic-GMP phosphodiesterase activity,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0042578~phosphoric ester hydrolase activity,GO:0008081~phosphoric diester hydrolase activity,GO:0005516~calmodulin binding,GO:0004117~calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,GO:0004115~3',5'-cyclic-AMP phosphodiesterase activity,GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004112~cyclic-nucleotide phosphodiesterase activity,												IPR036971:PDEase_catalytic_dom_sf,IPR023174:PDEase_CS,IPR023088:PDEase,IPR013706:PDEase_N,IPR003607:HD/PDEase_dom,IPR002073:PDEase_catalytic_dom,												hsa05032:Morphine addiction,hsa04924:Renin secretion,hsa04742:Taste transduction,hsa04740:Olfactory transduction,hsa04020:Calcium signaling pathway,hsa01100:Metabolic pathways,hsa00230:Purine metabolism,												618140~Deafness, autosomal dominant 74,													SM00471:HDc,												REGION:Disordered,REGION:Calmodulin-binding,DOMAIN:PDEase,COMPBIAS:Polar residues,COMPBIAS:Basic and acidic residues,ACT_SITE:Proton donor,
35373_at	phosphoinositide-3-kinase regulatory subunit 1(PIK3R1)	Homo sapiens	63.LAT_couples_T-cell_receptor,37.Akt-PKB_Effector_of_P13K_in_Vivo,2.Cytokine_Receptors,107.mRNA_translation-protein_synthesis,106.Glycogen_synthase-synthesis,105.Signaling_glucose_uptake,104.Insulin_signaling,												h_vegfPathway:VEGF, Hypoxia, and Angiogenesis,h_trkaPathway:Trka Receptor Signaling Pathway,h_tpoPathway:TPO Signaling Pathway,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,h_tcrPathway:T Cell Receptor Signaling Pathway,h_rasPathway:Ras Signaling Pathway,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_rac1Pathway:Rac 1 cell motility signaling pathway,h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_plcPathway:Phospholipase C Signaling Pathway,h_pdgfPathway:PDGF Signaling Pathway,h_par1pathway:Thrombin signaling and protease-activated receptors,h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity,h_ngfPathway:Nerve growth factor pathway (NGF),h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_mtorPathway:mTOR Signaling Pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_longevityPathway:The IGF-1 Receptor and Longevity,h_insulinPathway:Insulin Signaling Pathway,h_il7Pathway:IL-7 Signal Transduction,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_igf1Pathway:IGF-1 Signaling Pathway,h_igf1mtorPathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway,h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_hdacPathway:Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK),h_hcmvPathway:Human Cytomegalovirus and Map Kinase Pathways,H_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,h_ghPathway:Growth Hormone Signaling Pathway,h_gcrpathway:Corticosteroids and cardioprotection,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_erk5Pathway:Role of Erk5 in Neuronal Survival,h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,h_egfPathway:EGF Signaling Pathway,h_edg1Pathway:Phospholipids as signalling intermediaries,h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_crebPathway:Transcription factor CREB and its extracellular signals,h_cdc42racPathway:Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration,h_bcellsurvivalPathway:B Cell Survival Pathway,h_badPathway:Regulation of BAD phosphorylation,h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_aktPathway:AKT Signaling Pathway,h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis,												GO:2001141~regulation of RNA biosynthetic process,GO:2000147~positive regulation of cell motility,GO:2000145~regulation of cell motility,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1990778~protein localization to cell periphery,GO:1905898~positive regulation of response to endoplasmic reticulum stress,GO:1905897~regulation of response to endoplasmic reticulum stress,GO:1905477~positive regulation of protein localization to membrane,GO:1905475~regulation of protein localization to membrane,GO:1904951~positive regulation of establishment of protein localization,GO:1904591~positive regulation of protein import,GO:1904589~regulation of protein import,GO:1904377~positive regulation of protein localization to cell periphery,GO:1904375~regulation of protein localization to cell periphery,GO:1903829~positive regulation of cellular protein localization,GO:1903827~regulation of cellular protein localization,GO:1903729~regulation of plasma membrane organization,GO:1903707~negative regulation of hemopoiesis,GO:1903706~regulation of hemopoiesis,GO:1903557~positive regulation of tumor necrosis factor superfamily cytokine production,GO:1903555~regulation of tumor necrosis factor superfamily cytokine production,GO:1903533~regulation of protein targeting,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903078~positive regulation of protein localization to plasma membrane,GO:1903076~regulation of protein localization to plasma membrane,GO:1902904~negative regulation of supramolecular fiber organization,GO:1902903~regulation of supramolecular fiber organization,GO:1902745~positive regulation of lamellipodium organization,GO:1902743~regulation of lamellipodium organization,GO:1902680~positive regulation of RNA biosynthetic process,GO:1902593~single-organism nuclear import,GO:1902589~single-organism organelle organization,GO:1902582~single-organism intracellular transport,GO:1902580~single-organism cellular localization,GO:1902106~negative regulation of leukocyte differentiation,GO:1902105~regulation of leukocyte differentiation,GO:1901701~cellular response to oxygen-containing compound,GO:1901700~response to oxygen-containing compound,GO:1901699~cellular response to nitrogen compound,GO:1901698~response to nitrogen compound,GO:1901653~cellular response to peptide,GO:1901652~response to peptide,GO:1900182~positive regulation of protein localization to nucleus,GO:1900180~regulation of protein localization to nucleus,GO:1900103~positive regulation of endoplasmic reticulum unfolded protein response,GO:1900101~regulation of endoplasmic reticulum unfolded protein response,GO:0098602~single organism cell adhesion,GO:0097659~nucleic acid-templated transcription,GO:0097581~lamellipodium organization,GO:0097529~myeloid leukocyte migration,GO:0097435~supramolecular fiber organization,GO:0097193~intrinsic apoptotic signaling pathway,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097190~apoptotic signaling pathway,GO:0090316~positive regulation of intracellular protein transport,GO:0090087~regulation of peptide transport,GO:0080135~regulation of cellular response to stress,GO:0080134~regulation of response to stress,GO:0072659~protein localization to plasma membrane,GO:0072657~protein localization to membrane,GO:0072594~establishment of protein localization to organelle,GO:0071706~tumor necrosis factor superfamily cytokine production,GO:0071705~nitrogen compound transport,GO:0071495~cellular response to endogenous stimulus,GO:0071482~cellular response to light stimulus,GO:0071478~cellular response to radiation,GO:0071417~cellular response to organonitrogen compound,GO:0071378~cellular response to growth hormone stimulus,GO:0071375~cellular response to peptide hormone stimulus,GO:0071351~cellular response to interleukin-18,GO:0071345~cellular response to cytokine stimulus,GO:0071310~cellular response to organic substance,GO:0071214~cellular response to abiotic stimulus,GO:0070887~cellular response to chemical stimulus,GO:0070727~cellular macromolecule localization,GO:0070673~response to interleukin-18,GO:0070201~regulation of establishment of protein localization,GO:0061572~actin filament bundle organization,GO:0061024~membrane organization,GO:0060548~negative regulation of cell death,GO:0060491~regulation of cell projection assembly,GO:0060416~response to growth hormone,GO:0060396~growth hormone receptor signaling pathway,GO:0060341~regulation of cellular localization,GO:0055082~cellular chemical homeostasis,GO:0051674~localization of cell,GO:0051649~establishment of localization in cell,GO:0051641~cellular localization,GO:0051497~negative regulation of stress fiber assembly,GO:0051494~negative regulation of cytoskeleton organization,GO:0051493~regulation of cytoskeleton organization,GO:0051492~regulation of stress fiber assembly,GO:0051491~positive regulation of filopodium assembly,GO:0051489~regulation of filopodium assembly,GO:0051272~positive regulation of cellular component movement,GO:0051270~regulation of cellular component movement,GO:0051254~positive regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051241~negative regulation of multicellular organismal process,GO:0051240~positive regulation of multicellular organismal process,GO:0051223~regulation of protein transport,GO:0051222~positive regulation of protein transport,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051170~nuclear import,GO:0051169~nuclear transport,GO:0051130~positive regulation of cellular component organization,GO:0051129~negative regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051093~negative regulation of developmental process,GO:0051050~positive regulation of transport,GO:0051049~regulation of transport,GO:0051017~actin filament bundle assembly,GO:0050900~leukocyte migration,GO:0050821~protein stabilization,GO:0050778~positive regulation of immune response,GO:0050776~regulation of immune response,GO:0048878~chemical homeostasis,GO:0048870~cell motility,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048659~smooth muscle cell proliferation,GO:0048584~positive regulation of response to stimulus,GO:0048534~hematopoietic or lymphoid organ development,GO:0048468~cell development,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0046907~intracellular transport,GO:0046854~phosphatidylinositol phosphorylation,GO:0046847~filopodium assembly,GO:0046834~lipid phosphorylation,GO:0046824~positive regulation of nucleocytoplasmic transport,GO:0046822~regulation of nucleocytoplasmic transport,GO:0046649~lymphocyte activation,GO:0046488~phosphatidylinositol metabolic process,GO:0046486~glycerolipid metabolic process,GO:0046326~positive regulation of glucose import,GO:0046324~regulation of glucose import,GO:0046323~glucose import,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045671~negative regulation of osteoclast differentiation,GO:0045670~regulation of osteoclast differentiation,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0045321~leukocyte activation,GO:0045184~establishment of protein localization,GO:0045089~positive regulation of innate immune response,GO:0045088~regulation of innate immune response,GO:0045087~innate immune response,GO:0044802~single-organism membrane organization,GO:0044744~protein targeting to nucleus,GO:0044255~cellular lipid metabolic process,GO:0044089~positive regulation of cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044085~cellular component biogenesis,GO:0043491~protein kinase B signaling,GO:0043484~regulation of RNA splicing,GO:0043434~response to peptide hormone,GO:0043149~stress fiber assembly,GO:0043069~negative regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptotic process,GO:0042981~regulation of apoptotic process,GO:0042886~amide transport,GO:0042593~glucose homeostasis,GO:0042592~homeostatic process,GO:0042307~positive regulation of protein import into nucleus,GO:0042306~regulation of protein import into nucleus,GO:0042127~regulation of cell proliferation,GO:0042113~B cell activation,GO:0042110~T cell activation,GO:0040017~positive regulation of locomotion,GO:0040012~regulation of locomotion,GO:0040011~locomotion,GO:0035967~cellular response to topologically incorrect protein,GO:0035966~response to topologically incorrect protein,GO:0035655~interleukin-18-mediated signaling pathway,GO:0035556~intracellular signal transduction,GO:0034976~response to endoplasmic reticulum stress,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034644~cellular response to UV,GO:0034620~cellular response to unfolded protein,GO:0034613~cellular protein localization,GO:0034504~protein localization to nucleus,GO:0034446~substrate adhesion-dependent cell spreading,GO:0034143~regulation of toll-like receptor 4 signaling pathway,GO:0034121~regulation of toll-like receptor signaling pathway,GO:0034097~response to cytokine,GO:0033554~cellular response to stress,GO:0033500~carbohydrate homeostasis,GO:0033365~protein localization to organelle,GO:0033157~regulation of intracellular protein transport,GO:0033120~positive regulation of RNA splicing,GO:0033043~regulation of organelle organization,GO:0033036~macromolecule localization,GO:0033002~muscle cell proliferation,GO:0032989~cellular component morphogenesis,GO:0032970~regulation of actin filament-based process,GO:0032956~regulation of actin cytoskeleton organization,GO:0032880~regulation of protein localization,GO:0032870~cellular response to hormone stimulus,GO:0032869~cellular response to insulin stimulus,GO:0032868~response to insulin,GO:0032774~RNA biosynthetic process,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032680~regulation of tumor necrosis factor production,GO:0032640~tumor necrosis factor production,GO:0032388~positive regulation of intracellular transport,GO:0032386~regulation of intracellular transport,GO:0032232~negative regulation of actin filament bundle assembly,GO:0032231~regulation of actin filament bundle assembly,GO:0031647~regulation of protein stability,GO:0031589~cell-substrate adhesion,GO:0031349~positive regulation of defense response,GO:0031347~regulation of defense response,GO:0031346~positive regulation of cell projection organization,GO:0031344~regulation of cell projection organization,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031032~actomyosin structure organization,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0030335~positive regulation of cell migration,GO:0030334~regulation of cell migration,GO:0030316~osteoclast differentiation,GO:0030258~lipid modification,GO:0030217~T cell differentiation,GO:0030183~B cell differentiation,GO:0030155~regulation of cell adhesion,GO:0030099~myeloid cell differentiation,GO:0030098~lymphocyte differentiation,GO:0030097~hemopoiesis,GO:0030038~contractile actin filament bundle assembly,GO:0030036~actin cytoskeleton organization,GO:0030032~lamellipodium assembly,GO:0030031~cell projection assembly,GO:0030030~cell projection organization,GO:0030029~actin filament-based process,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0022610~biological adhesion,GO:0022607~cellular component assembly,GO:0019725~cellular homeostasis,GO:0019637~organophosphate metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0019221~cytokine-mediated signaling pathway,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0017038~protein import,GO:0016477~cell migration,GO:0016310~phosphorylation,GO:0016070~RNA metabolic process,GO:0015833~peptide transport,GO:0015758~glucose transport,GO:0015749~monosaccharide transport,GO:0015031~protein transport,GO:0012501~programmed cell death,GO:0010941~regulation of cell death,GO:0010828~positive regulation of glucose transport,GO:0010827~regulation of glucose transport,GO:0010812~negative regulation of cell-substrate adhesion,GO:0010810~regulation of cell-substrate adhesion,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010639~negative regulation of organelle organization,GO:0010628~positive regulation of gene expression,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010592~positive regulation of lamellipodium assembly,GO:0010591~regulation of lamellipodium assembly,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010256~endomembrane system organization,GO:0010243~response to organonitrogen compound,GO:0010033~response to organic substance,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009893~positive regulation of metabolic process,GO:0009891~positive regulation of biosynthetic process,GO:0009725~response to hormone,GO:0009719~response to endogenous stimulus,GO:0009628~response to abiotic stimulus,GO:0009416~response to light stimulus,GO:0009411~response to UV,GO:0009314~response to radiation,GO:0008645~hexose transport,GO:0008643~carbohydrate transport,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0008380~RNA splicing,GO:0008286~insulin receptor signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0008283~cell proliferation,GO:0008219~cell death,GO:0008104~protein localization,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0007162~negative regulation of cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007155~cell adhesion,GO:0007015~actin filament organization,GO:0007010~cytoskeleton organization,GO:0007009~plasma membrane organization,GO:0006986~response to unfolded protein,GO:0006974~cellular response to DNA damage stimulus,GO:0006955~immune response,GO:0006952~defense response,GO:0006928~movement of cell or subcellular component,GO:0006915~apoptotic process,GO:0006913~nucleocytoplasmic transport,GO:0006886~intracellular protein transport,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006650~glycerophospholipid metabolic process,GO:0006644~phospholipid metabolic process,GO:0006629~lipid metabolic process,GO:0006606~protein import into nucleus,GO:0006605~protein targeting,GO:0006396~RNA processing,GO:0006366~transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0002764~immune response-regulating signaling pathway,GO:0002762~negative regulation of myeloid leukocyte differentiation,GO:0002761~regulation of myeloid leukocyte differentiation,GO:0002758~innate immune response-activating signal transduction,GO:0002757~immune response-activating signal transduction,GO:0002687~positive regulation of leukocyte migration,GO:0002685~regulation of leukocyte migration,GO:0002684~positive regulation of immune system process,GO:0002683~negative regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002573~myeloid leukocyte differentiation,GO:0002521~leukocyte differentiation,GO:0002520~immune system development,GO:0002253~activation of immune response,GO:0002224~toll-like receptor signaling pathway,GO:0002221~pattern recognition receptor signaling pathway,GO:0002218~activation of innate immune response,GO:0001953~negative regulation of cell-matrix adhesion,GO:0001952~regulation of cell-matrix adhesion,GO:0001819~positive regulation of cytokine production,GO:0001817~regulation of cytokine production,GO:0001816~cytokine production,GO:0001775~cell activation,GO:0001678~cellular glucose homeostasis,GO:0000904~cell morphogenesis involved in differentiation,GO:0000902~cell morphogenesis,												GO:1990578~perinuclear endoplasmic reticulum membrane,GO:0097651~phosphatidylinositol 3-kinase complex, class I,GO:0097038~perinuclear endoplasmic reticulum,GO:0061695~transferase complex, transferring phosphorus-containing groups,GO:0048471~perinuclear region of cytoplasm,GO:0044432~endoplasmic reticulum part,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0030054~cell junction,GO:0019898~extrinsic component of membrane,GO:0005943~phosphatidylinositol 3-kinase complex, class IA,GO:0005942~phosphatidylinositol 3-kinase complex,GO:0005911~cell-cell junction,GO:0005829~cytosol,GO:0005801~cis-Golgi network,GO:0005783~endoplasmic reticulum,												GO:1990782~protein tyrosine kinase binding,GO:1901363~heterocyclic compound binding,GO:0098772~molecular function regulator,GO:0098531~transcription factor activity, direct ligand regulated sequence-specific DNA binding,GO:0097159~organic cyclic compound binding,GO:0060090~binding, bridging,GO:0052742~phosphatidylinositol kinase activity,GO:0051219~phosphoprotein binding,GO:0046983~protein dimerization activity,GO:0046982~protein heterodimerization activity,GO:0046935~1-phosphatidylinositol-3-kinase regulator activity,GO:0045309~protein phosphorylated amino acid binding,GO:0044877~macromolecular complex binding,GO:0043560~insulin receptor substrate binding,GO:0043559~insulin binding,GO:0043548~phosphatidylinositol 3-kinase binding,GO:0043125~ErbB-3 class receptor binding,GO:0042562~hormone binding,GO:0042277~peptide binding,GO:0036312~phosphatidylinositol 3-kinase regulatory subunit binding,GO:0035591~signaling adaptor activity,GO:0035014~phosphatidylinositol 3-kinase regulator activity,GO:0033218~amide binding,GO:0032403~protein complex binding,GO:0030971~receptor tyrosine kinase binding,GO:0030674~protein binding, bridging,GO:0030234~enzyme regulator activity,GO:0019903~protein phosphatase binding,GO:0019902~phosphatase binding,GO:0019901~protein kinase binding,GO:0019900~kinase binding,GO:0019899~enzyme binding,GO:0019209~kinase activator activity,GO:0019207~kinase regulator activity,GO:0017046~peptide hormone binding,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0016301~kinase activity,GO:0008047~enzyme activator activity,GO:0005168~neurotrophin TRKA receptor binding,GO:0005167~neurotrophin TRK receptor binding,GO:0005165~neurotrophin receptor binding,GO:0005159~insulin-like growth factor receptor binding,GO:0005158~insulin receptor binding,GO:0005126~cytokine receptor binding,GO:0005102~receptor binding,GO:0005068~transmembrane receptor protein tyrosine kinase adaptor activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0004871~signal transducer activity,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003676~nucleic acid binding,GO:0001784~phosphotyrosine binding,GO:0001071~nucleic acid binding transcription factor activity,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,												IPR044124:ISH2_PIK3R1,IPR036860:SH2_dom_sf,IPR036028:SH3-like_dom_sf,IPR035591:PI3K_p85alpha_SH3,IPR035022:PI3kinase_P85_nSH2,IPR035020:PI3kinase_P85_cSH2,IPR032498:PI3K_P85_iSH2,IPR008936:Rho_GTPase_activation_prot,IPR003070:NR4A1-3,IPR001452:SH3_domain,IPR000980:SH2,IPR000198:RhoGAP_dom,												hsa05418:Fluid shear stress and atherosclerosis,hsa05417:Lipid and atherosclerosis,hsa05415:Diabetic cardiomyopathy,hsa05235:PD-L1 expression and PD-1 checkpoint pathway in cancer,hsa05231:Choline metabolism in cancer,hsa05230:Central carbon metabolism in cancer,hsa05226:Gastric cancer,hsa05225:Hepatocellular carcinoma,hsa05224:Breast cancer,hsa05223:Non-small cell lung cancer,hsa05222:Small cell lung cancer,hsa05221:Acute myeloid leukemia,hsa05220:Chronic myeloid leukemia,hsa05218:Melanoma,hsa05215:Prostate cancer,hsa05214:Glioma,hsa05213:Endometrial cancer,hsa05212:Pancreatic cancer,hsa05211:Renal cell carcinoma,hsa05210:Colorectal cancer,hsa05208:Chemical carcinogenesis - reactive oxygen species,hsa05207:Chemical carcinogenesis - receptor activation,hsa05206:MicroRNAs in cancer,hsa05205:Proteoglycans in cancer,hsa05203:Viral carcinogenesis,hsa05200:Pathways in cancer,hsa05171:Coronavirus disease - COVID-19,hsa05170:Human immunodeficiency virus 1 infection,hsa05169:Epstein-Barr virus infection,hsa05168:Herpes simplex virus 1 infection,hsa05167:Kaposi sarcoma-associated herpesvirus infection,hsa05166:Human T-cell leukemia virus 1 infection,hsa05165:Human papillomavirus infection,hsa05164:Influenza A,hsa05163:Human cytomegalovirus infection,hsa05162:Measles,hsa05161:Hepatitis B,hsa05160:Hepatitis C,hsa05146:Amoebiasis,hsa05142:Chagas disease,hsa05135:Yersinia infection,hsa05131:Shigellosis,hsa05100:Bacterial invasion of epithelial cells,hsa05020:Prion disease,hsa05017:Spinocerebellar ataxia,hsa05010:Alzheimer disease,hsa04973:Carbohydrate digestion and absorption,hsa04960:Aldosterone-regulated sodium reabsorption,hsa04935:Growth hormone synthesis, secretion and action,hsa04933:AGE-RAGE signaling pathway in diabetic complications,hsa04932:Non-alcoholic fatty liver disease,hsa04931:Insulin resistance,hsa04930:Type II diabetes mellitus,hsa04929:GnRH secretion,hsa04926:Relaxin signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04919:Thyroid hormone signaling pathway,hsa04917:Prolactin signaling pathway,hsa04915:Estrogen signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04910:Insulin signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04725:Cholinergic synapse,hsa04722:Neurotrophin signaling pathway,hsa04670:Leukocyte transendothelial migration,hsa04668:TNF signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04664:Fc epsilon RI signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04630:JAK-STAT signaling pathway,hsa04625:C-type lectin receptor signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04613:Neutrophil extracellular trap formation,hsa04611:Platelet activation,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04510:Focal adhesion,hsa04380:Osteoclast differentiation,hsa04370:VEGF signaling pathway,hsa04360:Axon guidance,hsa04218:Cellular senescence,hsa04213:Longevity regulating pathway - multiple species,hsa04211:Longevity regulating pathway,hsa04210:Apoptosis,hsa04152:AMPK signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04150:mTOR signaling pathway,hsa04140:Autophagy - animal,hsa04072:Phospholipase D signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04068:FoxO signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04062:Chemokine signaling pathway,hsa04024:cAMP signaling pathway,hsa04015:Rap1 signaling pathway,hsa04014:Ras signaling pathway,hsa04012:ErbB signaling pathway,hsa01524:Platinum drug resistance,hsa01522:Endocrine resistance,hsa01521:EGFR tyrosine kinase inhibitor resistance,												616005~Immunodeficiency 36,615214~Agammaglobulinemia 7, autosomal recessive,269880~SHORT syndrome,													SM00326:SH3,SM00324:RhoGAP,SM00252:SH2,												REGION:Disordered,DOMAIN:SH3,DOMAIN:SH2 2,DOMAIN:SH2 1,DOMAIN:SH2,DOMAIN:Rho-GAP,COMPBIAS:Pro residues,
40959_at	pleckstrin homology and RhoGEF domain containing G3(PLEKHG3)	Homo sapiens			GO:2000145~regulation of cell motility,GO:2000114~regulation of establishment of cell polarity,GO:1902531~regulation of intracellular signal transduction,GO:0051674~localization of cell,GO:0051270~regulation of cellular component movement,GO:0051056~regulation of small GTPase mediated signal transduction,GO:0048870~cell motility,GO:0040012~regulation of locomotion,GO:0040011~locomotion,GO:0035556~intracellular signal transduction,GO:0032878~regulation of establishment or maintenance of cell polarity,GO:0030334~regulation of cell migration,GO:0023051~regulation of signaling,GO:0010646~regulation of cell communication,GO:0009966~regulation of signal transduction,GO:0007163~establishment or maintenance of cell polarity,GO:0006928~movement of cell or subcellular component,												GO:0005829~cytosol,												GO:0098772~molecular function regulator,GO:0051020~GTPase binding,GO:0031267~small GTPase binding,GO:0019899~enzyme binding,GO:0008092~cytoskeletal protein binding,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0003779~actin binding,												IPR043324:PH_PLEKHG1_G2_G3,IPR035899:DBL_dom_sf,IPR011993:PH-like_dom_sf,IPR001849:PH_domain,IPR000219:DH-domain,															SM00325:RhoGEF,SM00233:PH,												REGION:Disordered,DOMAIN:PH,DOMAIN:DH,COMPBIAS:Polar residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Acidic residues,
35956_s_at	pregnancy specific beta-1-glycoprotein 4(PSG4)	Homo sapiens			GO:0044706~multi-multicellular organism process,GO:0044703~multi-organism reproductive process,GO:0022414~reproductive process,GO:0007565~female pregnancy,GO:0002682~regulation of immune system process,GO:0000003~reproduction,												GO:0009986~cell surface,GO:0005576~extracellular region,												GO:1990782~protein tyrosine kinase binding,GO:0019901~protein kinase binding,GO:0019900~kinase binding,GO:0019899~enzyme binding,												IPR036179:Ig-like_dom_sf,IPR013783:Ig-like_fold,IPR013106:Ig_V-set,IPR007110:Ig-like_dom,IPR003599:Ig_sub,IPR003598:Ig_sub2,															SM00409:IG,SM00408:IGc2,												REGION:Disordered,DOMAIN:Immunoglobulin V-set,DOMAIN:Ig-like V-type,DOMAIN:Ig-like C2-type 3,DOMAIN:Ig-like C2-type 2,DOMAIN:Ig-like C2-type 1,DOMAIN:Ig-like,CARBOHYD:N-linked (GlcNAc...) asparagine,
38948_at	protein phosphatase 1 regulatory subunit 3D(PPP1R3D)	Homo sapiens			GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:0070873~regulation of glycogen metabolic process,GO:0055114~oxidation-reduction process,GO:0044723~single-organism carbohydrate metabolic process,GO:0044275~cellular carbohydrate catabolic process,GO:0044264~cellular polysaccharide metabolic process,GO:0044262~cellular carbohydrate metabolic process,GO:0044042~glucan metabolic process,GO:0043471~regulation of cellular carbohydrate catabolic process,GO:0043470~regulation of carbohydrate catabolic process,GO:0043467~regulation of generation of precursor metabolites and energy,GO:0043255~regulation of carbohydrate biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034637~cellular carbohydrate biosynthetic process,GO:0033692~cellular polysaccharide biosynthetic process,GO:0032885~regulation of polysaccharide biosynthetic process,GO:0032881~regulation of polysaccharide metabolic process,GO:0031329~regulation of cellular catabolic process,GO:0019318~hexose metabolic process,GO:0016052~carbohydrate catabolic process,GO:0016051~carbohydrate biosynthetic process,GO:0015980~energy derivation by oxidation of organic compounds,GO:0010962~regulation of glucan biosynthetic process,GO:0010906~regulation of glucose metabolic process,GO:0010675~regulation of cellular carbohydrate metabolic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0009894~regulation of catabolic process,GO:0009250~glucan biosynthetic process,GO:0006112~energy reserve metabolic process,GO:0006109~regulation of carbohydrate metabolic process,GO:0006091~generation of precursor metabolites and energy,GO:0006073~cellular glucan metabolic process,GO:0006006~glucose metabolic process,GO:0005996~monosaccharide metabolic process,GO:0005981~regulation of glycogen catabolic process,GO:0005979~regulation of glycogen biosynthetic process,GO:0005977~glycogen metabolic process,GO:0005976~polysaccharide metabolic process,GO:0005975~carbohydrate metabolic process,GO:0000271~polysaccharide biosynthetic process,												GO:1903293~phosphatase complex,GO:0042587~glycogen granule,GO:0008287~protein serine/threonine phosphatase complex,GO:0000164~protein phosphatase type 1 complex,												GO:2001069~glycogen binding,GO:0042578~phosphoric ester hydrolase activity,GO:0030247~polysaccharide binding,GO:0030246~carbohydrate binding,GO:0019903~protein phosphatase binding,GO:0019902~phosphatase binding,GO:0019899~enzyme binding,GO:0016791~phosphatase activity,GO:0008157~protein phosphatase 1 binding,GO:0004722~protein serine/threonine phosphatase activity,GO:0004721~phosphoprotein phosphatase activity,GO:0001871~pattern binding,												IPR038175:CBM21_dom_sf,IPR017434:Pase-1_reg-su_3B/C/D_met,IPR005036:CBM21_dom,												hsa04931:Insulin resistance,hsa04910:Insulin signaling pathway,													PIRSF038207:PP1_GT_animal,													REGION:Disordered,MOTIF:PP1-binding motif,DOMAIN:CBM21,COMPBIAS:Pro residues,
38646_s_at	regenerating family member 1 alpha(REG1A)	Homo sapiens			GO:1901700~response to oxygen-containing compound,GO:1901698~response to nitrogen compound,GO:1901652~response to peptide,GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide,GO:0051707~response to other organism,GO:0043434~response to peptide hormone,GO:0043207~response to external biotic stimulus,GO:0042127~regulation of cell proliferation,GO:0019730~antimicrobial humoral response,GO:0010243~response to organonitrogen compound,GO:0010033~response to organic substance,GO:0009725~response to hormone,GO:0009719~response to endogenous stimulus,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0008284~positive regulation of cell proliferation,GO:0008283~cell proliferation,GO:0006959~humoral immune response,GO:0006955~immune response,												GO:1903561~extracellular vesicle,GO:0070062~extracellular exosome,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:0097367~carbohydrate derivative binding,GO:0070492~oligosaccharide binding,GO:0060089~molecular transducer activity,GO:0042834~peptidoglycan binding,GO:0038023~signaling receptor activity,GO:0030246~carbohydrate binding,GO:0008083~growth factor activity,GO:0005539~glycosaminoglycan binding,GO:0005102~receptor binding,GO:0004872~receptor activity,GO:0004871~signal transducer activity,												IPR018378:C-type_lectin_CS,IPR016187:CTDL_fold,IPR016186:C-type_lectin-like/link_sf,IPR001304:C-type_lectin-like,															SM00034:CLECT,												DOMAIN:C-type lectin,CARBOHYD:O-linked (GalNAc) threonine,
36766_at	ribonuclease A family member 2(RNASE2)	Homo sapiens			GO:1901361~organic cyclic compound catabolic process,GO:0098542~defense response to other organism,GO:0051707~response to other organism,GO:0051607~defense response to virus,GO:0046700~heterocycle catabolic process,GO:0045087~innate immune response,GO:0044764~multi-organism cellular process,GO:0044419~interspecies interaction between organisms,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044270~cellular nitrogen compound catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0043207~response to external biotic stimulus,GO:0042330~taxis,GO:0040011~locomotion,GO:0034655~nucleobase-containing compound catabolic process,GO:0019439~aromatic compound catabolic process,GO:0016070~RNA metabolic process,GO:0016032~viral process,GO:0009615~response to virus,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0009057~macromolecule catabolic process,GO:0006955~immune response,GO:0006952~defense response,GO:0006935~chemotaxis,GO:0006401~RNA catabolic process,GO:0002385~mucosal immune response,GO:0002252~immune effector process,GO:0002251~organ or tissue specific immune response,GO:0002227~innate immune response in mucosa,												GO:1903561~extracellular vesicle,GO:0099503~secretory vesicle,GO:0070062~extracellular exosome,GO:0060205~cytoplasmic vesicle lumen,GO:0044437~vacuolar part,GO:0044433~cytoplasmic vesicle part,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0042582~azurophil granule,GO:0035578~azurophil granule lumen,GO:0034774~secretory granule lumen,GO:0031983~vesicle lumen,GO:0030141~secretory granule,GO:0005775~vacuolar lumen,GO:0005773~vacuole,GO:0005766~primary lysosome,GO:0005764~lysosome,GO:0005615~extracellular space,GO:0005576~extracellular region,GO:0000323~lytic vacuole,												GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0016894~endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,GO:0016892~endoribonuclease activity, producing 3'-phosphomonoesters,GO:0004540~ribonuclease activity,GO:0004522~ribonuclease A activity,GO:0004521~endoribonuclease activity,GO:0004519~endonuclease activity,GO:0004518~nuclease activity,GO:0003676~nucleic acid binding,												IPR036816:RNaseA-like_dom_sf,IPR023412:RNaseA_domain,IPR023411:RNaseA_AS,IPR001427:RNaseA,															SM00092:RNAse_Pc,												DOMAIN:Ribonuclease A-domain,CARBOHYD:N-linked (GlcNAc...) asparagine,CARBOHYD:C-linked (Man) tryptophan,ACT_SITE:Proton donor,ACT_SITE:Proton acceptor,
33979_at	ribonuclease A family member 3(RNASE3)	Homo sapiens			GO:1901361~organic cyclic compound catabolic process,GO:0098542~defense response to other organism,GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide,GO:0051707~response to other organism,GO:0050830~defense response to Gram-positive bacterium,GO:0050829~defense response to Gram-negative bacterium,GO:0046700~heterocycle catabolic process,GO:0045087~innate immune response,GO:0044270~cellular nitrogen compound catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0043207~response to external biotic stimulus,GO:0043152~induction of bacterial agglutination,GO:0042742~defense response to bacterium,GO:0042330~taxis,GO:0040011~locomotion,GO:0034655~nucleobase-containing compound catabolic process,GO:0019731~antibacterial humoral response,GO:0019730~antimicrobial humoral response,GO:0019439~aromatic compound catabolic process,GO:0016070~RNA metabolic process,GO:0009617~response to bacterium,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0009057~macromolecule catabolic process,GO:0006959~humoral immune response,GO:0006955~immune response,GO:0006952~defense response,GO:0006935~chemotaxis,GO:0006401~RNA catabolic process,GO:0002385~mucosal immune response,GO:0002251~organ or tissue specific immune response,GO:0002227~innate immune response in mucosa,												GO:0099503~secretory vesicle,GO:0060205~cytoplasmic vesicle lumen,GO:0044437~vacuolar part,GO:0044433~cytoplasmic vesicle part,GO:0044421~extracellular region part,GO:0042582~azurophil granule,GO:0035578~azurophil granule lumen,GO:0034774~secretory granule lumen,GO:0031983~vesicle lumen,GO:0030141~secretory granule,GO:0005775~vacuolar lumen,GO:0005773~vacuole,GO:0005766~primary lysosome,GO:0005764~lysosome,GO:0005615~extracellular space,GO:0005576~extracellular region,GO:0000323~lytic vacuole,												GO:1901363~heterocyclic compound binding,GO:0097367~carbohydrate derivative binding,GO:0097159~organic cyclic compound binding,GO:0008289~lipid binding,GO:0004540~ribonuclease activity,GO:0004519~endonuclease activity,GO:0004518~nuclease activity,GO:0003676~nucleic acid binding,GO:0001530~lipopolysaccharide binding,												IPR036816:RNaseA-like_dom_sf,IPR023412:RNaseA_domain,IPR023411:RNaseA_AS,IPR001427:RNaseA,												hsa05310:Asthma,														SM00092:RNAse_Pc,												SITE:May be involved in LPS-binding,SITE:May be involved in LPS- and LTA-binding,REGION:Required for nearly all of the bactericidal activity; partially involved in LPS-binding and bacterial membrane depolarization,MUTAGEN:I->A: Loss of in vitro formation of amyloid-like aggregates.,DOMAIN:Ribonuclease A-domain,CARBOHYD:N-linked (GlcNAc...) asparagine,ACT_SITE:Proton donor,ACT_SITE:Proton acceptor,
32413_at	ribosomal protein S14(RPS14)	Homo sapiens			GO:2001141~regulation of RNA biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1902679~negative regulation of RNA biosynthetic process,GO:1901566~organonitrogen compound biosynthetic process,GO:0097659~nucleic acid-templated transcription,GO:0071826~ribonucleoprotein complex subunit organization,GO:0070925~organelle assembly,GO:0065003~macromolecular complex assembly,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0048872~homeostasis of number of cells,GO:0048534~hematopoietic or lymphoid organ development,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0044085~cellular component biogenesis,GO:0043933~macromolecular complex subunit organization,GO:0043604~amide biosynthetic process,GO:0043603~cellular amide metabolic process,GO:0043043~peptide biosynthetic process,GO:0042592~homeostatic process,GO:0042274~ribosomal small subunit biogenesis,GO:0042255~ribosome assembly,GO:0042254~ribosome biogenesis,GO:0034660~ncRNA metabolic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034622~cellular macromolecular complex assembly,GO:0034470~ncRNA processing,GO:0034248~regulation of cellular amide metabolic process,GO:0034101~erythrocyte homeostasis,GO:0032774~RNA biosynthetic process,GO:0032268~regulation of cellular protein metabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031324~negative regulation of cellular metabolic process,GO:0030490~maturation of SSU-rRNA,GO:0030218~erythrocyte differentiation,GO:0030099~myeloid cell differentiation,GO:0030097~hemopoiesis,GO:0022618~ribonucleoprotein complex assembly,GO:0022613~ribonucleoprotein complex biogenesis,GO:0022607~cellular component assembly,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016072~rRNA metabolic process,GO:0016070~RNA metabolic process,GO:0010629~negative regulation of gene expression,GO:0010608~posttranscriptional regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0009892~negative regulation of metabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0006518~peptide metabolic process,GO:0006417~regulation of translation,GO:0006412~translation,GO:0006396~RNA processing,GO:0006366~transcription from RNA polymerase II promoter,GO:0006364~rRNA processing,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0002520~immune system development,GO:0002262~myeloid cell homeostasis,GO:0002181~cytoplasmic translation,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000028~ribosomal small subunit assembly,												GO:1990904~ribonucleoprotein complex,GO:1903561~extracellular vesicle,GO:0099572~postsynaptic specialization,GO:0098984~neuron to neuron synapse,GO:0098794~postsynapse,GO:0070161~anchoring junction,GO:0070062~extracellular exosome,GO:0045202~synapse,GO:0044456~synapse part,GO:0044445~cytosolic part,GO:0044421~extracellular region part,GO:0044391~ribosomal subunit,GO:0043230~extracellular organelle,GO:0032279~asymmetric synapse,GO:0032040~small-subunit processome,GO:0030684~preribosome,GO:0030529~intracellular ribonucleoprotein complex,GO:0030055~cell-substrate junction,GO:0030054~cell junction,GO:0022627~cytosolic small ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0015935~small ribosomal subunit,GO:0014069~postsynaptic density,GO:0005925~focal adhesion,GO:0005924~cell-substrate adherens junction,GO:0005912~adherens junction,GO:0005840~ribosome,GO:0005829~cytosol,GO:0005730~nucleolus,GO:0005654~nucleoplasm,GO:0005576~extracellular region,												GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0048027~mRNA 5'-UTR binding,GO:0045182~translation regulator activity,GO:0005198~structural molecule activity,GO:0003735~structural constituent of ribosome,GO:0003729~mRNA binding,GO:0003723~RNA binding,GO:0003676~nucleic acid binding,												IPR036967:Ribosomal_uS11_sf,IPR018102:Ribosomal_uS11_CS,IPR001971:Ribosomal_uS11,												hsa05171:Coronavirus disease - COVID-19,hsa03010:Ribosome,												153550~Macrocytic anemia, refractory, due to 5q deletion, somatic,												PIRSF002131:Ribosomal_S11,													TRANSMEM:Helical,REGION:Disordered,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),
36328_at	sex hormone binding globulin(SHBG)	Homo sapiens				GO:1903561~extracellular vesicle,GO:0070062~extracellular exosome,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0005576~extracellular region,												GO:0097159~organic cyclic compound binding,GO:0042562~hormone binding,GO:0008289~lipid binding,GO:0005497~androgen binding,GO:0005496~steroid binding,												IPR013320:ConA-like_dom_sf,IPR001791:Laminin_G,															SM00282:LamG,												REGION:Disordered,DOMAIN:Laminin G-like 2,DOMAIN:Laminin G-like 1,DOMAIN:Laminin G,CARBOHYD:O-linked (GalNAc...) threonine,CARBOHYD:N-linked (GlcNAc...) asparagine,
37097_at	solute carrier family 17 member 1(SLC17A1)	Homo sapiens			GO:0098662~inorganic cation transmembrane transport,GO:0098661~inorganic anion transmembrane transport,GO:0098660~inorganic ion transmembrane transport,GO:0098656~anion transmembrane transport,GO:0098655~cation transmembrane transport,GO:0072521~purine-containing compound metabolic process,GO:0071705~nitrogen compound transport,GO:0055085~transmembrane transport,GO:0046415~urate metabolic process,GO:0044341~sodium-dependent phosphate transport,GO:0035725~sodium ion transmembrane transport,GO:0035435~phosphate ion transmembrane transport,GO:0034220~ion transmembrane transport,GO:0030001~metal ion transport,GO:0015747~urate transport,GO:0015711~organic anion transport,GO:0015698~inorganic anion transport,GO:0015672~monovalent inorganic cation transport,GO:0006820~anion transport,GO:0006817~phosphate ion transport,GO:0006814~sodium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,GO:0006082~organic acid metabolic process,												GO:0098590~plasma membrane region,GO:0045177~apical part of cell,GO:0016324~apical plasma membrane,												GO:1901677~phosphate transmembrane transporter activity,GO:0046873~metal ion transmembrane transporter activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0022853~active ion transmembrane transporter activity,GO:0022804~active transmembrane transporter activity,GO:0015296~anion:cation symporter activity,GO:0015294~solute:cation symporter activity,GO:0015293~symporter activity,GO:0015291~secondary active transmembrane transporter activity,GO:0015114~phosphate ion transmembrane transporter activity,GO:0015103~inorganic anion transmembrane transporter activity,GO:0015081~sodium ion transmembrane transporter activity,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0008509~anion transmembrane transporter activity,GO:0008324~cation transmembrane transporter activity,GO:0005436~sodium:phosphate symporter activity,												IPR036259:MFS_trans_sf,IPR020846:MFS_dom,IPR011701:MFS,IPR004745:Pi_cotranspt,																TRANSMEM:Helical,DOMAIN:Major facilitator superfamily (MFS) profile,CARBOHYD:N-linked (GlcNAc...) asparagine,
34436_at	solute carrier family 17 member 3(SLC17A3)	Homo sapiens			GO:1990961~drug transmembrane export,GO:1901998~toxin transport,GO:1901264~carbohydrate derivative transport,GO:0098662~inorganic cation transmembrane transport,GO:0098660~inorganic ion transmembrane transport,GO:0098656~anion transmembrane transport,GO:0098655~cation transmembrane transport,GO:0072521~purine-containing compound metabolic process,GO:0071705~nitrogen compound transport,GO:0055085~transmembrane transport,GO:0046618~drug export,GO:0046415~urate metabolic process,GO:0042493~response to drug,GO:0035725~sodium ion transmembrane transport,GO:0034220~ion transmembrane transport,GO:0030001~metal ion transport,GO:0015893~drug transport,GO:0015760~glucose-6-phosphate transport,GO:0015748~organophosphate ester transport,GO:0015747~urate transport,GO:0015712~hexose phosphate transport,GO:0015711~organic anion transport,GO:0015698~inorganic anion transport,GO:0015672~monovalent inorganic cation transport,GO:0006855~drug transmembrane transport,GO:0006820~anion transport,GO:0006817~phosphate ion transport,GO:0006814~sodium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,GO:0006082~organic acid metabolic process,												GO:0098862~cluster of actin-based cell projections,GO:0098590~plasma membrane region,GO:0048471~perinuclear region of cytoplasm,GO:0045177~apical part of cell,GO:0044432~endoplasmic reticulum part,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0031526~brush border membrane,GO:0031253~cell projection membrane,GO:0016324~apical plasma membrane,GO:0005903~brush border,GO:0005789~endoplasmic reticulum membrane,GO:0005783~endoplasmic reticulum,												GO:1901702~salt transmembrane transporter activity,GO:1901677~phosphate transmembrane transporter activity,GO:0046873~metal ion transmembrane transporter activity,GO:0042910~xenobiotic transporter activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0022853~active ion transmembrane transporter activity,GO:0022838~substrate-specific channel activity,GO:0022836~gated channel activity,GO:0022832~voltage-gated channel activity,GO:0022804~active transmembrane transporter activity,GO:0022803~passive transmembrane transporter activity,GO:0019534~toxin transporter activity,GO:0015562~efflux transmembrane transporter activity,GO:0015296~anion:cation symporter activity,GO:0015294~solute:cation symporter activity,GO:0015293~symporter activity,GO:0015291~secondary active transmembrane transporter activity,GO:0015267~channel activity,GO:0015143~urate transmembrane transporter activity,GO:0015114~phosphate ion transmembrane transporter activity,GO:0015103~inorganic anion transmembrane transporter activity,GO:0015081~sodium ion transmembrane transporter activity,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0008514~organic anion transmembrane transporter activity,GO:0008509~anion transmembrane transporter activity,GO:0008324~cation transmembrane transporter activity,GO:0008308~voltage-gated anion channel activity,GO:0005436~sodium:phosphate symporter activity,GO:0005342~organic acid transmembrane transporter activity,GO:0005253~anion channel activity,GO:0005244~voltage-gated ion channel activity,GO:0005216~ion channel activity,												IPR036259:MFS_trans_sf,IPR020846:MFS_dom,IPR017373:Na-dep_P-transpt_4_prd,IPR011701:MFS,													612671~Uric acid concentration, serum, QTL4,612671~Gout susceptibility 4,												PIRSF038072:Na(+)/PI_cotransporter4_prd,													TRANSMEM:Helical,REGION:Disordered,DOMAIN:Major facilitator superfamily (MFS) profile,COMPBIAS:Polar residues,CARBOHYD:N-linked (GlcNAc...) asparagine,
32084_at	solute carrier family 22 member 5(SLC22A5)	Homo sapiens			GO:1990961~drug transmembrane export,GO:1902603~carnitine transmembrane transport,GO:1902270~(R)-carnitine transmembrane transport,GO:1900749~(R)-carnitine transport,GO:0098655~cation transmembrane transport,GO:0072488~ammonium transmembrane transport,GO:0071705~nitrogen compound transport,GO:0070715~sodium-dependent organic cation transport,GO:0060731~positive regulation of intestinal epithelial structure maintenance,GO:0060730~regulation of intestinal epithelial structure maintenance,GO:0060729~intestinal epithelial structure maintenance,GO:0060456~positive regulation of digestive system process,GO:0060249~anatomical structure homeostasis,GO:0055085~transmembrane transport,GO:0051707~response to other organism,GO:0051240~positive regulation of multicellular organismal process,GO:0048871~multicellular organismal homeostasis,GO:0046618~drug export,GO:0045087~innate immune response,GO:0044058~regulation of digestive system process,GO:0044057~regulation of system process,GO:0043207~response to external biotic stimulus,GO:0042592~homeostatic process,GO:0042493~response to drug,GO:0034612~response to tumor necrosis factor,GO:0034341~response to interferon-gamma,GO:0034220~ion transmembrane transport,GO:0034097~response to cytokine,GO:0032846~positive regulation of homeostatic process,GO:0032844~regulation of homeostatic process,GO:0030277~maintenance of gastrointestinal epithelium,GO:0030001~metal ion transport,GO:0022600~digestive system process,GO:0015893~drug transport,GO:0015879~carnitine transport,GO:0015838~amino-acid betaine transport,GO:0015697~quaternary ammonium group transport,GO:0015696~ammonium transport,GO:0015695~organic cation transport,GO:0015672~monovalent inorganic cation transport,GO:0010669~epithelial structure maintenance,GO:0010033~response to organic substance,GO:0009617~response to bacterium,GO:0009609~response to symbiotic bacterium,GO:0009608~response to symbiont,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0007586~digestion,GO:0006955~immune response,GO:0006952~defense response,GO:0006855~drug transmembrane transport,GO:0006814~sodium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,GO:0003008~system process,GO:0001894~tissue homeostasis,												GO:1903561~extracellular vesicle,GO:0098862~cluster of actin-based cell projections,GO:0098590~plasma membrane region,GO:0070062~extracellular exosome,GO:0045178~basal part of cell,GO:0045177~apical part of cell,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0031526~brush border membrane,GO:0031253~cell projection membrane,GO:0016324~apical plasma membrane,GO:0016323~basolateral plasma membrane,GO:0009925~basal plasma membrane,GO:0005903~brush border,GO:0005829~cytosol,GO:0005783~endoplasmic reticulum,GO:0005576~extracellular region,												GO:1901363~heterocyclic compound binding,GO:1901265~nucleoside phosphate binding,GO:1901235~(R)-carnitine transmembrane transporter activity,GO:0097367~carbohydrate derivative binding,GO:0097159~organic cyclic compound binding,GO:0072349~modified amino acid transmembrane transporter activity,GO:0043168~anion binding,GO:0043167~ion binding,GO:0042910~xenobiotic transporter activity,GO:0036094~small molecule binding,GO:0035639~purine ribonucleoside triphosphate binding,GO:0032559~adenyl ribonucleotide binding,GO:0032555~purine ribonucleotide binding,GO:0032553~ribonucleotide binding,GO:0030554~adenyl nucleotide binding,GO:0030165~PDZ domain binding,GO:0022804~active transmembrane transporter activity,GO:0019904~protein domain specific binding,GO:0017076~purine nucleotide binding,GO:0015651~quaternary ammonium group transmembrane transporter activity,GO:0015293~symporter activity,GO:0015291~secondary active transmembrane transporter activity,GO:0015226~carnitine transmembrane transporter activity,GO:0015199~amino-acid betaine transmembrane transporter activity,GO:0015101~organic cation transmembrane transporter activity,GO:0008519~ammonium transmembrane transporter activity,GO:0008324~cation transmembrane transporter activity,GO:0005524~ATP binding,GO:0000166~nucleotide binding,												IPR045915:S22A4/5,IPR036259:MFS_trans_sf,IPR020846:MFS_dom,IPR011701:MFS,IPR005829:Sugar_transporter_CS,IPR005828:MFS_sugar_transport-like,IPR004749:Orgcat_transp/SVOP,												hsa05231:Choline metabolism in cancer,												212140~Carnitine deficiency, systemic primary,														TRANSMEM:Helical; Name=9,TRANSMEM:Helical; Name=8,TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=12,TRANSMEM:Helical; Name=11,TRANSMEM:Helical; Name=10,TRANSMEM:Helical; Name=1,TRANSMEM:Helical,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,REGION:Disordered,MUTAGEN:N->Q: Reduces expression to 50%. No effect on carnitine transporter activity.,MUTAGEN:M->R: Loss of both carnitine and organic cation transport functionalities. No effect on protein expression.,DOMAIN:Major facilitator superfamily (MFS) profile,CARBOHYD:N-linked (GlcNAc...) asparagine,
35121_at	solute carrier family 6 member 6(SLC6A6)	Homo sapiens			GO:1905039~carboxylic acid transmembrane transport,GO:1903825~organic acid transmembrane transport,GO:1902837~amino acid import into cell,GO:0098739~import across plasma membrane,GO:0098662~inorganic cation transmembrane transport,GO:0098660~inorganic ion transmembrane transport,GO:0098657~import into cell,GO:0098656~anion transmembrane transport,GO:0098655~cation transmembrane transport,GO:0089718~amino acid import across plasma membrane,GO:0072348~sulfur compound transport,GO:0071705~nitrogen compound transport,GO:0055085~transmembrane transport,GO:0051939~gamma-aminobutyric acid import,GO:0051094~positive regulation of developmental process,GO:0050804~modulation of synaptic transmission,GO:0046942~carboxylic acid transport,GO:0045597~positive regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0044745~amino acid transmembrane import,GO:0043090~amino acid import,GO:0042918~alkanesulfonate transport,GO:0042908~xenobiotic transport,GO:0035725~sodium ion transmembrane transport,GO:0034220~ion transmembrane transport,GO:0032328~alanine transport,GO:0030001~metal ion transport,GO:0023051~regulation of signaling,GO:0015849~organic acid transport,GO:0015812~gamma-aminobutyric acid transport,GO:0015804~neutral amino acid transport,GO:0015800~acidic amino acid transport,GO:0015734~taurine transport,GO:0015718~monocarboxylic acid transport,GO:0015711~organic anion transport,GO:0015672~monovalent inorganic cation transport,GO:0010646~regulation of cell communication,GO:0006865~amino acid transport,GO:0006836~neurotransmitter transport,GO:0006820~anion transport,GO:0006814~sodium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,GO:0003333~amino acid transmembrane transport,												GO:0098982~GABA-ergic synapse,GO:0098858~actin-based cell projection,GO:0098794~postsynapse,GO:0098590~plasma membrane region,GO:0097458~neuron part,GO:0097060~synaptic membrane,GO:0045211~postsynaptic membrane,GO:0045202~synapse,GO:0045177~apical part of cell,GO:0044456~synapse part,GO:0044297~cell body,GO:0043025~neuronal cell body,GO:0043005~neuron projection,GO:0036477~somatodendritic compartment,GO:0031528~microvillus membrane,GO:0031253~cell projection membrane,GO:0030425~dendrite,GO:0016324~apical plasma membrane,GO:0016323~basolateral plasma membrane,GO:0005902~microvillus,												GO:1901682~sulfur compound transmembrane transporter activity,GO:0046943~carboxylic acid transmembrane transporter activity,GO:0046873~metal ion transmembrane transporter activity,GO:0042959~alkanesulfonate transporter activity,GO:0042910~xenobiotic transporter activity,GO:0022890~inorganic cation transmembrane transporter activity,GO:0022858~alanine transmembrane transporter activity,GO:0022853~active ion transmembrane transporter activity,GO:0022804~active transmembrane transporter activity,GO:0015370~solute:sodium symporter activity,GO:0015296~anion:cation symporter activity,GO:0015294~solute:cation symporter activity,GO:0015293~symporter activity,GO:0015291~secondary active transmembrane transporter activity,GO:0015185~gamma-aminobutyric acid transmembrane transporter activity,GO:0015175~neutral amino acid transmembrane transporter activity,GO:0015171~amino acid transmembrane transporter activity,GO:0015081~sodium ion transmembrane transporter activity,GO:0015077~monovalent inorganic cation transmembrane transporter activity,GO:0008514~organic anion transmembrane transporter activity,GO:0008509~anion transmembrane transporter activity,GO:0008324~cation transmembrane transporter activity,GO:0008028~monocarboxylic acid transmembrane transporter activity,GO:0005416~cation:amino acid symporter activity,GO:0005369~taurine:sodium symporter activity,GO:0005368~taurine transmembrane transporter activity,GO:0005343~organic acid:sodium symporter activity,GO:0005342~organic acid transmembrane transporter activity,GO:0005332~gamma-aminobutyric acid:sodium symporter activity,GO:0005283~sodium:amino acid symporter activity,												IPR037272:SNS_sf,IPR002434:Na/ntran_symport_taurine,IPR000175:Na/ntran_symport,													145350~Hypotaurinemic retinal degeneration and cardiomyopathy,														TRANSMEM:Helical; Name=9,TRANSMEM:Helical; Name=8,TRANSMEM:Helical; Name=7,TRANSMEM:Helical; Name=6,TRANSMEM:Helical; Name=5,TRANSMEM:Helical; Name=4,TRANSMEM:Helical; Name=3,TRANSMEM:Helical; Name=2,TRANSMEM:Helical; Name=12,TRANSMEM:Helical; Name=11,TRANSMEM:Helical; Name=10,TRANSMEM:Helical; Name=1,TRANSMEM:Helical,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,REGION:Disordered,COMPBIAS:Polar residues,COMPBIAS:Basic residues,COMPBIAS:Basic and acidic residues,CARBOHYD:N-linked (GlcNAc...) asparagine,
35439_at	splicing factor 1(SF1)	Homo sapiens			GO:2001141~regulation of RNA biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903311~regulation of mRNA metabolic process,GO:1902679~negative regulation of RNA biosynthetic process,GO:0097659~nucleic acid-templated transcription,GO:0071826~ribonucleoprotein complex subunit organization,GO:0065003~macromolecular complex assembly,GO:0061458~reproductive system development,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0050810~regulation of steroid biosynthetic process,GO:0050684~regulation of mRNA processing,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048659~smooth muscle cell proliferation,GO:0048608~reproductive structure development,GO:0048024~regulation of mRNA splicing, via spliceosome,GO:0046890~regulation of lipid biosynthetic process,GO:0046661~male sex differentiation,GO:0046546~development of primary male sexual characteristics,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045137~development of primary sexual characteristics,GO:0044702~single organism reproductive process,GO:0044085~cellular component biogenesis,GO:0043933~macromolecular complex subunit organization,GO:0043484~regulation of RNA splicing,GO:0042127~regulation of cell proliferation,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034622~cellular macromolecular complex assembly,GO:0033327~Leydig cell differentiation,GO:0033002~muscle cell proliferation,GO:0032774~RNA biosynthetic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031324~negative regulation of cellular metabolic process,GO:0030575~nuclear body organization,GO:0030238~male sex determination,GO:0022618~ribonucleoprotein complex assembly,GO:0022613~ribonucleoprotein complex biogenesis,GO:0022607~cellular component assembly,GO:0022414~reproductive process,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019218~regulation of steroid metabolic process,GO:0019216~regulation of lipid metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016071~mRNA metabolic process,GO:0016070~RNA metabolic process,GO:0010629~negative regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0009892~negative regulation of metabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0008610~lipid biosynthetic process,GO:0008584~male gonad development,GO:0008406~gonad development,GO:0008380~RNA splicing,GO:0008285~negative regulation of cell proliferation,GO:0008283~cell proliferation,GO:0008202~steroid metabolic process,GO:0007548~sex differentiation,GO:0007530~sex determination,GO:0006997~nucleus organization,GO:0006629~lipid metabolic process,GO:0006397~mRNA processing,GO:0006396~RNA processing,GO:0006376~mRNA splice site selection,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0003006~developmental process involved in reproduction,GO:0000398~mRNA splicing, via spliceosome,GO:0000389~mRNA 3'-splice site recognition,GO:0000377~RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,GO:0000375~RNA splicing, via transesterification reactions,GO:0000245~spliceosomal complex assembly,GO:0000003~reproduction,												GO:1990904~ribonucleoprotein complex,GO:0089701~U2AF,GO:0044451~nucleoplasm part,GO:0030529~intracellular ribonucleoprotein complex,GO:0016604~nuclear body,GO:0005840~ribosome,GO:0005681~spliceosomal complex,GO:0005654~nucleoplasm,												GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0045131~pre-mRNA branch point binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0042802~identical protein binding,GO:0036002~pre-mRNA binding,GO:0008270~zinc ion binding,GO:0003729~mRNA binding,GO:0003723~RNA binding,GO:0003714~transcription corepressor activity,GO:0003712~transcription cofactor activity,GO:0003676~nucleic acid binding,GO:0000989~transcription factor activity, transcription factor binding,GO:0000988~transcription factor activity, protein binding,												IPR047086:SF1-HH_sf,IPR045071:BBP-like,IPR036612:KH_dom_type_1_sf,IPR032570:SF1-HH,IPR004088:KH_dom_type_1,IPR004087:KH_dom,IPR001878:Znf_CCHC,															SM00343:ZnF_C2HC,SM00322:KH,												ZN_FING:CCHC-type,REGION:Disordered,MUTAGEN:W->F: No effect.,MUTAGEN:W->A: Abolishes interaction with U2AF2.,MUTAGEN:S->T: Decreases interaction with U2AF2.,MUTAGEN:S->A: Strongly decreases interaction with U2AF2 and spliceosome assembly.,MUTAGEN:R->K: No effect.,MUTAGEN:R->A: Strongly reduces RNA-binding.,MUTAGEN:R->A: Slightly decreases RNA-binding.,MUTAGEN:R->A: Decreases interaction with U2AF2 and spliceosome assembly.,MUTAGEN:N->A: Decreases RNA-binding.,MUTAGEN:L->A: Slightly decreases RNA-binding.,MUTAGEN:L->A: Decreases RNA-binding.,MUTAGEN:KRK->EDE: Abolishes interaction with U2AF2.,MUTAGEN:KKR->EED: Abolishes interaction with U2AF2.,MUTAGEN:K->A: Abolishes RNA-binding.,MOTIF:Nuclear localization signal,DOMAIN:Splicing factor 1 helix-hairpin,DOMAIN:KH,DOMAIN:CCHC-type,COMPBIAS:Pro residues,COMPBIAS:Polar residues,COMPBIAS:Basic and acidic residues,
38691_s_at	surfactant protein C(SFTPC)	Homo sapiens			GO:0007585~respiratory gaseous exchange,												GO:0099503~secretory vesicle,GO:0097486~multivesicular body lumen,GO:0097208~alveolar lamellar body,GO:0045334~clathrin-coated endocytic vesicle,GO:0044440~endosomal part,GO:0044433~cytoplasmic vesicle part,GO:0044432~endoplasmic reticulum part,GO:0044421~extracellular region part,GO:0042599~lamellar body,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0031906~late endosome lumen,GO:0031904~endosome lumen,GO:0030141~secretory granule,GO:0030139~endocytic vesicle,GO:0030136~clathrin-coated vesicle,GO:0030135~coated vesicle,GO:0005789~endoplasmic reticulum membrane,GO:0005783~endoplasmic reticulum,GO:0005771~multivesicular body,GO:0005770~late endosome,GO:0005768~endosome,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:0042802~identical protein binding,												IPR018051:SP-C_palmitoylation_site,IPR015091:Surfactant_protein_propep,IPR007084:BRICHOS_dom,IPR001729:SP-C,													610913~Surfactant metabolism dysfunction, pulmonary, 2,													SM01039:BRICHOS,SM00019:SF_P,												TRANSMEM:Helical,REGION:Disordered,LIPID:S-palmitoyl cysteine,DOMAIN:BRICHOS,
38508_s_at	tenascin XA (pseudogene)(TNXA)	Homo sapiens				GO:1903561~extracellular vesicle,GO:0070062~extracellular exosome,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0005576~extracellular region,													IPR036116:FN3_sf,IPR013783:Ig-like_fold,IPR003961:FN3_dom,															SM00060:FN3,												REGION:Disordered,DOMAIN:Fibronectin type-III 3,DOMAIN:Fibronectin type-III 2,DOMAIN:Fibronectin type-III 1,COMPBIAS:Polar residues,
39198_s_at	trafficking protein particle complex subunit 12(TRAPPC12)	Homo sapiens			GO:1905342~positive regulation of protein localization to kinetochore,GO:1905340~regulation of protein localization to kinetochore,GO:1903829~positive regulation of cellular protein localization,GO:1903827~regulation of cellular protein localization,GO:1902115~regulation of organelle assembly,GO:0099022~vesicle tethering,GO:0098813~nuclear chromosome segregation,GO:0090234~regulation of kinetochore assembly,GO:0090230~regulation of centromere complex assembly,GO:0090114~COPII-coated vesicle budding,GO:0071824~protein-DNA complex subunit organization,GO:0071822~protein complex subunit organization,GO:0071459~protein localization to chromosome, centromeric region,GO:0070925~organelle assembly,GO:0070727~cellular macromolecule localization,GO:0070271~protein complex biogenesis,GO:0065004~protein-DNA complex assembly,GO:0065003~macromolecular complex assembly,GO:0061024~membrane organization,GO:0060341~regulation of cellular localization,GO:0051656~establishment of organelle localization,GO:0051650~establishment of vesicle localization,GO:0051649~establishment of localization in cell,GO:0051648~vesicle localization,GO:0051641~cellular localization,GO:0051640~organelle localization,GO:0051310~metaphase plate congression,GO:0051303~establishment of chromosome localization,GO:0051276~chromosome organization,GO:0051128~regulation of cellular component organization,GO:0050000~chromosome localization,GO:0048208~COPII vesicle coating,GO:0048207~vesicle targeting, rough ER to cis-Golgi,GO:0048199~vesicle targeting, to, from or within Golgi,GO:0048193~Golgi vesicle transport,GO:0046907~intracellular transport,GO:0044087~regulation of cellular component biogenesis,GO:0044085~cellular component biogenesis,GO:0043933~macromolecular complex subunit organization,GO:0043254~regulation of protein complex assembly,GO:0034622~cellular macromolecular complex assembly,GO:0034613~cellular protein localization,GO:0034508~centromere complex assembly,GO:0034502~protein localization to chromosome,GO:0034501~protein localization to kinetochore,GO:0033365~protein localization to organelle,GO:0033044~regulation of chromosome organization,GO:0033043~regulation of organelle organization,GO:0033036~macromolecule localization,GO:0032880~regulation of protein localization,GO:0022607~cellular component assembly,GO:0022402~cell cycle process,GO:0016192~vesicle-mediated transport,GO:0016050~vesicle organization,GO:0010256~endomembrane system organization,GO:0008104~protein localization,GO:0007059~chromosome segregation,GO:0007049~cell cycle,GO:0007030~Golgi organization,GO:0006903~vesicle targeting,GO:0006901~vesicle coating,GO:0006900~membrane budding,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0006461~protein complex assembly,												GO:1990072~TRAPPIII protein complex,GO:0099023~tethering complex,GO:0098687~chromosomal region,GO:0048471~perinuclear region of cytoplasm,GO:0044431~Golgi apparatus part,GO:0044427~chromosomal part,GO:0030008~TRAPP complex,GO:0005829~cytosol,GO:0005794~Golgi apparatus,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005694~chromosome,GO:0005654~nucleoplasm,GO:0000776~kinetochore,GO:0000775~chromosome, centromeric region,													IPR019734:TPR_repeat,IPR011990:TPR-like_helical_dom_sf,													617669~Encephalopathy, progressive, early-onset, with brain atrophy and spasticity,													SM00028:TPR,												REPEAT:TPR 4,REPEAT:TPR 3,REPEAT:TPR 2,REPEAT:TPR 1,REPEAT:TPR,REGION:Disordered,COMPBIAS:Pro residues,COMPBIAS:Polar residues,COMPBIAS:Basic and acidic residues,
38816_at	transforming acidic coiled-coil containing protein 2(TACC2)	Homo sapiens			GO:1903047~mitotic cell cycle process,GO:1902850~microtubule cytoskeleton organization involved in mitosis,GO:0060322~head development,GO:0048285~organelle fission,GO:0030900~forebrain development,GO:0022402~cell cycle process,GO:0021987~cerebral cortex development,GO:0021543~pallium development,GO:0021537~telencephalon development,GO:0008283~cell proliferation,GO:0007420~brain development,GO:0007417~central nervous system development,GO:0007399~nervous system development,GO:0007067~mitotic nuclear division,GO:0007052~mitotic spindle organization,GO:0007051~spindle organization,GO:0007049~cell cycle,GO:0007017~microtubule-based process,GO:0007010~cytoskeleton organization,GO:0000280~nuclear division,GO:0000278~mitotic cell cycle,GO:0000226~microtubule cytoskeleton organization,												GO:0015630~microtubule cytoskeleton,GO:0005829~cytosol,GO:0005815~microtubule organizing center,GO:0005813~centrosome,GO:0005654~nucleoplasm,												GO:0016922~ligand-dependent nuclear receptor binding,GO:0005102~receptor binding,												IPR039915:TACC,IPR007707:TACC_C,																REGION:Disordered,DOMAIN:Transforming acidic coiled-coil-containing protein C-terminal,DOMAIN:SPAZ,COMPBIAS:Pro residues,COMPBIAS:Polar residues,COMPBIAS:Basic and acidic residues,
37898_r_at	trefoil factor 3(TFF3)	Homo sapiens		h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,												GO:0060249~anatomical structure homeostasis,GO:0048871~multicellular organismal homeostasis,GO:0044262~cellular carbohydrate metabolic process,GO:0042592~homeostatic process,GO:0030277~maintenance of gastrointestinal epithelium,GO:0022600~digestive system process,GO:0010906~regulation of glucose metabolic process,GO:0010675~regulation of cellular carbohydrate metabolic process,GO:0010669~epithelial structure maintenance,GO:0007586~digestion,GO:0006109~regulation of carbohydrate metabolic process,GO:0005975~carbohydrate metabolic process,GO:0003008~system process,GO:0001894~tissue homeostasis,												GO:0099503~secretory vesicle,GO:0044421~extracellular region part,GO:0030141~secretory granule,GO:0005615~extracellular space,GO:0005576~extracellular region,												GO:0042802~identical protein binding,												IPR044913:P_trefoil_dom_sf,IPR017994:P_trefoil_chordata,IPR017957:P_trefoil_CS,IPR000519:P_trefoil_dom,															SM00018:PD,												REGION:Disordered,DOMAIN:P-type,DISULFID:Interchain,
36713_at	tripartite motif containing 58(TRIM58)	Homo sapiens			GO:2001141~regulation of RNA biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1903900~regulation of viral life cycle,GO:1903506~regulation of nucleic acid-templated transcription,GO:1902838~regulation of nuclear migration along microtubule,GO:1902582~single-organism intracellular transport,GO:1902580~single-organism cellular localization,GO:1902533~positive regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:1902513~regulation of organelle transport along microtubule,GO:0099111~microtubule-based transport,GO:0097659~nucleic acid-templated transcription,GO:0072384~organelle transport along microtubule,GO:0070647~protein modification by small protein conjugation or removal,GO:0065009~regulation of molecular function,GO:0060632~regulation of microtubule-based movement,GO:0060341~regulation of cellular localization,GO:0051865~protein autoubiquitination,GO:0051656~establishment of organelle localization,GO:0051649~establishment of localization in cell,GO:0051641~cellular localization,GO:0051640~organelle localization,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0051270~regulation of cellular component movement,GO:0051252~regulation of RNA metabolic process,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,GO:0051049~regulation of transport,GO:0050792~regulation of viral process,GO:0048584~positive regulation of response to stimulus,GO:0046907~intracellular transport,GO:0046596~regulation of viral entry into host cell,GO:0045087~innate immune response,GO:0044764~multi-organism cellular process,GO:0044419~interspecies interaction between organisms,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044265~cellular macromolecule catabolic process,GO:0044257~cellular protein catabolic process,GO:0044093~positive regulation of molecular function,GO:0043903~regulation of symbiosis, encompassing mutualism through parasitism,GO:0043900~regulation of multi-organism process,GO:0043632~modification-dependent macromolecule catabolic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043122~regulation of I-kappaB kinase/NF-kappaB signaling,GO:0036211~protein modification process,GO:0035556~intracellular signal transduction,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0032886~regulation of microtubule-based process,GO:0032880~regulation of protein localization,GO:0032774~RNA biosynthetic process,GO:0032446~protein modification by small protein conjugation,GO:0032386~regulation of intracellular transport,GO:0031331~positive regulation of cellular catabolic process,GO:0031329~regulation of cellular catabolic process,GO:0031325~positive regulation of cellular metabolic process,GO:0030705~cytoskeleton-dependent intracellular transport,GO:0030163~protein catabolic process,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0019941~modification-dependent protein catabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019058~viral life cycle,GO:0018130~heterocycle biosynthetic process,GO:0016567~protein ubiquitination,GO:0016070~RNA metabolic process,GO:0016032~viral process,GO:0010970~transport along microtubule,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010508~positive regulation of autophagy,GO:0010506~regulation of autophagy,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009896~positive regulation of catabolic process,GO:0009894~regulation of catabolic process,GO:0009893~positive regulation of metabolic process,GO:0009057~macromolecule catabolic process,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0007018~microtubule-based movement,GO:0007017~microtubule-based process,GO:0006955~immune response,GO:0006952~defense response,GO:0006928~movement of cell or subcellular component,GO:0006914~autophagy,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006508~proteolysis,GO:0006464~cellular protein modification process,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0000209~protein polyubiquitination,												GO:0005829~cytosol,GO:0005654~nucleoplasm,												GO:0061659~ubiquitin-like protein ligase activity,GO:0061630~ubiquitin protein ligase activity,GO:0046983~protein dimerization activity,GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0045505~dynein intermediate chain binding,GO:0045504~dynein heavy chain binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0042803~protein homodimerization activity,GO:0042802~identical protein binding,GO:0019901~protein kinase binding,GO:0019900~kinase binding,GO:0019899~enzyme binding,GO:0019787~ubiquitin-like protein transferase activity,GO:0008270~zinc ion binding,GO:0004842~ubiquitin-protein transferase activity,												IPR043136:B30.2/SPRY_sf,IPR042699:TRIM58_RING-HC,IPR035787:SPRY/PRY_TRIM58,IPR017907:Znf_RING_CS,IPR013320:ConA-like_dom_sf,IPR013083:Znf_RING/FYVE/PHD,IPR006574:PRY,IPR003879:Butyrophylin_SPRY,IPR003877:SPRY_dom,IPR001870:B30.2/SPRY,IPR001841:Znf_RING,IPR000315:Znf_B-box,															SM00589:PRY,SM00449:SPRY,SM00336:BBOX,SM00184:RING,												ZN_FING:RING-type,ZN_FING:B box-type,DOMAIN:B30.2/SPRY,
34629_at	tumor protein p53 inducible protein 11(TP53I11)	Homo sapiens			GO:0042127~regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008283~cell proliferation,														IPR028266:TP53I11,																TRANSMEM:Helical,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,REGION:Disordered,COMPBIAS:Polar residues,
1974_s_at	tumor protein p53(TP53)	Homo sapiens	99.NF-kB_activation,94.E2F_transcriptional_activity_cell_cycle,38.Cell_cycle_arrest_and_apoptosis_ceramide,157.14-3-3_Cell_Cycle,152.altered_synaptic_signalling-neurodegenerative_disorders,1.RBphosphoE2F,												h_tidPathway:Chaperones modulate interferon Signaling Pathway,h_tertPathway:Overview of telomerase protein component gene hTert Transcriptional Regulation ,h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,h_rnaPathway:Double Stranded RNA Induced Gene Expression,h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage,h_pmlPathway:Regulation of transcriptional activity by PML,h_plk3Pathway:Regulation of cell cycle progression by Plk3,h_p53Pathway:p53 Signaling Pathway,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_g2Pathway:Cell Cycle: G2/M Checkpoint,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_EfpPathway:Estrogen-responsive protein Efp controls cell cycle and breast tumors growth,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_btg2Pathway:BTG family proteins and cell cycle regulation,h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_atmPathway:ATM Signaling Pathway,h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,												GO:2001251~negative regulation of chromosome organization,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,GO:2001242~regulation of intrinsic apoptotic signaling pathway,GO:2001235~positive regulation of apoptotic signaling pathway,GO:2001233~regulation of apoptotic signaling pathway,GO:2001141~regulation of RNA biosynthetic process,GO:2001020~regulation of response to DNA damage stimulus,GO:2000774~positive regulation of cellular senescence,GO:2000772~regulation of cellular senescence,GO:2000647~negative regulation of stem cell proliferation,GO:2000379~positive regulation of reactive oxygen species metabolic process,GO:2000378~negative regulation of reactive oxygen species metabolic process,GO:2000377~regulation of reactive oxygen species metabolic process,GO:2000279~negative regulation of DNA biosynthetic process,GO:2000278~regulation of DNA biosynthetic process,GO:2000269~regulation of fibroblast apoptotic process,GO:2000178~negative regulation of neural precursor cell proliferation,GO:2000177~regulation of neural precursor cell proliferation,GO:2000144~positive regulation of DNA-templated transcription, initiation,GO:2000142~regulation of DNA-templated transcription, initiation,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000108~positive regulation of leukocyte apoptotic process,GO:2000106~regulation of leukocyte apoptotic process,GO:2000045~regulation of G1/S transition of mitotic cell cycle,GO:1990440~positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,GO:1990144~intrinsic apoptotic signaling pathway in response to hypoxia,GO:1905856~negative regulation of pentose-phosphate shunt,GO:1905710~positive regulation of membrane permeability,GO:1904357~negative regulation of telomere maintenance via telomere lengthening,GO:1904356~regulation of telomere maintenance via telomere lengthening,GO:1904024~negative regulation of glucose catabolic process to lactate via pyruvate,GO:1904023~regulation of glucose catabolic process to lactate via pyruvate,GO:1903845~negative regulation of cellular response to transforming growth factor beta stimulus,GO:1903844~regulation of cellular response to transforming growth factor beta stimulus,GO:1903799~negative regulation of production of miRNAs involved in gene silencing by miRNA,GO:1903798~regulation of production of miRNAs involved in gene silencing by miRNA,GO:1903579~negative regulation of ATP metabolic process,GO:1903578~regulation of ATP metabolic process,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903451~negative regulation of G1 to G0 transition,GO:1903450~regulation of G1 to G0 transition,GO:1903147~negative regulation of mitophagy,GO:1903146~regulation of mitophagy,GO:1903047~mitotic cell cycle process,GO:1903008~organelle disassembly,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1902893~regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1902807~negative regulation of cell cycle G1/S phase transition,GO:1902806~regulation of cell cycle G1/S phase transition,GO:1902749~regulation of cell cycle G2/M phase transition,GO:1902692~regulation of neuroblast proliferation,GO:1902689~negative regulation of NAD metabolic process,GO:1902688~regulation of NAD metabolic process,GO:1902680~positive regulation of RNA biosynthetic process,GO:1902679~negative regulation of RNA biosynthetic process,GO:1902593~single-organism nuclear import,GO:1902589~single-organism organelle organization,GO:1902582~single-organism intracellular transport,GO:1902580~single-organism cellular localization,GO:1902533~positive regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:1902403~signal transduction involved in mitotic DNA integrity checkpoint,GO:1902402~signal transduction involved in mitotic DNA damage checkpoint,GO:1902400~intracellular signal transduction involved in G1 DNA damage checkpoint,GO:1902253~regulation of intrinsic apoptotic signaling pathway by p53 class mediator,GO:1902108~regulation of mitochondrial membrane permeability involved in apoptotic process,GO:1902031~regulation of NADP metabolic process,GO:1901991~negative regulation of mitotic cell cycle phase transition,GO:1901990~regulation of mitotic cell cycle phase transition,GO:1901988~negative regulation of cell cycle phase transition,GO:1901987~regulation of cell cycle phase transition,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1901701~cellular response to oxygen-containing compound,GO:1901700~response to oxygen-containing compound,GO:1901699~cellular response to nitrogen compound,GO:1901698~response to nitrogen compound,GO:1901653~cellular response to peptide,GO:1901652~response to peptide,GO:1901615~organic hydroxy compound metabolic process,GO:1901566~organonitrogen compound biosynthetic process,GO:1901525~negative regulation of macromitophagy,GO:1901524~regulation of macromitophagy,GO:1901216~positive regulation of neuron death,GO:1901214~regulation of neuron death,GO:1901135~carbohydrate derivative metabolic process,GO:1901003~negative regulation of fermentation,GO:1900543~negative regulation of purine nucleotide metabolic process,GO:1900542~regulation of purine nucleotide metabolic process,GO:1900119~positive regulation of execution phase of apoptosis,GO:1900117~regulation of execution phase of apoptosis,GO:0098781~ncRNA transcription,GO:0097659~nucleic acid-templated transcription,GO:0097300~programmed necrotic cell death,GO:0097252~oligodendrocyte apoptotic process,GO:0097194~execution phase of apoptosis,GO:0097193~intrinsic apoptotic signaling pathway,GO:0097190~apoptotic signaling pathway,GO:0090559~regulation of membrane permeability,GO:0090403~oxidative stress-induced premature senescence,GO:0090400~stress-induced premature senescence,GO:0090399~replicative senescence,GO:0090398~cellular senescence,GO:0090343~positive regulation of cell aging,GO:0090342~regulation of cell aging,GO:0090288~negative regulation of cellular response to growth factor stimulus,GO:0090287~regulation of cellular response to growth factor stimulus,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:0090199~regulation of release of cytochrome c from mitochondria,GO:0090101~negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0090092~regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0090068~positive regulation of cell cycle process,GO:0080135~regulation of cellular response to stress,GO:0080134~regulation of response to stress,GO:0072717~cellular response to actinomycin D,GO:0072716~response to actinomycin D,GO:0072594~establishment of protein localization to organelle,GO:0072593~reactive oxygen species metabolic process,GO:0072524~pyridine-containing compound metabolic process,GO:0072521~purine-containing compound metabolic process,GO:0072431~signal transduction involved in mitotic G1 DNA damage checkpoint,GO:0072422~signal transduction involved in DNA damage checkpoint,GO:0072413~signal transduction involved in mitotic cell cycle checkpoint,GO:0072401~signal transduction involved in DNA integrity checkpoint,GO:0072395~signal transduction involved in cell cycle checkpoint,GO:0072359~circulatory system development,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:0072331~signal transduction by p53 class mediator,GO:0072091~regulation of stem cell proliferation,GO:0072089~stem cell proliferation,GO:0071897~DNA biosynthetic process,GO:0071887~leukocyte apoptotic process,GO:0071824~protein-DNA complex subunit organization,GO:0071822~protein complex subunit organization,GO:0071705~nitrogen compound transport,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0071559~response to transforming growth factor beta,GO:0071496~cellular response to external stimulus,GO:0071495~cellular response to endogenous stimulus,GO:0071494~cellular response to UV-C,GO:0071482~cellular response to light stimulus,GO:0071480~cellular response to gamma radiation,GO:0071479~cellular response to ionizing radiation,GO:0071478~cellular response to radiation,GO:0071466~cellular response to xenobiotic stimulus,GO:0071456~cellular response to hypoxia,GO:0071453~cellular response to oxygen levels,GO:0071417~cellular response to organonitrogen compound,GO:0071407~cellular response to organic cyclic compound,GO:0071363~cellular response to growth factor stimulus,GO:0071359~cellular response to dsRNA,GO:0071356~cellular response to tumor necrosis factor,GO:0071346~cellular response to interferon-gamma,GO:0071345~cellular response to cytokine stimulus,GO:0071310~cellular response to organic substance,GO:0071236~cellular response to antibiotic,GO:0071216~cellular response to biotic stimulus,GO:0071214~cellular response to abiotic stimulus,GO:0071158~positive regulation of cell cycle arrest,GO:0071156~regulation of cell cycle arrest,GO:0070997~neuron death,GO:0070920~regulation of production of small RNA involved in gene silencing by RNA,GO:0070918~production of small RNA involved in gene silencing by RNA,GO:0070897~DNA-templated transcriptional preinitiation complex assembly,GO:0070887~cellular response to chemical stimulus,GO:0070848~response to growth factor,GO:0070727~cellular macromolecule localization,GO:0070661~leukocyte proliferation,GO:0070482~response to oxygen levels,GO:0070314~G1 to G0 transition,GO:0070271~protein complex biogenesis,GO:0070266~necroptotic process,GO:0070265~necrotic cell death,GO:0070245~positive regulation of thymocyte apoptotic process,GO:0070243~regulation of thymocyte apoptotic process,GO:0070242~thymocyte apoptotic process,GO:0070234~positive regulation of T cell apoptotic process,GO:0070232~regulation of T cell apoptotic process,GO:0070231~T cell apoptotic process,GO:0070230~positive regulation of lymphocyte apoptotic process,GO:0070228~regulation of lymphocyte apoptotic process,GO:0070227~lymphocyte apoptotic process,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0065009~regulation of molecular function,GO:0065004~protein-DNA complex assembly,GO:0065003~macromolecular complex assembly,GO:0061726~mitochondrion disassembly,GO:0061614~pri-miRNA transcription from RNA polymerase II promoter,GO:0061351~neural precursor cell proliferation,GO:0061053~somite development,GO:0061024~membrane organization,GO:0060969~negative regulation of gene silencing,GO:0060968~regulation of gene silencing,GO:0060967~negative regulation of gene silencing by RNA,GO:0060966~regulation of gene silencing by RNA,GO:0060965~negative regulation of gene silencing by miRNA,GO:0060964~regulation of gene silencing by miRNA,GO:0060548~negative regulation of cell death,GO:0060429~epithelium development,GO:0060411~cardiac septum morphogenesis,GO:0060348~bone development,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0060322~head development,GO:0060284~regulation of cell development,GO:0060261~positive regulation of transcription initiation from RNA polymerase II promoter,GO:0060260~regulation of transcription initiation from RNA polymerase II promoter,GO:0060253~negative regulation of glial cell proliferation,GO:0060251~regulation of glial cell proliferation,GO:0060249~anatomical structure homeostasis,GO:0060218~hematopoietic stem cell differentiation,GO:0060149~negative regulation of posttranscriptional gene silencing,GO:0060147~regulation of posttranscriptional gene silencing,GO:0055114~oxidation-reduction process,GO:0055086~nucleobase-containing small molecule metabolic process,GO:0051974~negative regulation of telomerase activity,GO:0051972~regulation of telomerase activity,GO:0051961~negative regulation of nervous system development,GO:0051960~regulation of nervous system development,GO:0051726~regulation of cell cycle,GO:0051649~establishment of localization in cell,GO:0051641~cellular localization,GO:0051402~neuron apoptotic process,GO:0051348~negative regulation of transferase activity,GO:0051346~negative regulation of hydrolase activity,GO:0051338~regulation of transferase activity,GO:0051336~regulation of hydrolase activity,GO:0051276~chromosome organization,GO:0051262~protein tetramerization,GO:0051259~protein oligomerization,GO:0051254~positive regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051248~negative regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051241~negative regulation of multicellular organismal process,GO:0051198~negative regulation of coenzyme metabolic process,GO:0051196~regulation of coenzyme metabolic process,GO:0051195~negative regulation of cofactor metabolic process,GO:0051193~regulation of cofactor metabolic process,GO:0051186~cofactor metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051170~nuclear import,GO:0051169~nuclear transport,GO:0051156~glucose 6-phosphate metabolic process,GO:0051130~positive regulation of cellular component organization,GO:0051129~negative regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051123~RNA polymerase II transcriptional preinitiation complex assembly,GO:0051097~negative regulation of helicase activity,GO:0051095~regulation of helicase activity,GO:0051094~positive regulation of developmental process,GO:0051093~negative regulation of developmental process,GO:0051053~negative regulation of DNA metabolic process,GO:0051052~regulation of DNA metabolic process,GO:0050821~protein stabilization,GO:0050790~regulation of catalytic activity,GO:0050768~negative regulation of neurogenesis,GO:0050767~regulation of neurogenesis,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:0048863~stem cell differentiation,GO:0048699~generation of neurons,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048598~embryonic morphogenesis,GO:0048589~developmental growth,GO:0048585~negative regulation of response to stimulus,GO:0048584~positive regulation of response to stimulus,GO:0048568~embryonic organ development,GO:0048539~bone marrow development,GO:0048534~hematopoietic or lymphoid organ development,GO:0048512~circadian behavior,GO:0048511~rhythmic process,GO:0048468~cell development,GO:0048147~negative regulation of fibroblast proliferation,GO:0048145~regulation of fibroblast proliferation,GO:0048144~fibroblast proliferation,GO:0046907~intracellular transport,GO:0046902~regulation of mitochondrial membrane permeability,GO:0046677~response to antibiotic,GO:0046651~lymphocyte proliferation,GO:0046649~lymphocyte activation,GO:0046496~nicotinamide nucleotide metabolic process,GO:0046365~monosaccharide catabolic process,GO:0046034~ATP metabolic process,GO:0046031~ADP metabolic process,GO:0045980~negative regulation of nucleotide metabolic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045937~positive regulation of phosphate metabolic process,GO:0045936~negative regulation of phosphate metabolic process,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045930~negative regulation of mitotic cell cycle,GO:0045926~negative regulation of growth,GO:0045912~negative regulation of carbohydrate metabolic process,GO:0045899~positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,GO:0045898~regulation of RNA polymerase II transcriptional preinitiation complex assembly,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045861~negative regulation of proteolysis,GO:0045815~positive regulation of gene expression, epigenetic,GO:0045787~positive regulation of cell cycle,GO:0045786~negative regulation of cell cycle,GO:0045727~positive regulation of translation,GO:0045596~negative regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0045321~leukocyte activation,GO:0045184~establishment of protein localization,GO:0045165~cell fate commitment,GO:0045087~innate immune response,GO:0044843~cell cycle G1/S phase transition,GO:0044819~mitotic G1/S transition checkpoint,GO:0044802~single-organism membrane organization,GO:0044783~G1 DNA damage checkpoint,GO:0044774~mitotic DNA integrity checkpoint,GO:0044773~mitotic DNA damage checkpoint,GO:0044772~mitotic cell cycle phase transition,GO:0044770~cell cycle phase transition,GO:0044764~multi-organism cellular process,GO:0044744~protein targeting to nucleus,GO:0044724~single-organism carbohydrate catabolic process,GO:0044723~single-organism carbohydrate metabolic process,GO:0044712~single-organism catabolic process,GO:0044419~interspecies interaction between organisms,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044282~small molecule catabolic process,GO:0044275~cellular carbohydrate catabolic process,GO:0044262~cellular carbohydrate metabolic process,GO:0044092~negative regulation of molecular function,GO:0044089~positive regulation of cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044085~cellular component biogenesis,GO:0043933~macromolecular complex subunit organization,GO:0043620~regulation of DNA-templated transcription in response to stress,GO:0043618~regulation of transcription from RNA polymerase II promoter in response to stress,GO:0043604~amide biosynthetic process,GO:0043603~cellular amide metabolic process,GO:0043525~positive regulation of neuron apoptotic process,GO:0043523~regulation of neuron apoptotic process,GO:0043516~regulation of DNA damage response, signal transduction by p53 class mediator,GO:0043504~mitochondrial DNA repair,GO:0043471~regulation of cellular carbohydrate catabolic process,GO:0043470~regulation of carbohydrate catabolic process,GO:0043467~regulation of generation of precursor metabolites and energy,GO:0043465~regulation of fermentation,GO:0043456~regulation of pentose-phosphate shunt,GO:0043455~regulation of secondary metabolic process,GO:0043436~oxoacid metabolic process,GO:0043331~response to dsRNA,GO:0043254~regulation of protein complex assembly,GO:0043153~entrainment of circadian clock by photoperiod,GO:0043086~negative regulation of catalytic activity,GO:0043069~negative regulation of programmed cell death,GO:0043068~positive regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043043~peptide biosynthetic process,GO:0043009~chordate embryonic development,GO:0042981~regulation of apoptotic process,GO:0042886~amide transport,GO:0042772~DNA damage response, signal transduction resulting in transcription,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0042770~signal transduction in response to DNA damage,GO:0042752~regulation of circadian rhythm,GO:0042594~response to starvation,GO:0042592~homeostatic process,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0042149~cellular response to glucose starvation,GO:0042127~regulation of cell proliferation,GO:0042113~B cell activation,GO:0042110~T cell activation,GO:0042098~T cell proliferation,GO:0042063~gliogenesis,GO:0040029~regulation of gene expression, epigenetic,GO:0040008~regulation of growth,GO:0040007~growth,GO:0036294~cellular response to decreased oxygen levels,GO:0036293~response to decreased oxygen levels,GO:0036211~protein modification process,GO:0036003~positive regulation of transcription from RNA polymerase II promoter in response to stress,GO:0035794~positive regulation of mitochondrial membrane permeability,GO:0035556~intracellular signal transduction,GO:0035282~segmentation,GO:0035264~multicellular organism growth,GO:0035196~production of miRNAs involved in gene silencing by miRNA,GO:0035195~gene silencing by miRNA,GO:0035194~posttranscriptional gene silencing by RNA,GO:0034976~response to endoplasmic reticulum stress,GO:0034660~ncRNA metabolic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034644~cellular response to UV,GO:0034622~cellular macromolecular complex assembly,GO:0034613~cellular protein localization,GO:0034612~response to tumor necrosis factor,GO:0034599~cellular response to oxidative stress,GO:0034504~protein localization to nucleus,GO:0034349~glial cell apoptotic process,GO:0034341~response to interferon-gamma,GO:0034250~positive regulation of cellular amide metabolic process,GO:0034249~negative regulation of cellular amide metabolic process,GO:0034248~regulation of cellular amide metabolic process,GO:0034103~regulation of tissue remodeling,GO:0034097~response to cytokine,GO:0033554~cellular response to stress,GO:0033365~protein localization to organelle,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0033077~T cell differentiation in thymus,GO:0033044~regulation of chromosome organization,GO:0033043~regulation of organelle organization,GO:0033036~macromolecule localization,GO:0032943~mononuclear cell proliferation,GO:0032845~negative regulation of homeostatic process,GO:0032844~regulation of homeostatic process,GO:0032787~monocarboxylic acid metabolic process,GO:0032774~RNA biosynthetic process,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032211~negative regulation of telomere maintenance via telomerase,GO:0032210~regulation of telomere maintenance via telomerase,GO:0032205~negative regulation of telomere maintenance,GO:0032204~regulation of telomere maintenance,GO:0032200~telomere organization,GO:0032042~mitochondrial DNA metabolic process,GO:0031669~cellular response to nutrient levels,GO:0031668~cellular response to extracellular stimulus,GO:0031667~response to nutrient levels,GO:0031647~regulation of protein stability,GO:0031571~mitotic G1 DNA damage checkpoint,GO:0031570~DNA integrity checkpoint,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031334~positive regulation of protein complex assembly,GO:0031330~negative regulation of cellular catabolic process,GO:0031329~regulation of cellular catabolic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031324~negative regulation of cellular metabolic process,GO:0031050~dsRNA fragmentation,GO:0031047~gene silencing by RNA,GO:0030902~hindbrain development,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0030308~negative regulation of cell growth,GO:0030217~T cell differentiation,GO:0030183~B cell differentiation,GO:0030162~regulation of proteolysis,GO:0030098~lymphocyte differentiation,GO:0030097~hemopoiesis,GO:0023057~negative regulation of signaling,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0022607~cellular component assembly,GO:0022411~cellular component disassembly,GO:0022402~cell cycle process,GO:0022037~metencephalon development,GO:0022008~neurogenesis,GO:0021549~cerebellum development,GO:0019752~carboxylic acid metabolic process,GO:0019748~secondary metabolic process,GO:0019693~ribose phosphate metabolic process,GO:0019682~glyceraldehyde-3-phosphate metabolic process,GO:0019674~NAD metabolic process,GO:0019661~glucose catabolic process to lactate via pyruvate,GO:0019660~glycolytic fermentation,GO:0019659~glucose catabolic process to lactate,GO:0019637~organophosphate metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0019362~pyridine nucleotide metabolic process,GO:0019320~hexose catabolic process,GO:0019318~hexose metabolic process,GO:0019221~cytokine-mediated signaling pathway,GO:0019220~regulation of phosphate metabolic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018212~peptidyl-tyrosine modification,GO:0018193~peptidyl-amino acid modification,GO:0018130~heterocycle biosynthetic process,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0017148~negative regulation of translation,GO:0017038~protein import,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0016458~gene silencing,GO:0016441~posttranscriptional gene silencing,GO:0016310~phosphorylation,GO:0016242~negative regulation of macroautophagy,GO:0016241~regulation of macroautophagy,GO:0016236~macroautophagy,GO:0016072~rRNA metabolic process,GO:0016071~mRNA metabolic process,GO:0016070~RNA metabolic process,GO:0016052~carbohydrate catabolic process,GO:0016049~cell growth,GO:0016032~viral process,GO:0015980~energy derivation by oxidation of organic compounds,GO:0015833~peptide transport,GO:0015031~protein transport,GO:0014070~response to organic cyclic compound,GO:0014014~negative regulation of gliogenesis,GO:0014013~regulation of gliogenesis,GO:0014009~glial cell proliferation,GO:0012501~programmed cell death,GO:0010948~negative regulation of cell cycle process,GO:0010942~positive regulation of cell death,GO:0010941~regulation of cell death,GO:0010906~regulation of glucose metabolic process,GO:0010833~telomere maintenance via telomere lengthening,GO:0010823~negative regulation of mitochondrion organization,GO:0010822~positive regulation of mitochondrion organization,GO:0010821~regulation of mitochondrion organization,GO:0010721~negative regulation of cell development,GO:0010675~regulation of cellular carbohydrate metabolic process,GO:0010666~positive regulation of cardiac muscle cell apoptotic process,GO:0010665~regulation of cardiac muscle cell apoptotic process,GO:0010663~positive regulation of striated muscle cell apoptotic process,GO:0010662~regulation of striated muscle cell apoptotic process,GO:0010661~positive regulation of muscle cell apoptotic process,GO:0010660~regulation of muscle cell apoptotic process,GO:0010659~cardiac muscle cell apoptotic process,GO:0010658~striated muscle cell apoptotic process,GO:0010657~muscle cell apoptotic process,GO:0010648~negative regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010639~negative regulation of organelle organization,GO:0010638~positive regulation of organelle organization,GO:0010629~negative regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010608~posttranscriptional regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010564~regulation of cell cycle process,GO:0010563~negative regulation of phosphorus metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010507~negative regulation of autophagy,GO:0010506~regulation of autophagy,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010332~response to gamma radiation,GO:0010259~multicellular organism aging,GO:0010243~response to organonitrogen compound,GO:0010225~response to UV-C,GO:0010212~response to ionizing radiation,GO:0010165~response to X-ray,GO:0010035~response to inorganic substance,GO:0010033~response to organic substance,GO:0009991~response to extracellular stimulus,GO:0009968~negative regulation of signal transduction,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009952~anterior/posterior pattern specification,GO:0009895~negative regulation of catabolic process,GO:0009894~regulation of catabolic process,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0009891~positive regulation of biosynthetic process,GO:0009890~negative regulation of biosynthetic process,GO:0009887~animal organ morphogenesis,GO:0009792~embryo development ending in birth or egg hatching,GO:0009790~embryo development,GO:0009719~response to endogenous stimulus,GO:0009651~response to salt stress,GO:0009649~entrainment of circadian clock,GO:0009648~photoperiodism,GO:0009628~response to abiotic stimulus,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0009416~response to light stimulus,GO:0009411~response to UV,GO:0009410~response to xenobiotic stimulus,GO:0009314~response to radiation,GO:0009303~rRNA transcription,GO:0009299~mRNA transcription,GO:0009267~cellular response to starvation,GO:0009259~ribonucleotide metabolic process,GO:0009205~purine ribonucleoside triphosphate metabolic process,GO:0009199~ribonucleoside triphosphate metabolic process,GO:0009185~ribonucleoside diphosphate metabolic process,GO:0009179~purine ribonucleoside diphosphate metabolic process,GO:0009167~purine ribonucleoside monophosphate metabolic process,GO:0009161~ribonucleoside monophosphate metabolic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009144~purine nucleoside triphosphate metabolic process,GO:0009141~nucleoside triphosphate metabolic process,GO:0009135~purine nucleoside diphosphate metabolic process,GO:0009132~nucleoside diphosphate metabolic process,GO:0009126~purine nucleoside monophosphate metabolic process,GO:0009123~nucleoside monophosphate metabolic process,GO:0009117~nucleotide metabolic process,GO:0008637~apoptotic mitochondrial changes,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008340~determination of adult lifespan,GO:0008285~negative regulation of cell proliferation,GO:0008283~cell proliferation,GO:0008219~cell death,GO:0008156~negative regulation of DNA replication,GO:0008104~protein localization,GO:0007623~circadian rhythm,GO:0007622~rhythmic behavior,GO:0007610~behavior,GO:0007569~cell aging,GO:0007568~aging,GO:0007507~heart development,GO:0007420~brain development,GO:0007417~central nervous system development,GO:0007406~negative regulation of neuroblast proliferation,GO:0007405~neuroblast proliferation,GO:0007399~nervous system development,GO:0007389~pattern specification process,GO:0007369~gastrulation,GO:0007346~regulation of mitotic cell cycle,GO:0007265~Ras protein signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007178~transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0007093~mitotic cell cycle checkpoint,GO:0007050~cell cycle arrest,GO:0007049~cell cycle,GO:0007006~mitochondrial membrane organization,GO:0007005~mitochondrion organization,GO:0007004~telomere maintenance via telomerase,GO:0006984~ER-nucleus signaling pathway,GO:0006983~ER overload response,GO:0006979~response to oxidative stress,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0006974~cellular response to DNA damage stimulus,GO:0006970~response to osmotic stress,GO:0006955~immune response,GO:0006952~defense response,GO:0006915~apoptotic process,GO:0006914~autophagy,GO:0006913~nucleocytoplasmic transport,GO:0006886~intracellular protein transport,GO:0006839~mitochondrial transport,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006753~nucleoside phosphate metabolic process,GO:0006739~NADP metabolic process,GO:0006734~NADH metabolic process,GO:0006733~oxidoreduction coenzyme metabolic process,GO:0006732~coenzyme metabolic process,GO:0006606~protein import into nucleus,GO:0006605~protein targeting,GO:0006518~peptide metabolic process,GO:0006508~proteolysis,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0006461~protein complex assembly,GO:0006417~regulation of translation,GO:0006412~translation,GO:0006396~RNA processing,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006352~DNA-templated transcription, initiation,GO:0006351~transcription, DNA-templated,GO:0006302~double-strand break repair,GO:0006289~nucleotide-excision repair,GO:0006281~DNA repair,GO:0006278~RNA-dependent DNA biosynthetic process,GO:0006275~regulation of DNA replication,GO:0006260~DNA replication,GO:0006259~DNA metabolic process,GO:0006163~purine nucleotide metabolic process,GO:0006140~regulation of nucleotide metabolic process,GO:0006113~fermentation,GO:0006109~regulation of carbohydrate metabolic process,GO:0006098~pentose-phosphate shunt,GO:0006091~generation of precursor metabolites and energy,GO:0006090~pyruvate metabolic process,GO:0006089~lactate metabolic process,GO:0006082~organic acid metabolic process,GO:0006081~cellular aldehyde metabolic process,GO:0006007~glucose catabolic process,GO:0006006~glucose metabolic process,GO:0005996~monosaccharide metabolic process,GO:0005975~carbohydrate metabolic process,GO:0003279~cardiac septum development,GO:0003206~cardiac chamber morphogenesis,GO:0003205~cardiac chamber development,GO:0003007~heart morphogenesis,GO:0003002~regionalization,GO:0002931~response to ischemia,GO:0002521~leukocyte differentiation,GO:0002520~immune system development,GO:0002366~leukocyte activation involved in immune response,GO:0002360~T cell lineage commitment,GO:0002326~B cell lineage commitment,GO:0002309~T cell proliferation involved in immune response,GO:0002286~T cell activation involved in immune response,GO:0002285~lymphocyte activation involved in immune response,GO:0002263~cell activation involved in immune response,GO:0002252~immune effector process,GO:0002244~hematopoietic progenitor cell differentiation,GO:0001934~positive regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,GO:0001836~release of cytochrome c from mitochondria,GO:0001775~cell activation,GO:0001756~somitogenesis,GO:0001701~in utero embryonic development,GO:0001666~response to hypoxia,GO:0001558~regulation of cell growth,GO:0001501~skeletal system development,GO:0000723~telomere maintenance,GO:0000423~macromitophagy,GO:0000422~mitophagy,GO:0000278~mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000077~DNA damage checkpoint,GO:0000075~cell cycle checkpoint,GO:0000002~mitochondrial genome maintenance,												GO:0090734~site of DNA damage,GO:0044451~nucleoplasm part,GO:0044429~mitochondrial part,GO:0044427~chromosomal part,GO:0043073~germ cell nucleus,GO:0035861~site of double-strand break,GO:0034399~nuclear periphery,GO:0017053~transcriptional repressor complex,GO:0016605~PML body,GO:0016604~nuclear body,GO:0016363~nuclear matrix,GO:0015630~microtubule cytoskeleton,GO:0005829~cytosol,GO:0005815~microtubule organizing center,GO:0005813~centrosome,GO:0005783~endoplasmic reticulum,GO:0005759~mitochondrial matrix,GO:0005739~mitochondrion,GO:0005730~nucleolus,GO:0005694~chromosome,GO:0005667~transcription factor complex,GO:0005657~replication fork,GO:0005654~nucleoplasm,GO:0000785~chromatin,												GO:1990841~promoter-specific chromatin binding,GO:1990837~sequence-specific double-stranded DNA binding,GO:1990782~protein tyrosine kinase binding,GO:1901363~heterocyclic compound binding,GO:0098772~molecular function regulator,GO:0097718~disordered domain specific binding,GO:0097617~annealing activity,GO:0097371~MDM2/MDM4 family protein binding,GO:0097159~organic cyclic compound binding,GO:0071889~14-3-3 protein binding,GO:0061629~RNA polymerase II sequence-specific DNA binding transcription factor binding,GO:0051721~protein phosphatase 2A binding,GO:0051087~chaperone binding,GO:0046983~protein dimerization activity,GO:0046982~protein heterodimerization activity,GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0044389~ubiquitin-like protein ligase binding,GO:0044212~transcription regulatory region DNA binding,GO:0043621~protein self-association,GO:0043565~sequence-specific DNA binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0042826~histone deacetylase binding,GO:0042802~identical protein binding,GO:0036310~annealing helicase activity,GO:0035033~histone deacetylase regulator activity,GO:0031625~ubiquitin protein ligase binding,GO:0030971~receptor tyrosine kinase binding,GO:0030234~enzyme regulator activity,GO:0019904~protein domain specific binding,GO:0019903~protein phosphatase binding,GO:0019902~phosphatase binding,GO:0019901~protein kinase binding,GO:0019900~kinase binding,GO:0019899~enzyme binding,GO:0017111~nucleoside-triphosphatase activity,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0016462~pyrophosphatase activity,GO:0008270~zinc ion binding,GO:0008134~transcription factor binding,GO:0005507~copper ion binding,GO:0005102~receptor binding,GO:0003730~mRNA 3'-UTR binding,GO:0003729~mRNA binding,GO:0003723~RNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003690~double-stranded DNA binding,GO:0003682~chromatin binding,GO:0003677~DNA binding,GO:0003676~nucleic acid binding,GO:0002039~p53 binding,GO:0002020~protease binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001159~core promoter proximal region DNA binding,GO:0001099~basal RNA polymerase II transcription machinery binding,GO:0001098~basal transcription machinery binding,GO:0001094~TFIID-class transcription factor binding,GO:0001091~RNA polymerase II basal transcription factor binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001071~nucleic acid binding transcription factor activity,GO:0001067~regulatory region nucleic acid binding,GO:0001047~core promoter binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001012~RNA polymerase II regulatory region DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000975~regulatory region DNA binding,												IPR040926:p53_TAD2,IPR036674:p53_tetramer_sf,IPR015155:PFU,IPR013872:p53_transactivation_domain,IPR012346:p53/RUNT-type_TF_DNA-bd_sf,IPR011615:p53_DNA-bd,IPR010991:p53_tetrameristn,IPR008967:p53-like_TF_DNA-bd_sf,IPR002117:p53_tumour_suppressor,												hsa05418:Fluid shear stress and atherosclerosis,hsa05417:Lipid and atherosclerosis,hsa05230:Central carbon metabolism in cancer,hsa05226:Gastric cancer,hsa05225:Hepatocellular carcinoma,hsa05224:Breast cancer,hsa05223:Non-small cell lung cancer,hsa05222:Small cell lung cancer,hsa05220:Chronic myeloid leukemia,hsa05219:Bladder cancer,hsa05218:Melanoma,hsa05217:Basal cell carcinoma,hsa05216:Thyroid cancer,hsa05215:Prostate cancer,hsa05214:Glioma,hsa05213:Endometrial cancer,hsa05212:Pancreatic cancer,hsa05210:Colorectal cancer,hsa05206:MicroRNAs in cancer,hsa05205:Proteoglycans in cancer,hsa05203:Viral carcinogenesis,hsa05202:Transcriptional misregulation in cancer,hsa05200:Pathways in cancer,hsa05169:Epstein-Barr virus infection,hsa05168:Herpes simplex virus 1 infection,hsa05167:Kaposi sarcoma-associated herpesvirus infection,hsa05166:Human T-cell leukemia virus 1 infection,hsa05165:Human papillomavirus infection,hsa05163:Human cytomegalovirus infection,hsa05162:Measles,hsa05161:Hepatitis B,hsa05160:Hepatitis C,hsa05131:Shigellosis,hsa05016:Huntington disease,hsa05014:Amyotrophic lateral sclerosis,hsa05012:Parkinson disease,hsa04919:Thyroid hormone signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04310:Wnt signaling pathway,hsa04218:Cellular senescence,hsa04216:Ferroptosis,hsa04211:Longevity regulating pathway,hsa04210:Apoptosis,hsa04151:PI3K-Akt signaling pathway,hsa04137:Mitophagy - animal,hsa04115:p53 signaling pathway,hsa04110:Cell cycle,hsa04071:Sphingolipid signaling pathway,hsa04010:MAPK signaling pathway,hsa01524:Platinum drug resistance,hsa01522:Endocrine resistance,												Pancreatic cancer, somatic 260350~Pancreatic cancer, somatic 260350,618165~Bone marrow failure syndrome 5,614740~Basal cell carcinoma 7,607107~Nasopharyngeal carcinoma, somatic,260500~Choroid plexus papilloma,259500~Osteosarcoma,202300~Adrenocortical carcinoma, pediatric,151623~Li-Fraumeni syndrome,137800~Glioma susceptibility 1,114550~Hepatocellular carcinoma, somatic,114500~Colorectal cancer,114480~Breast cancer, somatic,														TRANSMEM:Helical,SITE:Interaction with DNA,REGION:Transcription activation (acidic),REGION:Required for interaction with ZNF385A,REGION:Required for interaction with FBXO42,REGION:Oligomerization,REGION:Interaction with the 53BP2 SH3 domain,REGION:Interaction with WWOX,REGION:Interaction with USP7,REGION:Interaction with MORN3,REGION:Interaction with HRMT1L2,REGION:Interaction with HIPK2,REGION:Interaction with HIPK1,REGION:Interaction with E4F1,REGION:Interaction with DNA,REGION:Interaction with CCAR2,REGION:Interaction with CARM1,REGION:Interaction with AXIN1,REGION:Disordered,REGION:Basic (repression of DNA-binding),MUTAGEN:T->E: Inhibits strongly its transcriptional activity.,MUTAGEN:T->A: No effect on interaction with MDM2 and increase in protein levels after DNA damage.,MUTAGEN:T->A: No effect SUMO1 conjugation.,MUTAGEN:T->A: Blocks phosphorylation by TAF1.,MUTAGEN:S->E: Inhibits strongly its transcriptional activity.,MUTAGEN:S->E: Inhibits slightly its transcriptional activity.,MUTAGEN:S->D: Constitutively increased TP53 protein levels.,MUTAGEN:S->D: Abolishes phosphorylation by MAPKAPK5.,MUTAGEN:S->A: Loss of interaction with PPP2R5C, PPP2CA AND PPP2R1A.,MUTAGEN:S->A: Abolishes strongly phosphorylation.,MUTAGEN:S->A: Abolishes phosphorylation.,MUTAGEN:S->A: Abolishes phosphorylation site. Abolishes increase in protein levels after DNA damage.,MUTAGEN:S->A: Abolishes phosphorylation by DYRK2 and HIPK2 and acetylation of K-382 by CREBBP.,MUTAGEN:S->A: Abolishes binding to USP7.,MUTAGEN:RGRER->KGKEK: Reduced methylation by PRMT5. Reduced nuclear localization. Decreased binding to promoters of target genes. Reduced transcriptional activity. Decrease in cell cycle arrest.,MUTAGEN:R->S: Does not induce SNAI1 degradation.,MUTAGEN:P->D: Abolishes binding to USP7.,MUTAGEN:Missing: Alters interaction with WWOX.,MUTAGEN:LW->QS: Loss of interaction with MDM2, leading to constitutively increased TP53 protein levels.,MUTAGEN:L->A: Abolishes S-315 phosphorylation by CDK2/cyclin A.,MUTAGEN:KK->RR: Abolishes polyubiquitination by MKRN1.,MUTAGEN:K->R: Induces a decrease in protein stabilization.,MUTAGEN:K->R: Induces a decrease in methylation by SMYD2.,MUTAGEN:K->R: Decreased acetylation.,MUTAGEN:K->R: Abolishes ubiquitination by MUL1.,MUTAGEN:K->R: Abolishes monomethylation by KMT5A.,MUTAGEN:K->R: Abolishes dimethylation by EHMT1 and EHMT2.,MUTAGEN:K->Q: Mimics acetylation, leading to increased stability.,MUTAGEN:K->A: Loss of nuclear localization; when associated with A-320 and A-321.,MUTAGEN:K->A: Loss of nuclear localization; when associated with A-319 and A-321.,MUTAGEN:K->A: Loss of nuclear localization; when associated with A-319 and A-320.,MUTAGEN:K->A: Abolishes acetylation by CREBBP.,MUTAGEN:K->A: Abolishes SUMO1 conjugation, in vitro and in vivo.,MUTAGEN:G->E: Abolishes binding to USP7.,MUTAGEN:F->A: Reduced SUMO1 conjugation.,MUTAGEN:E->A: Abolishes SUMO1 conjugation.,MOTIF:[KR]-[STA]-K motif,MOTIF:TADII,MOTIF:TADI,MOTIF:Nuclear export signal,MOTIF:Bipartite nuclear localization signal,DOMAIN:p53 transactivation,DOMAIN:p53 tetramerisation,DOMAIN:p53 DNA-binding,DOMAIN:PFU,DOMAIN:Cellular tumor antigen p53 transactivation,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),COMPBIAS:Pro residues,COMPBIAS:Polar residues,COMPBIAS:Basic residues,COMPBIAS:Basic and acidic residues,
36378_at	uroplakin 1A(UPK1A)	Homo sapiens			GO:0060429~epithelium development,GO:0030855~epithelial cell differentiation,												GO:1903561~extracellular vesicle,GO:0120001~apical plasma membrane urothelial plaque,GO:0098590~plasma membrane region,GO:0070062~extracellular exosome,GO:0045177~apical part of cell,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0031226~intrinsic component of plasma membrane,GO:0016324~apical plasma membrane,GO:0009986~cell surface,GO:0005887~integral component of plasma membrane,GO:0005783~endoplasmic reticulum,GO:0005576~extracellular region,													IPR018499:Tetraspanin/Peripherin,IPR008952:Tetraspanin_EC2_sf,IPR000301:Tetraspanin_animals,														PIRSF002419:Tetraspanin,													TRANSMEM:Helical,TOPO_DOM:Extracellular,TOPO_DOM:Cytoplasmic,CARBOHYD:N-linked (GlcNAc...) asparagine,
35566_f_at	zinc finger CW-type and PWWP domain containing 2(ZCWPW2)	Homo sapiens					GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0042393~histone binding,GO:0035064~methylated histone binding,GO:0008270~zinc ion binding,												IPR042778:ZCWPW1/ZCWPW2,IPR011124:Znf_CW,IPR000313:PWWP_dom,																ZN_FING:CW-type,REGION:Disordered,MUTAGEN:W->P: Loss of histone H3K4me3 binding.,MUTAGEN:W->M: Loss of histone H3K4me3 binding; when associated with F-41.,MUTAGEN:W->L: Loss of histone H3K4me3 binding; when associated with F-41.,MUTAGEN:W->F: Significantly reduced histone H3K4me3 binding. Loss of histone H3K4me3 binding; when associated with L-30 or M-30.,MUTAGEN:W->C,D,E,H,K,R: Significantly reduced histone H3K4me3 binding.,MUTAGEN:W->A,V,L,M,G,S,T,N,Q: Reduced histone H3K4me3 binding.,MUTAGEN:Missing: Little effect on histone H3K4me3 binding.,MUTAGEN:F->S,I,P,D,E,H,R,Q: Little effect on histone H3K4me3 binding.,DOMAIN:PWWP,DOMAIN:CW-type,COMPBIAS:Basic and acidic residues,
41113_at	zinc finger protein 500(ZNF500)	Homo sapiens			GO:2001141~regulation of RNA biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1903506~regulation of nucleic acid-templated transcription,GO:0097659~nucleic acid-templated transcription,GO:0051252~regulation of RNA metabolic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016070~RNA metabolic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,													GO:1990837~sequence-specific double-stranded DNA binding,GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0046872~metal ion binding,GO:0044212~transcription regulatory region DNA binding,GO:0043565~sequence-specific DNA binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003690~double-stranded DNA binding,GO:0003677~DNA binding,GO:0003676~nucleic acid binding,GO:0001159~core promoter proximal region DNA binding,GO:0001071~nucleic acid binding transcription factor activity,GO:0001067~regulatory region nucleic acid binding,GO:0001012~RNA polymerase II regulatory region DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000975~regulatory region DNA binding,												IPR038269:SCAN_sf,IPR036236:Znf_C2H2_sf,IPR036051:KRAB_dom_sf,IPR013087:Znf_C2H2_type,IPR003309:SCAN_dom,IPR001909:KRAB,															SM00431:SCAN,SM00355:ZnF_C2H2,												ZN_FING:C2H2-type 5,ZN_FING:C2H2-type 4,ZN_FING:C2H2-type 3,ZN_FING:C2H2-type 2,ZN_FING:C2H2-type 1,REGION:Disordered,DOMAIN:SCAN box,DOMAIN:KRAB,DOMAIN:C2H2-type,COMPBIAS:Polar residues,